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Abstract 
 
Sepsis and multi-organ failure are the most frequently reported causes of death in 
burn injuries. Their early identification allows therapies and resources to be targeted 
in a more effective and efficient way. Due to its frequent antibiotic drug resistance 
Acinetobacter baumannii  (MRAB) is increasingly causing a problem in burns units. 
New strategies need to be found to combat infection and sepsis in the burn ICU.  
This study examines the potential of the Albumin Creatinine Ratio, a marker of 
systemic endothelial dysfunction in predicting outcomes, sepsis and multi-organ 
failure; the role of Acinetobacter in causing organ failure; and explores for the 
presence of the cathelicidin, LL-37 in the burn wound and examines it potential utility 
for treating infection and sepsis. 
It was found that ACR on admission and at 48 hours is predictive of patient outcomes 
and the development of sepsis, and may be of use predicting multi-organ failure. 
Multi-organ failure occurs more frequently in MRAB patients compared to those 
patients with drug sensitive Acinetobacter baumannii. The number of agency nursing 
staff and work intensity are possible contributing factors in MRAB acquisition. LL-37 
has been found in both acute burn wounds as well as in the grafted healing burn 
wound and is active against drug resistant Acinetobacter baumannii.  
ACR can therefore identify those patients at risk of sepsis and may have a role in 
predicting multi-organ failure. 
MRAB acquisition in the burns intensive care unit is a significant cause for concern 
as patients are more likely to suffer from multi-organ failure as well as prolonging 
their hospital stay and resulting in poorer outcomes. 
LL-37 has many functions and importantly plays a role in the body’s innate immune 
system. In the era of increasing antibiotic resistance it may provide a novel 
therapeutic role in treating MRAB infection. 
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Chapter 1 Burn injuries and treatment- an overview  
   
1.1 Introduction 
Until a few hundred years ago fire was considered one of the four main 
ingredients from which all other substances could be formed. This hypothesis has 
long since been debunked but it is without doubt that fire and the ability to tame 
it has been key to the evolution and development of man. 
Man has used fire for around a million years, from the time of Homo erectus, 
man’s predecessor, and it is safe to assume that burns have been sustained from 
this time. 
Until relatively recently, few statistics were gathered about the nature or extent 
of burns sustained and most reports of fires, such as the Great Fire of London, 
centred their attention on the number of buildings destroyed rather than the 
number of deaths and certainly little if any mention was made of non lethal 
injury. 
In recent years the information regarding burns and scalds has been collected in a 
more systematic and thorough way.  The government publish yearly figures for 
the number of scalds and burns in the UK (Mortality Statistics, Accidents and 
Violence http://www.statistics.gov.uk/hub/population/deaths/mortality-rates) and 
the general trend has been a reduction in the number of deaths over the last 40 
years. Deaths attributable to fires (even if the death occurred weeks or months 
later) number between 400-500 per annum (United Kingdom Fire Statistics 2008, 
www.communities.gov.uk) with the majority being house fires. 
Most burns units collect their own data and the minimal information would 
include age, sex, cause and extent of injury, type of burn, time of accident and 
time between injury and hospital assessment or admission, 1st aid and treatment 
prior to formal assessment, family size, socio/marital status. An appreciation of 
these factors is essential to directing burn care and especially burn prevention 
programmes.  
A variety of burns units have looked at their data in more detail and the types of 
burns and ages of patients affected. Despite local differences the results are 
broadly similar when comparing units in different parts of the world. For 
instance, looking at a specific group, scald burns accounted for 65.7% of the total 
 22 
number of children treated for burns in a study in the USA (Drago 2005). A 10-
year retrospective study in India showed similar results with 63.1% of burns in 
the paediatric population being due to scalds (Kumar et al., 2001) and in the UK 
figures for paediatric scalds attending an emergency department were 51% 
(Rawlins et al., 2007). In general children are more likely to suffer scalds and 
adults, flame related injuries. 
The treatment and management of burns has certainly been advanced and driven 
by a variety of factors. These include increasing industrialisation which increased 
the number of work related incidents, including flame, scald and chemical; and 
secondly, within the last century, major world wars which meant large numbers 
of casualties attending hospitals at one time. In combination with advances in 
other fields’ i.e. microbiology, anaesthesia and surgery, post war burn care has 
made great leaps in understanding the nature of the injuries, the healing process 
and the ability to return function and cosmetic appearance to the patients. 
The last 30 years have seen a new age in burns care and research as the scientific 
advances are being translated to the clinical setting. There is still much to be 
learnt however, in the prevention, treatment and rehabilitation of burn injuries.        
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1.1.2 Skin Pathophysiology 
 
Normal skin Anatomy 
The skin is one of the largest organs in the body ranging from 0.025 m2 in the 
newborn to 1.8 m2 in the adult (Arturson 1996 B) it comprises 16% of body 
weight (Gawkrodger 2002). The skin consists of two layers; the epidermis and 
dermis. The epidermis ranges in depth from 0.05 mm thick (eyelids) to over 
1mm thick on the soles of the feet; and the dermis is usually 10 times thicker 
than the associated epidermis. An average total skin depth is 1-2mm (Williams 
2001). 
Skin is thin in infants and increases in adults to the ages of between 30-40 years 
old whereupon it tends to decrease with age. 
 
Figure 1.0 A schematic cross-section of the skin showing the layers of the skin 
and structures found within the skin (http://www.mydr.com). 
 
Skin Development 
Epidermis 
The epidermis originating from ectoderm is formed of stratified squamous 
epithelium; it is mainly composed of keratinocytes and is arranged in four layers: 
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stratum corneum (or five layers if the stratum lucidum, found only in the palms 
and soles is counted), stratum granulosum, stratum spinosum and stratum basale. 
The basal layer is the deepest layer and rests on the basement membrane, which 
attaches it to the dermis. It consists mostly of young keratinocytes that are 
mitotically active, as well as melanocytes (5-10% of the basal cell population) 
and infrequently, merkel cells. It is a single layer of columnar cells, the basal 
surfaces of which sprout fine processes and hemi desmosomes, anchoring them 
to the lamina densa of the basement membrane. From the basal layer, cells 
migrate up and outwards maturing to become the stratum spinosum; a layer 
where mitosis no longer occurs but protein synthesis is prominent (Williams 
2001). Langerhans cells are mostly found in this layer. The next layer of 
maturation is the stratum granulosum in which keratin production is prominent. 
It can be seen that cells become flattened and lose their nuclei. The last layer of 
keratinocyte maturation is the stratum corneum, a dead layer of cells composed 
of keratin and cellular debris. This is a relatively impervious layer that eventually 
desquamates.  
 
Dermis 
The dermis is derived from the mesoderm and is comprised of fibrous connective 
tissue containing specialized structures. The main cell type is the fibroblast, 
which produces extracellular protein, primarily collagen and elastin. Collagen 
makes up 70% of the dermis. It is secreted into the extracellular matrix where it 
undergoes maturation (cross-linking and coiling) into strong fibres oriented so as 
to allow stretchability whilst providing tensile strength (Herndon 2002). 
Elastin fibres are loosely arranged in all directions of the skin and provide 
elasticity and an element of resting tension in the skin. 
There is a constant turnover (degradation, re-modelling and production of 
collagen) of these elements. This occurs at a lower rate in unstressed skin but at a 
higher rate when healing is occurring or chronic mechanical stresses are applied. 
The extracellular matrix, or ground substance, of the skin is made up of 
glycoaminoglycans, proteoglycans and other macromolecules; it provides a semi 
fluid matrix that lubricates the cellular and fibrillar components. It is through the 
ground substance that cells including inflammatory cells migrate, and nutrients 
diffuse. 
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The dermis is divided into 2 main layers, the superficial papillary dermis which 
interdigitates with the epidermal rete ridges and the thicker reticular dermis. A 
large plexus of vessels beneath the dermis, known as the sub-dermal plexus 
sends vessels upward to form a plexus between the reticular and papillary 
dermis. More superficially, there lies a network of small vessels, the papillary 
plexus. The dermis also contains hair follicles, sweat glands, lymphatics and 
open-ended nerve fibres (Arturson 1996 B).  It is from some of the adnexal 
structures that re-epithelialisation occurs in superficial burns. 
At the dermo-epidermal junction exists the basement membrane, a layer 
composed of mucopolysaccarides, which is also rich in fibronectin. Cells of the 
basal epidermal layer are joined to the basement membrane by hemidesmosomes. 
The basement membrane is anchored to the dermis with the help of special 
fibrils. (Herndon 2002)   
    
Skin Function 
Protective-barrier. 
The stratum corneum is an effective barrier to the penetration of external agents, 
its structural integrity also protects against invasion by microorganisms. Barrier 
function is compromised when the stratum corneum is removed i.e. skin disease 
or injury. Penetration of a substance through the epidermis is indirectly 
proportional to the thickness of the stratum corneum and directly proportional to 
its concentration difference across the barrier layer (Hunter 2002). A rise in skin 
temperature aids penetration (Hunter 2002).  
As previously mentioned, melanocytes are found interspersed between the 
keratinocytes in the basal layer. Melanocytes are dendritic cells, derived from the 
neural crest, which are responsible for melanin pigment production. The main 
stimulus to melanin production is ultraviolet radiation. Melanin protects the cell 
nuclei in the epidermis from the harmful effects of ultraviolet (UV) radiation. 
 
The Protective/Immunological Role of Skin 
The skin may be defined as an immunological organ as it contains nearly all the 
elements of cellular immunity (with the exception of B cells which are not found 
in normal skin but are in some disease states). The epidermal barrier can be 
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considered an example of innate immunity since the majority of microorganisms 
that have contact with the skin do not penetrate it (Lawrence 1996). The profuse 
blood supply and lymphatics to the dermis provide conduits through which 
immune cells can pass to or from their site of action. 
The next immunological aspects of the skin to consider are the cells. 
Keratinocytes function as the first line of defence; as well as providing a physical 
barrier they are immune cells in their own right.  As such, they produce a number 
of cytokines and on their surface express intracellular adhesion molecules (ie 
ICAM-1) and immune reactive molecules (ie MHC class II antigens) as well as 
preparing external antigens for presentation to T lymphocytes which then mount 
an immune response. 
Keratinocytes also store the antimicrobial peptide cathelicidin,  (a peptide 
involved in immune defense that is part of the innate immune system) in lamellar 
bodies (Braff et al., 2005) as well as the defensins and a range of other 
antimicrobial peptides that help protect the skin from bacterial invasion. 
Langerhans cells found in skin are dendritic cells derived from the bone marrow; 
they play a role in antigen presentation. 
T lymphocytes can circulate through normal skin. Different T lymphocytes 
perform different functions i.e. helper cells, cytotoxic T cells and suppressor 
cells. Mast cells, like macrophages, are resident in the dermis and are recruited in 
inflammatory reactions.  
 
Fluid and electrolyte homeostasis. 
The stratum corneum prevents the loss of interstitial fluid from within. 
 
Thermoregulation. 
Thermoregulation of the body is achieved by a variety of systems in the body of 
which the skin plays an important role. 
Blood flow is controlled by the sympathetic nervous system at the arteriovenous 
anastomoses at the superficial venous plexus. Local factors, physical and 
chemical i.e. H+, CO2 also have an effect. The blood flow can be varied from 1-
100 ml/min per 100g of skin (skin of fingers and forearm) (Gawkrodger 2002) 
depending on environmental and physiological influences. 
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The production of sweat also cools the body through evaporation. Sweat levels 
can vary between 0.5-10 litres in a day (Gawkrodger 2002). 
 
Neurosensory 
The skin is well supplied by the nervous system. Different areas of the body have 
different amounts of nerve endings, the skin of the hands, face and genitalia 
being particularly well supplied. The nerves supplying the skin have their cell 
bodies in the dorsal root ganglia. The nerve supply is by dermatome with varying 
degrees of overlap. Free sensory nerve endings are found in the dermis, 
extending to the epidermis where they are often associated with Merkel cells 
(Gawkrodger 2002). These nerve endings can detect heat, cold, pain and 
itch/tickle. There are also specialised corpuscular receptors in the dermis, the 
Pancinian corpuscle, which detects pressure and vibration, and Meissner’s 
corpuscle, which is sensitive to touch (Gawkrodger 2002). 
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1.2 Burn Wounds 
 
Thermal Energy 
Thermal injury occurs as a result of an energy transfer from a heat source to the 
body. This may be by three main methods: 
Conduction; whereby the energy is transferred from high-energy molecules to 
lower energy by direct contact. 
Convection; the transfer of heat, in a gas or liquid, by the circulation of currents, 
from one region to another. 
Radiation; where a molecule may give up kinetic energy through conversion to 
electromagnetic energy.   
The energy transfer may depend on a variety of factors (Arturson, 1996 B.) 
1. The conductivity, which varies in different kind of tissues. 
2. The rate of absorption or dissipation of heat, which is dependent initially 
upon the function of the peripheral circulation. 
3. The presence or absence of insulation such as hair; cornified layers of 
surface epithelium, natural skin oils etc. 
4. The total water content of the skin. 
5. The amount of surface pigmentation. 
6. The presence or absence of clothing of different kinds. 
 
As these factors are impossible to measure directly in an injured patient it is 
therefore better to classify burn injury by factors such as the intensity of heat 
exposure, duration of exposure and anatomically by depth of injury relative to 
the thickness of the epidermis and dermis in different areas of the body. These 
details frequently cannot be obtained from the patient (if confused or 
unconscious) and may have to be deciphered anecdotally from emergency 
personnel or witnesses, making their accuracy difficult to verify. 
 
Duration of heat exposure 
The body can resist heat damage of even a high temperature if it is for a short 
duration. Prolonged heat exposure of a moderate temperature can likewise not 
cause significant damage. If the rate of heat dissipation is less than heat 
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absorption the tissue temperature will gradually rise to a point at which cellular 
disintegration will occur. The heat and time for which the temperature is 
sustained determine the level of damage incurred by the tissues.  
Using a porcine model Moritz and Henriquez (1947) established the time-
temperature relationship in thermal injury to skin. Using temperatures ranging 
from 44o to 100o C and between 1 second and seven hours they studied the 
relationship to damage incurred to the skin. From their findings they concluded 
that the rate at which irreversible cellular injury was sustained increased rapidly 
as the surface temperature was raised and that for each degree rise in surface 
temperature between 44o and 51o C the time required to produce such injury was 
reduced by approximately one-half. Above 51o C the relationship was no longer 
linear but followed the previously established trend. 
 
At sustained temperatures enzyme systems begin to malfunction, early 
denaturation of proteins occurs and cellular functions are impaired, one of which 
is the Na+ pump. This failure results in high Na+ intracellular concentrations and 
concomitant swelling. At 44o C and above, damage to the cells exceeds the speed 
of repair, which eventually leads to cellular necrosis (again depending on the 
length of exposure to the heat source) (Williams 2001). 
If the heat source is withdrawn, damage will continue until the temperature of the 
tissues is reduced to a range that the tissues can tolerate normally. This is the 
basis of emergency management of thermal burns; quickly reducing the 
temperature of the cells (usually by cold water in the emergency setting) may 
reduce cell damage. 
 
Tissue Destruction 
As has been mentioned, fairly low temperatures for a sustained period can cause 
enzyme systems to begin to malfunction. Increased temperatures can cause 
severe changes to proteins, known as coagulation, which involves destruction of 
all levels of protein architecture. At this stage cell necrosis is complete starting 
from the area where the heat energy was most focused (usually the surface of the 
skin) extending downwards. This is called the zone of coagulation. This area 
corresponds to the first of three areas of burn injury described by Jackson (1953). 
This area of coagulation is the burn eschar. 
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The next area of injury is the zone of stasis, so called because the damage leads 
to a slowing of the circulation, which eventually becomes static. A number of 
factors contribute to circulatory stasis such as formation of obstructing platelet 
microthrombi and microemboli (Boykin et al., 1980). 
If this compromised area sustains further insults i.e. an ischaemic episode, 
dehydration, hypovolaemia or infection then the entire zone may become 
necrotic and be converted to dead eschar. Stasis may be reversed with cell 
recovery occurring within a week if the wound is treated optimally. Zawacki 
(1974) found in a study on burns induced on guinea pigs that in undressed 
wounds with the blisters removed reversal of capillary stasis was least and the 
necrosis full thickness in depth, the worst possible outcome. However reversal of 
capillary stasis was complete and necrosis absent when the blister was removed 
and the underlying tissue covered with a split thickness skin (porcine) graft, 
giving the best result. 
Beyond the zone of stasis is the zone of hyperaemia. This area has minimal 
cellular injury but exhibits vasodilation as part of the inflammatory response. 
Provided this area does not undergo any further physiological insults complete 
recovery of the cells usually occurs in this area. 
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The role of wound oedema in the burn wound. 
Severe burns cause a systemic inflammatory response and a microvascular leak 
of protein and fluid into the interstitium termed oedema. 
Oedema formation occurs in a variety of disease processes in any part of the 
body and is due to a number of physiological causes. The oedema has a 
detrimental effect on nutrient and oxygen delivery. Oedema formation has 
positive and negative contributions to the burn wound. Firstly it can beneficially 
deliver substances into the interstitium to help fight bacteria. In addition, with the 
lymphatic system it aids bacterial and debris removal (Williams 2001). Its 
negative effects are the reduction of oxygen and nutrients delivered to the tissues 
and the increased risk of infection. 
In animal models systemic capillary leak occurs during the first 24 hours, when 
thermal injury exceeds 30 TBSA% (Arturson 1961, Carvajal et al., 1979). 
Oedema formation is quick with an immediate transit phase lasting 10-15 
minutes followed by a sustained phase of oedema formation. The speed and 
extent of oedema formation is dependent upon the severity of the burn injury. 
The oedema starts to be reabsorbed immediately and continues as long as the 
oedema is present depending on the welfare of the patient. Typically oedema is 
maximal at 12-24 hours and is maintained at a high level for 48-72 hours 
(Williams 2001). 
 
Why does oedema form? 
Arturson (1967) established that oedema formation occurred rapidly after burn 
injury by observing a dog paw before and after scalding inside a 
plethysomograph. It was found that lymph flow increased after injury. In 
addition to increased lymph flow after injury, protein levels in the lymph were 
also increased, suggesting that the microvasculature had become more 
permeable. The two possible reasons for this are: 
1. Direct damage to the microvasculature (capillary and venular endothelial cells) 
by the heat. This causes cells to swell disrupting intracellular connections, 
creating pathways through which fluid can be lost (Cotran 1965) 
2. A variety of chemical mediators are released (histamine, bradykinins, oxygen 
free radicals, sensory neuropeptides) which increase vascular permeability 
(Arturson 2000). 
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Arturson (1967, 2000) also established that very large pressures (200-300mmHg) 
would be needed to drive fluid to create the large amounts of fluid seen in the 
oedematous burn. This was subsequently endorsed by Pitt et al., (1987) who 
demonstrated that capillary pressures almost double early after burn injury, and 
who proposed histamine as one of the agents responsible due to its dilatory 
properties on arteries. It was also established that interstitial hydrostatic pressures 
are dramatically reduced in the post-burn period, dependant on the severity of the 
burn (Lund et al., 1988). The reason for this is thought to be that the collagen 
fibres and their connections to cells are damaged, resulting in a mechanical 
expansion of the interstitial space creating a vacuum. This, in effect, sucks fluid 
into the interstitial space. 
Finally, in addition to the changes in hydrostatic pressure there is an increase in 
interstitial osmotic pressure. This can occur because of a greater number of 
osmotically active particles being present due to the breakdown of collagen and 
other interstitial proteins. 
 
Endothelial dysfunction 
An important aspect of the systemic inflammatory response is the endothelial 
dysfunction that contributes to the leak of protein and oedema formation. 
Methods of assessing this leak have traditionally involved radioisotope or dye 
labelling of albumin and artificial lymphatic fistulas in animal models. 
Immunoassays have subsequently been developed that can detect low 
concentrations of albumin in the urine in a range of 30-200 mg/L which is 
termed microalbuminuria (Vlachou et al., 2006). An increase of radiolabelled 
albumin escape rate has been demonstrated during surgery, sepsis and 
malignancy with a time frame similar to microalbuminuria (Fleck et al., 1972 
Fleck et al., 1985).  In humans, acute inflammatory insults such as surgery have 
also resulted in microalbuminuria (Gosling et al., 1988). These results have led to 
the hypothesis that microalbuminuria is a reflection of systemic vascular 
dysfunction (Gosling 1995) which has subsequently been proved by Jensen et al., 
(1995). 
Microalbuminuria has since been used in a variety of settings to predict outcome 
as it is considered a surrogate marker of systemic inflammation. It has been used 
in acute medical illnesses such as pancreatitis (Shearman et al., 1989) and 
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meningitis (Roine 1993); surgery (Tsang et al., 1998); trauma (De Gaudio et al., 
1999, Gosling et al., 1986, Gosling et al., 1994) and to predict outcome in 
patients admitted to intensive care (Gosling et al., 2003, 2006). Currently there 
have been limited studies in burn patients (Vlachou et al., 2006, 2008, Cochran et 
al., 2008) and it is not clear if microalbuminuria can predict outcomes in the ICU 
burn population. 
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1.3 Principles and Practice of Burn Management   
Burn Wound Depth 
 
The depth of a burn wound determines the treatment and is classified in relation 
to the anatomical level of injury. Burns traditionally used to be divided into first, 
second, third and fourth degree, they are now generally divided into the 
following categories: 
i.  Superficial burns (erythema),  
ii. Partial thickness which can be superficial dermal or deep dermal, and  
iii. Full thickness burns. 
 
Superficial burns 
 
Superficial burns affect only the outer epidermis and are characterised by mild 
pain or discomfort and erythema due to vasodilation (Benson et al., 2006). The 
pain usually lasts for two to three days. Eventually desquamation of the damaged 
superficial epithelium occurs and is followed by scar less healing in 7-10 days. 
These burns were formally known as first degree burns. 
 
Partial thickness burns 
 
Partial thickness burns are divided into two categories, again dependent on the 
depth of the burn. In a partial thickness burn the entire epidermis and a varying 
amount of the dermis is destroyed. Because of survival of nerve endings in the 
superficial to mid part of the dermis these burns can be acutely painful. There is 
often a protein rich oedema resulting in separation of the damaged epidermis and 
blister formation. 
 
i Superficial partial thickness: describes destruction involving the epidermis and 
upper third of the dermis. (See table 1). A burn of this depth will normally heal 
well within ten days to two weeks with minimal scarring. This is due to rapid re-
epithelialisation of the surface due to migration of epithelial cells that have 
survived in deeper parts of the hair follicles and other adnexal structures such as 
the sweat and sebaceous glands. 
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One caveat is that these wounds may have a significant zone of stasis underneath 
the superficial damage and are therefore at risk of conversion to a deeper wound 
if factors such as infection, ischaemia or inadequate rehydration intervene. 
The treatment for a superficial dermal burn consists of simple dressings and 
wound checks. 
 
ii Deep partial thickness: describes injuries involving the epidermis along with 
most of the underlying dermis. At this level, only a few of the remaining 
epithelial cells that are located in the deepest parts of the epithelial appendages 
are viable. As a result, it would take months for re-epithelisation to complete if 
this type of wound were left to heal by itself. In this instance, blisters do not 
occur because of the thick burn eschar which is adherent to the underlying 
dermal collagen (Arturson 1996 B). In addition pain sensation may be limited 
because the nerve endings have been destroyed, although some deep pressure 
sensors may still function. 
If the wound is allowed to heal without intervention a dense scar forms with 
poorly functioning skin and a thin epidermis. The prolonged time for re-
epithelialisation results in a long inflammatory phase allowing a large amount of 
collagen to be deposited, thus resulting in the dense scar. For this reason deep 
dermal burns are treated as full thickness burns (Arturson 1996 B) 
 
Full thickness burns 
 
Full thickness burns involves necrosis of the whole thickness of the skin and may 
involve underlying structures such as muscle, nerve, tendon cartilage or bone. As 
the whole thickness of the skin is involved there is limited opportunity for the 
wound to heal without extensive scarring which inevitably takes a long time as 
the epithelium has to migrate from the wound edges. The wound may also be 
reduced to some degree by contraction of the wound as it heals. 
The wound is not painful, as all the nerve endings have been destroyed. It can 
have a characteristic appearance due to the heat coagulating the dermal blood 
vessels (rendering the damaged tissue avascular) which is a white waxy colour 
although depending on the injury the skin can appear leathery brown as well or 
even charred and black if prolonged heat exposure has occurred. To avoid the 
extensive scarring and contractures the recommended treatment for these burns is 
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excision of the burnt tissue and subsequent skin grafts. These wounds were 
formally called third degree burns. 
If structures deeper than the skin were involved (bone, tendon or muscle) then 
these burns could frequently require more extensive reconstruction than just skin 
grafts such as local or distant tissue transfer or even amputation if reasonable 
function could not be restored.   
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Table 1.0 Classification and clinical appearance of thermal injury of different depth.  
Based on ABC of wound healing-Burns (Benson et al., 2006).  
 
Burn Type Usual 
History 
Skin colour Blisters Capillary refill Sensation Pinprick Healing 
Superficial Sunburn Red Absent Brisk Painful Bleeds Heals in 7 
days 
 
Superficial 
dermal 
Scalds of 
limited 
duration 
Pale pink 
Dark pink 
 
 
 
 
Present (small) Brisk Painful Bleeds Heals in 14 
days 
 
 
 
Deep 
dermal 
Scalds of 
long duration 
Contact with 
high 
temperature 
Dry blotchy 
red 
May be present Absent No pain No bleeding Heals in 
months 
 
 
Full 
thickness 
Contact with 
high 
temperature 
Chemicals 
Electrical 
injury 
Dry 
white/black 
Absent Absent No pain No bleeding Granulates 
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Burn Eschar 
In burn eschar all the protective functions of the skin (immunological, 
homeostasis, thermoregulation etc) have been lost and the burn is considered an 
open wound and therefore liable to infection. Pruitt et al., (1967) state that the 
eschar actually provides a medium for bacterial growth. The eschar has a high 
degree of permeability (Jelenko et al., 1971) and as a result the ability to retain 
fluid and electrolytes and plasma components is diminished. 
 
Assessment of the burn wound  
The ability to accurately assess the depth of a burn is notoriously difficult, and 
inaccurate analysis could easily lead to unnecessary or more extensive surgical 
procedures that may otherwise have been avoided. 
 
Factors that are used in the assessment include; 
 
1. History of the injury i.e. causative agent (scald, flame, chemical, cold etc), 
duration of exposure, first aid and care given prior to assessment etc. 
2. Appearance of the wound (see table 1) 
3. Assessment of pain. A gauge of the depth of the wound can be made by 
assessing how sensate it is to soft touch, and more accurately by pinprick. 
4. Capillary return. The return of capillary filling after blanching caused by 
pressure on the wound (by pressing a finger onto the burnt tissue) gives an 
estimate of wound depth. Superficial burns blanch and capillary refill is rapid. 
Deep burns may be pale and show no capillary return due to the fact that the skin 
is avascular because the heat has coagulated the dermal vessels. 
5. Surface temperature of the burn. It has been found that the temperature 
difference between burned and unburned skin correlates with the depth of injury 
(Wyllie and Sutherland 1991). In reality this is seldom used clinically as first aid 
(usually cold water) applied to the burn gives artificial results making for 
inaccurate assessment. 
6. Laser Doppler. This is a method of determining blood flow in the burn wound 
and thus getting an idea of depth of damage to the tissues. The basic principle is 
that light from a helium-neon laser is shone over the skin where it ‘interacts with 
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both stationary structures and moving blood cells. Back-scattered light from the 
moving cells is shifted in velocity using the Doppler principle, while back 
scattered light from stationary light from stationary objects remains at its original 
frequency. The mixing of these light waves is translated to an electrical signal, 
and mathematical estimation of blood flow can be made in normal versus study 
areas of skin (Herndon 2002). 
 
When the type of wound has been determined the extent of injury is established 
by working out the percentage of body surface area affected. In children burns of 
>10% total body surface area must be admitted to hospital for treatment. In 
adults the cut off point is 15%. These are not hard and fast rules and obviously 
depend on the type of burn, age of patient and other co-morbid factors. Even if 
the injury does not require surgery burns of this size will require fluid 
replacement (due to the large losses through the damaged skin), which will have 
to monitored. 
 
Surgical treatment of a burn 
Superficial burns and partial thickness burns of the superficial dermal variety of 
almost any size can be treated conservatively with appropriate dressings and 
fluid replacement. The required fluid replacement will be determined by the 
percentage of total body area affected. 
Very small deep dermal and full thickness burns can be fully excised and closed 
directly by suturing the wound edges together. Only a few burns however fall 
into this category, the majority are larger and cannot be closed directly. In these 
circumstances the wound are typically tangential excised (Janzekovic 1970). 
This technique removes the necrotic tissue whilst preserving as much of the 
underlying tissue as possible. Partial thickness burns are debrided to a white, 
shiny dermal surface until punctate bleeding is apparent. In deep dermal burns 
this bleeding will be less frequent as the excision will uncover bigger vessels. 
Sometimes the tangential excision has to be continued to normal healthy fat 
(seen as yellow and glistening) is seen. 
In small to medium sized injuries the wound can be closed by a skin graft, 
typically a split thickness skin graft (obtained by shaving a normal area of skin 
with a specialised knife or a dermatome and taking a layer of 8-10/1000th inch in 
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depth). This can be applied as a ‘sheet’ of unmeshed skin and secured in place 
and dressed appropriately. 
If the burns are more extensive or donor sites are limited then the skin may be 
meshed at a variety of ratios, 1.5:1, 4:1 or even 6:1 to enable the skin to be 
stretched out to cover the resulting defect. 
In the smaller burns and depending on the affected site of the body the skin graft 
may be a full thickness skin graft, as the cosmetic appearance is generally better. 
 
In extensive or deep burns the tangential excision method may be redundant and 
instead the treatment consists of surgical excision down to the level of the 
underlying fascia. This includes the full depth of the skin as well as underlying 
subcutaneous fat down to the layer of investing fascia. 
Burns affecting tendon, muscle and bone will require excision of all necrotic 
tissue and reconstruction using local or distant flaps as appropriate. 
 
Recent advances in wound closure 
Cultured Epithelial Autografts (CEA) and skin substitutes 
Extensive burns (50-70%) result in a massive physiological stress on the patient 
and unique challenges as the donor sites are possibly going to be limited. One 
solution is the use of Cell cultured epithelial autograft (CEA) procedures that 
utilise skin cells from the patient usually taken at the time of primary burn 
excision. These are used to grow ‘sheets’ of new skin cells in a laboratory. These 
new sheets are used as grafts. Because these grafts are very thin (only a few cell 
layers thick) they are fragile and have a variable success rate. Because of this, 
and the time taken to produce the new skin the uptake of this method is limited. 
However, newer grafting procedures combine CEA with a dermal matrix for 
more support. 
One of several relatively new materials being used is IntegraTM, which is a 
synthesized dermal replacement. It is a ‘bilaminar composite that has a 
neodermis of bovine collagen held in a matrix pattern with shark cartilage 
chondroitin-6-sulphate. A layer of rubberised silicone is pressed sealed onto this 
and acts as a neoepidermis’ (Herndon 2002). Over the next 2-3 weeks the 
neodermis becomes vascularised from the underlying wound and once this has 
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occurred the silicon sheet can be carefully removed and the underlying wound 
bed grafted with 6-8/1000th inch autograft or even CEA. 
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1.4 The Inflammatory Response to Burn Wounds  
Inflammation is an essential component of normal wound healing when the 
wound is small and localised. In large burn injuries multiple biological cascades 
are initiated in a temporal fashion. There is initially an acute hyper-reactive 
immune response followed later by a hyporeactive phase. In critical burn injuries 
that inflammatory response can become deranged due to the global involvement 
of multiple tissue beds and recruitment of immune and non immune cells which 
puts a significant metabolic and strain on the repair process and the patient.  
The inflammatory response is complex and many of the biological pathways 
overlap, influence each other and sometimes work in opposition. The balance of 
these factors determines the healing of the burn wound and is examined below. 
 
When an organ or tissue is damaged in general it is unable to regenerate but 
instead forms a fibrotic scar. In the wound healing process the organ/tissue may 
not be fully restored to its previous state but repaired sufficiently to return to or 
maintain function. If the normal wound healing process is altered in any way it 
can result in greater tissue or organ damage and sub-optimal functional results. 
Wound healing is complex with multiple processes interacting. It cannot be seen 
as a linear process but rather as a series of overlapping processes that have 
variable degrees of influence on each other. 
Conventionally cutaneous wound repair has been divided into three parts as 
shown in the diagram below. 
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Figure 1.1 Phases of wound healing 
 
Firstly the inflammatory stage which can be sub-divided into early and late 
stages. The second phase is re-epithelialisation and granulation tissue formation 
and then lastly matrix formation and re-modelling. 
Collagen accumulation starts shortly after the onset of granulation tissue 
formation. (Clark 1996) 
 
The following section gives an overview of cutaneous wound healing with 
specific reference to the process that occurs in a burns wound. Like any 
inflammatory reaction, burn wound inflammation comprises a whole cascade of 
interacting and overlapping mechanisms, which serve to respond to and treat the 
severe physiological challenges that a burn constitutes. The ‘insult’ of a major 
burn will result in both local effects and generalised responses involving the 
whole body. Because the effects of a large thermal injury are so complex with 
multiple interactions between various systems in the body some authors suggest 
looking upon a major burn wound as “a specialised organ with its own blood 
supply and unique metabolic characteristics” (Arturson 1996 A). 
During the inflammatory phase of wound healing many of the inflammatory 
cascades overlap and occur concurrently; however for the sake of clarity they 
will be mentioned in the order that they tend to occur. 
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Inflammatory stage 
 
Coagulation-fibrinolytic cascade 
The first process that occurs during a major injury is damage to the blood vessels 
with the blood constituents being released into the wound, in the case of a burn 
wound this may occur with increased blood flow to the injured area due to 
vasodilatation and as was described in the chapter on burn wounds, oedema 
formation also occurs due to increased extravascular osmotic activity.  Exposure 
of the blood to injured tissue results in the blood clotting. The blood clots as a 
result of 1) Surface activation of Hageman factor, 2) tissue pro-coagulant factor 
released from damaged cells, 3) surface membrane coagulation factors and 
phospholipids expressed on activated platelets and endothelial cells (Furie & 
Furie 1988). By a similar process Hageman factor activates the coagulation-
fibrinolytic system in a burn. 2-3 hours after scalding the lymph and plasma in 
thermally damaged tissue displays hypercoagulability (Edery 1963). 
With blood coagulation, platelet aggregation also occurs. This results in the 
formation of a fibrin rich clot that helps stop bleeding by plugging the damaged 
vessels and to some extent fills in wound space resulting from the injury. The 
fibrin matrix (a co-polymer of fibrin and fibronectin) can trap cellular debris and 
bacteria. The blood clot in the wound space will provide a provisional matrix for 
cell migration and act as a provisional matrix for the influx of monocytes. 
Blood coagulation and platelet aggregation will cease when the stimuli to form 
the clot disappear. A number of factors are responsible for this including 
prostacyclin, antithrombin III, protein C, and plasminogin activator. (Clark 1996) 
Platelets also release chemotactic factors for blood leukocytes and growth factors 
such as platelet-derived growth factor (PDGF), transforming growth factor -α 
(TGF) and TGF-β which in turn activate macrophages and fibroblasts (Arturson 
1996 A). 
 
Complement 
Concurrently with activation of the coagulation cascade the complement cascade 
is activated. The complement system is a group of ~20 different proteins found 
in the serum, which control inflammation. The complement cascade has two 
methods of activation, the classical or alternative pathways.  
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The classical pathway is activated by immune complexes containing antibodies 
of the IgG and IgM types as well as a number of other substances such as 
heparin, bacterial lipopolysaccharides and polynucleotides. The alternative 
pathway is activated by less specific mechanism in response to substances such 
as foreign substances (Arturson 1996 A). Activation of complement results in 
vasodilatation and increased microvascular permeability. 
There are three major biological activities of the complement system (Roitt 
1993) 
1. The activation of phagocytes, including macrophages and neutrophils. 
2. Opsonization (coating) of microorganisms and immune complexes so they can 
be recognised by cells expressing complement receptors. 
3. Lysis of target cells. 
 
Activation of either pathway results in the formation of fragments of 
complement factor C3. These fragments are activated by receptors that promote 
chemotaxis and phagocytosis of foreign particles and bacteria, in addition to 
facilitating cytotoxic reactions and the release of enzymes from the cells of the 
immune system. (Arturson1996 A).  
At the same time the complement system is activated a whole host of other 
inflammatory mediators and pathways are activated including the kinin system, 
the arachadonic acid cascade, platelet activating factor and a variety of cytokines 
and chemokines. 
 
Cytokines and Chemokines 
The initial inflammatory response to trauma (whether it is a burn, infection or 
traumatic episode) is designed to maintain cellular function and restore 
homeostasis whilst responding to microbial challenges. The following anti-
inflammatory phase helps restore function to normal. One group of molecules 
that modulates all of these aspects of inflammatory and anti-inflammatory 
response is the cytokine family.  
The term cytokine includes interleukins, lymphokines and some other signalling 
molecules such as interferon and tumour necrosis factor-α (TNF-α). They are 
produced by a number of cells but are derived mainly from cells of the 
reticuloendothelial system (e.g. monocytes, macrophages and Kupffer cells) 
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(Gosain and Gamelli 2005). Cytokines work by their ability to bind to specific 
cellular receptors and influence immune cell differentiation and proliferation via 
intracellular pathways and gene transcription. Cytokines also influence their own 
and other cytokine production and suppression by positive and negative feedback 
loops. 
Cytokines, when released work both locally and systematically where they exert 
their effects through endocrine, paracrine, autocrine and intracrine mechanisms 
(Clark 1991). An appropriate response results in inflammation at the injury site 
removal of any infection and then progress to normal wound healing. An 
inadequate or reduced cytokine response may result in delayed wound healing 
whilst an exaggerated response can result in haemodynamic instability, multi-
organ failure and death (Gosain and Gamelli 2005).  
A number of studies have looked at cytokine profiles post burn injury or wound 
manipulation to elucidate the relationship. Many of the studies have used animal 
models and in burns particularly the murine or rat model. Extrapolating animal 
model results to humans is not always accurate but Finnerty et al., (2009) 
assessed the similarities between humans and murine models in cytokine 
expression after burns. They found the post burn cytokine expression of 11 
cytokines was similar in mice and children that confirmed the utility of the 
burned mouse model for studying human cytokine profiles. 
Interleukins form a large group of cytokines. The majority are produced by T-
cells, but they are also formed from mononuclear phagocytes. Whilst many 
interleukins have been studied in relation to thermal injury this study will focus 
on some of the more important proinflammatory molecules, in particular IL-6 
and IL-8. Furthermore IFN-γ another pro-inflammatory cytokine will also be 
examined in more detail. 
 
Cytokines in burns 
It has long been established that cytokines levels are altered in response to a 
thermal injury. Early work by Drost et al. (1993 A) showed that plasma samples 
with detectable amounts of IL-1 beta and IL-6 were significantly more frequent 
in burned patients than in controls. Further work by the same team also showed 
that IL6 and TNF alpha levels were increased in severely infected burn patients 
as compared to patients who remained free of infection, and the IL6 level was 
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higher in infected patients who died than those who survived (Drost et al., 1993 
B). Subsequent work has demonstrated that the relationship between cytokines 
and the factors that stimulate or suppress them are complicated and although 
many advances have been made in the last decade it will take many years before 
the complex response in burns is understood. 
In general, however, the cytokine expression over time in burn patients follows a 
similar course if not complicated by organ failure or sepsis. Finnerty et al., 
(2006) demonstrated the normal trend by comparing cytokine expression profiles 
from severely burned children without signs of infections or inhalation injury to 
the cytokine profiles from normal, non-infected, non-burned children. The 
expression of pro-inflammatory and anti-inflammatory cytokines was maximal 
during the first week after thermal injury. Significant increases were measured 
for a large number of mediators during the first week after thermal injury: 
interleukin (IL) 1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 p70, IL-13, 
IL-17 and interferon gamma (IFN-γ). Within five weeks the serum 
concentrations of most cytokines started decreasing towards normal levels. This 
data was correlated by a larger study (of 242 paediatric patients). Of 17 cytokines 
studied, 16 were drastically increased, most significantly IL-6, IL-8, monocyte 
chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1 (MIP-
1), and granulocyte colony- stimulating factor (G-CSF). Even so called anti-
inflammatory cytokines increased significantly post-burn. Only IL-5 was in the 
normal range post-burn and decreased over time (Jeschke et al., 2008).  
At this stage it was not appreciated how prolonged the cytokines response could 
be. It was only after a further study by Jeschke et al., (2011); the largest series to 
date (977 paediatric patients) that again confirmed the previous findings but also 
demonstrated how long the inflammatory and metabolic response continues for. 
They followed up their patients for up to three years. Whilst most cytokines 
again showed a response to the burn injury dramatic changes were observed for 
serum IL-6, IL-8, G-CSF and MCP-1. These cytokines demonstrated an up to 
2,000-fold increase immediately upon burn trauma and remained significantly 
elevated throughout the time period studied when compared with the 
concentrations detected in non-burned controls. INF-γ, TNF- α, IL-1β, IL-2, IL-
5, IL-7, IL-10, and IL-17 significantly increased by 2- to 20-fold in response to 
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burn injury and revealed relatively constant, but significantly increased levels for 
most of the three- year period post-burn compared to non-burned patients. IL-
12p70 was not significantly altered compared to controls. 
Whilst this cytokine response is generally consistent for most major burns there 
are significant differences between the adult and paediatric population. In a study 
comparing adults and children who had received burns greater than 20% TBSA 
it was found that during the first week following burn injury, IFN-gamma, IL-
10, IL-17, IL-4, IL-6, and IL-8 were detected at significantly higher levels in 
adults compared with children. There were no differences in IL-12, IL-2, IL-7, or 
TNF levels in adult compared with pediatric burn patients at any time point. The 
authors concluded that this might provide an insight to the higher morbidity rate 
in adults. Also, the dramatic discrepancies observed in plasma cytokine detection 
between children and adults may mean that these two patient populations may 
benefit from different therapeutic interventions to attenuate the post-burn 
inflammatory response (Finnerty et al., 2008).  
The next question is whether there is a relationship between the size of the burn 
and the cytokine response. Several small studies looking at only one or two 
cytokines have found conflicting results but the largest study by Jeschke et al., 
(2007) looked at 189 paediatric patients divided into different groups according 
to burn size. They found firstly that the burn size determines the inflammatory 
and hypermetabolic response. In terms of cytokines only six were significantly 
affected. Serum IL-8, TNF, IL-6, IL-12p70, monocyte chemoattractant protein-1 
and granulocyte–macrophage colony-stimulating factor were significantly 
increased in the large burns. In general, it was found that the smaller the burn 
size, the lower the cytokine concentration, perhaps indicating a relationship 
between burn size and cytokine expression. Other cytokines, such as IL-1β, 
macrophage inflammatory protein-1β, IFNγ, IL-10, granulocyte colony-
stimulating factor, IL-17, IL-13, IL-7, IL-5, IL-4, and IL-2, were affected by the 
burn but not by the size of the burn. These cytokines showed no significant 
difference between the burn size groups, but did present with significant changes 
over time. 
Whilst these are significant findings the clinically relevance of the response of 
each cytokine is yet to be determined, it is not known which mediators are 
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induced directly by the burn injury and which are secondary mediators indicative 
only of systemic inflammation. One way of doing this has been to look at the 
cytokine response in specific circumstances. Certain cytokines seem to play a 
more prominent in the post burn response especially if there is a concomitant 
injury or a complication and many studies have therefore looked at the cytokine 
profile of patients under these conditions to investigate this.  
Gauglitz et al., (2008) compared severely burned children suffering from 
inhalation injury who did not survive with those who survived. They found 
significant differences in the serum levels of IL-4, IL-6, IL-7 IL-10 and IL-13. 
Of note IL-6 and IL-10 were significantly elevated in non-survivors at admission 
compared with survivors. Non- survivors had significantly lower IL-7 serum 
levels 5-7 days after hospital admission compared with survivors. A number of 
other cytokines were not significantly different between the groups (IL-2, IL-4, 
IL-5, IL-6, IL-8). By using logistical regression they found that the risk for 
mortality increased as the levels of IL-6 and IL-10 increased and that the risk of 
mortality increased as the levels of IL-7 decreased. A further study by the same 
group, again looking at paediatric patients and comparing a group with inhalation 
injury with a group without inhalation injury found that an inhalation injury 
causes alterations in IL-7 and IL-12p70. However there were no increased levels 
of pro-inflammatory cytokines, indicating that an inhalation injury in addition to 
a burn injury does not augment the systemic inflammatory response early after 
burn (Finnerty et al., 2007 A). 
In an animal model (rats) Orman et al., (2012) looked at serial values of 
cytokines in response to a burn and septic shock (so called double-hit). The rats 
received a burn injury followed two days later by cecum ligation and puncture 
(CLP) to induce sepsis. Following this the rats were sacrificed at different time 
points and their cytokine profiles analysed. They found IL-6 (exhibiting both pro 
and anti inflammatory properties) was up regulated on the 7th and 10th days and 
postulated it might be to protect the host system from the subsequent 
complications caused by the burn and sepsis. In a further study by the same 
group (Orman et al., 2011), the response following the cecum ligation and 
puncture (CLP) or its corresponding control treatment (sham-CLP or SCLP) in 
male rats was analyzed by measuring different cytokines and chemokines. Whilst 
a number of cytokines were significantly altered in both burn and CLP (B+CLP) 
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and B+SCLP groups, IL-10 and IL-6 were significantly up regulated in the 
B+CLP group when compared to the B+SCLP group. 
In humans a number of studies have found an increased risk of sepsis linked to 
certain cytokines. A recent study by Pileri et al., (2008) looked at the plasma 
levels of IL-6 and IL-10 in burn patients and correlated the levels with the 
severity of sepsis. They looked at 60 burn patients (adults), 34 of which 
developed sepsis (the control group was healthy volunteers). They found that 
both IL-6 and IL-10 levels, were significantly higher in septic patients than in 
non-septic patients. In the case of IL-6 this was after three days and for IL-10 
throughout all points of the study. In addition Finnerty et al., (2007 B) found 
serum IL-6, IL-12 p70, and TNF can be used to identify paediatric burned 
patients who are at high risk of death from sepsis. Earlier work by Yeh et al., 
(2002) had suggested this by noting that a marked increase in serum levels of IL-
6 before death by sepsis in their study of burned patients.  
 
From the studies above it appears that the cytokine profile can be heavily 
influenced by either a concurrent injury (i.e. an inhalation injury) or a double hit 
such as sepsis. However, it must be noted that there is also evidence that the 
cytokine response can be altered significantly by interventions that occur during 
the care of the burn patients. Papini et al., (1997) examined the response of 
tumour necrosis factor (TNF) and IL-6 after burn wound dressing changes and 
débridement. They found that concentrations of tumour necrosis factor changed 
little during surgery or dressing changes, whilst there were dramatic increases 
(X3) in plasma concentrations of IL-6 during surgery or dressing change. A 
further part of the study found that bacteraemia can further increase the IL-6 
response but preventing Gram- positive bacteraemia (by using teicoplanin) did 
not significantly affect IL-6 concentrations which may mean release of IL-6 is 
not the direct result of infection. 
The above studies demonstrate that although significant insights have been 
gained into the inflammatory response and cytokine release over the last twenty 
years further studies are required to determine the clinical relevance of these 
findings as it is not clear which mediators are induced directly by the burn injury 
and which are secondary mediators indicative only of systemic inflammation. 
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Interleukin-6 
IL-6 is produced by, T and B cells, endothelial cells, macrophages and 
fibroblasts. Its expression can be induced by other proinflammatory mediators 
such as IL-1, TNF and LPS (Cicco et al., 1990). It has multiple actions. It can 
induce B cells to differentiate into antibody forming cells, the proliferation of T 
cells and stimulates the production of a range of acute phase proteins (Gosain 
and Gamelli 2005). In patients with multiple trauma or sepsis, the degree of IL-6 
elevation correlates with the risk of morbidity and mortality (Calandra et al., 
1991) although a causative role for IL-6 has not been found, suggesting that it 
may be a marker for disease severity. Increased levels of IL-6 have been seen 
after major burns (Yeh et al., 1999, Jeschke et al., 2008) and most recently 
Jeschke et al., (2011) have demonstrated an up to 2,000-fold increase 
immediately upon burn trauma and found that levels remained significantly 
elevated up to sixty days post injury when compared with the concentrations 
detected in non-burned controls. 
Abdel-Hafez et al., 2007 demonstrated a significantly higher level of IL-6 in a 
paediatric burn population that developed sepsis, those that died and also found a 
correlation of IL-6 with the TBSA% burned. 
 
Interleukin-8  
Interleukin-8 (IL-8, CXCL8) is a chemokine associated with acute inflammation 
and is found elevated in human wounds (Garner et al., 1994). IL-8 was 
discovered in 1987 (Yoshimura et al., 1987) It is a 8-10 kDa protein found in the 
form of two active isomers, a 77 amino acid form and the more active 72 amino 
acid form. It modulates the function of a number of inflammatory cells involved 
in the healing process.  
Since its discovery its structure, gene location, and receptor structure and 
properties have all been established (Iocono et al., 2000). 
IL-8 is secreted constitutively or in response to proinflammatory stimuli from a 
wide variety of cells including monocytes/macrophages, neutrophils, eosinophils, 
T-cells, keratinocytes, fibroblasts, endothelial cells and chondrocytes (Iocono et 
al 2000). 
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IL-8 production in macrophages is stimulated by a number of factors including 
TNF-α, IL-1α and IL-1β. 
IL-8 is resistant to temperature and proteolysis and relatively resistant to an 
acidic environment (Remick 2005). These characteristics help it to survive in the 
suboptimal conditions that occur in sites of acute inflammation. Again, in burns 
patients, levels have been found to be raised very soon after injury and like IL-6 
can be elevated for prolonged periods (Jeschke et al., 2008, Jeschke et al., 2011). 
Whilst the main studies that have looked at IL-8 in burns have been mentioned 
above, IL-8 has also been examined in regards to its role in lung injury. 
Rodriguez et al., (1993) looked at 88 patients with acute thermal injuries. Forty-
eight hours after injury IL-8 (as well as TNF and IL-6) was significantly present 
in the systemic circulation, lung, normal skin, and thermally injured skin.  
The presence of IL-8 (and TNF and IL-6) proteins in the lung, normal skin, and 
thermally injured skin were associated with TNF, IL-6, and IL-8 mRNA up-
regulation. Using logistic regression analysis this team demonstrated that the 
presence of IL-8 in the lung was associated with early pulmonary physiologic 
dysfunction and nosocomial pulmonary infection. They concluded that acute 
thermal injury initiates an early systemic, lung, and skin response involving IL-8 
TNF and IL-6 and that the TNF, IL-6, and IL-8 protein present in the lung and 
skin in response to acute thermal injury are generated locally and do not originate 
from the systemic cytokine pool. Furthermore they postulated that the lung 
cytokine response to acute thermal injury might initiate local organ failure. 
Just a year later Donnelly et al., (1994) examined the cytokine profile associated 
with adult respiratory distress syndrome (ARDS) a complication seen after 
severe accidental trauma, including burns. Plasma samples were examined post 
injury and at 4 hourly intervals. Plasma IL-8 (and IL-6) concentrations were 
markedly increased starting in the immediate post injury period in both ARDS 
and non-ARDS patients, but no significant differences were found between the 
two groups until 16 hours after injury when plasma IL-8 concentrations became 
significantly higher in the ARDS group. From their results they concluded that 
measurements of plasma concentrations of proinflammatory cytokines, were not 
helpful in predicting the development of ARDS after severe accidental injury. 
Kurzius-Spencer et al., (2008) also examined inflammatory markers in the lungs 
to assess the value of initial concentrations as predictors of subsequent lung 
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injury. Using a population of intubated, inhalation smoke victims they assayed 
the tracheobronchial fluid collected every two hours to determine which 
cytokines were present. In addition the partial pressure of arterial oxygen (Pao2) 
and the fraction of inspired oxygen (Fio2) were recorded approximately every 6 
hours. The Pao2/Fio2 ratio is used to determine hypoxemia and is one of the 
criteria used to diagnose ARDS. Of the cytokines examined only initial IL-8 was 
associated with increased Pao2/Fio2 and with a minimum Pao2/Fio2 during the 
first 72 hours. In smoke inhalation victims, tracheobronchial IL-8 increases 
rapidly and the authors thought that high initial IL-8 may predict improved 
oxygenation. So it appears that IL-8 levels alone may not predict subsequent 
lung injury but used in conjunction with measures of lung function there may yet 
be a clinical use for determining IL-8 in lung injury. 
 
Interferon (IFN) 
There are three groups, IFN-α made by leukocytes, IFN-β made by fibroblasts 
and IFN-γ made by predominantly T and NK lymphocytes.  
IFN-γ, which has been studied most, has been found to have antiviral activity, 
broad proinflammatory activity inducing the expression of TNF and IL-1 and be 
involved in the priming of circulating and tissue macrophages (Nathan et al., 
1983). IFN-γ is produced by type 1 Th (T Helper) cells (CD4+ and CD8+) and 
natural killer cells. IFN-γ also promotes the differentiation of CD4+ T cells to the 
TH1 phenotype, producing a positive-feedback loop and augmenting its own 
production (Gosain and Gamelli, 2005). Because of its role in priming 
macrophages as well as the anti-infective effects of IFN-γ observed in animal 
models and other clinical studies IFN-γ was used in a Phase III multicentre 
European trial to see if giving IFN-γ subcutaneously reduced infection rates or 
mortality in burn victims. After comparing the treatment group with the control 
group (who received a placebo) no difference was found in the mortality at 90 
days, incidence of infectious complications and duration of intensive care unit or 
hospital stay (Wasserman et al., 1998). 
IFN-γ production is reduced in mice from 2-7 days post burn (Suzuki and Pollard 
1982). In human patients however, there are significant time-dependent changes 
in plasma concentrations of IFN-γ. Initially levels were found to be low but 
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began to rise from day 5 to 10 and decreased subsequently (Vindenes et al., 
1995).  
In the study by Jeschke et al., (2011) INF-γ, significantly increased by 2- to 20-
fold in response to burn injury and revealed relatively constant, but most 
interestingly displayed significantly increased levels for most of the three-year 
period post-burn compared to non-burned patients. Again like other cytokines 
there are variations between the paediatric and adult population with IFN-gamma 
being detected at significantly higher levels in adults compared with children in 
the first week post burn (Finnerty et al., 2008). 
 
Platelets 
Platelets originate from megakaryocytes in the bone marrow. Their main role has 
long been considered to be in blood clotting but increasingly their role in 
inflammation is being recognised. When the endothelial cells are injured platelets 
stick to the exposed cell surface. Platelets release into the wound a number of 
cytokines including insulin like growth factor 1 (IGF-1), platelet factor IV, 
transforming growth factor beta (TGF-β), platelet derived growth factor (PDGF) 
and epidermal growth factor (EGF). All of these factors in turn attract and 
activate macrophages and fibroblasts (Arturson 1996 B).  
 
Mast Cells 
Mast cells can be activated by immunological stimuli, toxins, and some drugs. 
All of these stimuli cause an influx of Ca2+ ions, which causes degranulation of 
the mast cell. There is an exocytosis of the granule mast cell contents with the 
release of a number of preformed mediators. 
Histamine is one of the main mediators released. These mediators have three 
main areas of physiological effects. There are chemoattractants (Platelet 
activating factor (PAF), Leukotiene B4 (LTB4), IL-8, and TNF-α), 
vasoactivators (histamine, PAF, kininogenase) and spasmogens (histamine, 
prostaglandin D2 (PGD2), LTC4, LTD4 (Arturson 1996 B). 
The release of chemoattractants from the mast cells contributes to the recruitment 
and interstitial migration of leukocytes. Also due to the release of mediators from 
mast cells there is arteriolar constriction this will result in a reduced blood flow. 
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This will create the right haemodynamic conditions for blood clotting and the 
migration of leucocytes (Arturson 1996 A) 
 
Neutrophils 
As haemostasis is achieved neutrophils are attracted to the wound site 
(monocytes are also attracted but neutrophils initially arise in greater numbers). 
They migrate to a site of injury via the blood stream; they then attach to the 
endothelium and pass through to the surrounding tissue.   
The role of neutrophils is to initially bind to the invading organisms, ingest and 
kill them. Arturson (1996 B) reports that a number of studies have shown that 
after thermal injury there may be defects in neutrophil chemotaxis, phagocytosis 
and killing but other functions may be enhanced. 
Neutrophil activity is determined by the amount of wound contamination. 
Through phagocytosis and subsequent enzyme and oxygen free radical release, 
contaminating bacteria will be destroyed. When the wound is cleared of debris 
and bacteria neutrophil infiltration will cease in a few days. Most of the 
neutrophils will become enmeshed in the wound clot and desiccated tissue. This 
eschar will slough in time as the tissue regenerates. 
In a heavily contaminated wound where there are excessive micro-organisms or 
indigestible particles neutrophil infiltration will be prolonged and may be 
damaging due to the enzyme and oxygen free radical release. 
Those neutrophils which are in viable tissue, become senescent after a few days, 
and will be phagocytosed by macrophages (Newman et al., 1982).    
 
Monocytes 
Regardless of whether the neutrophil infiltration stops or continues monocyte 
will migrate into the tissue and bind to specific extracellular matrix proteins. 
Once activated, (by cytokines such as TNF-α and IFN-γ) the monocytes will 
become macrophages. They will then phagocytose and digest pathogenic 
organisms, redundant neutrophils and tissue debris resulting in wound 
débridement.  
In addition to the production of cytokines, wound macrophages also produce a 
range of extracellular matrix molecules. These molecules with the addition of 
fibrin and fibrinogen from the blood clot, fibroblasts, endothelial cells and matrix 
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molecules from degranulating platelets form the granulation tissue or provisional 
matrix.  
 
 
Re-epithelialisation and granulation tissue formation 
 
After the epithelial barrier has been breached many of the protective functions of 
the skin are lost resulting in an increased morbidity and mortality unless the 
deficit can be restored. This process actually starts within hours after an injury as 
epithelial cells from residual epithelial structures (either the wound edges or 
adnexal structures) start to move across the wound deficit. 
There are ranges of phenotypic changes that occur in the epithelial cells that 
allow lateral movement (i.e. decreased binding between the epidermis and the 
dermis and between the epidermis and the basement membrane) and enable the 
cell to be mobile (through formation of peripheral cytoplasmic actin filaments) 
(Singer and Clark 1999). The epithelial cells at the wound edge lose their apical-
basal polarity and external pseudopodia from their free basolateral sides into the 
wound. (Clark 1996) 
Krawczyk (1971) found that the epithelial cells at the wound edge started to 
proliferate one to two days after injury. There are a variety of postulated reasons 
for this such as absence of neighbouring cells, or increase in local growth factors. 
Growth factors are released from macrophages and the keratinocytes themselves. 
Many of these growth factors have stimulated re-epithelialisation in animal 
models (Brown et al., 1989) or have been absent in models of deficient re-
epithelialisation (Werner et al., 1994). It is likely that they are present during the 
repair that occurs in a normal wound and the most likely substances include 
epidermal growth factor, transforming factor-α (TGF-α) and keratinocyte growth 
factor.  
A few days after injury, macrophages, wound fibroblasts or migrating epidermal 
cells deposit fibronectin. Wound keratinocytes not only cover the wound with a 
provisional matrix but also express cell surface receptors that facilitate their 
migration across the matrix. 
If the basement membrane has been destroyed by the injury, the epidermal cells 
migrate over a provisional matrix of fibrin, fibronectin, type I and type V 
collagen, tenasin and vitronectin. If the basement membrane is intact fibronectin 
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infiltrates the basement membrane. Fibronectin and fibrin originally comes from 
the circulation but after a few days is produced from a variety of cells, such as 
wound fibroblasts, macrophages and migrating epidermal cells. (Clark 1996) 
Sometimes the epidermis dissects through a wound through the production of 
collagenase separating non-viable tissue from viable tissue. The epidermal 
movement through tissue relies on the production of collagenase produced by the 
epidermal cells. 
As re-epithelialisation continues the basement membrane reappears sequentially 
from the wound margins inwards. The epidermal cells revert to their normal 
phenotype and attach to the basement membrane through hemidesmosomes and 
the underlying neodermis through type VII collagen fibrils.  
 
Granulation tissue 
Granulation tissue is formed about four days post injury. It consists of new blood 
vessels, macrophages, fibroblasts and loose connective tissue. The granulation 
tissue is stimulated by the range of cytokines and growth factors released from 
the platelets, monocytes and macrophages. The macrophages supply a continuing 
source of growth factors necessary to stimulate fibroplasia and angiogenesis. The 
fibroblasts are stimulated to construct the new extracellular matrix by a range of 
cytokines with chemotactic, mitogenic and modulatory activities. 
The structural molecules of newly formed extracellular matrix, called the 
provisional matrix contribute to formation of granulation tissue by providing a 
scaffold for cell migration. These molecules include fibrin, fibronectin and 
hyaluronic acid (Singer and Clark 1999) 
The provisional extracellular matrix is gradually replaced with a collagenous 
matrix, initially types I and III. 
Once enough collagen has been deposited in the wound, fibroblasts cease 
collagen production. Factors that may down-regulate fibroblast proliferation and 
matrix synthesis are thought to include gamma interferon and the collagen 
matrix. (Clark 1996) Gradually a relatively acellular scar replaces the fibroblast 
rich, granulation tissue. 
Concurrently with the newly formed extracellular matrix and fibroblast complex 
there must also be angiogenesis. As early as the second day endothelial cells 
migrate through the basement membrane in response. A whole variety of 
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substances have been shown to have angiogenic properties including TGF-α, 
TGF-β, TNF-α, PDECGF (platelet derived endothelial cell growth factor), 
vascular endothelial growth factor (VEGF), and IL-8 (Clark 1996). 
The migrating endothelial cells form capillary sprouts that lengthen and branch at 
their tips and join forming capillary loops through which blood flows. New 
sprouts can then extend from these loops to form a capillary plexus. 
 
Tissue Remodelling 
 
The third phase of wound repair is the tissue remodelling which is a process of 
cell maturation, cell apoptosis and extracellular remodelling. This starts at the 
wound margin as granulation tissue is still invading the wound space. When the 
granulation has filled the wound space and has been covered with a neodermis 
the fibroblasts transform into myofibroblasts, which start to contract the wound. 
The collagen remodelling and that occurs during the transformation from 
granulation tissue to scar tissue relies on a fine balance between continued 
breakdown of collagen and continued synthesis of collagen. The breakdown of 
collagen is controlled by molecules, called matrix metalloproteinases (MMPs). 
These are proteolytic enzymes produced by macrophages, epidermal cells, 
fibroblasts and endothelial cells. (Singer and Clark 1999) The eventual wound 
repair depends on a balance between MMPs and their respective tissue inhibitors.  
As healing proceeds, the number of inflammatory cells and fibroblasts decreases 
and the increasing collagen matrix becomes organised into thicker, more heavily 
cross-linked bundles. During this time the ratio of collagen types during wound 
healing varies with type III collagen predominating in the early wound but type I 
collagen takes over later in the healing process.  
Scars continue to remodel for a considerable length of time and are generally 
considered to be in a steady state two years post the initial injury. 
 
Abnormal wound healing 
As might be imagined from such a complex process with so many interacting 
processes and molecules with multiple functions there are many physiological 
and biochemical changes and defects that can lead to impaired healing. It is too 
big a subject to examine these multiple factors in detail but sufficient for the 
moment to give some examples of the potential causes of impaired healing. An 
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impaired supply of oxygen or nutrients to the wound site, prolonged 
inflammation (possibly due to infection), impaired neovascularization or 
decreased synthesis of growth factors or collagen will all impede the formation 
of a strong healthy scar. 
Further complications of scar formation are the fibroproliferative disorders that 
result in the excessive accumulation of collagen resulting in hypertrophic or 
keloid scars. These conditions have been linked to a range of problems including 
prolonged inflammation and disorders of the synthesis and secretion of 
extracellular proteins and cytokines as well as disordered remodelling (Singer 
and Clark 1999). 
 
Infection in burns wounds-The clinical consequences of burn wounds. 
Burn mortality has decreased significantly in recent years (Lionelli et al., 2005, 
Xiao et al., 1992) and this has been due to advances in many aspects of burn 
care, including nutritional support, pulmonary care, changes in surgical practice 
and the use and development of antibiotics.  
Burn mortality has been linked to a number of factors including age, inhalation 
injury and total body surface area (TBSA) percentage greater than 40 (Ryan et 
al., 1998). With the skin playing such a vital role as a defensive barrier it is not 
surprising that the greater the TBSA % burned the greater the mortality. It has 
been shown that a greater number of deaths are due to sepsis in those patients 
with a greater percentage TBSA burned, (Bang et al., 2002) and following on 
from this the greater the TBSA % burned, the greater the risk of infection (Kagan 
et al., 1985). As well as an increased mortality, infected burn wounds also result 
in a greater morbidity with prolonged hospital stays, greater scarring and a 
greater need for revision surgery. 
Due to changes in management of the burns patients’ mortality due to sepsis has 
also dropped over the years, thus echoing the advances in other aspects of burn 
care. Before early surgical excision of the burn was advocated, management was 
far more conservative. The natural colonisation of the wound was allowed to 
occur as it allowed the burn eschar to separate spontaneously. The resulting 
wound would re-epithelialise leaving pronounced scarring and contractures. 
Subsequently treatment used to consist of immersion hydrotherapy and cleaning 
of the wound until granulation tissue appeared, after which the site could be skin 
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grafted (Church et al., 2006). At times other methods gained popularity such as 
the open or exposure method in which its advocates noted the improved comfort 
of the patients (Sneve 1905). This technique was revived briefly in the 1940s in 
both the US and UK and it was seen not as a form of abandonment but a way of 
actively managing the wound. 
Exposure meant the wound rapidly became colonized with bacteria, the only 
benefit being that the relative dryness discouraged growth of some bacteria such 
as Pseudomonas.   
Current treatment consists of early excision (for full thickness and deep partial 
thickness burns) and grafting to achieve wound closure whether it is by 
autograft, allograft or occasionally skin substitutes. This more aggressive 
approach has not only reduced the mortality rate (in patients without inhalation 
injuries) (Ong et al., 2006) and length of the hospital stay (Heimbach 1987, Ong 
et al., 2006) but has also lowered hospital costs (Munster et al., 1994). By 
shortening the hospital stay, early closure of the burn wound also reduces 
infective complications (Atiyeh et al., 2005, Kagan et al., 1985). Despite these 
advances, sepsis is still responsible for a large proportion of the deaths of burns 
victims (Bang et al., 1998) and infection still contributes significantly to the 
patient morbidity.  
The first studies into burns and bacteria came shortly after the discovery of 
bacteria and the theory of germs. Lustgarten (1891) implicated Proteus in sepsis 
in 1891 but it was not until many years later that other bacterial studies made an 
impact. Pack (1926) and Aldrich (1933) reported a high incidence of Strep. 
pyogenes  and other bacteria in burns (Lawrence 1992). Further studies endorsed 
this work, Cruickshank  (1935) noted that haemolytic streptococci rates rose six-
fold from admission to 3-6 days later. He also noted that haemolytic streptococci 
were found in higher numbers in the air of the burn ward compared to the general 
surgical ward. In 1940 other bacteria were implicated in burn sepsis such as 
Pseud. aeruginosa, Staph. aureus and Proteus (Heggie and Heggie 1940). In 
1943 penicillin became available and topical applications with antimicrobial 
substances such as silver nitrate became part of mainstream care in the 1960s and 
1970s. 
It has taken many years however for the factors that influence burn wound 
colonisation and the consequences to become clearer.  
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Immediately following a burn, the wound surface is sterile, however 
microorganisms rapidly colonize it. Factors that may influence this include the 
depth and extent of the injury, the causative factor (i.e. flame burns are more 
susceptible to sepsis (Bang et al., 1998)) and history of the injury. For instance 
contamination is more likely in explosive injuries and some industrial injuries 
than a scald by a kettle at home. The site of the burn may increase the risk of 
colonization and type of organism isolated. A perineal burn is difficult to keep 
clean and is more likely to become contaminated by gram-negative 
gastrointestinal flora than a burn of similar size and depth on the forearm. 
Some bacteria can survive the initial insult (particularly in deep partial thickness 
burns) as they maintain a presence in the sweat glands and hair follicles. These 
are typically staphylococci, which colonise the wound within 48 hours unless a 
topical antimicrobial agent is used (Church et al., 2006, Erol et al., 2004).    
Subsequently (around 5-7 days) other microbes colonise the wounds, often from 
the patients’ endogenous microflora from the respiratory tract, gastrointestinal 
tract or skin. These may be gram positive or gram-negative bacteria. 
Colonisation by yeasts or fungi tends to occur later due to the frequent use of 
empirical broad-spectrum antibiotics. The type of organism changes during the 
history of the burn wound and as a result drug sensitivities and resistance also 
changes. These factors should be taken into consideration when starting 
empirical antibiotic therapies (Altoparlak et al., 2004). Erol et al., (2004) took 
periodic swabs from patients on admission, on the 7th, 14th and 21st days of 
hospitalization. The swabs were from the wound site as well as other areas on the 
body (nasal, axillary, inguinal and umbilical). On admission coagulase negative 
staphylococci and staphylococcus aureus were most prevalent. Over time there 
was a decrease in the number of coagulase negative staphylococcus isolated and 
an increase in staphylococcus aureus and pseudomonas. These findings endorse 
a previous study by Vindenes et al., (1995). Of note Erol et al., (2004) found 
35.3 % of wounds were sterile on admission but 86.3 % were colonised by the 
end of the first week and that methicillin resistance of staphylococcal strains 
increased during the study period. At any one of these stages described above 
microorganisms can also be transferred to the patient’s skin or wound by contact 
with the hospital environment (contaminated surfaces, equipment, air, water or 
 62 
fomites) in addition to contamination transferred from the hands of healthcare 
personnel working with and in close proximity to the patient. 
In recent years gram negative organisms have played a more important role in 
burn wound infections partially due to their large number of virulence factors 
and also increasing strains with antimicrobial resistance (Geyik et al., 2003, 
Singh et al., 2003).  One of the key gram-negative organisms that have gained 
prominence in recent years is Acinetobacter baumannii. It is an aerobic, gram 
negative, oxidase negative non-fermenting bacterium (Appleman et al., 2000) 
that is normally a commensal organism but due to growing antibiotic resistance 
is now a key opportunistic pathogen in burns and intensive care units. 
Nosocomial outbreaks of A. baumannii have previously been described in the 
literature and many of the outbreaks have been associated with multiresistant 
strains (Lyytikainen et al., 1995, Mulin et al., 1995 and Simor et al., 2002). 
Multiresistant strains of these species causing bacteraemia, pneumonia, 
meningitis, urinary tract infections and surgical wound infections have been 
isolated from hospitalised patients worldwide (Van Looveren et al., 2004). The 
overall incidence of A. baumannii as a nosocomial infection was 9% in Europe in 
1995 (Vincent at al., 1995) but a higher reported incidence has been found in 
burn units, 13% in a Canadian burns unit (Simor et al., 2002) and 14% in a 
Brazilian unit (Santucci 2003). A number of factors have been identified for the 
risk of acquisition and subsequent mortality of multi resistant Acinetobacter 
baumannii (MRAB). (Acinetobacter baumannii that is resistant to carbapenem 
has been termed MRAB-C).  The factors for acquisition of MRAB include 
receipt of blood products and duration of mechanical ventilation (Simor et al., 
2002), Acute Physiology and Chronic Health Evaluation (APACHE II) score on 
admission (a measure of physiological variables to determine severity of disease) 
and number of intravascular lines placed (Wong et al., 2002). Previous broad-
spectrum antibiotics have been found to play an important role in MRAB 
acquisition (Mulin et al., 1995, Villiers et al., 1998, Ayan et al., 2003). Factors 
associated with mortality include immunosuppression, shock, recent surgery, 
invasive procedures such as central venous or pulmonary catheterization and 
mechanical ventilation (Chen et al., 2005). In the same study mortality was 
significantly associated with lower platelet count and lower serum albumin 
concentration. 
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In addition many outbreaks have been linked to equipment or the inanimate 
hospital environment. This is partly due to the ability of Acinetobacter to survive 
for long periods on dry surfaces (Wendt et al., 1997). Catalano et al., (1999) 
describe the survival of Acinetobacter on hospital bed rails causing sporadic 
outbreaks whilst Neely et al., (1999) report the presence of Acinetobacter on 
computer keyboards in the burns unit. Beck-Sague et al., (1990) again found 
higher rates of Acinetobacter in ventilated patients although found no link to the 
equipment.  
One important aspect not to be forgotten is that transmission via the hands of 
hospital staff can be a frequent cause of spread of infection. Acinetobacter is 
considered a low-grade pathogen and can remain on or in the human body 
without causing illness, and for this reason dissemination via the hands of 
hospital staff may remain undetected (Joly-Guillou 2005). Close adherence to 
standard levels of hand hygiene can have an important impact on reducing or 
eliminating outbreaks of colonization or infection (Chan et al., 2007). Other 
factors that have been implicated in the transmission and spread of infection 
within a hospital or unit include bed occupancy and therefore the turnover of 
patients. The number of procedures or points of contact between the patient and 
members of staff as well as the level of training of the staff involved may also be 
important.  
For those patients with infections possibly caused by Acinetobacter, a β-lactam 
alone or in combination with an aminoglycoside or fluoroquinolone was the 
initial empirical therapy (Meyer 2005). This regimen has become less effective 
due to the appearance of β-lactamases (Rahal and Urban 2000), extended 
spectrum β-lactamases (ESBLs) and enzymes that inactivate aminoglycosides 
(Bergogne-Bérézin and Towner 1996).  
The speed in which Acinetobacter baummannii has become a significant problem 
in hospitals is illustrated by the rise in cases resistant to carbapenem in one unit 
increasing from 0% to 55% between 1998 and 2006 This overall increase 
coincides with the emergence of the MRAB-C OXA-23 clone-1 as the most 
prevalent strain in London and South East England (Wareham et al., 2008). 
There appears to be little clinical difference in clinical outcome in patients with 
bacteraemia from Acinetobacter baumannii and other Acinetobacter species 
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(Choi et al., 2006) but it may be that different clones of MRAB result in different 
patient morbidity or mortality rates. 
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Innate and adaptive immune responses 
Host defences against infection can be divided into innate and adaptive immune 
responses. The innate response is initiated rapidly after a thermal injury by 
stimulating local and systemic inflammatory reactions, which allows time for the 
adaptive immune response to become active. The innate immune system is 
composed of natural barriers to microbial invasion as well as cellular 
(neutrophils, macrophages, NK-cells, and monocytes) and humeral 
(complement) elements (Church et al., 2006). In contrast the adaptive immune 
system is related to T and B cell activation in response to antigens. 
Part of the innate immune system that is being extensively investigated is a 
group of compounds that make up a family of proteins called antimicrobial 
peptides. They are thought to play a key role in skin defence by being able to 
directly kill or inhibit a large variety of bacteria and fungi (Pazgier et al., 2006, 
Durr et al 2006). In addition to this they can also influence other cells in both the 
innate and adaptive immune system. In mammalian skin two groups of anti-
microbial peptide have been discovered, cathelicidins, of which the sole human 
cathelicidin is LL-37, and the defensins of which there are three sub-families. 
LL-37 can promote the recruitment of inflammatory cells directly by stimulating 
leukocyte chemotaxis (Yang et al., 2001) and LL-37 may also have a key role in 
wound healing as it has been shown to induced angiogenesis (Koczulla et al., 
2003). Whilst both defensins and LL-37 have been found in burn wounds studies 
have been limited. Milner and Ortega (1999) studied defensins and showed 
reduced expression in human burn wounds and staining in a number of 
subcutaneous structures and reticular dermis, most notably in eccrine and 
apocrine gland acini (Milner et al., 2004).  
Kaus et al., (2007) examined LL-37 in addition to defensins in burn wounds. 
They found no differences in hCAP-18/LL-37 expression levels when comparing 
burned skin with healthy controls. Further experiments showed In situ 
hybridisation revealed expression of hCAP-18/LL-37, hBD2 and hBD3 at the 
surface of burns was independent of burn depth.  
The study of LL-37 is not only confined to cutaneous wounds, it has also been 
isolated from serum. Lippross et al., (2011) examined the serum profiles of 
defensins, cathelicidins and pro-inflammatory cytokines post trauma and found 
that hBD-2, hBD-3 and LL-37 concentrations were significantly elevated after 
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trauma and followed different characteristic concentration curves. In addition, 
similar patterns of concentration profiles were recorded for hBD-2/IL-6 and 
hBD-3/IFN-gamma.  
The anti microbial properties of LL-37 and other AMPs have led researchers to 
speculate that it may offer an alternative to conventional antibiotics especially in 
the era of growing antibiotic resistance. 
As yet the role of LL-37 in burns wounds is yet to be fully defined, especially 
what happens post the acute injury. In addition no studies have looked at 
systemic levels of LL-37 in burn patients to determine if there is any relationship 
between the magnitude of the injury and it’s subsequent expression. 
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1.5 Hypothesis 
Great advances have been made in burn care in the last forty years with a 
resultant decrease in morbidity and mortality.  
Despite these advances, infection and organ dysfunction are still the most 
frequently reported causes of death.  Multi-organ failure (MOF) is responsible 
for 25-65% of all burn deaths (in Europe) and sepsis for 2%-14% of all burns 
deaths. The increasing presence of multi-resistant organisms makes treating these 
complications even more difficult. Instead of continued reliance on conventional 
antibiotic therapies new treatments should be sought for the treatment of 
infections.  
One problem in burn care is the early recognition of the patients who go on to 
develop sepsis and organ failure. Early identification allows therapies and 
resources to be targeted in a more effective and efficient way.  
This study hypothesizes that the Albumin-Creatinine Ratio (ACR), a marker of 
endothelial dysfunction can be used as a diagnostic tool to predict outcome 
(mortality) and can identify those patients that may develop sepsis and organ 
failure. 
Despite the improvements in burn care and management we hypothesize that the 
reason sepsis and organ failure still make such a contribution to the mortality rate 
is the due to the increased prevalence of multi-drug resistant organisms.  
The impact of acquisition of a multi-drug resistant organism (Acinetobacter 
baumannii) is studied particularly looking at patient outcomes and multi-organ 
failure. 
Because of the growing drug resistance to many antibiotics alternative treatments 
for infections are being sought. One such candidate, an antimicrobial peptide, the 
cathelicidin, LL-37 serves in a protective role in the skin. Its role in the burn 
patient is still unknown. This study hypothesizes that LL-37 is present in the 
acute and healing burn wound and may have activity against multi drug resistant 
organisms.  
It is hoped the results of this study will be clinically relevant and continue to 
improve burn care. 
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1.6 Aims 
By a retrospective analysis of admissions to a burn ICU the clinical utility of 
urinary ACR sampling at admission and post resuscitation in determining 
outcome will be examined. Secondary measures are to investigate the prevalence 
of microalbuminuria in burns patients and to determine any relationships 
between ACR and mechanism of injury, inhalation injury, body surface area 
burnt and length of stay.  
In addition by a retrospective analysis of adult burn patients we aim to determine 
whether ACR can predict the development of sepsis and multi-organ failure in 
the burn ICU setting.  
 
The frequent cause of sepsis and organ failure is infection. We aim to determine 
the impact Acinetobacter baumannii, a multi-drug resistant organism on a UK 
burn unit and its relationship to patient outcomes. 
 
Because of the growing drug resistance to many antibiotics alternative treatments 
for infections are being sought one potential candidate is the peptide LL-37. It’s 
presence and role in acute burn injuries is yet to be defined. We aim to determine 
the presence of LL-37 in skin after a burn injury and subsequently in the healing 
phase compared with normal, healthy controls by immunohistochemistry and rt 
PCR and to examine serum levels of LL-37 and pro-inflammatory cytokines post 
burn injury to investigate any relationships with injury or outcome. 
Finally we plan to examine whether LL-37 has antimicrobial properties against 
Acinetobacter baumannii and therefore potential use in the clinical burn setting. 
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Chapter 2 Albumin creatinine ratio in the burn ICU 
 
2.1.1 Introduction 
 
Definition of Albumin Creatinine Ratio 
Inflammation is an essential part of normal healing. In a small burn this may 
manifest itself as a mild rise in cytokines with no clinical signs. In a large burn a 
major systemic inflammatory response may be seen resulting in endothelial 
dysfunction and a microvascular leak of fluid and protein into the interstitium. 
Almost 40 years ago Parving et al., (1974) showed that there was a correlation 
between microalbuminuria and the increased rate of transcapillary escape of 
radiolabelled albumin in hypertensive and diabetic patients. A link between 
increased systemic vascular permeability to albumin and microalbuminuria was 
therefore made. 
Microalbuminuria is thought to reflect the glomerular component of the systemic 
capillary leak (Gosling 1995). As a result of the increased glomerular 
permeability renal resorption cannot cope with an increase in filtered albumin 
and urinary albumin increases. Small increases in glomerular permeability are 
amplified by the renal concentrating mechanism to produce large changes in 
albumin excretion. This is because normally >99% of filtered albumin is 
reabsorbed by the kidney by mechanisms close to saturation (Sarti et al., 2001). 
Due to the fact the kidneys receive around a quarter of the cardiac output the 
kidneys can convert a 1% increase in vascular permeability to a nine-fold 
increase in urinary albumin (Gosling et al., 1994). 
Since Parving’s findings microalbuminuria has been used as a surrogate marker 
for systemic endothelial dysfunction and a predictor of outcome in a variety of 
surgical and intensive care settings (Vlachou et al., 2006).  
 
Clinically proteinuria is defined as a urine protein concentration above 0.2g/L 
(Vlachou et al., 2006) whilst microalbuminuria is defined as a urinary albumin 
concentration of 30-200 mg/litre-1 (Yew and Pal 2006). To correct for variations 
of urinary flow it is normally expressed as the urinary albumin to creatinine ratio 
(ACR). This is variably referred to as ACR or microalbuminuria/urinary 
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creatinine ratio (MACR). For clarity, in this text it will be referred to as ACR 
even if MACR was used in the original reference. Normally to calculate the 
albumin excretion rate an overnight or twenty-four hour collection of urine is 
used, however assuming the urinary creatinine ratio remains constant (Gosling 
1995) the ACR can be calculated from a bedside spot urine test.  
In many of the earlier references when an overnight or twenty-four hour 
collection of urine was used to determine the albumin excretion the results are 
expressed in mg/litre-1. In later references the ACR is expressed in mg mmol-1 or 
mg/g. In this work the ACR is expressed in mg mmol-1 however when quoting 
other results the units used in the original reference will be used. 
The normal value of ACR is defined as less than 2.3 mg mmol-1. The presence 
of microalbuminuria in normal healthy adults is 3.3% but may be up to 29% in 
adults with diabetes or 18.8% in those with hypertension (Jones et al., 2002).   
 
Patients sustaining burns injuries are at a high risk of systemic inflammatory 
response syndrome (SIRS). When severe, SIRS leads onto organ failure. The 
inflammatory response to the injury, trauma or infection is wide spread and may 
damage organs distant from the initial insult. Although the sequence of 
inflammation, organ failure and sometimes ultimately death is well recognised 
the exact mechanisms are still poorly understood. One difficulty encountered 
when caring for the patients is identifying at an early enough stage those that 
may develop SIRS and multi-organ failure in order that the clinician may try and 
modulate the inflammatory and immune response. 
One of the first features of inflammation is an increased capillary permeability to 
plasma proteins. This can occur within a few minutes after injury and can take 12 
hours to return to normal (Vlachou et al., 2006). 
Albumin, globulin and fibrinogen are the major proteins present in the plasma. In 
health albumin, which is formed by the liver, plays a number of roles in the 
human body. Albumin helps in the transport of bilirubin and free fatty acids and 
well as playing a lesser role in the transport of cortisol and some of the thyroid 
hormones. The major function of albumin however, is to provide colloid osmotic 
pressure in the plasma. The colloid osmotic pressure tends to cause fluid 
movement by osmosis from the interstitial spaces into the blood. This osmotic 
pressure exerted by the plasma proteins normally prevents significant loss of 
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fluid volume from the blood into the interstitial spaces. Due to its charge and 
weight in the healthy patient almost all the albumin is reabsorbed and not filtered 
by the kidneys. 
 
Using radiolabelled albumin it has been found that the transcapillary escape of 
albumin increases significantly in patients with malignancies and infection, 
septic shock and cardiac surgery (Fleck et al., 1985). Gosling et al., (1988) found 
urinary total protein and albumin levels were raised after a variety of general 
surgical procedures on humans and postulated that measurements of protein 
excretion may be used to predict postoperative complications. Subsequent work 
by Shearman et al (1989) found low proteinuria is a very early response in acute 
pancreatitis, and thought that it may reflect the severity of inflammation. 
This combined evidence resulted in a hypothesis that following acute 
inflammatory insults urine albumin reflects systemic endothelial dysfunction as 
part of the early inflammatory response (Gosling et al., 1988). 
 
2.1.2 ACR in non-burn patients 
Medical patients 
In both diabetic and non-diabetic patients microalbuminuria has been recognised 
as an important risk factor for renal and cardiovascular disease (Ritz et al., 2010.) 
Further studies have demonstrated an association between urine albumin and 
albumin transcapillary escape rate and evidence of systemic endothelial 
dysfunction in normal subjects and those with diabetes (Feldt-Rasmussen 2000, 
Pedrinelli et al., 2001). 
Microalbuminuria has been found to be predictive of outcome or has shown an 
association between the urinary albumin and the severity of the inflammatory 
insult in a number of acute medical conditions such as ischaemia reperfusion 
injuries (Matsushita et al., 1996), meningitis in children (Roine 1993), acute 
pancreatitis (Shearman et al., 1989) and anaphylactic shock (Wood et al., 2000). 
Disease activity (Mahmud 1994) and tumour necrosis levels in patients with 
inflammatory bowel disease (Mahmud 1995) have been correlated with urinary 
albumin. Furthermore ACR after an acute myocardial infarction has been found 
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to be a good predictor of short-term mortality and long-term mortality (after a 10 
year follow-up) (Berton et al., 2010).  
 
Trauma, Surgery and Urinary Albumin 
Urinary albumin has been shown to be raised post surgical procedures (Gosling 
et al., 1988) and after trauma. In trauma patients the urinary excretion of total 
protein, albumin and gamma glutamyl transpeptidase (GGT) activity was 
assessed over the 6 days post trauma. The excretion of total protein and albumin 
was positively correlated with injury severity (Gosling and Sutcliffe 1986). 
Microalbuminuria seems not only to be raised according to the severity of the 
injury but also seems to be useful for predicting postoperative complications. 
Gosling (1995) has reported that in both surgical and trauma patients whose 
microalbuminuria is maintained and does not return to normal within 4 and 8 
hours (respectively) post insult it has been possible to predict subsequent organ 
failure. Patients who sustained blunt trauma have shown that the urinary albumin 
is proportional to the severity of the injury (Gosling et al., 1994, Gosling and 
Sutcliffe 1986) and is predictive of acute lung injury and acute respiratory 
distress syndrome (Pallister et al., 1997). The urinary albumin levels taken within 
4 hours of the start of aortic surgery have been found to be able to predict those 
patients who would later develop pulmonary complications that were non 
cardiogenic in origin (Smith et al., 1994). Honarmand et al., (2009) demonstrated 
that microalbuminuria (determined by a sample taken on the first day of 
admission) in critically ill trauma patients also estimates the risk of prolonged 
mechanical ventilation. Not all studies have found that ACR predicts 
postoperative complications. Norwood and Sayers (2005) studied forty-four 
patients undergoing elective infrarenal abdominal aortic aneurysm repair and 10 
control patients undergoing major abdominal surgery. Urine samples were taken 
before, immediately after and 24 h after the procedure. Whilst the urine samples 
of the control patients were not raised post operatively compared with the study 
group, the changes in ACR in the study group had no correlation with the 
development of postoperative complications. 
Sarti et al., (2001) studied forty children undergoing elective surgery (all patients 
with diabetes, nephropathies, recent infections and malignancies were excluded) 
and found that the ACR showed a progressive increase during surgery and 
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subsequent decrease after surgery. In most cases the pre-operative value was 
achieved within 24 hours after the end of surgery. There was a significant 
correlation between the increase in ACR and the severity of the surgical trauma 
as measured by the Oxford Surgical Stress Score (This is a scoring system based 
on the main factors that contribute to surgical stress: volume of blood loss, the 
degree of superficial dissection, the extent of visceral trauma and the duration of 
the operation). This study is important because it shows that the paediatric 
population responds in the same way as adults.  
In addition two patients showed a rise in ACR after the initial postoperative 
value returned to normal but before the clinical appearance of a surgical 
complication (peritonitis and a large subcutaneous haematoma). A further patient 
showed a persistent rise in ACR before the appearance of a septic complication. 
This useful finding, of ACR rising prior to a septic episode has been endorsed by 
De Gaudio et al., (2000). They examined 55 patients post major abdominal or 
vascular surgery. Again any patient with any pathological condition (such as 
hypertension, diabetes or kidney failure) that may be associated with a chronic 
baseline presence of microalbuminuria was excluded. They found that the 
postoperative patients that developed sepsis showed an increase in glomerular 
permeability as shown by the ACR. The increase of the ACR was also positively 
correlated to the increase in the sepsis related organ failure assessment (SOFA) 
score (This is a scoring system based on physiological parameters that 
determines the degree of organ failure a patient may be suffering from). 
A similar pilot study by MacKinnon et al., (2000) looking at a similar number 
but broader range of patients demonstrated that microalbuminuria 6 hours after 
admission to a general ICU could identify patients at risk of developing multi-
organ failure and those at a greater risk of death. 
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2.1.3 Microalbuminuria as a predictive tool for outcomes in the 
Intensive Care Unit (ICU). 
Further studies have examined the use of the urine albumin-creatinine ratio in the 
ICU setting (Abid et al., 2001, Gosling et al., 2003, Gosling et al., 2006, 
Thorevska et al., 2003).  The general conclusion from these studies is that ACR 
may have a predictive role in determining organ failure and /or mortality. One of 
the problems is that the studies tend to have wide patient demographics with 
some not differentiating between medical, surgical, or trauma patients, there are 
also different cut-off values for ACR, and variability in the timing of the tests 
and methods of quantification. This was confirmed in a systematic review by 
Gopal et al., (2006) who looked at all studies between 1951 and 2004 that 
provided data on the diagnostic accuracy of microalbuminuria on the intensive 
care unit. From 35 potentially relevant abstracts only 9 were included in their 
final review. Their conclusion was that microalbuminuria may hold promise as a 
predictor of illness severity and mortality on the ICU but further studies should 
be carried out. 
 
2.1.4 ACR and physiology scoring systems 
Although ACR seems to have a useful potential for predicting outcomes, it is 
necessary to see how well it fairs against the conventionally used outcome 
measures. 
Gosling et al., (2003) looked at a mixed cohort of 140 patients (including 11 
burns patients) by measuring ACR within 15 minutes of admission to the 
intensive care unit and comparing it to APACHE II and SAP II scores (The 
APACHE and SAP scores are two scoring systems looking at physiological 
parameters that are frequently used in the ICU setting to predict outcome and 
severity of illness). They found that for surgical, trauma and burns patients but 
not medical patients microalbuminuria predicted death as well as APACHE II 
and SAP II scores calculated after 24 hours. 
Of note they found that in the burns cases ACR was positively associated with 
ICU stay (as well as highest serum CRP and highest bilirubin). 
A further larger study by Gosling et al., (2006) examined a mixed cohort of 
medical (205 patients) and surgical (225) patients. In this study ACR was 
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measured on admission and after 4-6 hours. It was found that the urinary albumin 
changes rapidly within the first six hours post ICU admission and that ACR 
predicted ICU mortality and inotrope requirements as well or better than 
APACHE II and SOFA scores. Again this study had a small number of burns 
patients (n=21). 
Although both of these studies include burns patients the numbers examined are 
too small to be able to extrapolate the results to all burns patients. Neither study 
comments on the size of the burn. Previous work, mentioned above, has shown 
that the rise in urinary albumin is related to the severity of the trauma and one 
might hypothesize that the greater the total body surface area involved in the 
injury may be reflected in the level of the rise of the microalbuminuria.  
Secondly although the presence of inhalation injuries was noted in the first study 
(Gosling et al., 2003) no mention was made of whether it affected 
microalbuminuria. Again it might be hypothesized that as urinary albumin has 
predicted pulmonary complications post surgery and blunt trauma it may also do 
so where there has been a direct insult to the respiratory system. 
 
2.1.5 Burn wounds and ACR 
There have been only a limited number of studies looking directly burns and 
microalbuminuria. The first by Vlachou et al., (2006) looked at 43 adult burns 
patients. Serial urine samples were taken between 2-36 hours after injury (every 
hour for the first 12 hours and then 4 hourly to 36 hours. In addition urine 
samples to determine the ACR were taken during 44 episodes of wound 
manipulation during the same period. Their results showed that median ACR was 
highest 2 hours after injury returning to normal within 6 hours. Furthermore the 
ACR remained high for up to 8 hours in the presence of inhalation injury, 
accelerant use or alcohol intoxication. The ACR showed a positive correlation 
with TBSA at 3 and 7 hours post injury (p<0.05). However the percentage of full 
thickness burn (%FTB) was significantly correlated with ACR at 3-7 hours post 
injury.   
One of the most important results to come out of the study was the strong 
association between ACR and wound manipulation (escharotomy or wound 
scrubbing). During wound manipulation the urinary specimens were collected at 
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more frequent intervals (half hourly during the procedure) with a baseline level 
prior to the manipulation. 
An increase in ACR within 30 minutes of a surgical insult has been noted 
previously when it was recorded to rise 20 minutes after the start of 
cardiopulmonary bypass (Tsang et al., 1998) but most importantly in Vlachou’s 
study (2006) was the demonstration of how sensitive the microvascular response 
is to pro-inflammatory stimuli as even simple wound scrubbing provoked a 
measurable response. This obviously has a profound impact on using ACR as a 
predictive tool. 
One fault common to many of the studies previously listed is that no mention is 
made of the timing of the urinary sampling and any prior procedures. Patients, 
especially those admitted to ICU may undergo a variety of invasive tests or 
monitoring modalities that could subsequently, albeit transiently affect the ACR. 
The first study to look at outcomes was by Yew and Pal (2006) and was a 
retrospective analysis of burns of at least 40% TBSA or significant inhalation 
injury in 21 patients. Non-thermal burns and paediatric patients were excluded 
from this study. 
They found that a mean ACR of 20 mg mmol-1 or more was associated with a 
poorer outcome in their cohort. They also noted a biphasic variation of mean 
ACR in those patients that died with either an early peak in the first week or a 
later peak a month later, which they ascribe to the “two cascades of organ 
failure”. The early peak occurring during the first week is caused by failure of 
reversal of burn shock. The later cascade is typified by an infectious process and 
is usually associated with pneumonia (Yew and Pal 2006). Unlike other studies 
they did not find a correlation between ACR on admission and outcome. As the 
authors themselves note, this is most likely due to the fact that most patients in 
their cohort are stabilised in a peripheral hospital prior to transfer therefore the 
admission ACR in ICU may not reflect early ACR elevation due to the burn 
injury. 
A further study by Vlachou et al., (2008) looked specifically at ACR during burn 
excision. Serial half hourly ACR levels were measured in 25 adult patients 
during 44 burn excision procedures. They found that ACR increases during 
surgery (maximally a three-fold rise 1.5 hours from the start of surgery); there 
was no significant difference between the pre-operative ACR for those that 
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received blood transfusions and those that did not. Most importantly was the 
finding that in 15 patients that suffered post operative complications the ACR 
was significantly higher both pre and peri-operatively. Lastly, they demonstrated 
that there was an increased ACR response to surgery if the surgery was carried 
out seven days or more after the injury. 
In the same year, Cochran et al., (2008) published their results investigating 
ACR compared with injury severity and resuscitation demands. They examined 
30 patients and looked at time to resuscitation (defined as the time of conversion 
from lactated Ringers solution to maintenance fluids or when the calculated 
maintenance rate for fluids was maintained for two hours). They hypothesized 
that an ideal marker of inflammation and associated resuscitation demands would 
help optimise burn shock resuscitation and also minimise secondary 
complications and therefore that ACR would correlate with injury severity or 
burn shock parameters. Their study found no correlation with TBSA, volume of 
resuscitation fluid used and in contradiction to other studies the presence of 
inhalation injury.  
There may be several reasons for their results; firstly the sample size may be too 
small. Secondly they make no mention of the precise timings of the ACR 
sampling. Each of the three measurements could have been taken over a wide 
range of times. As previous studies have demonstrated the sensitivity of the ACR 
may mean the timing or the limited number of samples may not have reflected 
the severity or duration of the inflammatory response. 
  
 78 
2.2 Aims  
To examine the clinical utility of urinary ACR sampling at admission and post 
resuscitation in determining outcome by a retrospective analysis of burns 
admissions to a burn ICU between November 2003-September 2009.  Secondary 
measures were to investigate the prevalence of microalbuminuria in burns 
patients admitted to ICU and to determine any relationships between ACR and 
mechanism of injury, inhalation injury, body surface area burnt and length of 
stay.  
 
2.3 Methods 
2.3.1 Clinical Setting 
The Burns Service compromises twenty beds including four intensive care and 
four high dependency beds. There are twelve low dependency / rehabilitation 
beds. The unit is a tertiary referral centre and accepts patients from a population 
of over 6 million people. Patients are also taken from out of traditional catchment 
areas and occasionally internationally. 
A multidisciplinary team including microbiologists, pharmacists, anaesthetists 
and burn surgeons review all major burns daily. The Parkland formula is used in 
the initial resuscitation to maintain a urine output of 0.5 ml/kg/h in adults and 1 
ml/kg/h in children. Nutritional supplementation is via nasoduodenal enteral 
nutrition with high calorie, low fat formulas. As part of the burn treatment 
protocol, gastric ulcer prophylaxis is performed with H2 antagonists. Low 
molecular weight heparin (40mgs/day) is prescribed daily. Early excision and 
grafting is routinely performed for deep burns that would take more than two 
weeks to heal without surgical intervention using allografting, auto-grafting or 
dermal substitutes depending on the individual characteristics of burn injuries.  
Retrospective collection of data regarding demographic details, mode of injury, 
examination findings was from clinical records. All other results were obtained 
from the Burns ITU computer system MetaVision (iMDsoft, Massachusetts, 
USA). 
All patients admitted to the burns unit between November 2003 and September 
2009 that fulfilled the unit’s admission criteria were included in the study.  
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2.3.2 Exclusions 
Exclusions were those patients with non-thermal processes including 
desquamating skin disorders, meningococcal septicaemia, necrotising fasciitis 
and purpura fulminans; patients who stayed in the ITU for less than 24 hours 
were excluded; patients who were transferred from other hospitals more than 5 
days post injury; patients with multiple injuries (where the burn was clinically 
judged not to be the main injury); patients for compassionate care only; patients 
with no or inadequately recorded ACR results. 
Patients with a diagnosis of Type I or Type II diabetes mellitus were included. 
Parameters recorded included patient characteristic data such as age, gender, co-
morbidities, injury data including time of injury, mechanism and TBSA. ACR 
was routinely measured on admission and recorded daily. 
Inhalation injuries were determined by appearance on bronchoscopy. Smoke 
inhalation injury is restricted to injury below the glottis caused by products of 
combustion. The diagnosis requires both of the following: History of exposure to 
products of combustion and bronchoscopy relevant signs below the glottis. The 
signs observed below the glottis that indicate smoke inhalation include 
carbonaceous material, oedema, or ulceration. Erythema or carbon staining in the 
absence of evidence of other signs of injury was not considered an indicator of 
smoke inhalation injury. 
 
2.3.3 Analysis of urine 
On admission a sample of urine was collected within the first six hours, 
subsequently a fresh sample of urine was collected daily via an in-dwelling 
urinary catheter at 06.00 daily for the duration of the admission.   
ACR was measured using the DCA 2000 Analyser manufactured by Bayer 
(Parsons et al 1999). It runs a quantitative assay for microalbumin and creatinine 
in the urine sample. Only 0.4mls of urine is required to perform the analysis. The 
principle of measurement of microalbumin is based on immunoturbidmetry, and 
that of creatinine is based on colourimetry. The albumin to creatinine ratio is 
calculated by the machine and expressed in mg mmol-1 after 7 minutes. (Yew 
and Pal 2006) 
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2.3.4 Statistics 
The analysis performed was a bootstrap analysis and regression analysis. 
Regression analysis has been performed using the computer program R (R 
development Core Team 2011).  
Bootstrap analysis was chosen because a paper submitted to the journal Burns as 
part of this work had been rejected as the statistical analysis (ANOVA) was 
thought by the reviewers to be too simple. Advice was then sought from a 
medical statistician (Dr Mike Parker, Anglia Ruskin University, Chelmsford) 
who advised the bootstrap analysis. All bootstrap and regression analysis in this 
thesis was performed by Dr Mike Parker. 
Bootstrap analysis is a computer based method for assigning measures of 
accuracy to sample estimates. For this analysis it is assumed the observations 
form an independent and identically distributed population. The computer 
programme can implement bootstrapping by constructing a number of re-
samples of the dataset and of equal size to the observed dataset, which is 
obtained by random sampling with replacement from the original dataset. The 
idea of bootstrapping is that the sample collected is the best guess of the shape of 
the population it was taken from, for instance two peaks in distribution in the 
sample would not be well approximated by a Gaussian curve, which has only one 
peak. 
Bootstrapping is used when parametric inference is in doubt or requires very 
complicated formulas for the calculation of standard errors. Bootstrapping also 
checks the reliability of the dataset. 
 When bootstrapping is performed, repeated sampling is used (in this case 9999 
times) which gives a histogram of bootstrap means i.e. it produces a simulated 
distribution of the statistic we are interested in. This gives an estimate of the 
distribution of the mean from which one can answer how much the mean varies. 
Bootstrapping of the mean allows one to construct a confidence interval for the 
mean. It has been found that the simulated distribution has a shape that distorts 
the confidence limits and the distribution tails off more slowly that the Normal 
distribution (so called bias, although it is not bias in the conventional sense) so a 
correction is applied to make it tail off quicker (the accelerated bootstrap). This 
is remedied by using the "accelerated and bias-corrected" approach. When an 
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accelerated bootstrap was performed it is noted in the main text. This is to 
improve the accuracy of the confidence limits (rather than correcting for bias in 
the conventional sense of the word) and is performed within the computer 
package. 
A 95% confidence limit (interval) has been used throughout this study when 
looking at the bootstrapping results. The confidence interval describes a range of 
values within which we can be reasonably sure that the true effect actually lies. 
(The true effect being the experimental intervention’s effect compared with the 
control intervention). The confidence interval is based on the hypothetical notion 
of considering the results that would be obtained if the study were repeated many 
times. So if a study were repeated infinitely often, and on each occasion a 95% 
confidence interval calculated, then 95% of these intervals would contain the true 
effect. A narrow confidence interval gives us greater certainty in this, but if the 
interval is wider the uncertainty is greater. If the confidence interval includes 0 
we can say that there is no significant difference between the means of the two 
populations, at a given level of confidence (in this study 95%). In addition whilst 
a result may show statistical significance it should always be examined in the 
clinical context to determine the relevance of the result to clinical practice. 
(http://handbook.cochrane.org/chapter_12/12_4_1_confidence_intervals.htm).  
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2.4 Results 
2.4.1 Demographics 
A total of 547 patients were eligible for the study from which 202 were 
excluded. The reasons for exclusion are summarised in the flow chart Figure 1.   
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Figure 2.1. Flow chart showing the number of burns patients recruited and 
reasons for exclusions. Data shows 547 patients admitted to the burn ICU 
between November 2003-September 2009 were eligible for the study. After 202 
exclusions, 345 adult and paediatric patients were studied of which 243 were 
adults and 102 children. 
 
 
Necrotising fasciitis 
n=1 
Patients n=547 
Non-desquamating skin 
conditions n=25 
Compassionate care 
n=28 
Meningococcal septicaemia n=3 
Transfer >5 days post injury n=14 
Purpura fulminans n=1 
Multiple injury n=1 Admission to ICU due to 
aspiration during surgery n=4 
Self discharge n=1 
Patients following 
exclusions n=345 
dult patients n=243 Paediatric patients n=102 
Inadequate results n=124 
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Figure 2.2. The number of patients in each age group admitted to the burns 
ITU.  The data demonstrates the age in years, of the patients admitted to the burn 
unit in the study period, November 2003-September 2009. The data shows the 
percentage of the total each group contributes with the total number in the group 
in brackets. Each age range is a decade except for the patients aged 80 years or 
greater which form one group.     
 
The demographics of the population studied showed that out of the 345 patients 
studied the mean age (range) is 33.2 years (1 month-95 years old). Figure 2.2 
demonstrates the number of patients in each age group and shows that almost 
half the patients (49%) were in the three youngest age groups (ages 0-9, 10-19 
and 20-29). This is in keeping with similar studies of westernised urban 
populations. Of note the majority of injuries in the 0-9-age range tended to be 
scalds (water or oil), whilst flame burns predominated in the older age ranges 
(data is not shown) again this is in keeping with similar studies of westernised 
urban populations.  
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18% (66)
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Figure 2.3. The number of patients within each range of TBSA% burned. 
The data shows the percentage and number (in brackets) of patients within each 
range of TBSA% burned admitted to the burn unit in the study period, November 
2003-September 2009. Each group is a range of 15% except for the group 
representing burns of 75-100%. 
 
 
Figure 2.4. The mechanism of injury resulting in the patients being admitted 
to the burns ITU. The data shows the cause of the injury leading to admission 
for both the adult and paediatric population. 
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Within the 345 patients, 90 patients sustained inhalation injuries (26.1%) (Table 
2.3) and 44 patients died (12.75%). There were 220 male patients and 125 female 
patients (table 2.2). The mean ACR on admission was 7.21 mg mmol-1 (range 
0.09-192 mg mmol-1) from the 301 patients that had a value recorded on 
admission   (table 2.1). 
The mean length of stay was 15.3% (1-175 days) with the mean stay per 
percentage burn being 0.6-days/%burn. 
Normally, a burn ITU admits patients with significant injuries only and does not 
typically admit patients that do not need formal resuscitation. The cut off figure 
is 10% for children and 15% for adults. Burns small than this can be treated in 
the standard burn ward. There are exceptions however, which include chemical 
burns and small body surface area burns in high-risk populations (paediatric or 
elderly) or particular areas of the body such as the face (particularly eyes and 
mouth) or the perineum. Figure 2.3 summarises the number of patients and the 
percentage of body surface area burn sustained. It can be seen that 28% of burns 
are in the group 0-15 TBSA%. This large number of smaller burns tended to be 
in the younger age groups and the elderly where even a small burn is potentially 
life threatening. The mean TBSA% sustained (range) was 28.2% (2-90%) 
demonstrated in table 2.1. 
The mechanism of injury contributing to admissions to the burn unit is 
summarised in figure 2.4. In keeping with other units that serve a generally urban 
population the majority of injuries are flame burns and scalds. The lack of major 
industry locally means there are relatively few chemical burns, of those admitted 
about half were accidents in or around the home compared with in factories or at 
work. The three contact burns were due to falls against radiators or other heating 
equipment. The electrical burns were mainly high voltage burns associated with 
industrial cables being severed or touched rather than domestic supply accidents. 
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2.4.2 ACR on admission 
On admission 301 patients had a urinary sample taken and ACR recorded on 
admission (defined as being taken within 6 hours of coming to the unit). One 
hundred and thirty seven of these patients (45.5%) had an elevated ACR (>2.3 
mg mmol-1). Forty-four patients did not have an ACR recorded within 6 hours of 
admission. The mean ACR on admission (range) was 7.2 mg mmol-1 (0.3-120). 
Post resuscitation, (defined as 48 hours post admission) mean ACR was 4.38 mg 
mmol-1 (0.34-77.1). 
 
 
Variable Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
ACR at 
admission 7.21 19.45 0.09 0.98 2.12 4.55 192.00 301 
Age 33.25 23.78 0.10 14.00 31.00 51.00 95.00 345 
% TBSA 28.23 19.02 2.00 15.00 25.00 35.00 90.00 345 
Table 2.1: Summary of statistics of variables used in analysis of ACR on 
admission 
 
 
Sex Count Percentage 
Male 220 63.8 
Female 125 36.2 
Overall 345 100.0 
Table 2.2: Sex of patients-number and percentage of total 
 
Inhalation Count Percentage 
No 255 73.9 
Yes 90 26.1 
Overall 345 100.0 
Table 2.3: Number of inhalation injuries 
Tables 2.1-2.3 are summaries of the statistics used in the regression model. They 
are included to demonstrate that the population studied is typical of a large burn 
ICU in Western Europe and are comparable with data produced by similar units. 
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When looking at the data for the mechanism of injury it became apparent that the 
numbers of patients suffering from some of the mechanisms was very small. The 
first three categories in Table 2.4 below contain small numbers and would mean 
that if the variable were included in a regression model some regression 
coefficient estimates would be unreliable.  
 
 Count Percentage 
Chemical 9 2.6 
Contact 3 0.9 
Electrical 18 5.2 
Flame 241 69.9 
Scald 74 21.4 
Overall 345 100.0 
 
Table 2.4: Mechanism of injury resulting in admission for all patients 
eligible for inclusion in the study.  Data shows the number and percentage of 
patients being admitted for each mechanism of injury.  
 
To avoid this, these three categories (contact, chemical and electrical) have been 
combined in a derived variable- Mechanism 3 (Table 2.5). One problem with 
grouping mechanisms of injury together is that different mechanisms can affect 
the patient in radically different ways and thus the results can also be skewed. 
Electrical burns, for example may have occult injuries that the total body surface 
area percentage may not reflect. For instance a high voltage electrical injury may 
only ‘burn’ a few percent of TBSA (at the entry and exit points or where clothing 
has caught fire) but also cause extensive internal damage, such as muscle 
damage. It is unknown what effect this may have on the ACR compared with a 
straightforward thermal injury. Of the few other studies looking at burns ACR in 
the ITU setting Vlachou et al., (2008) looked at only flame burns making direct 
comparison to our study group difficult because of the mixed aetiology of this 
cohort of patients. Gosling et al., (2003) examined 11 burn patients but did not 
specify mechanism of injury.  
After statistical advice (Dr Mike Parker, Anglia Ruskin University, Chelmsford) 
the three mechanisms, chemical, contact and electrical injury were grouped 
together to ensure the regression model was as accurate as possible accepting 
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that larger data sets for the burns caused by chemical, contact or electrical 
injuries may change the results.  
 
Mechanism Count Percentage 
Flame 241 69.9 
Scald 74 21.4 
Mechanism 3 30 8.7 
Overall 345 100.0 
 
Table 2.5: The mechanism of injury sustained-revised table.  The revised data 
from table 2.4 for mechanism of injury having combined chemical, contact and 
electrical as one mechanism (mechanism 3). 
 
 
A multiple regression model was preformed looking at the log ACR at admission 
versus a number of variables that might influence ACR. Only 301 patients had 
their admission ACR values recorded so all statistics discussed in relationship to 
admission ACR refer to these patients only. The studied variables were: Age, 
TBSA%, sex, inhalation and mechanism. Please see Appendix I for full details 
and statistical analysis performed (Appendix I, section 2, figure 1). Further 
analysis with different regression models is also included in Appendix I (Section 
3). 
In summary the sex of the patient, inhalation injury and mechanism had no 
influence on the ACR value on admission. The two other factors that consisted of 
continuous variables, TBSA% and age are looked at in more detail. 
 
The fit of simple regression lines with continuous variables are shown below. 
The standard errors and 95% confidence limits for the fitted regression line have 
been obtained using a bootstrap. This involves taking repeated random samples 
of the data and performing calculations of the resulting distribution of the 
estimate of interest. In the bootstrap analyses here 9999 samples have been 
selected. The bootstrap analyses were performed using R package boot (Canty 
and Ripley 2010).   
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Figure 2.5. Log ACR at admission against TBSA%. Data shows the 
correlation between the log ACR at admission against the percentage of total 
body surface area burned. Regression analysis was carried out using R package 
boot (Canty and Ripley 2010). The regression slope obtained was 0.00484; 
Bootstrap CI (95%)  (-0.00359, 0.01426) shows there was no statistical 
significance.  
 
 
Looking at the regression line in Figure 2.5 demonstrates that in the 301 patients 
who had ACR taken at admission (within 6 hours of arrival) there was no 
statistically significant link between the ACR on admission to the size of the 
burn sustained. Although the slope of the regression line is positive the breadth 
of the confidence interval shows that any effect of TBSA% on admission ACR 
would be zero or very small. This corresponds with what can be found clinically. 
The TBSA%, whilst giving an indication of the scale of the injury does not 
always reflect the severity of the burn i.e. a 10% burns that extends to muscle of 
bone may be more severe than a 25% partial thickness burn. 
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Figure 2.6. Log ACR at admission against age. Data shows a scatter plot of the 
correlation between Log ACR at admission against age. Regression analysis was 
carried out using R package boot (Canty and Ripley 2010). The regression slope 
obtained was 0.00779; Bootstrap 95% confidence interval (0.00097, 0.01455) 
shows there was statistical significance. 
 
Figure 2.6 demonstrates that as the age of the patients increased their admission 
ACR was also higher. This was statistically significant. There are several ways to 
interpret this result. Firstly it is known that the ability to respond to injury and 
illness tends to decrease with age, as organ function tends to deteriorate with 
time. It may be possible that with age the physiological response to burn injury is 
altered and this is reflected in an increased capillary permeability and therefore 
higher ACR. However it must be noted that diabetic patients and a number of 
patients with cardiovascular disease also have raised ACR (Ritz et al., 2010 and 
Feldt-Rasmussen 2000, Pedrinelli et al., 2001) and diabetes and cardiovascular 
disease are more likely to be seen in an older population. It is therefore unclear 
whether the higher ACR seen in older patients is due to increased vascular 
permeability that occurs with age or with other medical illness that are more 
frequently associated with age, or elements of both. It would require further 
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analysis of the data to determine the influence of associated medical illnesses on 
the ACR the patients.  
 
2.4.3 Length of stay in the ICU related to ACR 
The use of log length of stay and log ACR produce straight-line relationships. 
However, for the data considered here this has not produced model residuals that 
are normally distributed as required for statistical inference. A residual is the 
difference between the actual value of a variable and the value of variable that 
was predicted by a statistical model. Bootstrapping is called "model-based" 
where the model residuals are repeatedly sampled, and each sample of residuals 
provides a new set of estimates of the model's fitted terms. By producing a large 
number of such estimates one can use the observed statistical distribution of the 
estimates to obtain confidence limits. The confidence limits for the regression 
coefficients are therefore biased-corrected and accelerated bootstrap estimates 
obtained using R functions boot and boot.ci from the R package boot (Canty and 
Ripley 2011, Davison and Hinkley 1997). Further explanation of confidence 
intervals, bias correcting and the accerated bootstrap is givenon pages 80-81.  
 
Peak ACR 
To determine if any relationship existed between the length of stay in the ICU 
and the ACR the first aspect to be examined was the peak ACR during the in-
patient stay or until time of death. A summary of the statistics used are in the 
analysis of peak ACR are detailed in Appendix I Table 1. 
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Figure 2.7. Log of length of stay against log of peak ACR. Data shows the 
correlation between log of length of stay in the ITU (days) against log peak 
ACR. Regression analysis was carried out using R package boot (Canty and 
Ripley 2010).  The scatter plot has regression lines fitted separately to the 
groups. The alive group (open triangle and solid line) regression slope obtained 
was 0.67; Boot strap confidence levels of 95% (0.581, 0.761) showed statistical 
significance. Died group (closed circles and dashed regression line) regression 
slope was 0.202; Boot strap 95% confidence levels (-0.091, 0.482) showed no 
statistical significance. 
 
There is an increasing trend in length of stay with increasing peak ACR for the 
patients that survived which is demonstrated in figure 2.7, this is statistically 
significant. If it is accepted that ACR reflects the degree of inflammation and 
therefore injury, then it may be expected that those patients with worse injuries 
have a larger ACR. Those patients with more significant injuries (if they survive) 
tend to need more surgical interventions and normally have a longer course of 
treatment than those with small injuries.  This association of length of stay with 
peak ACR is not statistically significant for the patients that died. The trend fails 
to be established for the patients that died because there are few cases with the 
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lower values of peak ACR, and hence the range of the values is too limited to 
make it clear that a relationship exists. 
 
 
 
 
Figure 2.8. Log of length of stay per percent TBSA against log of peak ACR 
Data shows the correlation between log of length of stay per percent TBS against 
log peak ACR. Regression analysis was carried out using R package boot (Canty 
and Ripley 2010).  The scatter plot has regression lines fitted separately to the 
groups. The alive group (open triangle and solid line) regression slope obtained 
was 0.523; Boot strap confidence levels of 95% (0.441, 0.605) showed statistical 
significance. Died group (closed circles and dashed regression line) regression 
slope was 0.006; Boot strap 95% confidence levels (-0.325, 0.336) showed no 
statistical significance. 
 
Traditionally the length of stay has been estimated by the TBSA% with every 
percentage of the body affected equalling one day in the hospital so a 30% burns 
might be expected to stay 30 days. Now the average length of hospital stay for 
most serious burn injuries can be expected to be only 0.5 days per percent of 
TBSA that is burned. However as noted before a burn of 10% full thickness may 
be a more significant injury that a 20% superficial burn. For this reason the 
length of stay per percent TBSA is often used as it gives an idea of the severity 
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of the injury and allows a clearer comparison when looking at different units 
data. We therefore looked at the length of stay per TBSA% against peak ACR. 
Like figure 2.7, figure 2.8 shows that there is an increasing trend of length of 
stay per percent burn with increasing peak ACR for the patients that survived. 
This is statistically significant. Although the TBSA% does not always correlate 
with the extent of the injury in general the larger the TBSA% burned the greater 
the injury and therefore the greater the endothelial dysfunction and ACR.  This 
trend is not statistically significant for the patients that died. The trend fails to be 
established for the patients that died because again there are few cases with the 
lower values of peak ACR, and hence the range of the values is too limited to 
make it clear that a relationship exists. 
 
From the above data it is clear in the patients that survived there was a clear 
relationship between the peak ACR and the length of stay. Whilst this may have 
no clinical use, (as one can never predict when the peak ACR value will be either 
in the patients that survive or die) from those results one might hypothesize that 
those patients with greater injuries or inpatient complications (displayed by a 
higher ACR peak) have more systemic endothelial dysfunction and therefore 
require more intensive therapy intervention (requiring a longer in-patient stay).  
Clinically it would be far more useful to see if the ACR at admission could 
predict length of stay. Establishing which patients may stay a prolonged time in 
ICU could help target therapies to individual patients or aid decision-making in 
resource allocation.   
A regression analysis was performed looking at this using R package boot (Canty 
and Ripley 2010). 
A summary of the statistics of ACR at admission is shown in table 2.1. 
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Figure 2.9. Log of length of stay against log of ACR at admission.  
Data shows the correlation between log of length of stay per in the ITU (days) 
against log of ACR at admission. Regression analysis was carried out using R 
package boot (Canty and Ripley 2010).  The scatter plot has regression lines 
fitted separately to the groups. The alive group (open triangle and solid line) 
regression slope obtained was 0.034; Bootstrap confidence levels of 95% (-
0.108, 0.177) did not show statistical significance. For the Died group (closed 
circles and dashed regression line) the regression slope was -0.302; Boot strap 
95% confidence levels (-0.508, -0.102) showed statistical significance. 
 
 
Figure 2.9 demonstrates that there is a decreasing trend in length of stay with 
increasing ACR at admission for the patients that died. This is statistically 
significant. If higher ACR values indicate increasing ill health this result would 
be expected because the patients who die early have a reduced length of stay. For 
the patients that survived there was no statistically significant link between 
admission ACR and length of stay. For those patients that survived, the ACR at 
admission was unable to distinguish those patients that might have prolonged in-
patient stays compared to the peak ACR that could (figure 2.7). This is probably 
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because the peak ACR whilst an in-patient will reflect events such as sepsis or 
organ failure that will generally cause a prolonged stay in ITU.  
 
 
 
 
 
Figure 2.10. Log of length of stay per percent TBSA against log of ACR at 
admission. Data shows the correlation between log of length of stay per percent 
TBSA against log of ACR at admission. Regression analysis was carried out 
using R package boot (Canty and Ripley 2010).  The scatter plot has regression 
lines fitted separately to the groups. The alive group (open triangle and solid 
line) regression slope obtained was 0.043; Boot strap confidence levels of 95% (-
0.83, 0.164) did not show statistical significance. For the Died group (closed 
circles and dashed regression line) the regression slope was -0.204; Boot strap 
95% confidence levels (-0.439, 0.027) showed statistical significance. 
 
In figure 2.10 both for the patients that survived and died there was no trend 
between log ACR at admission and Log of length of stay per percent TBSA. The 
apparent trends in the graph are not statistically significant. A summary table of 
statistics for length of stay per percent burn and ACR is found in Appendix 1, 
Table 2. As previously described the reason for these results may be related to 
the fact that the TBSA% does not always correlate with the extent of the injury. 
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Because large burns can cause such a rapid and profound systematic response it 
is argued that the physiological response seen in the first twenty-four hours may 
not be representative of the true nature of the injury. With adequate resuscitation 
many of the early physiological derangements can be correctable presenting a 
very different picture of the patients’ physiological state and potential prognosis. 
To determine if the ACR echoed this picture and could be radically altered post 
resuscitation (and therefore be a more useful prognostic indicator of length of 
stay) a regression analysis was performed looking at ACR at 48 hours and length 
of ICU stay.  
 
 
 
Figure 2.11. Log of length of stay (days) against log of ACR at 48 hours. 
Data shows the correlation between log of length of stay (days) against log of 
ACR at 48 hours. Regression analysis was carried out using R package boot 
(Canty and Ripley 2010).  The scatter plot has regression lines fitted separately 
to the groups. The alive group (open triangle and solid line) regression slope 
obtained was 0.013; Bootstrap confidence levels of 95% (-0.132, 0.158) did not 
show statistical significance. For the Died group (closed circles and dashed 
regression line) the regression slope was -0.279; Boot strap 95% confidence 
levels (-0.483, -0.069) showed statistical significance. 
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Similar to figure 2.9 the results in Figure 2.11 shows there is a decreasing trend 
in length of stay with increasing log ACR at 48 hours for the patients that died. If 
higher ACR values do indicate increasing ill health then as the patients who die 
early have a reduced length of stay the trend is to be expected. For the patients 
that survive there is no trend between log ACR at 48 hours and length of stay. 
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Figure 2.12 Log of length of stay per percent TBSA against log of ACR at 48 
hours. Data shows the correlation between log of length of stay per percent 
TBSA against log of ACR at 48 hours. Regression analysis was carried out using 
R package boot (Canty and Ripley 2010).  The scatter plot has regression lines 
fitted separately to the groups. The alive group (open triangle and solid line) 
regression slope obtained was 0.046; Boot strap confidence levels of 95% (-0.89, 
0.177) did not show statistical significance. For the Died group (closed circles 
and dashed regression line) the regression slope was -0.172; Boot strap 95% 
confidence levels (-0.461, 0.093) showed no statistical significance. 
 
As can be seen from the confidence intervals the apparent trends in figure 2.12 
are not statistically significant. Normally one expects that the greater the injury 
the longer the stay in hospital. At 48 hours the patient has normally been 
resuscitated and their acute response to the injury has been treated (although may 
be ongoing). The measures required to resuscitate the patient will also have an 
effect on their endothelial dysfunction and figure 2.12 shows that an ACR value 
taken at this time has no prognostic value on the duration of their ITU stay. 
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2.4.4 ACR and outcome prediction 
For all ROC curve statistics the analysis has been performed with computer 
programme R (R Development Core Team, 2011). 
Diagnostic predictor cut-off value 
This section examines the use of a simple cut-off value for diagnostic prediction 
of Outcome. For each set up considered below the receiver operating 
characteristic (ROC) curve shows the optimum cut-off value according to the 
maximum Youden Index. The analysis has been performed using the function 
ROC from the R package DiagnosisMed (Brasil P 2010). The bootstrap 
confidence limits have been obtained using 9999 bootstrap replicates with the 
function roc from the R package pROC (Robin et al 2011). 
Receiver Operating Characteristics (ROC) Curve and The Youden index 
The ROC curve is a graphical method of displaying the discriminatory accuracy 
of a marker (diagnostic test) for distinguishing two populations (Fluss et al., 
2005) i.e. diseased or not diseased (or in this case dead or alive). The ROC curve 
is the true positive rate (sensitivity) versus the false positive rate (1-specificity) 
over all the threshold values of the marker. It gives the ability to choose an 
optimal cut-off value for an index given the investigators criteria. It is common 
to summarize the information in a ROC curve in a single value (or index). The 
area under the ROC curve (AUC) is a commonly used index of diagnostic 
accuracy as is the Youden Index (Youden 1950). The AUC may be computed 
and its difference relative to 0.5 statistically assessed. If the AUC is not different 
from 0.5 it means the considered index is as useful as tossing a coin. A ROC 
curve that operates no better than chance for detecting disease will lie along the 
45 degree line that runs from the intersection of the x and y axis to the upper 
right hand corner of the graph. Points along this line would indicate that this teat 
provides an equal number of true and false positives and that it does not 
discriminate between healthy and ill patients hence being as useful as a coin toss. 
The Youden index is the difference between the true positive rate and the false 
positive rate. One advantage the Youden index has over the AUC is that it 
provides a criterion for choosing the optimal value or cut off point, so called 
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maximising the index. This index ranges between 0 and 1, with values close to 1 
indicating that the biomarker’s effectiveness is relatively large and values close 
to 0 indicating limited effectiveness. By identifying the optimal cut-point for 
calling a patient diseased, the numbers of correctly classified individuals are 
maximized.  
The data used to help determine both the ROC curve and Youden index (in 
figure 2.13) is shown below in table 2.6. This contingency table allows the 
sensitivity, specificity and positive predictive value (PPV) and negative 
predictive value (NPV) to be worked out. The sensitivity is the probability that a 
test result will be positive when the disease is present (i.e. the true positive rate). 
The specificity is the probability that a test result will be negative when the 
disease is not present (i.e. the true negative rate). The PPV is the probability that 
the disease is present when the test is positive and the NPV is the probability that 
the disease is not present when the test is negative. 
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Using Peak ACR in outcome prediction in burns 
 
 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
Alive Died 
Observed 
outcome 
Alive 186 105 291 63.7 
Died 4 38 42 90.9 
 Total 190 143 333 67.3 
 
 
Table 2.6. Diagnostic classification table for using a cut-off value 8.58 mg 
mmol-1 for the peak ACR. Shows the data used to derive the contingency table 
from which the sensitivity, specificity, PPV and NPV were derived. Diagnostic 
performance values obtained from the above table and their 95% confidence 
intervals are: sensitivity 90.9% (CI: 77.9%, 96.2%), specificity 63.7% (CI: 
58.3%, 69.2%), Positive predictive value (PPV) 26.6% (CI: 20.0%, 34.4%), and 
Negative predictive value (NPV) 97.9% (CI: 94.7%, 99.2%). The area under the 
curve with bootstrap 95% confidence interval is 0.8367 (CI: 0.7751, 0.8927).  
 
The data in table 2.6 is used to help construct the ROC curve and Youden index 
in figure 2.13. It shows that by maximizing the Youden index a cut-off Peak 
ACR value of 8.58 mg mmol-1 predicts the death of a patient with a sensitivity 
of 90.9% and specificity of 63.7% (see also figure 2.13).  
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Figure 2.13. ROC curve for outcome versus peak ACR.  Data shows a 
graphical plot of sensitivity against 1-specificity, (true positive against false 
positive) the ROC curve for outcome (death) against peak ACR. The cut off 
ACR value of 8.58 is estimated by maximizing the Youden Index.  
 
Figure 2.13 demonstrates that using the Youden index a cut-off Peak ACR value 
of 8.58 mg mmol-1 predicts the death of a patient with a sensitivity of 90.9% and 
specificity of 63.7%. The AUC gives the overall performance of a diagnostic test 
and an AUC value of .83 shows this is a good test in determining patient death 
when using the peak ACR. One problem is that it is impossible to know when the 
peak ACR may occur so its clinical relevance is limited. It does however 
strengthen the argument that ACR values are related to outcome.  Clinically it 
would be more useful to see if the admission ACR has a role in predicting 
outcome. 
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ACR at admission to predict outcome in burns 
 
 
Figure 2.14 ROC curve for outcome versus ACR at admission. Data shows a 
graphical plot of sensitivity against 1-specificity, (true positive against false 
positive) the ROC curve for outcome (death) against admission ACR. The cut off 
ACR value of 3.78 is estimated by maximizing the Youden Index. The 
sensitivity for this test is 64.1 % and the specificity 72%. The AUC is .70, which 
shows this to be a fair test for determining outcome (death or survival) with a cut 
off value of 3.78 mg mmol-1. 
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 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
Alive Died 
Observed 
outcome 
Alive 190 72 262 72.5 
Died 14 25 39 64.1 
 Total 204 97 301 71.4 
 
Table 2.7 Diagnostic classification table for using a cut-off value for ACR at 
admission. Shows the data used to derive the contingency table from which the 
sensitivity, specificity, PPV and NPV were derived. Diagnostic performance 
values obtained from the above table (table 2.7) and their 95% confidence 
intervals are: sensitivity 64.1% (CI: 48.4%, 77.3%), specificity 72.5% (CI: 
66.8%, 77.6%), PPV 25.8% (CI: 18.1%, 35.3%), and NPV 93.1% (CI: 88.8%, 
95.9%). The area under the curve with bootstrap 95% confidence interval is 
0.7011 (CI: 0.5956, 0.7994). 
 
 
The data in table 2.7 is used to help construct the ROC curve and Youden index 
in figure 2.14. It shows that by maximizing the Youden index an ACR at 
admission of greater than or equal to 3.78 mg mmol-1 it predicts the death 
correctly 64.1% of the time. Whilst this is better than tossing a coin it may not be 
of sufficient value to be used clinically as there are many other pieces of 
information that would be used in conjunction with the clinical findings that 
would be used to assess the chances of a patients survival or not.  More useful is 
the negative predictive value of 93.1% which shows the probability that the 
disease is not present when the test is negative. Therefore we can say that a 
patient with an ACR less than 3.78 mg mmol-1 has a 93.1% chance of survival. 
Again because many of the physiological disturbances seen in burns are rapidly 
treated in the first 24-36 hours it was decided to see if the ACR at 48 hours 
would be better at predicting outcome. It may be that that if an ACR is still 
elevated at this time despite resuscitation then it is a more accurate reflection of 
the underlying inflammatory response and subsequently outcome.  
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ACR at 48 hours 
 
 
 
Figure 2.15 ROC curve for outcome versus ACR at 48 hours. Data shows a 
graphical plot of sensitivity against 1-specificity, (true positive against false 
positive) the ROC curve for outcome (death) against ACR at 48 hours. The cut 
off ACR value of 4.26 is estimated by maximizing the Youden Index. The 
sensitivity for this test is 47 % and the specificity 79%. The AUC is .62, which 
shows this to be a poor test for determining outcome (death or survival) with a 
cut off value of 4.26 mg mmol-1. 
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 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
Alive Died 
Observed 
outcome 
Alive 174 44 218 79.8 
Died 18 16 34 47.1 
 Total 192 60 252 75.4 
 
Table 2.8 Diagnostic classification table for using a cutoff value for ACR at 
48 hours 
Shows the data used to derive the contingency table from which the sensitivity, 
specificity, PPV and NPV were derived. Diagnostic performance values obtained 
from the above table (table 2.8) and their 95% confidence intervals are: 
sensitivity 47.1% (CI: 31.5%, 63.3%), specificity 79.8% (CI: 74.0%, 84.6%), 
PPV 26.7% (CI: 17.1%, 39.0%), and NPV 90.6% (CI: 85.7%, 94.0%). The area 
under the curve with bootstrap 95% confidence interval is 0.6238 (CI: 0.5098, 
0.7340). 
 
The data in table 2.8 is used in conjunction with figure 2.15 to examine whether 
the ACR readings at 48 hours are of any use in outcome prediction. It is clear 
that the sensitivity of 47.1% (table 2.8) is poor and indeed the AUC is .62 (figure 
2.15) showing this to be a poor test of outcome. There are a number of reasons 
why this maybe. The first is that the act of resuscitation itself may affect the 
body’s response to inflammation and therefore the endothelial dysfunction. As 
the inflammatory process is ongoing, a snap shot picture when treatment has 
commenced may not reflect the dynamic situation that is evolving. Although 
there are protocols for resuscitation it does vary according to the patient’s 
response to treatment and it may be that whilst many physiological parameters 
are normalized in the first 48 hours it does not reflect the inflammatory response 
at a molecular level and the endothelial dysfunction as a result. Another problem 
is the data collection and that as time progresses there is missing data possibly 
making the results less accurate. 
It was decided to see if any trends in the first four days of admission would be a 
more accurate way of predicting outcome. 
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2.4.5 Area under the curve of initial ACR values 
There are some problems with the recording of the ACR. To be able to use ACR 
for the prediction of patient outcomes requires the diligent recording of readings 
at the initial stages of the patients’ stay in the ITU. 
Out of the 345 cases, for “ACR at admission” there are 301 (87.2%) readings 
recorded, leaving 44 (12.8%) missing. Out of the 301 cases where there is a 
reading for “ACR at admission” there are 22 (7.3%) cases where the reading for 
“Day 1” is missing. 
Out of the 345 cases, for “ACR at 48hrs” there are 252 (73.0%) readings 
recorded, leaving 93 (27.0%) missing. Out of the 252 cases where there is a 
reading for “ACR at 48hrs” there are 2 (0.8%) cases where the reading for “Day 
2” is missing. 
Out of the 345 cases, there are 65 (18.8%) of cases for which there is no reading 
for “Day 1”, and there are 24 (7.0%) of cases for which there are no readings for 
either “Day 1” or “Day 2”. 
Out of the 345 cases, there are 280 (81.2%) of cases for which there is a reading 
for “Day 1”, 209 (60.6%) of cases for which there are readings for both “Day 1” 
and “Day 2”, 162 (47.0%) of cases for which there are readings for all the first 
three days, and 134 (38.8%) of cases for which there are readings for all the first 
four days. 
To check whether the initial ACR readings could predict the final outcome the 
area under the curve of the ACR values for days 1 to 4 was calculated. To 
increase the number of cases where the area could be calculated in the presence 
of missing values, if the value for day 3 was missing it was assigned the value 
for day 2 (which might also be missing), and if the value for day 4 was missing it 
was assigned the value for day 3 (which might also be missing). The algorithm 
for calculating the area would only produce a result if there were an ACR 
reading for all four days. This left 140 cases out of 345 that could be used in the 
analysis. 
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Figure 2.16 ROC curve for outcome versus area under the curve (AUC) of 
ACR for up to 4 days. A cut off of 37 mg mmol-1 gives a sensitivity of 31.8% 
and specificity of 92.3%. Data shows a graphical plot of sensitivity against 1-
specificity, (true positive against false positive) the ROC curve for outcome 
(death) against AUC of ACR for up to 4 days. The cut off ACR value of 37 is 
estimated by maximizing the Youden Index. The sensitivity for this test is 31 % 
and the specificity 92%. The AUC is .62, which shows this to be a poor test for 
determining outcome (death or survival). 
 
The ROC curve in figure 2.16 shows that the use of the area under the curve of 
the initial ACR values in the first 4 days is not a successful diagnostic measure. 
Firstly the AUC of .62 suggests this is a poor test for separating survivors from 
those that die and secondly the cut off of 37 mg mmol-1 is too high to be used in 
a clinical setting as the number of patients achieving this ACR is limited and the 
sensitivity is too low to be a useful clinical tool.  
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2.5 Discussion 
This study of adults and children admitted to a UK burns ICU and requiring 
resuscitation shows a high prevalence rate (45.5%) for microalbuminuria on 
admission.   
The prevalence of microalbuminuria in normal healthy adults is 3.3% (Jones et 
al., 2002). A number of studies have demonstrated an increased ACR in critically 
ill patients and after surgery and trauma (Matsushita et al., 1996, Shearman et al., 
1989, Wood et al., 2000, Mahmud 1994, Gosling et al., 1988, Gosling and 
Sutcliffe 1996). 
This study shows a lower prevalence than other critical care populations. 
Thorevska et al., (2003) found 69% of their patients’ demonstrated 
microalbuminuria and clinical proteinuria on the first day of admission. This 
higher rate may be explained by a number of factors. Firstly their study 
examined medical patients, in which a higher proportion had diabetes or 
hypertension (co-morbidities that in isolation may increase ACR) than this study 
of burns patients. The patients admitted suffered from a variety of medical 
problems that may have a greater effect on endothelial dysfunction. It is not clear 
when their samples were taken, and from Vlachou’s work (2008) it has been 
shown that the ACR can be very sensitive to surgical procedures or wound 
manipulations. It is possible that the timing of the samples may have influenced 
their results.  
A further reason may be that the average age of their population was much 
higher (64.5 years) and as figure 2.6 demonstrates ACR values increase as age 
increases. Although the regression of log ACR on age is statistically significant it 
only explains about 2% of the variance of log ACR. And so is unlikely to be 
clinically useful. 
 
This study demonstrates the usefulness of urinary ACR at admission to the burns 
unit in predicting outcome.  
Looking firstly at the peak ACR and outcome, a cut-off ACR value of 8.58 mg 
mmol-1 seems at first to be accurate at predicting those patients who may die 
from their injuries sensitivity 90.5% (CI: 77.9%, 96.2%) (Table 2.6 and Figure 
2.13) although the positive predictive value, PPV 26.6% (CI: 20.0%, 34.4%) is 
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less impressive. These results, however are no use in the clinical scenario, as the 
clinician will never know when the peak ACR results may be, but do 
demonstrate the relationship between ACR and outcome. Whilst peak ACR has 
no clinical application in individual patient’s treatment it may have a research 
role in comparing response to treatment between patients or even between burn 
centres. 
 
Using a cut off value of 3.78 mg mmol-1 the ACR at admission (Table 2.7) 
demonstrates a sensitivity of 64% with a specificity of 72%. The PPV was 25.8% 
and NPV 91.1% in determining outcome. Previously Yew and Pal (2006) had 
determined that a mean ACR of 20 mg mmol-1 was associated with poorer 
outcomes in patients with extensive burns. 
It is difficult to compare this data with other studies due to uncertainty of timings 
of ACR recordings and differences in the demographics of the patients studied. 
However looking at diagnostic accuracy (to determine the development of 
ARDS, Acute Respiratory Distress Syndrome) rather than outcome, Pallister’s 
study (2001) shows similar sensitivity and specificity rates (Sensitivity 63.4%, 
specificity 73.3%, PPV 54%, NPV 80%). The investigation by Gosling et al., 
(2003) provides the nearest demographic match to this study into burn patients. It 
examines the admission ACR in surgical and trauma patients admitted to 
intensive care and includes 11 burn patients. Their higher cut off ACR value of 
>5.9 mg mmol-1 gave sensitivity for death of 100% and specificity of 59% 
(PPV, 25% and NPV, 100%). This was found to predict death as well as other 
commonly used measures, in this case APACHE II and SAP scores. 
Whilst the sensitivity of ACR in determining outcome in burns patients may be 
improved by using a higher ACR value its clinical usefulness as a clinical tool 
will be reduced.  
Vlachou et al (2006) showed a positive correlation between urinary ACR and 
TBSA at 3 and 7 hours post injury and with the percentage of full thickness burn 
between 3 and 7 hours. Vlachou’s later work (2008) showed per-operative ACR 
was associated with % TBSA excised.  
In contradiction this study found no correlation between admission ACR and 
TBSA. One reason for this is that TBSA may not accurately reflect the degree of 
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injury that the patient suffers from. For example a 10% full thickness burn, 
which has burnt tissue down to bone, may elicit a greater systemic response than 
a larger but more superficial burn. Further studies would have to include the 
%FTB as well as the TBSA% to clarify the relationship between ACR and burn 
size.  
All the patients in Vlachou’s study (2008) were flame related which may have an 
impact on interpretation of their results as the mechanism of burn injury has a 
significant influence on outcome. Flame burns result in a higher proportion of 
cases of multi-organ failure, and have a higher mortality rate (Kraft et al., 2011). 
In our study due to the low number of contact, chemical and electrical burns 
these mechanisms were grouped together and compared with scalds and flame 
injuries (Table 2.5). There was no associated between ACR and the mechanism 
of injury found in our study which suggests Vlachou’s results can be 
extrapolated to burns of all mechanisms. 
Previously Gosling et al., (2003) have demonstrated that ACR on admission was 
related to intensive care length of stay in surgical, trauma and burn patients 
although not for medical patients. Our study found no link between admission 
ACR and length of stay in those patients that survived but as may be expected a 
decreasing trend of length of stay with increasing ACR at admission in those 
patients that died (Table 2.7, Figure 2.10). Because of the rapid and profound 
systemic changes that occur in a major burn it may be argued that the admission 
ACR may be misleading because adequate resuscitation will correct may of the 
initial physiological abnormalities and thus stabilise the patient. ACR 
measurements after the period of resuscitation may therefore be a more accurate 
determinant of systemic vascular dysfunction. ACR at 48 hours echoed the 
results found on admission and therefore in patients that survived there is no 
correlation between ACR and length of stay. The variance with Gosling’s (2003) 
results may be the result of the same sample size of burns in that study.   
Vlachou et al., (2006) also found that the ACR was higher for up to 8 h in the 
presence of inhalation injury. Our study looked at inhalation injuries and 
performed multiple regression models  (summary data shown in Appendix 1, 
table 3 and table 4) and found that the standard errors were so large that no 
association between ACR (at admission) and inhalation injury could be made.  
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It has been made clear that the ACR is very sensitive to surgery and wound 
manipulations and therefore an inhalation injury could easily cause a rise in ACR 
shortly after injury. It must be noted that in Vlachou’s study (2006) all patients 
who presented to the unit after 6 hours were excluded. In our unit, many burns 
do not reach the unit within 6 hours and excluding these patients would have 
resulted in a far smaller study group. The majority of patients transferred from 
other hospitals will also have had some form of resuscitation started or even a 
surgical procedure such as wound débridement or cleaning. It may be that the 
first few hours after a burn are the most crucial when gathering ACR samples. 
After 6 hours the ACR may have reduced either because of the natural response 
of the patient’s body to the burn or fluid resuscitation has been started or been 
influenced by interventions in the referring hospital. 
Studies have found that a number of other inflammatory mediators are affected 
by wound manipulation. Commonly analysed markers include IL-6, CRP and 
procalcitonin. 
 As little as one hour after the start of elective surgery rises in serum levels of IL-
1 inhibitors, IL-6 and cortisol have been noted (Di Padova et al., 1991). However 
the rise of IL-6 can be even more sensitive. Papini et al., 1997 found a three-fold 
increase in IL-6 levels between pre-operative and recovery samples after 
dressing changes as well as débridement of both small and large burns. IL-6 
levels are related to the degree of surgical stress and trauma, and there is an 
association between IL-6 levels and adverse outcome (Jawa et al., 2011). It is 
less clear that the CRP level is affected in the same way as studies have shown 
conflicting results. CRP has also commonly been used as a measure of 
inflammatory response (and as a measure of adverse outcome (Kushner et al., 
2006)) and is sensitive to minor environmental irritants such as secondhand 
smoke exposure and air pollution (Peters et al., 2001), causing CRP elevation. 
However its significance when related to surgery is less clear, as no change 
(Cruickshank et al., 1990) or minor elevation (Nichol et al., 1998) has been 
found to occur to CRP levels after minor surgery when compared to more major 
surgical interventions. Procalcitonin has also been found to be elevated in a third 
of patients after minor surgical procedures (Meisner et al., 1998) however this 
like many of these studies fail to mention the precise timing of the blood sample 
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so it is difficult to compare to the sensitivity of ACR as demonstrated by 
Vlachou et al., (2006).  
The initial analysis had looked at the ACR at specific time points (admission, 48 
hours, peak ACR) and given only a ‘snap-shot’ of what may be going on. 
Therefore the trends in ACR were examined to see if they were useful in 
predicting outcome. One difficulty encountered was that there were days when 
the ACR had not been recorded. 
To check whether the initial ACR readings could predict the final outcome the 
area under the curve of the ACR values for days 1 to 4 was calculated. To 
increase the number of cases where the area could be calculated in the presence 
of missing values, if the value for day 3 was missing it was assigned the value 
for day 2 (which might also be missing), and if the value for day 4 was missing it 
was assigned the value for day 3 (which might also be missing). The algorithm 
for calculating the area would only produce a result if there were an ACR 
reading for all four days. The consequence of this was that only 140 cases out of 
345 could be used in the analysis. 
The results showed a sensitivity of 31.8% and a specificity of 92.3%. The ACR 
cut-off value was 37 however, which would limit its clinical application. Trends 
in ACR do not seem to have a role in predicting outcome in burns cases.  
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 ACR 
cut off 
value 
mg 
mmol-1 
Sensitivity 
% 
Specificity 
% 
PPV 
% 
NPV 
% 
AUC 
Peak 8.58 90.5% 
CI: 77.9%, 
96.2% 
63.9% 
CI: 58.3%, 
69.2% 
26.6% 
CI: 20.0%, 
34.4% 
97.9% 
CI: 94.7%, 
99.2% 
0.83 
Admission 3.78 64.1% 
CI: 48.4%, 
77.3% 
72.5% 
CI: 66.8%, 
77.6% 
25.8% 
CI: 18.1%, 
35.3% 
93.1% 
CI: 88.8%, 
95.9% 
0.70 
48 hours 4.26 47.1% 
CI: 31.5%, 
63.3% 
79.8% 
CI: 74.0%, 
84.6% 
26.7% 
CI: 17.1%, 
39.0% 
90.6% 
CI: 85.7%, 
94.0% 
0.63 
4 day 
trend 
37 31.8% 92.3%   0.62 
 
Table 2.9. A summary of analysis of ACR readings at different time points 
with outcome. Data show the ACR cut off points as maximized by the Youden 
index to determine outcome at the various time points when ACR was measured 
with the sensitivity, specificity, PPV and NPV for each category. 
  
Table 2.9 summarizes the analysis of ACR readings at different time points with 
outcome. Peak ACR as previously discussed has no clinical application in 
individual patient’s treatment but may have a research role in comparing 
response to treatment between patients or even between burn centres. 
Clinically a test that can be performed easily and swiftly (as soon as the patient is 
admitted to the unit) and can accurately predict outcome would be most useful. 
This study has demonstrated that an admission ACR with a cut-off value of 3.78 
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mg mmol-1 with a sensitivity and specificity similar to other studies could be 
used as part of the assessment of the patient in determining outcome.  
In conclusion, there have been limited studies determining the clinical utility of 
ACR in predicting burn patient outcome. This study suggests that ACR could be 
used as part of the assessment of the patient in determining outcome but the 
sensitivity and specificity are not high enough to use it as a clinical tool. It may 
be that its diagnostic accuracy could be improved by using it in conjunction with 
another marker of inflammatory response (such as C-reactive protein or 
procalcitonin). Another point to note, made clear by Vlachou’s work is the 
importance of timing of the ACR sampling and that due to the nature of the 
patient referrals to our centre very early results post injury are rarely obtained. 
This could mean the key period where ACR is most useful is missed by the time 
the patients attend our centre.  
ACR has been found to be of use not only in predicting outcome, but also in a 
number of other studies in ICU patients, can predict organ failure or sepsis.    
ACR may therefore have a role in predicting complications, sepsis or multi-
organ failure in burn patients. 
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Chapter 3 Sepsis in burns 
 
3.1.1 Introduction 
In addition to SIRS and multi-organ failure burns patients are also prone to the 
development of sepsis. Although defined criteria exist, sepsis can most simply be 
thought of as a change in the burn patient that triggers the concern for infection. 
Sepsis is a presumptive diagnosis when there is a concern of infection usually 
resulting in antibiotics being started whilst the source of the sepsis is being 
sought. Worldwide sepsis is a major cause of death and in the UK alone accounts 
for around 30,000 admissions to critical care units (Harrison et al., 2006). In 
Harrison’s study, 27.0% of patients were identified as having severe sepsis in the 
first 24 hours following admission. 
Sepsis in burn patients is not only a problem of increased morbidity, hospital stay 
and costs but also has a profound impact on mortality. The most recent review of 
severe burns injuries in Europe presented figures of between 2 % and 14% for 
the number of burn patients dying from sepsis (Brusselaers et al., 2010). 
 
Like MOF the criteria to define and categorise sepsis has been the subject of 
much debate and also like SIRS and MOF, burn patients have often been 
excluded from studies into sepsis. There may be a number of reasons for this, 
including the systemic response seen in burn patients making them difficult to fit 
into some of the normal patterns of sepsis seen in other critical care populations. 
Secondly burn patients treated in most critical care units (rather than specific 
burn units) usually present in such small numbers that it is difficult to study such 
small populations and to show meaningful results. 
 
Definition of sepsis 
The concept of sepsis has been used for many years. Attempts to refine the 
definition have occurred with a number of consensus conferences culminating in 
the definition that is used most frequently worldwide. This was produced by the 
American College of Chest Physicians, (ACCP) and the Society of Critical Care 
Medicine (SCCM) and is shown in table 3.1 (Bone et al., 1992). 
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Condition  Definition 
SIRS 
 
2 or more of the following criteria 
without another identified cause 
Temperature  > 38°C or  < 36°C  
Heart rate  90 beats/min  
Hyperventilation with respiratory rate 
>20/min or Paco2 <32 mm Hg  
White blood cell count >12,000 cells/L 
or <4000 cells/L 
 
Sepsis  
 
SIRS in the presence of documented 
infection 
 
Severe sepsis 
 
Sepsis with associated organ 
dysfunction, hypoperfusion, or 
hypotension 
 
Septic shock  
 
Sepsis with arterial hypotension despite 
adequate fluid resuscitation 
 
 
Table 3.1. ACCP/SCCM Definitions for Sepsis and Organ Failure 
 
In this definition sepsis can be categorised in three ways, reflecting the severity 
of the condition. The ACCP/SCCM definitions suffer a fault when applied to 
burns patients because of their reliance on the SIRS criteria. The systemic 
physiological changes in burn patients results in profound changes in many of 
the parameters used to define SIRS, such as a increased heart rate, temperature 
and respiratory rate as part of the hypermetabolic state seen in burn. Using these 
criteria, the majority of patients would be defined as having sepsis. 
The American Burns Association Consensus Conference therefore produced 
their criteria for a definition of sepsis (Greenhalgh et al., 2007). There are six 
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categories looking at physiological parameters or clinical signs. Some categories 
have subgroups. It must be noted that the criteria for the definition are age-
dependant with adjustments being made for children. 
For sepsis a patient needs three of the triggers listed in table 3.2 and it is required 
that a documented infection is identified. 
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Physiological parameters Criteria for definition of sepsis 
I. Temperature  
>39° or <36.5°C  
 
II. Progressive tachycardia 
 
A. Adults ჼ110 bpm  
B. Children >2 SD above age-specific norms 
(85% age-adjusted max heart rate)  
 
III. Progressive tachypnea 
 
A. Adults >25 bpm not ventilated  
i. Minute ventilation >12 l/min ventilated  
B. Children >2 SD above age-specific norms 
(85% age-adjusted max respiratory rate)  
 
IV. Thrombocytopenia (will not apply until 
3 days after initial resuscitation) 
A. Adults <100,000/mcl 
B. Children <2 SD below age-specific norms 
 
V. Hyperglycemia (in the absence of pre-
existing diabetes mellitus)  
 
A. Untreated plasma glucose  >200 mg/dl or 
equivalent mM/L  
B. Insulin resistance—examples include 
i. >7 units of insulin/hr intravenous drip 
(adults) 
ii. Significant resistance to insulin (>25% 
increase in insulin requirements over 24 hours) 
 
VI. Inability to continue enteral feedings >24 
hours  
 
A. Abdominal distension  
B. Enteral feeding intolerance (residual >150 
ml/hr in children or two times feeding rate in 
adults)  
C. Uncontrollable diarrhoea (>2500 ml/d for 
adults or >400 ml/d in children) 
 
In addition, it is required that a documented infection is identified by 
A. Culture positive infection, or  
B. Pathologic tissue source identified, or  
C. Clinical response to antimicrobials 
 
Table 3.2. Criteria required for a diagnosis of sepsis (Greenhalgh et al., 
2007).  
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As noted by Greenhalgh et al., (2007), sepsis is a presumptive diagnosis when 
there is a concern of infection usually resulting in antibiotics being started whilst 
the source of the sepsis is being sought. 
Whilst the definition of septic shock was kept for burn patients (as 
haemodynamic instability is similar irrespective of cause) the consensus dropped 
the term severe sepsis. This was because it was felt there was little clinical 
difference between sepsis and severe sepsis in burns. 
Whilst the treatment of sepsis has improved the focus has shifted to try and 
identify as early as possible those patients that may develop sepsis. In this way 
therapies and resources can be targeted in a more effective and efficient way. 
 
3.1.2 Prevention of sepsis 
As sepsis relies on the presence of infection it is logical to believe that reducing 
the chance of infection will reduce sepsis. From the moment the patient enters 
the burns unit steps can be taken to reduce the potential for infection. 
 
Antibiotic prophylaxis 
One possibility is whether this may be achieved by the prescription of 
prophylactic antibiotics?  
The potential risks of antibiotic prophylaxis in burns patients are great. 
Antibiotic resistance is a growing problem throughout the medical world. In a 
population who frequently harbour multiple pathogens and that are at high risk of 
infection this is magnified, and the blind use of antibiotics is considered to be 
counterproductive. In addition there is the obvious risk of side effects of the 
individual antibiotics used and polypharmacy. 
As noted by Chipp et al., (2010) the situation is less clear in paediatric patients 
due to the risk of toxic shock syndrome. This toxin-mediated febrile illness 
historically has a high death rate (McAllister et al., 1993) and the introduction of 
routine antibiotic prophylaxis in one unit (Rashid et al., 2005) was found to 
reduce its incidence. Toxic shock seems a particularly UK based phenomenon 
(Burd 2005) with three Dutch burn centres never having seen a case (all three 
centres used a different antibiotic and dressing protocol (Vloemans and Gorissen 
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2005). The result is that a third of hospitals in the UK give prophylactic 
antibiotics to children (Al-Benna et al., 2007). 
 
Burn wound excision 
Cope published evidence in over half a century ago that patients had a better 
outcome with early excision and grafting (Cope et al., 1947). This approach was 
popularised by Zora Janzekovic (1970) almost twenty years later who changed 
burn care by her method of tangential excision and grafting. By shaving 
sequential thin layers of burn eschar down to a layer of viable tissue, a clear 
visualisation of burn depth could be determined intra-operatively and definitive 
wound closure could be achieved at the same time. Although this is approach 
now forms the basis of burns management around the world it took time for this 
method to be accepted and the exact timing of burn wound excision can still be 
debated.  Barret and Herndon (2002) hypothesized that acute burn wound 
excision (defined as being ‘in the first 24 hours after burning’) would be superior 
to conservative treatment and delayed excision in preventing bacterial 
colonization and invasion. They found that patients admitted and treated later 
had higher bacterial counts (more than 105 bacteria) and were more likely to 
suffer from infections and graft loss. Ong et al., (2006) performed a meta 
analysis of early excision of burns and only found six papers (that fulfilled the 
criteria for their study) that clearly demonstrated a benefit to early excision. Of 
these six studies only two looked at sepsis as an outcome measure. 
It might seem logical to suppose that early burn excision by reducing bacterial 
counts and infection would also reduce sepsis rates. The little evidence however, 
is contradictory. 
Herndon et al., (1989) showed that early excision in adults (age range 17-30 
years and without inhalation injury) reduced mortality from 49% to 9% when 
compared with the conservative management group. No difference was seen in 
the groups however, when looking at length of stay, number of procedures or 
days septic. It must be noted that the criteria for sepsis were similar to the 
consensus definition in that they were based on physiological variables but were 
not as wide ranging. 
Conversely Subrahmanyam (1999) found that early excision reduced the chance 
of sepsis. In this study all the three deaths from sepsis were in the conservatively 
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managed group. The problem with this study is firstly that the conservative 
management was the use of honey. Although used widely for the dressings of 
wounds in general, honey is not the first line treatment in most countries. 
Secondly the criteria used to define sepsis were not given. It therefore remains 
unclear whether early excision of burn wounds influences the development of 
sepsis. 
 
Wound cover and grafting 
After excising the burn tissue, the underlying exposed tissue bed is grafted, 
usually with a split thickness skin graft, either as a sheet or meshed. In larger 
burns there may not be enough donor skin available and the remaining exposed 
areas need suitable dressings to reduce the risk of infection. 
In the majority of UK units the exposed areas are covered with a temporary 
biological dressing or skin substitute until the donor areas have healed 
sufficiently for re-harvesting more skin. The most frequently used dressings 
include cadaver allograft, xenograft (pig skin) as well as dermal scaffolds such as 
integra (Atiyeh et al., 2005) or matriderm (Ryssel et al., 2008). 
Although there are no recent studies looking at skin substitutes and sepsis it 
seems logical that coverage of large exposed areas will reduce the possibility of 
infection and therefore sepsis (personal opinion). 
 
Prevention of sepsis by controlling blood glucose 
Critically ill patients frequently suffer from hyperglycaemia and increased 
insulin resistance and this is also true of burns patients. Stress hyperglycaemia 
may increase the risk of infection and polyneuropathy in the critical care 
population (Van den Burghe et al., 2001). This study showed that attempting to 
maintain normoglycaemia could reduce the morbidity and mortality in critically 
ill patients. (This is generally through intravenous insulin therapy.) The effect on 
sepsis was also marked. Intensive insulin treatment reduced episodes of 
septicemia by 46 percent compared to the control group. Furthermore, markers of 
inflammation were less frequently abnormal in the intensive-treatment group 
than in the conventional-treatment group.  In addition the patients who received 
intensive insulin therapy were less likely to require prolonged use of antibiotics 
than were the patients who received conventional treatment, an effect that was 
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largely attributable to the lower rate of bacteremia in the intensive-treatment 
group. 
It can be seen therefore that maintenance of normoglycaemia may be particularly 
important in burns. Hyperglycaemia results in increased rates of skin graft loss 
(Mowlavi et al., 2000), infections, (Pham et al., 2005) sepsis and mortality 
(Pidcoke et al., 2009).  
 
The role of the gastrointestinal tract (GI) in burn sepsis  
The gastrointestinal tract plays an important role in the immune response to 
injury. In the 1980s and 1990s there were a number of studies that looked at the 
mechanisms of gut barrier failure and bacterial translocation (Gosain and 
Gamelli 2007). After burn injury there is a loss of gut barrier function. The GI 
tract normally keeps bacteria confined within its lumen. Burn injury may allow 
increased bacterial infiltration into mesenteric lymph nodes and other 
extraintestinal sites (such as the liver or blood). This results in a process called 
translocation (Deitch and Berg 1987). Using an animal model (rats) Horton 
(1994) demonstrated that bacterial translocation was much higher in the burn rats 
compared to the control group and that intestinal blood flow was much reduced 5 
hours after injury in the burn rats.  
The problem of bacterial translocation forms the basis for the therapeutic strategy 
of selective decontamination of the digestive tract (SDD) as well as interventions 
aimed at improving gut barrier function such as early enteral feeding.  
SDD is a prophylactic strategy consisting of treatment using enteral and 
parenteral antimicrobials that are used to decontaminate the oropharynx and 
intestine thus reducing the source of endogenous pathogenic organisms. A 
randomised, placebo controlled, double blind trial showed a mortality of 27.8% 
in the placebo group and 9.4 % in the SDD group in patients with severe burns 
(de la Cal et al., 2005). The use of SSD has been contentious however and 
Eiggiman et al., (2006) disputed the findings, believing the placebo group to be 
older and more severely injured and questioning the antibiotic regime of 
intravenous third-generation cephalosporin for initial prophylaxis due to its 
potential negative impact on the ecology of microorganisms. Since then there 
have been a number of studies in both the burn and critical care populations and 
more recently a systematic review of all the previous studies has concluded that 
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the protocol of SDD reduces mortality in critically ill patients, in particular when 
successful decontamination is obtained. However eighteen patients need to be 
treated with SDD to prevent one death (Silvestri et al., 2009). 
 
3.1.3 Diagnosis and prediction of sepsis 
A study by Poeze et al., (2004) found only a fifth of intensivists knew the 
ACCP/SCCM definition of sepsis and that the majority (83%) were concerned 
that sepsis was frequently missed. The Surviving Sepsis Campaign tackled this in 
2008 and highlighted early recognition and treatment of sepsis (Dellinger et al 
2008). 
One method of detection of sepsis is an ‘early warning system’ as used on many 
medical and surgical wards where physiological parameters are routinely 
measured. The deviation of the parameters beyond pre-determined set levels 
should initiate further investigation or intervention. Whilst use of this system on 
admission has successfully predicted admission to critical care units and 
mortality in acute medical admissions (Groarke et al., 2008) they have not been 
used specifically in burns. Again because of the altered physiology of severe 
burns the scoring system would heave to reflect the hypermetabolic state of these 
patients. 
 
3.1.4 Treatment of sepsis 
In terms of treatment, the sepsis that burns patients suffer from is no different 
from any other critical care population. There are international guidelines 
published as part of the Surviving Sepsis Campaign for managing severe sepsis 
and septic shock. 
The use of prophylactic antibiotics in adults and children has already been 
discussed. However once a burn patient has developed sepsis the rapid delivery 
of the correct antibiotic targeted to the causative organism/s is paramount. This is 
obviously guided by the culture results or if these are not available broad 
spectrum antibiotics determined by local policy depending on the most likely 
commonly found organism. An important point to remember is that bacteria are 
not the causative agent in all cases of sepsis. Fungal samples are frequently 
isolated from burn patients (although usually found as a result of colonization 
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rather than infection) and can cause invasive fungal infections. The increasing 
threat of multi-drug resistant organisms can make treatment and eradication of 
the infective agent difficult or prolonged.  
Attention has moved from treatment of the physiological consequences of sepsis 
to monitoring and altering the inflammatory response to sepsis. 
 
3.1.5 Inflammatory markers in sepsis 
Burn injuries even without the presence of sepsis or multiorgan failure result in 
the activation of inflammatory cytokines, interleukins and growth factors. 
Several studies have shown a variety of pro-inflammatory cytokines have a 
predictive role in outcomes in patients with severe sepsis (Oberholzer et al., 
2001) whilst other studies have not confirmed this. Oberholzer et al., (2005) 
found that baseline total protein C, IL-8, IL-10, TNF-a, and procalcitonin 
concentrations, and the change in plasma cytokine concentrations from baseline 
over the initial 4 days were not useful in predicting outcome in patients with 
severe sepsis. However when used in conjunction with the APACHE score and 
MOF scores IL-6 was useful in predicting outcome in severe sepsis.  
Despite the varying results, some pro-inflammatory cytokines can be used in 
outcome prediction. However this has not led to routine assays to monitor pro-
inflammatory cytokines as part of standard clinical care. One reason is that the 
induction of several of these cytokines is a universal response to activation of the 
innate immune response, and elevated concentrations of some of these cytokines 
occurs in a variety of acute and chronic inflammatory diseases, including cancer 
and autoimmune diseases. Raised cytokine levels may not be sensitive or specific 
enough to monitor the presence of a systemic inflammatory response.  
Instead of monitoring pro-inflammatory molecules the most frequently used 
biochemical markers to determine infection and inflammation clinically are the 
C-reactive protein (CRP), white cell count (WCC) and Erythrocyte 
Sedimentation Rate (ESR). One marker used less commonly is procalcitonin 
(PCT).  Uzzan et al.,  (2006) showed in a meta-analysis that Procalcitonin 
represents a good biological diagnostic marker for sepsis, severe sepsis, or septic 
shock in critically ill patients. They concluded that Procalcitonin is superior to C-
reactive protein in this respect and suggested that Procalcitonin should be 
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included in diagnostic guidelines for sepsis and in clinical practice in intensive 
care units. This work was further endorsed by Meynaar et al., (2011) who 
showed that PCT is more useful than LBP, CRP and IL-6 in differentiating sepsis 
from SIRS. 
There have been limited studies in burns with conflicting results. Neely et al., 
(2004) studied PCT in 20 paediatric patients and found that PCT was inferior to 
CRP in the diagnosis of sepsis and lagged behind the clinical diagnosis by 0.8 
days. In adult patients with burns, however, PCT has been found to be a useful 
diagnostic marker for sepsis (Lavrentieva et al., 2007), which has been 
confirmed in a meta-analysis by Mann et al., (2011). They concluded that PCT 
assay can be a helpful adjunct to clinical diagnosis of sepsis but is expensive and 
the ability to analyse it is not available in most hospitals limiting its usefulness. 
As yet limited availability of an inexpensive and rapid assay remains the obstacle 
to routine use of this test in mainstream burns care.   
 
3.1.6. Inflammatory response in burns 
With larger burns, the acute inflammatory response may not be contained to the 
burn site and the local surrounding area but may develop into the uncontrolled 
inflammatory response found in SIRS. 
SIRS is associated with increased production of pro-inflammatory chemo- and 
cytokines, increased free radical production and activation of complement and 
coagulation cascades. The subsequent pathophysiologcal impact of this is 
demonstrated by increasing vascular permeability, leukocytosis, tachypnea, 
temperature, peripheral vascular resistance, increased leukocyte mobilization and 
recruitment (Shankar et al., 2007). 
The innate immune response to inflammation and sepsis is a rapid response that 
is not pathogen specific (Oberholzer et al., 2001). After the discovery of 
inflammation associated cytokines many immunotherapies directed at 
neutralizing these bioactive compounds have been tried (Abraham 1999, Dubois 
and Vincent 2000). Using animal models many of these therapies have produced 
promising results, which unfortunately have not been reproduced in larger 
clinical trials (Abraham et al., 1998, Suntharalingam et al., 2006). One of the 
reasons for sepsis immunotherapies not to work is that they are monotherapies 
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directed against a single component of the inflammatory cascade. The 
complexity of the inflammatory immune cascade means that the pro- and anti-
inflammatory molecules released changes with the duration and severity of the 
injury (Shankar et al., 2007). Therefore treating just one part of this cascade is an 
imprecise and blunt tool. Any treatment of this type needs to be modulated over 
time to reflect the changes going on. 
Another factor that makes therapies targeting only one part of the immune 
cascade ineffective is multiple signalling mechanisms in inflammation and 
therefore the ability to evade pharmacological efforts to block certain key 
pathways such as IL-1 or TNF-α messaging. (Chipp et al., 2010)  
Drug treatments may have to target the inflammatory process at a different level. 
A potential target is the vascular endothelium as there is increasing evidence that 
the endothelium plays a central and pathogenic role in sepsis. The endothelium is 
composed of a single layer of cells that lines the interior surface of all blood 
vessels. It is estimated to comprise around 1013 cells, representing a weight of 1.5 
kg and covering 4,000–7,000 m2 (Ait-Oufella et al., 2010) Endothelial cells are 
diverse in their roles and are involved in a number of physiological functions, 
These include prevention of coagulation, orchestration of the migration of blood 
cells into the tissues by expression of adhesion molecules, production of 
chemoattractant compounds, regulation of the microcirculation by dictating the 
tonus of the arterioles, regulation of blood pressure (via their effects on 
arterioles), and regulation of vasopermeability (Hack and Zeerleder 2001) They 
provide the interface between a liquid phase, blood plasma, and a solid structure, 
basal membrane, and as such are very responsive to their extracellular 
environment. As a result of chemical or physical stimuli they can rapidly 
modulate both their structure and function. 
When exposed to certain agonists, such as lipopolysaccharide, cytokines, 
chemokines or growth factors, endothelial cells become activated. The activation 
state is manifested by enhanced permeability, increased leukocyte adhesion, a 
shift in the haemostatic balance towards a procoagulant phenotype, and altered 
regulation of vasomotor tone (Shapiro et al., 2010). This results in an increase of 
blood flow to the area of insult, local efflux of plasma proteins and leukocytes, 
and sequestering of the infection. The activated state may be considered 
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dysfunctional when instead of restoring it an overactive endothelium disturbs the 
homeostatic state. 
The end-result of diffuse endothelial activation and dysfunction may be the loss 
of microvascular barrier integrity, leading to tissue edema, shock and multiple 
organ failure. Endothelial activation also leads to an increase in angiopoietin-2, 
which is known to destabilize barrier function and promote inflammation (Lee 
and Lilies 2011).  
In sepsis, endothelial dysfunction typically involves some combination of 
increased leukocyte adhesion and transmigration, increased permeability, a shift 
in the hemostatic balance towards the pro-coagulant side and an alteration in 
vasomotor tone (Shapiro et al., 2010).   
It can seen therefore that in sepsis, endothelial activation and dysfunction are 
critical determinants of the host response and being able to measure the degree of 
endothelial dysfunction may be of benefit in early diagnosis or treatment of 
sepsis. 
Shapiro et al., (2010) looked at a broad range of biomarkers of endothelial 
dysfunction in 221 patients and used the ACCP/SCCM guidelines to define 
sepsis. They measured circulating levels of soluble leukocyte adhesion molecules 
(soluble vascular cell adhesion molecule (VCAM)-1, soluble inter- cellular 
adhesion molecule (ICAM-1) and sE-selectin (the soluble form of the cell 
adhesion molecule E-selectin); procoagulant/antifibrinolytic mediators 
(plasminogen activator inhibitors (PAI)-1); and a marker of vascular endothelial 
growth factor (VEGF) signaling (sFlt-1). An association was found with severity 
of sepsis and biomarker levels for sFlt-1, PAI-1, sE-selectin, sICAM-1, and 
sVCAM-1. The level of a number of these markers also correlated with the 
SOFA score (multi-organ failure score) and APACHE score. One fault of the 
study that the authors’ note is that the results do not test whether these changes 
were specific to sepsis, or whether endothelial cell activation occurs in critically 
ill patients with other insults such as trauma related inflammation. Whilst this 
study is very useful in identifying possible markers of endothelial dysfunction 
the molecules measured require expensive and time consuming tests. 
An alternative measure of endothelial dysfunction that can be used cheaply and 
at the bedside may also provide sufficient information to prognosticate and 
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initiate the treatment of sepsis. One potential test that may fulfill this role is the 
albumin creatinine ratio.  
Microalbuminuria has been found to be predictive of outcome or has shown an 
association between the urinary albumin and the severity of the inflammatory 
insult in a number of acute medical conditions such as ischaemia reperfusion 
injuries (Matsushita et al., 1996), meningitis in children (Roine 1993), acute 
pancreatitis (Shearman et al., 1989) and anaphylactic shock (Wood et al., 2000).  
A recent study by Basu et al., (2010) suggests that ACR has a role in predicting 
sepsis with the median ACR on admission being significantly higher in the sepsis 
group. Of note the study population was a mixed medical and surgical population 
that did not include burn patients. 
A study by Sarti et al., (2001) on a paediatric population noted a patient showed 
a persistent rise in ACR before the appearance of a septic complication. This 
useful finding of ACR rising prior to a septic episode has been endorsed by De 
Gaudio et al., (2000) who found that the postoperative patients that developed 
sepsis showed an increase in glomerular permeability as shown by the ACR.  
There has been no study looking at ACR and the development of sepsis in the 
burn population. 
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3.1.7 Aim 
Through a retrospective analysis of burn patient admissions to ICU to determine 
whether ACR can predict the development of sepsis and outcome in the burn 
ITU setting.  
 
3.2 Methods 
3.2.1 Clinical Setting 
 
The Burns Service compromises twenty beds including four intensive care and 
four high dependency beds. There are twelve low dependency / rehabilitation 
beds. The unit is a tertiary referral centre and accepts patients from a population 
of over 6 million people. Patients are also taken from out of traditional catchment 
areas and occasionally internationally. 
A multidisciplinary team including microbiologists, pharmacists, anaesthetists 
and burn surgeons review all major burns daily. The Parkland formula is used in 
the initial resuscitation to maintain a urine output of 0.5 ml/kg/h in adults and 1 
ml/kg/h in children. Nutritional supplementation is via nasoduodenal enteral 
nutrition with high calorie, low fat formulas. As part of the burn treatment 
protocol, gastric ulcer prophylaxis is performed with H2 antagonists. Low 
molecular weight heparin (40mgs/day) is prescribed daily. Early excision and 
grafting is routinely performed for deep burns that would take more than two 
weeks to heal without surgical intervention using allografting, auto-grafting or 
dermal substitutes depending on the individual characteristics of burn injuries.  
Retrospective collection of data regarding demographic details, mode of injury, 
examination findings was from clinical records. All other results were obtained 
from the Burns ITU computer system MetaVision (iMDsoft, Massachusetts, 
USA). 
All patients admitted to the burns unit between November 2003 and September 
2009 that fulfilled the unit’s admission criteria were included in the study.  
 
 
 
 
 133 
3.2.2 Exclusions 
Exclusions were those patients with non-thermal processes including 
desquamating skin disorders, meningococcal septicaemia, necrotising fasciitis 
and purpura fulminans; patients who stayed in the ITU for less than 24 hours 
were excluded; patients who were transferred from other hospitals more than 5 
days post injury; patients with multiple injuries (where the burn was clinically 
judged not to be the main injury); patients for compassionate care only; patients 
with no or inadequately recorded ACR results. 
Patients with a diagnosis of Type I or Type II diabetes mellitus were included. 
Parameters recorded included patient characteristic data such as age, gender, co-
morbidities, injury data including time of injury, mechanism and TBSA. ACR 
was routinely measured on admission and recorded daily. 
Inhalation injuries were determined by appearance on bronchoscopy. Smoke 
inhalation injury is restricted to injury below the glottis caused by products of 
combustion. The diagnosis requires both of the following: History of exposure to 
products of combustion and bronchoscopy relevant signs below the glottis. The 
signs observed below the glottis that indicate smoke inhalation include 
carbonaceous material, oedema, or ulceration. Erythema or carbon staining in the 
absence of evidence of other signs of injury was not considered an indicator of 
smoke inhalation injury. 
 
3.2.3 Analysis of urine 
On admission a sample of urine was collected within the first six hours, 
subsequently a fresh sample of urine was collected daily via an in-dwelling 
urinary catheter at 06.00 daily for the duration of the admission.   
ACR was measured using the DCA 2000 Analyser manufactured by Bayer 
(Parsons et al., 1999). It runs a quantitative assay for microalbumin and 
creatinine in the urine sample. Only 0.4mls of urine is required to perform the 
analysis. The principle of measurement of microalbumin is based on 
immunoturbidmetry, and that of creatinine is based on colourimetry. The 
albumin to creatinine ratio is calculated by the machine and expressed in mg 
mmol-1 after 7 minutes (Yew and Pal 2006). 
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3.2.4 Statistics 
The analysis performed was a bootstrap analysis and regression analysis. 
Regression analyses have been performed using the computer program R (R 
development Core Team 2011). Both the bootstrap and regression analysis where 
performed by Dr Mike Parker. 
Bootstrap analysis is a computer based method for assigning measures of 
accuracy to sample estimates. For this analysis it is assumed the observations 
form an independent and identically distributed population. The computer 
programme can implement bootstrapping by constructing a number of re-
samples of the dataset and of equal size to the observed dataset, which is 
obtained by random sampling with replacement from the original dataset. 
The re-sampling (in this case 9999 times) gives a histogram of bootstrap means 
i.e. it produces a simulated distribution of the statistic we are interested in. This 
gives an estimate of the distribution of the mean from which one can answer how 
much the mean varies. 
Bootstrapping of the mean allows one to construct a confidence interval for the 
mean. 
 
 
3.3 Results 
Demographics 
A total of 547 patients were eligible for the study from which 308 were 
excluded. The reasons for exclusion are summarised in Figure 3.1.   
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Figure 3.1. A flow chart showing the number of burns patients recruited 
and reasons for exclusions. 547 patients admitted to the burn ICU between 
November 2003-September 2009 were eligible for the study. After exclusions 
(308) 239 adult patients were studied of which 103 developed sepsis during their 
in-patient stay and 136 did not develop sepsis.   
Necrotising fasciitis 
n=1 
Patients n=547 
Non-desquamating skin 
conditions n=25 
Compassionate care 
n=28 
Meningococcal septicaemia n=3 
Transfer >5 days post injury n=14 
Purpura fulminans n=1 
Multiple injury n=1 Admission to ICU due to 
aspiration during surgery n=4 
Self discharge n=1 
Adult Patients 
following exclusions 
n=239 
No sepsis n=136 
Inadequate results n=128 
 
Paediatric patients n=102 
 
Sepsis n=103 
 136 
 No sepsis Sepsis 
No. Of patients 136 103 
Age in years, mean. 
(Range) 
42.4 (16-95) 44.97 (16-85) 
No. Of patients with 
inhalation injury 
20 49 
No. Of deaths 6 32 
Male: female 93: 43 63: 40 
TBSA% (mean) 20.86 39.25 
Length of ITU 
stay/%burn 
0.46 1.15 
Length of stay in days, 
mean 
5.48 32.65 
ACR admission (mean)  4.55 10.43 
Peak ACR (mean) 7.58 33.19 
ACR at 48 hours 3.74 4.31 
 
Table 3.3. A summary of the septic and non-septic patients admitted to the 
burns ICU. This table summarises the main data examined in the study and 
allows a comparison of the two groups studied, septic vs. non septic. 
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Figure 3.2 Mechanism of injury in non-septic adult patients. Data shows the 
mechanism of injury in the patients who did not develop sepsis as a percentage 
of the total number of non septic patients with the total number of patients in 
brackets.  
 
Figure 3.2 shows the mechanism of injury in the non-septic patients. The 
mechanisms and proportions are typical of a tertiary referral unit in Western 
Europe accepting patients from a mainly urbanised population with limited large-
scale industry nearby. The majority of burns are scalds and flame injuries (from 
household fires). In the adult population in can be seen that there are less scalds 
than when children are also included in the data (see figure 2.4 in which scalds 
make up 21.4% of the injuries). 
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Figure 3.3 Mechanism of injury in adult patients who developed sepsis. Data 
shows the mechanism of injury in the patients who developed sepsis as a 
percentage of the total with the total number of patients in brackets. 
 
Of note in figure 3.3 when compared to figure 3.2 there are even more flame 
related injuries. This is of importance, as there is evidence that flame burns result 
in a higher proportion of cases of multi-organ failure and has a higher mortality 
rate (Kraft et al 2011). It may also be the case that flame burns are more likely to 
cause sepsis. 
 
Analysis 
This analysis considers a comparison of patients who had episodes of sepsis with 
those that did not. The factor “Condition” is used to categorise patients as having 
had episodes of sepsis and those that had no sepsis. 
 
Analyses have been performed using the computer program R (R development 
Core Team 2011). 
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Figure 3.4. A boxplot graph of the log ACR at admission for the septic and 
non-septic patients. The length of the box covers the interquartile range, the 
lower edge of the box being the lower quartile, and the upper edge of the box 
being the upper quartile. The line across the box represents the median. The 
dotted lines represent the range and the circles as outlying results. The difference 
between the means of log ACR for the two groups is 0.298 with bootstrap 95% 
confidence limits (0.018, 0.604). This is statistically significant. (Data used to 
derive this graph is shown in Appendix II, Section I, Table I). N.B.  The typical 
way to show a box plot or whisker plot graph is with the length of the box 
showing the interquartile range with a horizontal line representing the median. 
For statistical analysis the mean is used and referred to in the text (Dr Mike 
Parker). 
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Figure 3.4 illustrates that there is a statistically significant difference in the 
admission mean ACR values between the septic and non-septic patients. To see 
how useful this may clinically a ROC curve analysis was performed. 
 
 
 
 
 
Figure 3.5 ROC curve for condition (sepsis/no sepsis) versus urinary ACR 
taken on admission to the burn unit.  
Data shows a ROC curve, a graphical plot of sensitivity against 1-specificity, 
(true positive against false positive) for condition (of having sepsis) against 
admission ACR. The cut off ACR value of 2.35 mg mmol-1 is estimated by 
maximizing the Youden Index. Using a cut-off ACR of 2.35 mg mmol-1 sepsis 
can be predicted with a sensitivity of 47.7% and a specificity of 68%. 
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 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
No sepsis Sepsis 
Observed 
outcome 
No sepsis 85 40 125 68.0 
Sepsis 46 42 88 47.7 
 Total 131 82 213 59.6 
 
Table 3.4 Diagnostic classification table for using a cut-off value for ACR at 
admission. The data used to derive the contingency table from which the 
sensitivity, specificity, PPV and NPV were determined. Diagnostic performance 
values obtained from the above table and their 95% confidence intervals are: 
sensitivity 47.7% (CI: 37.6%, 58.0%), specificity 68.0% (CI: 59.4%, 75.5%), 
PPV 51.2% (CI: 40.6%, 61.7%), and NPV 64.9% (CI: 56.4%, 72.5%). The area 
under the curve with bootstrap 95% confidence interval is 0.5549 (CI: 0.4747, 
0.6352). The AUC show this is a poor test for determining sepsis. 
 
 
Figure 3.5 gives the ROC curve for ‘condition’ (of having sepsis) against 
admission ACR. By maximizing the Youden index a cut off ACR value of equal 
or greater than 2.35 mg mmol-1 can determine whether a patient develops sepsis. 
The AUC is .55 however suggesting this is a poor test for determining sepsis. 
This is backed up by the data in table 3.4 that allows the PPV and NPV to be 
established. This test has a poor PPV and NPV, which mean that clinically it is 
unlikely to be of any use.   
There are many factors that may affect the development of sepsis. It was decided 
therefore to examine some of the characteristics of the patients and injuries to 
determine their potential influence on sepsis development.  
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Figure 3.6 A boxplot graph of the age in years for the septic and non-septic 
patients. The length of the box covers the interquartile range, the lower edge of 
the box being the lower quartile, and the upper edge of the box being the upper 
quartile. The line across the box represents the median values (no sepsis 39 
years, sepsis 44 years with mean values being 42.4 and 45 respectively). The 
dotted lines represent the range of values. The difference between the means for 
the two groups is 2.6 with 95% confidence limits 43.5 (41.12, 45.88). This is 
statistically significant. 
 
The first aspect to be examined was age. See appendix 2 table 2 for summary 
statistics used for comparing the age of septic and non-septic patients. Figure 3.6 
below shows there is a statistically significant difference in the age of the 
patients in the two groups. One explanations for this is that the response to injury 
is attenuated in the older patients making them less able to mount a response to 
the challenge posed by a burn and thus more likely to develop sepsis. Another 
reason could be that the older patients sustained worse burns making sepsis more 
likely. The TBSA% burnt and the development of sepsis was therefore examined 
to see if there was any correlation. 
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Figure 3.7. A boxplot graph demonstrating the percentage TBSA burned for 
the septic and non-septic patients. The length of the box covers the 
interquartile range, the lower edge of the box being the lower quartile, and the 
upper edge of the box being the upper quartile. The line across the box represents 
the median. The dotted lines represent the range of values. The difference 
between the means of % TBSA for the two groups is 18.4 with bootstrap 95% 
confidence limits (13.8, 23.0). This is statistically significant. 
 
Figure 3.7 illustrates that there is a significant difference between the means of 
% TBSA for the two groups is 18.4 with bootstrap 95% confidence limits (13.8, 
23.0). The patients who subsequently developed sepsis had significantly larger 
burns. This is exactly what one would expect. In general a larger wound surface 
area tends to mean a more significant injury (although this may not always be the 
case as the depth of the wound is also important, not just the surface area). 
Larger injuries as well as causing a larger systemic response also allows greater 
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opportunity for infection as there is a greater exposed area of skin that is 
compromised. Also the patients generally require more operations and more 
interventions (such as line changes for monitoring), which are again an 
opportunity for infection. Other factors examined were sex of the patient, the 
presence of inhalation injury. 
 
 
Sex 
Condition Overall Percentage 
with sepsis No sepsis Sepsis 
Male 93 63 156 40.4 
Female 43 40 83 48.2 
Overall 136 103 239 43.1 
 
Table 3.5. Effect of sex of patient on development of sepsis (Condition) Data 
demonstrates the number and sex of the patients and whether they developed 
sepsis or not. The difference between the percentages is 7.8% with 95% 
confidence limits (- 5.4%, 20.8%). This is not statistically significant. 
 
 
 
Inhalation 
Condition Overall Percentage 
with sepsis No sepsis Sepsis 
No 116 54 170 31.8 
Yes 20 49 69 71.0 
Overall 136 103 239 43.1 
 
Table 3.6. Effect of inhalation injury on the development of sepsis. 
Data demonstrates the influence an inhalation injury has on the subsequent 
development of sepsis. Inhalation appears to make a large difference in the 
likelihood of developing sepsis. The difference between the percentages is 39.2% 
with 95% confidence limits (25.5%, 50.7%). This is statistically significant. 
 
 
Many studies in burn patients have found that there are variations in outcome 
according to sex of the patient (Brusselaers et al., 2010). In our study we found 
shows that sex made no difference in the development of sepsis (table 3.5). Far 
more important in developing sepsis was the presence of an inhalation injury as 
shown in table 3.6. The next consideration was the effect sepsis had on outcome 
(death or survival). 
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Outcome 
Condition Overall Percentage 
with sepsis No sepsis Sepsis 
Alive 130 71 201 35.3 
Died 6 32 38 84.2 
Overall 136 103 239 43.1 
 
Table 3.7. Effect of sepsis on outcome. Data shows the consequences of 
developing sepsis. The difference between the percentages of those that died 
versus those that survived is 48.9% with 95% confidence limits (32.7%, 59.3%).  
 
Table 3.7 illustrates the profound influence sepsis has on outcome with almost 
half of the patients who developed sepsis dying. Of all the deaths in the study 
84% were sepsis related. In total the number of patients in the whole study group 
dying from sepsis is 32 (13.4%) which is comparable to European data presented 
by Brusselaers et al., 2010). 
Flame burns have been associated with a higher mortality rate (Kraft et al., 
2011). This may be explained by the fact that flame burns have also been 
associated with more-extensive, deeper burns and the presence of inhalation 
injury. So it may also be possible that the mechanism of the burn may play a role 
in determining the development of sepsis.  
 
 
 
Mechanism 
Condition Overall Percentage 
with sepsis No sepsis Sepsis 
Chemical 5 2 7 28.6 
Contact 2 1 3 33.3 
Electrical 9 5 14 35.7 
Flame 100 89 189 47.1 
Scald 20 6 26 23.1 
Overall 136 103 239 43.1 
 
Table 3.8. Effect of Mechanism of injury in developing sepsis. Data 
demonstrates how many people developed sepsis for each mechanism of burn. 
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Table 3.8 demonstrates the influence of the mechanism of the injury on the 
development of sepsis. The first three categories in Table 3.8 contain small 
numbers and would mean that if the variable were included in a regression model 
some regression coefficient estimates would be unreliable. To avoid this, these 
three categories (contact, chemical and electrical) have been combined have been 
combined in a derived variable- Other (demonstrated in table 3.9). This decision 
was made after consultation with a medical statistician (Dr Mike Parker, Anglia 
Ruskin University)  
 
 
 
Mechanism 
Condition Overall Percentage 
with sepsis No sepsis Sepsis 
Flame 100 89 189 47.1 
Scald 20 6 26 23.1 
Other 16 8 24 33.3 
Overall 136 103 239 43.1 
 
Table 3.9. Effect of Mechanism of injury in developing sepsis (revised). Data 
demonstrates how many people developed sepsis for each mechanism of burn 
with contact, flame and chemical burns being combined into a single group 
(labelled ‘Other’) to aid statistical analysis. 
 
Table 3.9 shows that flame burns not only are the most common mechanism of 
injury but also are the most likely to cause sepsis. These is not surprising, as 
flame burns result in a higher proportion of cases of multi-organ failure; and also 
have a higher mortality rate (Kraft et al., 2011). 
 
For the data presented above a far stronger indicator of the development of sepsis 
rather than ACR was the TBSA% sustained by the patients. We therefore 
investigated whether there was a size of injury or cut-off point (as determined by 
TBSA %) that would make the identification of sepsis patients clearer. 
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Prediction of sepsis 
This section examines the use of a simple cut-off value for diagnostic prediction 
of sepsis. For the set up considered below the receiver operating characteristic 
(ROC) curve shows the optimum cut-off value according to the maximum 
Youden Index. The analysis has been performed using the function ROC from 
the R package DiagnosisMed (Brasil P 2010). The bootstrap confidence limits 
have been obtained using 9999 bootstrap replicates with the function roc from 
the R package pROC (Robin et al., 2011). 
 
 
 
Figure 3.8 ROC curve for condition (sepsis/no sepsis) versus TBSA%. The 
cut off was estimated by maximizing the Youden Index. Data shows a graphical 
plot of sensitivity against 1-specificity, (true positive against false positive) the 
ROC curve for outcome (sepsis) against TBSA% of burn sustained. Using a cut-
off TBSA % of 32, sepsis can be predicted with a sensitivity of 57.2% and a 
specificity of 88%. The analysis has been performed using the function ROC 
from the R package DiagnosisMed (Brasil P 2010). The AUC show this is a 
good test for determining sepsis. 
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 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
No sepsis Sepsis 
Observed 
outcome 
No sepsis 120 16 136 88.2 
Sepsis 44 59 103 57.3 
 Total 164 75 239 74.9 
 
Table 3.10 Diagnostic classification table for using a cut-off value for % 
TBSA. The data used to derive the contingency table from which the sensitivity, 
specificity, PPV and NPV were determined. Diagnostic performance values 
obtained from the above table and their 95% confidence intervals are: sensitivity 
57.3% (CI: 47.6%, 66.4%), specificity 88.2% (CI: 81.7%, 92.6%), PPV 78.7% 
(CI: 68.1%, 86.4%), and NPV 73.2% (CI: 65.9%, 86.4%). The area under the 
curve with bootstrap 95% confidence interval is 0.7632 (CI: 0.6998, 0.8225). 
This show the test to be good at determining sepsis when the % TBSA is greater 
than or equal to 32%. 
 
 
Figure 3.8 demonstrates that a cut-off TBSA% of 32 (by cut-off we mean a 
TBSA% of 32 or greater) can be used to predict sepsis. The AUC is .76, which 
shows that it is a good test for determining sepsis The data in summary table 3.10 
show that the sensitivity, specificity, PPV and NPV are all superior to when the 
ACR on admission was used to determine sepsis (see figure 3.5 and table 3.4). 
Whilst this is a better test for determining the development of sepsis it may be 
argued that a cut off TBSA% of 32 is quite high and thus the clinical utility may 
be limited as many patients have smaller burns which can still be life threatening. 
The data presented in this chapter demonstrates that there are many factors that 
strongly influence the development of sepsis (particularly, TBSA%, inhalation 
injury and to a lesser extent age of the patient). To see if ACR has a role in sepsis 
prediction further analysis by logistical regression was performed. 
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Binary logistical regression to determine whether ACR can predict sepsis 
In order to determine if ACR has a role as a predictive tool for sepsis binary 
logistic regression models can be used. Regression analysis measures the 
strength of a relationship between a dependent variable (in this case sepsis) and 
one or more independent variables (such as TBSA% and inhalation injury). Then 
knowledge of the values of the independent variables enables prediction of the 
value of the dependent variable or likelihood of the occurrence of an event 
(sepsis). 
Binary (also known as binomial) logistic regression is used when the observed 
outcome can have only two possible types (e.g., "dead" vs. "alive", "success" vs. 
"failure", or in this case "sepsis" vs. "no sepsis") compared to multinomial 
logistic regression where the outcome can have three or more possible outcomes 
(such as better, worse and no change). The outcome is coded as "0" and "1" in 
binary logistic regression with the target group usually coded as "1" and the 
reference group as "0".  
Regression is often to make predictions, and using standard linear regression 
might make predictions that make no sense for dichotomous dependent variables. 
For instance if you code sepsis as 1 and no sepsis as 0, then linear regression 
might predict 0.5. This makes no sense, as a patient cannot partially have sepsis. 
To get around this instead of trying to model the dichotomy itself (sepsis/no 
sepsis) we transform it into the ODDS of getting sepsis. The odds are defined as 
the probability of a case (sepsis) divided by the probability of a non-case (no 
sepsis). 
In addition by using the odds ratio (OR) it tells us how the odds change when an 
independent variable changes. For instance how the odds change as the TBSA% 
increases. 
The odds ratio is the primary measure of effect size in logistic regression and can 
be worked out to compare the odds that membership in one group will lead to a 
case outcome with the odds that membership in some other group will lead to a 
case outcome. An odds ratio of one indicates that the odds of a case outcome are 
equally likely for both groups under comparison. The further the odds deviate 
from one, the stronger the relationship.  
Binary logistic regression was used to assess what variables (including ACR) a 
patient’s Condition (sepsis or no sepsis) is related to. Therefore, it allows the 
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importance of factors contributing to a patient being in the sepsis group to be 
assessed.  
The modelling used for the binary logistic regression is detailed below. Dr Mike 
Parker performed the logistic regression, explaination of goodness of fit statistics 
and tables 3.11-3.14. 
 
The dependent variable is the condition sepsis or no sepsis 
The potential model predictor variables are 
1. Age Age at admission in years 
2. TBSA% Percentage of total body surface area burned 
3. Sex 
4. Inhalation A categorical variable (Yes, No) 
5. Mechanism3 A categorical variable (Flame, Scald, Other) 
6. log ACR 
 
Models can be found that will fit all the observations in a data set perfectly, but 
the model may be of no value for a different data set. The more complicated a 
model is the more likely it is that it will apply only to the current data set and be 
poor at prediction for other data sets. The ideal model captures the important 
features in the data without being over complicated. To see how a statistical 
model fits a set of observations a “goodness of fit” is assessed. Measures of 
goodness of fit typically summarize the discrepancy between observed values 
and the values expected under the model in question. 
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The first model is shown in table 3.11 and uses a single predictor for sepsis. The 
second model uses two predictor variables for modelling, table 3.12 (Dr Mike 
Parker). 
The tables provide the following goodness of fit statistics for each model. 
1. p  The number of parameters fitted. The more parameters fitted the 
more complex the model is, and is therefore the more likely that it 
will not to be generalisable to other groups of patients.  
2. R2  In statistical modelling using ordinary multiple regression with a 
continuous response variable the R-square indicates the proportion 
of the variance explained by the model. There is no goodness of 
fitness statistic that is exactly equivalent for binary logistic 
models, but the Nagelkerke R-square is sometimes regarded as 
analogous. It is often called a pseudo-R-square. Higher values are 
sought. 
3. AIC  Akaike Information Criterion. This penalises models for every 
additional parameter that they estimate. Lower values are sought. 
4. CC  Percentage of subjects correctly classified. This uses the fitted 
model to classify each subject. As the same data set is used to both 
fit the model and classify the subjects it can be expected to be 
over optimistic. Higher values are sought. 
5. CCC  A cross-validated estimate of the percentage of subjects correctly 
classified. Each subject is itself excluded from the model used to 
classify it. The intention is that it should not be so over-optimistic. 
Higher values are sought.  
6. AUC  The area under the receiver operating characteristic curve. Higher 
values are sought. 
7. Brier CCC only corrects the over optimism in certain circumstances. 
The Brier score does not have this problem. The Briar score 
measures the accuracy of probabilistic predictions. Lower 
values are sought.  
8. BrierS The Brier score does not have a constant scale, and so the Scaled 
Brier score remedies this and it is expressed as a percentage. 
Higher values are sought. 
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Model Predictors p R2 AIC CC CCC AUC Brier BrierS 
1.1 TBSA% 1 29.8 240 75.1 74.6 0.7665 0.1852 23.6 
1.2 Inhalation 1 15.9 266 69.5 69.5 0.6626 0.2120 12.6 
1.3 Mechanism3 2 5.2 287 58.7 58.7 0.5768 0.2337 3.6 
1.4 Log ACR 1 2.5 289 59.2 58.7 0.5549 0.2378 1.9 
1.5 Sex 1 1.0 291 58.7 58.7 0.5429 0.2406 0.8 
1.6 Age 1 0.5 292 58.7 56.8 0.5595 0.2416 0.4 
 
Table 3.11. Summary statistics for the single-predictor models (6 possible 
models). The table of fitted models is sorted according to descending BrierS. 
The model has been fitted using the standard function glm in the computer 
program R. The data confirms that TBSA% is important for predicting sepsis. 
 
 
 
Table 3.11 confirms the importance of TBSA% in predicting sepsis. The AUC 
(.76) confirms that it is a good test and the CC confirms this as it show the 
percentage of subjects correctly classified as 75.1%.   
Table 3.11 also shows that inhalation has a role in predicting sepsis. As it is clear 
more than one variable can predict sepsis it may be that using a combination of 
the predictor variables may provide an even more accurate way of predicting 
sepsis. Table 3.12 show the summary statistics for the model to determine sepsis 
using a combination of two predictors. Table 3.12 show that the combination of 
TBSA% and inhalation injury are more useful in predicting sepsis than either of 
the variables, TBSA% or inhalation injury in by themselves. The AUC, (0.81) 
shows that it is a good test.  
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Model Predictors p R2 AIC CC CCC AUC Brier BrierS 
2.1 TBSA% +Inhalation 2 37.8 225 75.6 74.6 0.8168 0.1683 30.6 
2.2 TBSA% +Mechanism3 3 32.8 237 75.6 75.6 0.7897 0.1787 26.3 
2.3 TBSA% +Age 2 31.6 238 75.6 74.6 0.7877 0.1806 25.5 
2.4 TBSA% +log ACR 2 30.5 240 74.6 73.7 0.7764 0.1827 24.7 
2.5 TBSA% +Sex 2 31.1 239 73.7 72.8 0.7707 0.1828 24.6 
2.6 Inhalation +log ACR 2 17.7 265 70.0 69.0 0.7069 0.2086 14.0 
2.7 Mechanism3+Inhalation 3 17.8 267 70.0 69.5 0.6899 0.2087 13.9 
2.8 Sex +Inhalation 2 16.8 266 69.5 69.5 0.6958 0.2103 13.3 
2.9 Age +Inhalation 2 16.4 267 69.5 69.5 0.7018 0.2111 12.9 
2.10 Mechanism3+log_ACR 3 7.5 285 62.9 62.0 0.6240 0.2289 5.6 
 
Table 3.12 Summary statistics for two-predictor variables model. Data is 
shown summarising the statistics for the model using two variables for the 
prediction of sepsis. The table of fitted models is sorted according to descending 
BrierS. The model has been fitted using the standard function glm in the 
computer program R. TBSA% in combination with sepsis is the best predictor 
for developing sepsis. 
 
 
Further analysis of selected binary regression models is given below to estimate 
the probability of sepsis. As explained previously the odds ratio (OR) is given as 
it tells us how the odds change when an independent variable changes. For 
instance how the odds change as the TBSA% increases. An odds ratio greater 
than 1 indicates that the odds in favour of sepsis are increased by that factor. An 
odds ratio less than 1 indicates that the odds in favour of sepsis are reduced by 
the factor.  
The factor Inhalation is a categorical factor with two levels Yes and No 
(inhalation injury and no inhalation injury). The model has been set up so that 
the reference category is “No”. This means that the odds of 5.16 indicates that 
“Yes” increases the odds in comparison with “No” by more than five times. In 
other words an inhalation injury makes sepsis five times more likely. For 
continuous predictors there is no reference category so the odds ratio indicates 
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the change in the odds for each change of one unit in the predictor. For example, 
for TBSA%  (OR of 1.065) the odds ratio in favour of sepsis increases by 6.5% 
for each additional one percent TBSA. That is, the greater the percentage area 
burned increases the probability of sepsis. 
 
 
 
Predictor 
 
Odds 
ratio 
95% confidence 
limits 
Lower Upper 
TBSA% 1.065 1.046 1.088 
Inhalation (reference category No) 5.16 2.85 9.63 
Mechanism3 (reference category Flame) 
Scald 
Other 
 
0.356 
0.578 
 
0.130 
0.231 
 
0.858 
1.357 
Log ACR 1.21 0.98 1.51 
Sex (reference category Female) 0.729 0.427 1.244 
Age 1.007 0.994 1.021 
 
Table 3.13. The probability of sepsis using single predictor models. Data 
shows the odds ratios for predicting sepsis using a single variable. The model has 
been re-fitted using the package logistf (Ploner et al., 2010) for the computer 
program R. This uses Firth’s biased-reduced logistic regression approach that 
aims to reduce the statistical bias in the model fitting. The 95% confidence limits 
for the odds ratios indicate the range of plausible values for the odds ratio 
therefore only TBSA and an inhalation injury are useful in predicting sepsis.  
 
When looking at a range of variables (Age, TBSA%, Sex, Inhalation, 
Mechanism, log ACR on admission) in isolation only the TBSA% sustained and 
whether the patient had sustained an inhalation injury were of use in predicting 
sepsis, see table 3.13. When the confidence limits enclose the value 1 this 
indicates that we should not draw a firm conclusion about the effect of the factor. 
This is the case for log ACR, Sex, and Age.  
As noted before combining the two variables (TBSA and inhalation) showed 
even better ability to predict sepsis so a regression model was created to predict 
sepsis based on the two-predictor model. 
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Predictors 
 
Odds 
ratio 
95% confidence 
limits 
Lower Upper 
TBSA% 
Inhalation (reference category: No 
inhalation) 
1.065 
4.47 
1.043 
2.27 
1.089 
9.03 
 
Table 3.14. Two-predictor model with TBSA% and Inhalation 
demonstrating the odds ratio and 95% confidence intervals. Data shows the 
odds ratios for predicting sepsis using two variables. The model has been re-
fitted using the package logistf (Ploner et al., 2010) for the computer program R. 
This uses Firth’s biased-reduced logistic regression approach that aims to reduce 
the statistical bias in the model fitting. 
 
Table 3.14 summarises the odds ratio for both TBSA% and inhalation injury 
when using both variables in a single model to predict sepsis. The factor 
Inhalation is a categorical factor with two levels (“Yes” and “No” which signify 
inhalation injury and no inhalation injury). The model has been set up so that the 
reference category is “No”. This means that the odds of 4.47 indicates that “Yes” 
increases the odds in comparison with “No” by more than four times. This means 
the probability of sepsis is four times higher when an inhalation is present 
(“Yes”). For continuous predictors there is no reference category so the odds 
ratio indicates the change in the odds for each change of one unit in the predictor. 
For example for TBSA% the odds ratio of 1.065 indicates that the odds ratio in 
favour of sepsis increases by 6.5% for each additional one percent TBSA. In 
essence, that means the greater percentage area burned increases the probability 
of sepsis. 
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Figure 3.9 Binary logistic model of TBSA% and inhalation. The data shows 
the influence of the two variables (TBSA% and inhalation injury) on having 
sepsis. The fitted lines show the estimated probability of the condition (Y line = 
inhalation, N line =no inhalation). The observed successes are indicated with 
points at the probability of 1 and the failures are indicated at the probability of 0. 
 
 
A binary regression logistic model of TBSA% and inhalation was produced as 
shown in figure 3.9 to clearly demonstrate the effect of the two variables on 
sepsis development. The points have been jittered to enable them to be seen more 
easily when there are a lot of them clustered together. It is clear that for values of 
TBSA% a little above 30% or more there is a greatly increased chance of a 
patient having sepsis as the probability increases from just over a 30% chance of 
having sepsis to a 70% chance of developing sepsis. 
The estimated probability from a fitted binary logistic model can be used to 
produce a diagnostic indicator, as shown in the ROC curve below. 
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Figure 3.10 ROC curve for the logistic model: TBSA% and inhalation. 
Using a cut-off of .38 the sensitivity is 75% and the specificity 77%. Data shows 
a graphical plot of sensitivity against 1-specificity, (true positive against false 
positive) the ROC curve for the logistic model of TBSA% and inhalation. The 
cut off value of 0.387 is estimated by maximizing the Youden Index. The 
sensitivity for this test is 75 % and the specificity 77%. The AUC is 0.81, which 
shows this to be an excellent test for determining sepsis with a cut off value of 
0.387. Analysis performed by computer program R (R Development Core Team, 
2011). 
 
The ROC curve above in figure 3.10 displays an optimum cut off value of 0.387. 
This represents an estimated probability of sepsis, and the displayed values of 
sensitivity and specificity have been derived using this cut off. When you have a 
single variable such as TBSA% then a cut-off value on the TBSA% scale can be 
used to predict an outcome e.g. sepsis. This means a patient with a value higher 
than that cut-off predicts sepsis and a lower value predicts freedom from sepsis. 
When you have more than one variable they need to be used in some way to 
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produce a prediction. One way is to use them as predictor variables in a binary 
logistic multiple regression. The fitted model estimates the probability of an 
outcome (sepsis) and the cut off estimated probability can be used to predict 
sepsis. Normally one uses a cut-off estimated probability of 0.5, so that a patient 
with a higher probability is predicted to have sepsis, and a patient with a lower 
probability is predicted to be sepsis-free. The computer program used to produce 
the ROC curve automatically displays an optimum estimated probability to use 
as a cut-off. This is 0.3878. That means a patient for whom the binary logistic 
model estimated a probability of sepsis greater than 0.3878 is put in the 
prediction class of having sepsis. In this case the 0.387 is a number that works 
within the model but does not directly translate to a clinically derived figure such 
as TBSA% for example. This represents an estimated probability of sepsis, and 
the displayed values of sensitivity and specificity have been derived using this 
cut off. However, it is more usual to use the standard cut off probability of 0.5, 
so that patients are classified simply according to whether they are more likely to 
be in one category than another. For the model being considered here a cut off 
probability of 0.5 produces the following classification table (Dr Mike Paker). 
 
 Predicted outcome  
Total 
 
Percentage 
correctly 
classified 
No sepsis Sepsis 
Observed 
outcome 
No sepsis 117 19 136 86.0 
Sepsis 42 61 103 59.2 
 Total 159 80 239 74.5 
 
Table 3.15. Diagnostic classification table using a cut-off probability of 0.5 
for the two-predictor binary logistic model for sepsis. Data shows that the 
model predicts sepsis when the estimated probability is greater than or equal to 
0.5. Diagnostic performance values obtained from the above table and their 95% 
confidence intervals are: sensitivity 59.2% (CI: 49.6%, 68.2%), specificity 
86.0% (CI: 79.2%, 90.9%), PPV 76.3% (CI: 65.9%, 84.2%), and NPV 73.6% 
(CI: 66.2%, 79.8%). The area under the curve with bootstrap 95% confidence 
interval is 0.816 (CI: 0.759, 0.869). 
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Table 3.15 shows the cut-off being 0.5, the probability that they will fall into the 
sepsis category or the non-sepsis category. Whilst the area under the curve shows 
this to be an excellent test, by not choosing the optimum value (established in 
figure 3.10) the test loses both sensitivity and specificity.  
In summary the admission ACR is not of use in predicting the patients who will 
develop sepsis. More useful factors in predicting sepsis are the TBSA% and the 
presence or not, of an inhalation injury.  
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3.4 Discussion 
 
This study of adults admitted to a UK burns ICU and requiring resuscitation 
shows that admission ACR cannot be used to identify patients that will go on to 
develop sepsis. 
Table 3.3 compares the two study groups, those that developed sepsis and those 
that did not. The most recent review of severe burns injuries in Europe presented 
figures of between 2 % and 14% for the number of burn patients dying from 
sepsis (Brusselaers et al., 2010). The rate of sepsis in the study population is 43% 
and the death rate in those suffering from sepsis is 13.3%. Although this figure 
falls within the range published by Brusselaers the actual figure for the unit is 
lower as this is a study of adults only. The paediatric population suffer more 
frequently from scalds and have a lower rate of sepsis. In addition although the 
patients suffered from sepsis without access to the post mortem results it cannot 
always be determined that sepsis was definitely the cause of death. Many burn 
patients suffer from multiple co-morbidities and some will have died from other 
causes such as myocardial infarcts for instance.  
The impact that sepsis can have on a unit is clear by comparing the mean length 
of stay for the two groups. The septic patients stay over five and a half times 
longer than the non-septic patients (5.54 days vs. 32.65 days) resulting in a large 
difference in the amount of medical intervention required and costs incurred. 
   
The mean ACR on admission (Non-septic, 4.49 mg mmol-1 vs. septic 10.43 mg 
mmol-1) shows a pronounced difference and the difference in the log ACR 
(figure 3.4) is statistically significant. A study by Basu et al., (2010) suggests 
that ACR has a role in predicting sepsis. Looking at a mixed population of 
medical and surgical patients (that did not include burn patients) they found the 
median ACR on admission being significantly higher in the sepsis group. The 
admission ACR showed a sensitivity of 80% and specificity of 64.1% however 
the cut off ACR value to determine this was much higher (14 mg mmol-1) than 
in our study (2.35 mg mmol-1), which had a sensitivity of 47.7% and specificity 
of 68.0%. Using such a high ACR cut off would undoubtedly improve the 
sensitivity and specificity in our study but at the expense off its use in the clinical 
scenario.  
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Although there was a significant difference between the means one cannot 
necessarily interpret this to infer that log ACR predicts sepsis. 
Many factors may affect the development of sepsis so a binary logistical 
regression was performed to assess which variables sepsis may be related to. 
Both TBSA% and inhalation injury were found to be the strongest factors whilst 
admission ACR was not.  
In conclusion, although ACR may have a role in demonstrating sepsis currently 
in burns care it appears to be limited. It may be that because of the systemic 
impact that burns injuries are more complex than may other medical illnesses 
and looking at ACR in isolation is inadequate to reflect the inflammatory 
changes going on. Perhaps sampling ACR in combination with another marker of 
inflammation such as CRP or procalcitonin would provide more accurate results. 
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Chapter 4 Multi-organ failure and ACR in burns 
 
4.1 Introduction 
 
Despite decreases in mortality rate over the last four decades, burns trauma still 
results in a high morbidity and mortality (Brusselaers et al., 2010). Although 
some burns are obviously non- survivable and the patients die early after the 
injury a significant number of burns patients have prolonged in-patient stays 
interrupted by setbacks and complications. 
Infection and organ dysfunction is frequent and may ultimately lead to death; 
particularly in patients with larger burns but these factors also have an impact on 
the length of stay in hospital and the cost of care.   
Multi organ failure and sepsis are the most frequently reported causes of death 
with multi-organ failure responsible for 25-65% of all burn deaths (in Europe) 
and sepsis for 2%-14% of all burns deaths (again in Europe) (Brusselaers et al., 
2010).  
 
 
4.1.2 SIRS and Multi-organ dysfunction syndrome (MODS) 
Definition of SIRS and MODS 
Inflammation is an essential part of normal healing. In a small burn this may 
manifest itself as a mild rise in cytokines with no observable clinical signs. The 
inflammatory response that occurs after a large burn can manifest itself 
systemically with microcirculatory failure of capillaries supplying individual 
organs, acute respiratory syndrome, severe coagulopathy, and the eventual 
development of multi-organ failure (Shankar et al., 2007). 
After any large injury a number of biological cascades are activated in a temporal 
fashion. There is initially an acute phase of a hyper-reactive immune response 
followed by a hyporeactive phase. 
The hyperactive phase is called the ‘Systemic Inflammatory Response 
Syndrome,’ or SIRS and the hyporeactive phase is called ‘Counter Anti-
inflammatory Response Syndrome’ or CARS. The current definition of SIRS 
was introduced in the early 1990s at a consensus conference of critical care and 
trauma (Bone et al., 1992). It was designed to describe the widespread 
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inflammation (or clinical response to that inflammation) that can occur in 
patients with a range of disorders such as pancreatitis, ischaemia, trauma, 
hemorrhagic shock and immunologically mediated organ injury. Although sepsis 
can occur with SIRS the term sepsis was is to be used only if the patient has 
documented infection. 
 
4.1.3 Criteria for SIRS 
SIRS is considered to be present when a patients has two or more of the 
following problems: 
 
1. Temperature above 38oC or below 36oC. 
2. Heart rate >90 beats per minute (bpm) 
3. Respiratory rate>20/min or maintenance of PaCO2 <32mm Hg. 
4. WBC count >12,000/mm3 or <4000/mm3. 
 
The extent of organ dysfunction in SIRS patients can vary depending on several 
factors. Firstly the magnitude and duration of the initial injury and also host 
response factors which are partially determined by genetic variations in the 
magnitude of the inflammation (Bone et al., 1992). Thus the degree of organ 
dysfunction varies between patients and within the same patient over time. The 
term ‘Multiple Organ Dysfunction Syndrome’ (MODS) was therefore created to 
reflect the wide range of severity and changing nature of SIRS. MODS can 
develop via two pathways. First is a direct insult to the organ that shows an 
inflammatory response that is at least, initially confined to the affected organ. 
The second pathway is by infection or trauma in one part of the system resulting 
in systemic inflammatory responses and dysfunctions of organs elsewhere (Bone 
et al., 1992).  
 
4.1.4 Appropriateness of SIRS definition in burns 
Some studies have looked at SIRS on admission and found it to be predictive of 
mortality and ICU admission in trauma patients (Malone et al., 2001). In addition 
the admission SIRS score has been used to predict infection and outcome in 
 164 
blunt trauma (Bochicchio et al., 2001). However there has been no study looking 
at SIRS on admission or during in-patient stay in burns patients.  
After a major thermal injury the first barrier to microbial invasion is 
compromised and the patient is constantly exposed to the outside environment. 
In response to this, inflammatory mediators that change the baseline metabolic 
profile are continuously released. This results in a re-setting of the baseline 
temperature to around 38.5oC with co-existing tachycardia and tachypnea that 
can last for months in severe burns patients. 
As can be seen from the criteria for SIRS (referred to overleaf) a lot of burns 
patients will fulfil these criteria and yet be within the normal boundaries 
expected after an extensive burn. 
As most moderate sized burns will fulfil the criteria for SIRS (albeit fleetingly) 
perhaps the length of time that SIRS is manifested may be of more value? This 
has been found to be the case with trauma patients. SIRS for 3 days or more was 
found to be a strong determinant of developing MODS (Gando et al., 1999). 
Although not using the SIRS definition, a study by Sheridan et al., (1998) 
showed that there had been a prolonged period of organ failure in burns patients 
that eventually died. As well as characterizing the sequence of organ failure in 
those that died they also noted that those dying of multiple organ failure had 
most of their burn wounds closed. Also they were usually not suffering from 
uncontrolled infection at the time of their death, although they had suffered 
multiple infections prior to their death, each of which has been controlled. As 
noted above even after the acute inflammatory phase of the injury has settled the 
hypermetabolic phase can persist for weeks (even in the absence of infection) 
and no study has shown that in burns there is a period (either pre or post 
resuscitation) where the SIRS criteria becomes clinically valuable (Greenhalgh et 
al., 2007).  
Two parameters that have been shown to be related directly to mortality in burns 
are, the size of the burn (in percentage of total body surface area affected) and 
the presence of an inhalation injury (Miller et al., 2006). However there are no 
studies that look at SIRS and the relationship to burn size. In addition the SIRS 
criteria do not reflect the impact that an inhalation injury has on outcome. It has 
therefore been recommended that routine use of SIRS in burns should not be 
used at least until further studies have been performed (Greenhalgh et al 2007).  
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4.1.5 Illness severity scores and measuring organ dysfunction. 
The SIRS criteria have formed the basis of other scoring systems that are used in 
the general intensive care or critical care units. Many scoring systems have been 
designed but some of the most commonly used are the Acute Physiology and 
Chronic Health Evaluation scores (APACHE I-III)  (Knaus et al., 1981, Knaus et 
al., 1985, Knaus et al., 1991) and Simplified Acute Physiology Score (SAPS) 
(LeGall et al., 1984). These allow measurements to be made that can then be 
used in predicting probability of survival and therefore outcome and mortality. 
The Apache III score developed in 1991 scores patients for acute severity of 
illness by weighting physiological derangement using 27 physiological variables, 
which are scored 0 to 4 to reflect degree of derangement. The calculation is 
proprietary, and hospitals must ‘enroll’ with the APACHE system to access the 
decision support instrument (the programme used to calculate outcomes from the 
variables examined). The physiologic points are assigned for the worst value 
recorded in the first 24 hrs in the ICU. 
The SAPS score was developed to simplify the diagnostic data collection in the 
APACHE system, focusing on only physiologic measures easily and typically 
measured in ICU patients. The score is calculated from 12 routine physiological 
measurements during the first 24 hours and includes information about previous 
health status. It is designed to measure the severity of disease for patients 
admitted to the Intensive Care Unit and therefore is only calculated once during 
the admission. 
 
Burns patients were excluded from the original design of the APACHE scoring 
systems (II and III), however a few studies have found the APACHE III score to 
be able to predict mortality in burns patients (Moore et al., 2010, Tanaka et al., 
2007). Looking at the studies in more depth their results have to be interpreted 
with some caution. 
Firstly both looked retrospectively at patients admitted to their unit over a seven-
year and eleven year period. Over this time there may have been changes in 
practice due to technical developments or changes in technique or management. 
This would obviously mean different patients might have received different 
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standards or levels of care. This seems likely, as over the study period there was 
a decline in observed mortality accompanied by a parallel reduction in predicted 
risk of death (Moore et al., 2010), which suggests either an improvement in care 
or another factor such as a change in referral patterns. 
By applying the APACHE criteria all patients under the age of sixteen were 
excluded and therefore this data cannot be extrapolated to the paediatric 
population without further studies. Both studies applied slightly different 
inclusion criteria with Tanaka et al., (2007) excluding those patients who were 
on the unit for less than 24 hours and Moore et al., (2010) excluding all patients 
who were on the unit for less than 4 hours.  
Most importantly is the role of inhalation injuries and their assessment. Tanaka 
et al., recorded 31.4% of their study population receiving inhalation injuries. 
They excluded 5 of the patients with inhalation injuries who died, as their 
APACHE scores worsened rapidly over time although were not excessively high 
when admitted. No diagnostic criteria for inhalation injury were established in 
the study by Tanaka et al., (2007). In addition there was no data with which to 
quantify the severity of inhalation injury. They felt that the effect of inhalation 
injury might be under-estimated physiologically by the APACHE score. 
In contrast Moore et al., state 86% of their patients had airway involvement. This 
is a higher figure than most other studies. Brusselaers et al., (2010) in their 
systematic review report inhalation rates between 0.3% - 43% of all patients 
hospitalized due to severe burns. Other studies have linked inhalation injury to 
mortality (Brusselaers et al., 2009) but Moore et al., (2010) found this was not 
the case in their population. Firstly their population may not be representative of 
other burns populations. Alternatively their interpretation of the diagnosis of 
airway injury may be different to other units resulting in an over diagnosis of 
airway injury and thus a subsequent underestimation of the physiological effects 
of inhalation injuries. 
There have been several criticisms of the APACHE and SAPS scoring systems 
with the SAPS system never having been validated in a burns population. 
APACHE is complex to compute and the proprietary nature of APACHE III and 
its associated costs means that it is not used in all Intensive Care Units. Both 
systems suffer from the same fault of not being able to provide a score on 
admission as the scoring criteria include the worst measure of the physiological 
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parameters in the first 24 hours. By using the worst score in 24 hours there is 
also a question of the sensitivity of the score to precision of measuring the 
variables; one abnormal result throughout the day may not reflect the underlying 
trend therefore those ICUs using continuous electronic monitoring typically 
evaluate patients as being more severely ill. 
 
There are many other systems that aim to evaluate organ dysfunction. Some look 
at the presence or absence of organ failure whilst others grade organ failure by 
the severity of the degree of organ dysfunction (in general the greater the organ 
dysfunction the higher the assigned score). There is variability between the 
scoring systems as some evaluate different organs systems. Many predicting 
formulas are limited because they only give specific levels of mortality risk, 
instead of a continuous range. Furthermore the weighting given to degrees of 
dysfunction in a particular organ varies between scoring systems. Once more like 
the APACHE score, some systems are calculated from the worst score obtained 
in a 24-hour period or during the admission whilst others use the scores obtained 
at certain times of day or on admission. 
 
As both the SIRS criteria and the conventional scoring systems used in ICUs 
have significant failings the American Burn Association offered an alternative 
suggestion that the Marshall MODS Scoring System (Marshall et al., 1995) (as 
modified by Cook et al., 2001) be used to monitor and assess organ dysfunction 
in burns patients.  
A modified version of the Marshall MODS score has been used in burns patients 
in two separate studies (Cumming at al., 2001, Fitzwater et al., 2003).  The first 
of these by Cumming et al., (2001) looked at 104 adult patients with burns 
greater than 20%. Those patients for compassionate care and with inhalation 
injuries but burns less than 20% were excluded. They concluded that severe 
MOF was related to burn size, age and male sex in addition to intensive care unit 
length of stay and duration of mechanical ventilation. Several factors need to be 
noted when looking at their results. Only 17.6 % of the patients suffered 
inhalation injuries, a figure much lower than the studies mentioned above 
(Tanaka et al., 2007 and Moore et al., 2010). Secondly their definition of severe 
MOF (which they defined as a MOF score ≥ 6) was an arbitrary figure and they 
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admit that by considering the severe MOF patients as a group may not identify 
the factors that contribute to the most severe expression of organ dysfunction or 
failure.  
In their modification they omit the central nervous system (CNS) category from 
their assessment because of its subjectivity. They reason that is difficult to score 
the Glasgow Coma Scale (GCS) precisely because of the frequent concurrent use 
of neuromuscular blocking agents, sedatives and blocking agents. It is therefore 
unclear if CNS dysfunction is the result of CNS-active medications or the effect 
of systemic inflammation or hemodynamic changes in organ function. 
One important factor that is taken into account by the modification by Cumming 
et al is that measurements taken in the first 48 hours after admission were 
excluded. This period during burns resuscitation displays many acute but rapidly 
reversible changes in organ function and therefore may give a falsely worse 
MOF score and prognosis than is actually the case. 
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4.2 Aim: By a retrospective analysis of patients admitted to the Burn ICU 
between November 2003-September 2009 to determine whether ACR could 
predict the development of multi-organ failure and outcome in the burn ITU 
setting.  
 
4. 3 Methods 
4.3.1 Clinical Setting 
The Burns Service compromises twenty beds including four intensive care and 
four high dependency beds. There are twelve low dependency / rehabilitation 
beds. The unit is a tertiary referral centre and accepts patients from a population 
of over 6 million people. Patients are also taken from out of traditional catchment 
areas and occasionally internationally. 
A multidisciplinary team including microbiologists, pharmacists, anaesthetists 
and burn surgeons reviews all major burns daily. The Parkland formula is used in 
the initial resuscitation to maintain a urine output of 0.5 ml/kg/h in adults and 1 
ml/kg/h in children. Nutritional supplementation is via nasoduodenal enteral 
nutrition with high calorie, low fat formulas. As part of the burn treatment 
protocol gastric ulcer prophylaxis is performed with H2 antagonists. Low 
molecular weight heparin (40mgs/day) is prescribed daily. Early excision and 
grafting is routine performed for deep burns that would take more than two 
weeks to heal without surgical intervention using allografting, auto-grafting or 
dermal substitutes depending on the individual characteristics of burn injuries.  
Retrospective collection of data regarding demographic details, mode of injury, 
examination findings was from clinical records. All other results were obtained 
from the Burns ITU computer system MetaVision (iMDsoft, Massachusetts, 
USA). 
All adult patients admitted to the burns unit between November 2003 and 
September 2009 that fulfilled the unit’s admission criteria were included in the 
study.  
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4.3.2 Exclusions 
Exclusions were those patients with non-thermal processes including 
desquamating skin disorders, meningococcal septicaemia, necrotising fasciitis 
and purpura fulminans; patients who stayed in the ITU for less than 24 hours 
were excluded; patients who were transferred from other hospitals more than 5 
days post injury; patients with multiple injuries (where the burn was clinically 
judged not to be the main injury); patients for compassionate care only; patients 
with no or inadequately recorded ACR results. 
Patients with a diagnosis of Type I or Type II diabetes mellitus were included. 
Parameters recorded included patient characteristic data such as age, gender, co-
morbidities, injury data including time of injury, mechanism and TBSA. ACR 
was routinely measured on admission and recorded daily. 
Inhalation injuries were determined by appearance on bronchoscopy. 
Multi-organ failure was determined by using the Marshall score as modified by 
Cook et al., (2003) (see below table 4.1). 
 
 
 
 
 
 
 
 
 
 
Table 4.1. The Modified multiple organ dysfunction (MODS) score (Cook et 
al., 2003). 
All blood samples (to obtain the creatinine, bilirubin and platelet counts) were 
taken at 06.00 in the morning (the same time the urinary analysis of ACR was 
undertaken) and GCS, cardiovascular and respiratory system status were 
recorded at the same time. 
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4.3 Results 
Demographics 
A total of 547 patients were admitted to the unit within the study period for the 
study from which 304 were excluded. The reasons for exclusion are summarised 
in Figure 4.1.   
 
 
 
     
 
 
 
 
     
 
 
 
    
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. A flow chart showing the number of burns patients recruited 
and reasons for exclusions. 547 patients admitted to the burn ICU between 
November 2003-September 2009 were eligible for the study. Following 
exclusions 243 adult patients were eligible. 
 
Necrotising fasciitis 
n=1 
Patients n=547 
Non-desquamating skin 
conditions n=25 
Compassionate care 
n=28 
Meningococcal septicaemia n=3 
Transfer >5 days post injury n=14 
Purpura fulminans n=1 
Multiple injury n=1 Admission to ICU due to 
aspiration during surgery n=4 
Self discharge n=1 
Adult Patients 
following exclusions 
n=243 
Inadequate results n=124 
Paediatric patients 
n=102 
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Figure 4.2. Demonstrates the number of patients in each age range admitted 
to the burns ITU. The data demonstrates the age in years, of the patients 
admitted to the burn unit in the study period, November 2003-September 2009. 
The data shows the percentage of the total each group contributes with the total 
number in the group in brackets. Each age range is a decade except for the 
patients aged 80 years or greater and those aged less than 20, which form 
separate groups. 
 
Out of the 243 patients studied the mean age (range) 43.8 years (16-95 years 
old). Figure 4.2 demonstrates that the majority were aged between 20 and 59. 
This is a typical spread of ages to a UK burn unit when servicing a mainly urban 
population. 
7% (16)
12% (28)
17% (41)
15% (37)
16% (40)
22% (54)
7% (18)4% (9)
Less than 20
20-39
30-39
40-49
50-59
60-69
70-79
More than 80
 173 
 
Figure 4.3 Demonstrates the percentage of patients within each range of 
TBSA% burned. The data shows the percentage and number (in brackets) of 
patients within each range of TBSA% burned admitted to the burn unit in the 
study period, November 2003-September 2009. Each group is a range of 15% 
except for the group representing burns of 75-100%. 
 
Roughly three quarters of the patients had burns 45% TBSA or lower. This 
figure is in keeping with expectation given the admission criteria for burns ITU. 
Not only are higher TBSA% burns less frequent but also burns that affect a large 
TBSA are more likely to die at the scene. It should be noted that a number of 
burns with high TBSA% involvement were excluded from the study because 
they were for compassionate care only (n=28, see figure 4.1). The mean TBSA% 
sustained (range) was 29.5% (2-90%). The number of patients burned in each 
range of TBSA% is shown in figure 4.3. 
  
4% (9)
5% (12)
9% (23)
15% (37)
40% (97)
27% (65)
≤ 15
16-30
31-45
46-60
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Figure 4.4. The mechanism of injury resulting in the patients being admitted 
to the burns ITU. The data shows the cause of the injury leading to admission 
for the adult population. 
 
Within the 243 patients 74 patients’ sustained inhalation injuries (30.4%) and 40 
patients died (16.5%). There were 159 male patients and 84 female patients.  
The mean length of stay was 17.3% (1-175 days) with the mean stay per 
percentage burn being 0.76-days/%burn. In keeping with a standard UK burn 
unit the majority of adult admissions were due to flame burns. Table 4.4 shows 
that 192 (79%) patients suffered a flame burn as their primary reason for 
admission. The next highest category was scald injuries accounting for 27 (11%) 
of patients in the study. 
On admission 217 patients had a urinary sample taken and ACR recorded on 
admission (defined as being taken within 6 hours of coming to the unit). Twenty-
six patients did not have an ACR recorded within 6 hours of admission (10.6%). 
The mean ACR on admission (range) was 7.3 mg mmol-1 (0.3-120 mg mmol-1). 
Post resuscitation (defined as 48 hours post admission) the mean ACR was 4.1 
(0.34-77.1 mg mmol-1) and the mean peak ACR (range) was 18.85 mg mmol-1 
(0.47-231).
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Figure 4.5. Organ failure score on each day of admission for all patients. The two graphs above show the organ failure score on 
each day of admission for the patients that survived (upper graph) and the patients that died (lower graph)
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Figure 4.5 was performed to see if there were any obvious trends in MOF score 
over time comparing those patients that had died and survived. It demonstrates 
that the patients that died tended to have higher MOF scores and it can also be 
seen that some had protracted in-patient stays often with highly variable MOF 
scores. Therefore to determine the relationship the ACR was plotted against 
MOF for all patients (survivors and non-survivors) on all days.   
 
 
Figure 4.6. Multiple organ failure score against Albumin Creatinine Ratio 
(ACR). Data shows a scatter graph plotting combined data for all patients and all 
days of admission. The regression slope obtained was 0.024; Bootstrap CI (95%) 
(0.01682, 0.08247). The Correlation coefficient (r) obtained was 0.1658; 
Bootstrap CI (0.1139, 0.2154). There is a correlation between the MOF score and 
ACR score. The bootstrap confidence interval shows this is statistically 
significant. 
 
Figure 4.6 show there is a relationship between ACR and MOF score, the higher 
the ACR value the higher the MOF score. The correlation coefficient, r is a 
measure of the strength and direction of the linear relationship between the 
two variables ACR and MOF. The ACR and MOF scores were then examined 
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to see if ACR could be used to differentiate patient outcomes in those patients 
suffering from multi-organ failure.  
 
 
Figure 4.7. Daily mean MOF scores. The data compares the daily mean MOF 
score for those that survived and those that died with the number of days after 
admission.  The patients that lived are represented by the solid line and the 
patients that died by the dashed line. 
 
Because of the large numbers of patients (especially in the first weeks) it is 
difficult to determine any trends between the two groups in figure 4.5 so the 
daily mean MOF score was plotted for survivors and non-survivors. It is clearer 
to see in figure 4.7 that the mean MOF scores for those that die are higher than 
the survivors. Because of the small numbers of patients who stayed in hospital 
more than 75 days some caution must be used in drawing any conclusions from 
the trends seen from day 75 onwards. 
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Figure 4.8. Maximum MOF score and ACR at admission. The scatter graph 
demonstrates the relationship between maximum multiple organ failure score 
against Log of Albumin Creatinine Ratio (ACR) at admission. The regression 
slope obtained for the Alive group was 0.402; bootstrap 95% CI (0.032, 0.79) 
Died group regression slope was −0.279; bootstrap 95% CI (−0.886, 0.397). 
Alive group, open triangles and solid line, died group closed circles and dashed 
line.  
 
To determine if the ACR at admission was related to how sick the patients 
became (measured by their maximal MOF score) the log ACR at admission was 
related to the patient’s maximal MOF score in a scatter plot shown in figure 4.8. 
This showed that the maximum MOF score increases with increasing ACR for 
the patients that survived 0.402 (CI: 0.032, 0.79), suggesting there is a 
relationship between a high admission ACR and eventual degree of ill health (as 
measured by the maximal MOF score). From this you might expect therefore that 
the same trend would also be seen in the patients that eventually died. This was 
not the case; there was no relationship between log admission ACR and the 
maximal MOF score of those patients that died −0.279 (CI: −0.886, 0.397). 
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One problem with looking at the maximal score is that incorrect recording of just 
one of the one of the organ failure categories could easily skew the results. 
Another point is that a high score may be achieved on a particular day that may 
not be a reflection of their general state of health. We therefore looked to see if 
there was any relationships between log ACR at admission and the median MOF 
score as this may eliminate the potential sources of bias. 
 
 
 
Figure 4.9. Median MOF score and ACR on admission. The data 
demonstrates the relationship between the median multiple organ failure score 
against Log of Albumin Creatinine Ratio (ACR) at admission. The regression 
slope obtained for the Alive group (solid line) was 0.091; bootstrap 95% CI 
(−0.095, 0.287). Died group regression slope, dashed line (and bootstrap 95% 
confidence limits): 0.783 (0.236, 1.34). There is no correlation between median 
MOF score and ACR on admission for the patients that lived but there is for 
those that died. 
 
Figure 4.9 shows that for the patients that died the log ACR scores at admission 
are related to the median MOF score. It shows the higher the ACR on admission, 
the higher the median MOF scores. This method is probably a more sensible way 
of analysing multi-organ failure as it is more likely to represent the status of the 
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patient throughout their stay rather than a snapshot in time. However there is no 
relationship between the median MOF scores and admission ACR for the 
patients that lived. 
Because large burns can cause such a rapid and profound systematic response it 
is argued that the physiological response seen in the first twenty-four to forty 
eight hours may not be representative of the true nature of the injury. With 
adequate resuscitation many of the early physiological derangements can be 
correctable presenting a very different picture of the patients’ physiological state 
and potential prognosis. The MOF score may therefore change rapidly over the 
first few days of admission whilst resuscitation is ongoing. Daily plots of the 
MOF score against ACR were performed for the first 96 days to see if the 
relationship changes with time. Only the results for days 1-3 are shown below to 
illustrate the analysis in figure 4.10-4.12. 
 
 
 
Figure 4.10. Multiple organ failure score against ACR, Day 1. Data shows 
MOF Day 1 plotted against ACR Day 1. The regression slope obtained was 
0.09867; bootstrap 95% CI (0.05164, 0.13303) Correlation coefficient r = 
0.4416; bootstrap 95% CI (0.1848, 0.6004). 
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Figure 4.11. Multiple organ failure score against ACR, Day 2. Data shows 
MOF Day 2 plotted against ACR Day 2. The regression slope obtained was 
0.05501; bootstrap 95% CI (0.01067, 0.21416). Correlation coefficient r = 0.142; 
bootstrap 95% CI (0.0278, 0.3459). 
 
 
Figure 4.12. Multiple organ failure score against ACR, Day 3. Data shows 
MOF Day 3 plotted against ACR Day 3. The regression slope obtained was 
0.03373; bootstrap 95% CI (0.01241, 0.04869) Correlation coefficient r=0.305; 
bootstrap 95% CI (0.077, 0.461). 
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Figures 4.10, 4.11 and 4.12 show the multiorgan failure score plotted against 
ACR for each day. All graphs show that there is a correlation between the MOF 
score and the ACR; the higher the MOF score the higher the ACR. To get an idea 
of the strength of the relationship between the two variables the correlation 
coefficient was also measured. The correlation coefficient is measured between 0 
and 1 with 1 being a perfect correlation and 0 being no correlation. It can be seen 
from the figures 4.10-4.12 that there is a weak correlation. As the first days post 
injury involve resuscitation and or surgery the physiological changes are 
dynamic and it may be possible that the ACR or MOF score do not reflect what 
is going on when resuscitation has been completed and the patient has been 
stabilized. It was then decided to examine if the correlation coefficient changed 
over time and if there were any periods when there was a greater correlation 
between the two variables, figure 4.13. 
 
 
Figure 4.13. A summary chart of how the correlation coefficient varies with 
time. The data plotted shows the correlation coefficient against time (days). It 
can be seen that from day 50 the plots get more erratic as the number of patients 
diminishes. 
 
Over time the correlation coefficient (the measure of the strength of the linear 
relationship between two variables) appears to improve as shown in figure 4.13. 
Unfortunately this period (from around day 50 onwards) is when the number of 
patients diminishes and the correlation coefficient gets increasingly erratic. It is 
 183 
difficult therefore to ascribe the higher correlation coefficient scores seen in the 
later part of the graph to a genuine trend rather than a small number of individual 
patient scores skewing the data. 
To look more closely at the relationship between MOF score and the ACR the 
regression line intercept was plotted against time, figure 4.14.  
 
Figure 4.14. Plot of the regression line intercept against time. To examine the 
relationship between the two variables (MOF score and ACR) and how this 
changes with time the intercept point was plotted against time (days). It shows a 
downward trend over time. 
 
From figure 4.13 and 4.14 it seems clear that that the relationship between the 
MOF score and ACR within a day is rather weak. Certainly in the first few days 
there does not seem to be a good correlation between the MOF score and the 
ACR value (as seen in figure 4.13) and shown by the higher values of the 
regression line intercept point in figure 4.14. However with time there is a weak 
trend of improved correlation coefficient and the intercept point moves towards 
zero. This seems to arise because in the early days there are a lot of patients with 
high MOF scores that also have low values of ACR, so that the regression line 
intercept is high. In later days the patients with high MOF scores and low ACR 
have disappeared so that the regression line intercept is low.  
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4.4 Discussion  
Patients sustaining burns injuries are at a high risk of systemic inflammatory 
response syndrome (SIRS). When severe, SIRS leads onto organ failure. The 
inflammatory response to the injury, trauma or infection is wide spread and may 
damage organs distant from the initial insult. Although the sequence of 
inflammation, organ failure and sometimes ultimately death is well recognised 
the exact mechanisms are still poorly understood.  
In burn unit’s multi-organ failure is one of the most frequently reported causes of 
death, responsible for 25-65% of all burn deaths in Europe (Brusselaers et al., 
2010).  
One difficulty encountered when caring for the patients is identifying at an early 
enough stage those that may develop multi-organ failure in order that the 
clinician may try and modulate the inflammatory and immune response. 
This study of admissions to a UK burns ICU show that ACR does predict organ 
failure. Figure 4.6 demonstrates the relationship between ACR and MOF. With 
an increasing ACR the MOF score tends to be higher.  
Previous studies have suggested that ACR may have a role to play in identifying 
those patients that may suffer from organ failure. Gosling (1995) has reported 
that in both surgical and trauma patients whose microalbuminuria is maintained 
and does not return to normal within 4 and 8 hours (respectively) post insult it 
has been possible to predict subsequent organ failure. Smith et al., (1994) 
showed the urinary albumin levels taken within 4 hours of the start of aortic 
surgery have been found to be able to predict those patients who would later 
develop pulmonary complications that were non cardiogenic in origin  
De Gaudio et al., (2000) showed an increase of the ACR was also positively 
correlated to the increase in the sepsis related organ failure assessment (SOFA) 
score (This is a scoring system based on physiological parameters that 
determines the degree of organ failure a patient may be suffering from). 
A similar pilot study by MacKinnon et al., (2000) looking at a similar number 
but broader range of patients demonstrated that microalbuminuria 6 hours after 
admission to a general ICU could identify patients at risk of developing multi-
organ failure and those at a greater risk of death.  
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There is very little information on the ability of ACR to predict MOF in the burn 
population. Gosling et al., (2006) examined a mixed cohort of medical (205 
patients) and surgical (225) patients. In this study ACR was measured on 
admission and after 4-6 hours. It was found that ACR predicted ICU mortality 
and inotrope requirements as well or better than APACHE II and SOFA scores. 
This study had a small number of burns patients (n=21) and the results of the 
surgical, trauma and burns patients were grouped together so it is difficult to 
draw any conclusions. 
From our study although the relationship is clear between ACR and MOF it does 
not offer clear a clinical utility at the moment to identify those patients that may 
suffer from multi-organ failure. It may be that burn injuries are too complex and 
there are too many confounding factors in multi-organ failure for ACR to be able 
to distinguish those patients who will achieve higher MOF scores. 
One other intriguing aspect that came out of the study by Sarti et al., (2001) was 
that two patients showed a rise in ACR after the initial postoperative value 
returned to normal but before the clinical appearance of a surgical complication 
(peritonitis and a large subcutaneous haematoma). A further patient showed a 
persistent rise in ACR before the appearance of a septic complication. It may be 
that there is a time lag between a rise in ACR and development of MOF at a later 
date. 
 
Figure 4.15. MOF score with ACR from 20 days earlier. The graph shows the 
correlation of the MOF score with the ACR from 20 days earlier. 
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To test whether there is a time lag between an ACR rise and MOF the correlation 
of the MOF score with the ACR from 20 days earlier was analysed, figure 4.15. 
It appears that as patients remain in the study for a longer period there is an 
increasing trend in the correlation coefficient. This would mean that for the 
patients remaining later their MOF scores become more closely related to their 
ACR from 20 days earlier. Put another way, for the patients who stay longer the 
ACR can predict the MOF score 20 days ahead, and this prediction gets better 
the longer they stay. 
 
Unfortunately the number of patients that remain gets quite small at the later 
stages, so one cannot be very confident that this is a reproducible result. It could 
be an artefact arising from the few patients that have both high MOF scores and 
high ACR (perhaps for unrelated reasons) and remain in the unit. 
 
In conclusion whilst the ACR value is closely related to the MOF score further 
studies will be required before it can be demonstrated whether if has a role in the 
acute setting or can predict events at a later date.  
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Chapter 5  
The Impact of Acinetobacter baumannii on a UK Burn Unit and 
its relationship to patient outcomes 
5.1 Introduction  
Hospital acquired infections constitute a large and persistent problem in the UK 
and throughout the world. About 9% of inpatients have a hospital-acquired 
infection at any one time, equivalent to at least 100,000 infections a year 
(National Audit Office 2000 UK). The consequences to the patient may vary 
from discomfort or inconvenience to permanent ill health or even death in a 
small proportion of patients. Repercussions for the hospital are no less serious as 
hospital acquired infections result in increased length of inpatient stay, increased 
pressures on staff and a large financial burden. Government figures estimate the 
cost to the NHS to be as much as £1000 million a year (National Patient Safety 
Agency; The Economic Case 2004). 
Infection is a common complication in burns patients, and burns patients are 
particularly prone to nosocomial infections (Wertz et al., 1995). This can result 
in increased morbidity and mortality for the patient (Weber et al., 1997) or loss 
of grafted skin necessitating further operations and a subsequently prolonged 
hospital stay (Unal et al., 2005).  
In recent years, certainly in the mainstream media, the focus of attention has 
been on those organisms that have achieved multi drug resistance to standard 
antibiotic treatment for instance, MRSA (Multi Resistant Staphylococcus 
Aureus) and C. Diff (Clostridium Difficile). There are a wide variety of 
organisms causing significant problems in hospitals at the moment however. One 
that is increasingly found to have a clinical impact, especially in the critical care 
setting is Acinetobacter baumannii. 
The impact of multi drug resistant organisms is striking. In a study by Williams 
et al., (2009) into the causes of death in a paediatric population they found that 
from 1989 to 1999, sepsis accounted for 35% of deaths but increased to 54% 
from 1999 to 2009, which they attributed a significant increase in that proportion 
to antibiotic resistant organisms. 
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Acinetobacter baumannii 
Acinetobacter baumannii is an aerobic, gram negative, oxidase negative non-
fermenting bacterium (Appleman et al., 2000) that is normally a commensal 
organism but due to growing antibiotic resistance is now a key opportunistic 
pathogen in burns and intensive care units. Nosocomial outbreaks of A. 
baumannii have previously been described in the literature and many of the 
outbreaks have been associated with multiresistant strains (Lyytikainen et al., 
1995, Mulin et al., 1995 and Simor et al., 2002). Multiresistant strains of these 
species causing bacteraemia, pneumonia, meningitis, urinary tract infections and 
surgical wound infections have been isolated from hospitalised patients 
worldwide (Van Looveren et al. 2004). The overall incidence of A. baumannii as 
a nosocomial infection was 9% in Europe in 1995 (Vincent et al., 1995) but a 
higher reported incidence has been found in burn units, 13% in a Canadian burns 
unit (Simor et al., 2002) and 14% in a Brazilian unit (Santucci 2003). 
 
A number of factors have been identified for the risk of acquisition and 
subsequent mortality of multi resistant Acinetobacter baumannii (MRAB). 
(Acinetobacter baumannii that is resistant to carbapenem has been termed 
MRAB-C).  The factors for acquisition of MRAB include receipt of blood 
products and duration of mechanical ventilation (Simor et al., 2002), Acute 
Physiology and Chronic Health Evaluation (APACHE II) score on admission (a 
measure of physiological variables to determine severity of disease) and number 
of intravascular lines placed (Wong et al., 2002). Previous broad-spectrum 
antibiotics have been found to play an important role in MRAB acquisition 
(Mulin et al., 1995, Villiers et al., 1998, Ayan et al., 2003). Factors associated 
with mortality include immunosuppression, shock, recent surgery, invasive 
procedures such as central venous or pulmonary catheterization and mechanical 
ventilation (Chen et al., 2005). In the same study mortality was significantly 
associated with lower platelet count and lower serum albumin concentration. 
In addition many outbreaks have been linked to equipment or the inanimate 
hospital environment. This is partly due to the ability of Acinetobacter to survive 
for long periods on dry surfaces (Wendt et al., 1997). Catalano et al., (1999) 
describe the survival of Acinetobacter on hospital bed rails causing sporadic 
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outbreaks whilst Neely et al., (1999) report the presence of Acinetobacter on 
computer keyboards in the burns unit. Beck-Sague et al., (1990) again found 
higher rates of Acinetobacter in ventilated patients although found no link to the 
equipment.  
One important aspect not to be forgotten is that transmission via the hands of 
hospital staff can be a frequent cause of spread of infection. Acinetobacter is 
considered a low-grade pathogen and can remain on or in the human body 
without causing illness, and for this reason dissemination via the hands of 
hospital staff may remain undetected (Joly-Guillou 2005). Close adherence to 
standard levels of hand hygiene can have an important impact on reducing or 
eliminating outbreaks of colonization or infection (Chan et al., 2007). Other 
factors that have been implicated in the transmission and spread of infection 
within a hospital or unit include bed occupancy and therefore the turnover of 
patients. The number of procedures or points of contact between the patient and 
members of staff as well as the level of training of the staff involved may also be 
important. 
For those patients with infections possibly caused by Acinetobacter, a β-lactam 
alone or in combination with an aminoglycoside or fluoroquinolone was the 
initial empirical therapy (Meyer 2005). This regimen has become less effective 
due to the appearance of β-lactamases (Rahal and Urban 2000), extended 
spectrum β-lactamases (ESBLs) and enzymes that inactivate aminoglycosides 
(Bergogne-Bérézin and Towner 1996).  
The speed in which Acinetobacter baummannii has become a significant problem 
in hospitals is illustrated by the rise in cases resistant to carbapenem in one unit 
increasing from 0% to 55% between 1998 and 2006. This overall increase 
coincides with the emergence of the MRAB-C OXA-23 clone-1 as the most 
prevalent strain in London and South East England (Wareham et al., 2008). 
There appears to be little clinical difference in clinical outcome in patients with 
bacteraemia from Acinetobacter baumannii and other Acinetobacter species 
(Choi et al., 2006) but it may be that different clones of MRAB result in different 
patient morbidity or mortality rates. 
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5.2 Aim: By using retrospective case control study of all admissions to the 
burns ITU/HDU over a twenty-nine month period (2004-2006) to determine the 
impact of Acinetobacter baumannii on a UK burn unit and its relationship to 
patient outcomes and to look at possible influencing factors. 
 
5.3 Method  
5.3.1 Clinical setting 
The Burns Service compromises twenty beds including four intensive care and 
four high dependency beds. There are twelve low dependency / rehabilitation 
beds. The unit is a tertiary referral centre and accepts patients from a population 
of over 6 million people. Patients are also taken from outside of traditional 
catchment areas and occasionally internationally. 
A multidisciplinary team including microbiologists, pharmacists, anaesthetists 
and burn surgeons review all major burns daily. The Parkland formula is used in 
the initial resuscitation to maintain a urine output of 0.5 ml/kg/h in adults and 1 
ml/kg/h in children. Nutritional supplementation is via nasoduodenal enteral 
nutrition with high calorie, low fat formulas. As part of the burn treatment 
protocol, gastric ulcer prophylaxis is performed with H2 antagonists. Low 
molecular weight heparin (40mgs/day) is prescribed daily. Early excision and 
grafting is routinely performed for deep burns that would take more than two 
weeks to heal without surgical intervention using allografting, auto-grafting or 
dermal substitutes depending on the individual characteristics of burn injuries.  
Retrospective collection of data regarding demographic details, mode of injury, 
examination findings was from clinical records. All other results were obtained 
from the Burns ITU computer system MetaVision (iMDsoft, Massachusetts, 
USA). 
All patients admitted to the Burns ITU of the St Andrew’s Centre for Burns and 
Plastic Surgery over a 29-month period from were eligible for the study (2004-
2006). There were no omissions in this series.  
Records of Acinetobacter baumannii acquisition from 2000 -2004 were also 
examined to provide comparative data.  
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5.3.2 Definitions 
Acinetobacter baumannii resistance definition 
The UK Working Party Guidance on the Control of Multi-Resistant 
Acinetobacter outbreaks was used to define resistance. The working party 
defined multi-resistant Acinetobacter spp. “MRAB” as Acinetobacter spp.  
isolates that are resistant to any aminoglycoside (e.g. gentamicin) and to any 
third generation cephalosporin (e.g. ceftazidime, cefotaxime). Those isolates that 
are additionally resistant to imipenem and/or meropenem are designated 
“MRAB-C” (Cookson et al., 2007). During this study MRA has in been used to 
refer to both MRAB and MRAB-C unless otherwise stated. 
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Multi-organ failure definition-score.  
 
Multiorgan failure in patients was assessed by using the Organ Dysfunction 
and/or INfection Score (ODIN). 
 
Dysfunctions Variables 
Respiratory PaO2 < 60mmHg (FiO2=0,21) 
or: 
Need for ventilatory support 
Cardiovascular 
(in the absence of hypovolemia with 
CVP< 5 mmHg) 
Systolic Arterial Pressure < 90 mmHg 
with signs of peripheral hypoperfusion 
or : 
Continuous infusion of vasopressor 
or inotropic agent to maintain SBP > 
90 mmHg 
Renal 
(excluding chronic dialysis) 
Serum creatinine > 300 micromol /L 
or :Urine output < 500mL/24 h or 
<180 mL/8 h 
or :Need for hemodialysis or 
peritoneal dialysis 
Neurologic Glasgow < 6 (in absence of sedation at 
any time in the day) 
or : 
Sudden onset of confusion or 
psychosis 
Hepatic Serum bilirubin > 100 micromol /L 
or : 
Alkalines phosphatases > 3 x N 
Hematologic Hematocrit < = 20% 
o:WBC < 2.000 /mm3 
or :Platelet Count < 40.000 /mm3 
Infection 
(with clinical evidence of infection) 
2 positive blood cultures 
or: Presence of gross pus in a closed 
space 
or: Source of the infection determined 
during hospitalization or at autopsy in 
case of death within the 24 h 
 
Table 5.1 Organ Dysfunctions and/or Infection Score. Used as a measure of 
severity of organ dysfunction in a patient (Fagon et al., 1993). 
 
This is a scoring system with a range from 0-7. If a patient achieved one of the 
parameters listed above they got a score of one for that system. Patients cannot 
score more than one in any category. It assesses five organ systems as well as the 
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haematological response and response to infection. For consistency, each patient 
was scored using the same parameters for each system assessed. This scoring 
system was chosen after discussion with the lead surgical and anaesthetic 
consultants in the unit. Several scoring systems were looked at and the ODIN 
score was thought to be the most comprehensive and all the data to provide the 
scores was routinely recorded. Other scoring systems were more complicated and 
required information that was not routinely recorded in our unit therefore there 
would have been holes in the data set. 
 
5.3.3 Study design 
5.3.3 a) Study design for multi-organ failure study 
A retrospective case control study of all admissions to the burns ITU/HDU over 
a twenty-nine month period (2004-2006). All patients presenting within this 
period were eligible for the study if they met the criteria for admission to the 
burns unit ITU/HDU: 
• Total burn surface area (TBSA)>10% in adults, >5% in children 
• Extremes of age <5 years or  >60 years 
• Inhalation injury 
• Special sites: face, hands, feet, perineum, flexure surfaces, 
circumferential burns 
• Chemical, electrical or radiation injuries 
Group 1 contained all the patients with multi drug resistant Acinetobacter 
baumannii. Group 2 contained all the patients with drug sensitive Acinetobacter 
baumannii. Group 3 was a control group of patients who had not contracted any 
form of Acinetobacter baumannii.  
 
5.3.3 b) Study design for analysing MRA and bed occupancy rates and the use of 
agency nursing staff 
A retrospective cases control study of all admissions to the burns ITU/HDU 
during the main outbreak of MRA (April 2004-March 2005). All patients 
presenting within this period were eligible for the study if they met the criteria 
for admission to the burns unit ITU/HDU as outlined above. 
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5.4 Results 
5.4.1 Acinetobacter baumannii prevalence 
The prevalence of Acinetobacter baumannii was examined during an outbreak of 
MRA in 2004 onwards and then retrospectively to August 2000 when the first 
data was collected.  
 
 
 
Figure 5.1. Acinetobacter baumannii per year from August 2000-June 2006 
Data shows the total number of cases (both adult and paediatric) in the burns unit 
(this includes Burn ICU, HDU and rehabilitation ward). It includes both multi 
resistant Acinetobacter baumannii (MRAB) and Drug Sensitive Acinetobacter 
baumannii cases. 
 
The number of cases of Acinetobacter baumannii isolated in the burns unit varies 
from year to year. Figure 5.1 shows the number of patients through out the unit 
(including the ICU, HDU and rehabilitation wards but excluding the out patient 
clinic, which is geographically separated from the wards. It can be seen that 
Acinetobacter baumannii decreases in prevalence from 2001 to 2003. It is 
thought this is because after an outbreak of drug resistant Pseudomonas 
Aeruginosa in 2001 a strict hand washing policy was instituted in the unit, which 
appears to have had the knock-on effect of reducing the rate of Acinetobacter 
baumannii infection over the subsequent two years. An outbreak of MRA 
occurred early in 2004 and continued into 2006. One further case (of drug 
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sensitive Acinetobacter baumannii) not included in figure 5.1 is an 
environmental isolate from a mechanical arm used on some equipment in the 
ICU. 
 
 
 
Figure 5.2. Monthly variation in the total number of cases of Acinetobacter 
baumannii. This data shows the isolates per year from August 2000-June 2006 
in both the adult and paediatric population. This includes Burn ICU, HDU and 
the rehabilitation ward. It includes both multi resistant Acinetobacter baumannii 
(MRAB) and Drug Sensitive Acinetobacter baumannii cases. 
 
 
Looking at all the cases of Acinetobacter baumannii (both drug resistant and 
drug sensitive) it can be seen from Figure 5.2 that there appears to be a seasonal 
variation with a preponderance of cases between October and March. Other 
studies have had mixed results with some demonstrating a seasonal variation 
whilst others have found no variation.  As there was no change in operating 
policy from month it is presumed the variation is due to an as yet unidentified 
environmental factor. 
To investigate the extent of the problem MRAB might have on a burn unit the 
proportion of MRAB was looked at, table 5.2. It can be seen that there is a 
general trend for MRAB cases to make up a greater proportion of all the 
Acinetobacter isolates. In 2004 the number of cases of Acinetobacter baumannii 
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positive swabs isolated from patients started to increase and the number of MRA 
cases doubled when compared with 2002 as can be seen in table 5.2. There are so 
few cases in 2003 that the proportion of MRA cases should be ignored. It is 
unclear from the data why the total number of cases in 2003 is so low (despite 
the implementation of the hand washing regimen in 2001). Whilst the hand-
washing regimen may explain the reduction in isolates from 2001 it does not 
explain the substantial increase in 2004. It must be noted that there were no 
dramatic changes in operating policy during this period. 
 
Year Total 
Acinetobacter 
cases 
MRA cases (%) 
2000 12 0 
2001 78 15.3 
2002 28 10.7 
2003 3 33.3 
2004 67 19.4 
2005 62 30.6 
2006 17 41.1 
 
Table 5.2. The percentage of multi-resistant Acinetobacter baumannii cases 
per year for the whole unit (ICU/HDU and the rehabilitation ward). It must 
be noted that the results from 2000 are from August to December and the results 
from 2006 are to the end of June only. 
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5.4.2 Multi-organ failure and Acinetobacter baumannii 
acquisition. 
To look at MOF in burn patients all admissions over a twenty-nine month period 
were studied (April 2004-June 2006). 
Two hundred and eighty patients were admitted via ITU/HDU of which 53 
patients acquired Acinetobacter baumannii (18.9%) and of these cases 30 were 
MRA (10.7%). Three patient groups were identified. Group 1 had MRA (n=30), 
Group 2 had drug sensitive Acinetobacter (n=23) and Group 3 were a control 
group who had not contracted any form of Acinetobacter (n=31). 
Tables 5.3, 5.4 and 5.5 detail the individual patient results for each group and 
further summary data is shown in Appendix III, section 1. 
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Table 5.3 Group 1 MRA patients 
Patient 
Sex 
M=1 
Days on 
unit Died=1 Age 
TBSA 
% 
burn 
Total 
MOF 
score 
Theatre 
visits 
Days until 
acquisition 
Blood 
transfused 
before 
acquisition 
Blood after 
acquisition 
Blood 
total 
Inhalation 
injury =1 
1 1 36.3 0 33 30 4 2 11 2196 2044 4240 1 
2 0 37 0 41 30 1 3 2 3884 2291 6175 1 
3 1 18.83 0 1 40 2 4 7 510 483 993 0 
4 1 23.12 0 61 85 5 4 12 4970 9637 14607 1 
5 0 154.3 1 52 45 3 9 95 28222 4045 33971 1 
6 0 33.96 1 32 95 5 2 6 2080 3706 5786 0 
7 0 30.84 0 53 32 3 6 8 1200 7326 8526 0 
8 1 14.83 0 74 35 3 2 5 2258 2051 4309 0 
9 0 16.33 0 44 36 3 3 3 316 4624 4940 0 
10 1 20.23 0 28 40 3 3 5 4321 2061 6382 0 
11 1 32.36 0 45 80 2 6 1 0 8673 8673 1 
12 1 34.67 0 17 50 3 12 2 3590 3590 7180 0 
13 1 13.6 0 71 55 5 2 2 2849 2575 5424 1 
14 1 12.65 0 16 48 2 2 11 1200 220 1423 0 
15 1 22.16 0 14 23 3 2 9 2386 1898 4284 1 
16 1 46.01 0 35 35 4 6 23 5223 2226 5484 1 
17 1 82.18 1 55 37 5 7 9 2196 26135 28331 1 
18 1 26.82 0 38 30 4 5 26 7464 0 7464 1 
19 0 53.07 0 17 50 4 9 1 15075 0 15075 0 
20 1 27 0 1 37 1 6 9 710 450 1160 0 
21 0 94.8 1 52 30 5 2 8 821 9224 10045 1 
22 0 21.44 0 76 16 3 1 10 1395 2654 4049 0 
23 0 63.72 0 26 37 3 4 10 1817 6259 8076 1 
24 1 20.77 0 56 40 2 1 7 447 1538 1985 1 
25 0 15.13 0 15 42 3 2 9 2026 781 2807 0 
26 0 15.75 1 39 90 2 2 4 1440 5597 7037 0 
27 1 17.53 0 33 37 2 8 7 4193 0 4193 0 
28 0 19.58 0 26 46 3 3 20 3894 0 3894 0 
29 1 17.96 1 47 70 3 6 5 8139 3121 11260 0 
30 0 21.89 1 43 40 3 4 7 5178 3961 9139 0 
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Table 5.4  Group 2 Drug sensitive Acinetobacter baumannii patients 
Patient Sex M=1 
Days on 
unit Died=1 Age % burn 
Total 
MOF 
score 
Theatre 
visits 
Days until 
acquisition 
Blood 
transfused 
before 
acquisition 
Blood after 
acquisition 
Blood 
total 
Inhalation 
injury=1 
1 0 60.89 0 58 60 3 3 9 0 5467 5467 0 
2 1 51.88 0 20 28 3 3 15 1241 6190 7431 1 
3 1 0.42 0 18 7 0 0 1 0 0 0 0 
4 0 15.85 1 70 30 5 3 8 20402 8465 28867 0 
5 1 24.64 0 34 32 2 5 4 458 2149 3890 0 
6 0 0.84 0 8 14 0 1 1 0 0 0 0 
7 1 23.04 0 44 10 1 1 4 0 1402 1402 0 
8 1 0.83 1 35 13 0 2 1 0 0 0 0 
9 0 12.2 0 11 25 1 2 5 868 610 1478 0 
10 1 16.23 0 45 40 3 2 10 4241 0 4241 1 
11 0 2.14 0 62 8 0 2 1 0 0 0 0 
12 1 23.55 0 13 50 1 4 6 2919 2015 4934 0 
13 1 37.18 0 72 30 3 2 28 2630 600 3230 0 
14 0 23.4 1 58 45 2 4 3 4589 5669 10258 0 
15 1 22.42 0 26 45 1 13 16 3450 931 4381 0 
16 0 3.27 0 1.25 60 0 1 1 0 0 0 0 
17 1 25.38 0 31 8 2 2 2 329 853 1182 0 
18 1 5.9 0 53 25 0 1 3 775 0 775 0 
19 0 7.79 0 18 30 0 0 8 0 0 0 1 
20 1 32.28 0 43 40 3 4 29 2097 2506 4603 0 
21 0 89.39 0 44 60 4 9 15 7085 10359 17444 1 
22 1 23.94 0 60 37 2 2 7 778 3811 4589 0 
23 0 11.71 0 31 60 4 8 1 0 2532 2532 0 
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Table 5.5 Group 3 Control group.  Matched as closely as possible by age and sex to group 1 
Patient Sex M=1 Days on unit Died=1 Age % burn Total MOF 
score 
Theatre visits Blood total Inhalation 
injury 
1 1 14.68 0 37 44 1 2 1493 0 
2 0 24.61 0 53 35 1 3 5358 0 
3 1 3.86 0 1 40 0 4 250 0 
4 1 12.34 1 48 70 2 3 4107 1 
5 1 3.41 1 38 60 2 1 500 1 
6 1 42.54 1 33 85 3 6 12792 1 
7 0 2.42 0 45 25 0 1 0 0 
8 1 44.65 0 60 32 2 1 6129 1 
9 0 27.4 0 60 17 1 4 1203 1 
10 0 25.74 0 42 40 1 3 3324 0 
11 1 1.82 0 27 30 1 1 0 0 
12 1 3.23 0 44 30 1 1 0 0 
13 1 19.65 0 17 45 3 3 4292 0 
14 0 1.24 1 70 32 1 0 0 1 
15 1 9.95 0 15 47 1 3 1292 0 
16 1 1.88 0 21 25 1 1 0 0 
17 1 3.01 0 37 27 2 2 0 1 
18 1 1.27 1 56 35 1 0 575 1 
19 1 12.56 0 68 28 0 2 928 0 
20 1 6.53 0 17 40 1 3 300 0 
21 0 2.2 0 22 20 0 1 0 0 
22 1 39.89 0 36 33 2 5 6196 1 
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23 1 5.79 0 4 50 0 3 0 0 
24 1 26.65 0 50 35 1 3 1070 0 
25 0 6.17 0 36 42 2 1 0 0 
26 1 2 0 69 30 0 1 0 0 
27 0 87.2 0 28 65 2 11 32365 1 
28 1 10.67 1 29 90 2 4 10869 1 
29 1 10.93 0 13 25 1 2 1200 1 
30 1 12.38 0 39 30 0 2 500 0 
31 1 53.97 0 22 70 1 9 18474 1 
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 Group 1 n=30 Group 2 n=23 Group 3 n=31 
Sex M: F 17:13 13:10 23:8 
Days on unit, 
mean (range) 
34.8 (12-154) 22.39 (1-89) 16.8 (2-53) 
No. of patients 
that died 
7 3 6 
Age, mean 
(range)  
38 (1-76) 37.18 (1-72) 36.67 (1-70) 
TBSA%, mean 
(range) 
45.3 (16-95) 32.91 (7-60) 41.19 (17-90) 
MOF score, mean 
(range) 
3.13 (1-5) 1.73 (0-5) 1.16 (0-3) 
Theatre visits 4.26 (1-12) 3.21 (0-13) 2.77 (0-11) 
Days unit 
acquisition of 
Acinetobacter 
11.13 (1-95) 7.73 (1-29) N/A 
Volume of blood 
transfused pre 
Acinetobacter 
acquisition (mls) 
4000 (0-28222) 2254 (0-20402) N/A 
Volume of blood 
transfused post 
Acinetobacter 
acquisition (mls) 
3905 (0-26135) 2328 (0-10359) N/A 
Total blood 
volume 
transfused (mls) 
7897 (993-33971) 4639 (0-28867) 3652 (0-18474) 
Inhalation injury 13 4 13 
Table 5.6. Demographic and statistical data to compare groups 1, 2 and 3.  
To allow an easier comparison between the Acinetobacter and control groups the 
results from table 5.3, 5.4 and 5.5 have been summarised above. 
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Figure 5.3. Mortality and Multi-organ Failure compared with the original 
study by Fagin et al., (2003). A table comparing the mortality rate for each 
MOF score in the study (in red, labelled burns) with the original study by Fagon 
et al., (1993), in blue labelled ODIN.  
 
Figure 5.3 compares the mortality for each MOF score in our study with that in 
the original study by Fagon et al., (1993). Although no patient in our study 
obtained an MOF score of 6 or 7 and no patient with a score of 4 in our study 
died the results show the same progression; as the MOF score increases so does 
the mortality. This is one way of attempting to validate the use of the ODIN 
score as our study appears to identify the number of patients dying for each MOF 
score in roughly similar proportions as the original study by Fagon et al., (1993). 
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Figure 5.4. A graph showing the ODIN scores for all three groups. The data 
shows the number of patients getting an individual ODIN score for each group 
studied. 
 
It can be seen in figure 5.4 that in group 1, no patient ever obtains an MOF score 
of one and the majority of patients have a score of three or over. The maximal 
score is 5. Group 2 also has a maximal MOF score of 5 but seven patients have 
an MOF score of 0 and the scores are more evenly distributed. Finally, the 
majority of patients in Group 3 have low MOF scores with only two patients 
achieving a score of three. The data suggests that the severity of injury/illness is 
greatest in Group 1 patients and is less in Group 2, which in itself displays 
greater severity of injury than Group 3 (the least injured group). 
 
To determine whether there was a relationship between the acquisition of 
Acinetobacter or not and the development of multi-organ failure the multiple 
organ failure means were compared for the three groups, MRA, drug sensitive 
Acinetobacter and the control group (Groups 1, 2 and 3 respectively). 
Analyses have been performed using the computer program R (R development 
core team). Bootstrapping has been performed using functions one.boot and 
two.boot from R package simpleboot (Peng 2008). Bias-corrected and 
accelerated confidence limits have been obtained using function boot.ci from R 
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package boot (Canty and Ripley 2011, Davidson and Hinckley 1997). The 
permutation test for one-way analysis of variance has been done using function 
aovp from R package lmPerm. 
The main analysis used here is analysis of variance, and also multiple regressions 
to produce an analysis of covariance (performed by Dr Mike Parker). 
Firstly the three groups were compared without any attempt to allow for any 
differences between the groups (Appendix III, section 2) and then an analysis of 
covariance (Appendix III, section 3 and section 4) was performed to provide the 
estimated differences between the groups adjusted for the covariates. This is 
because many of the other covariates, sex, age TBSA%, blood volume transfused 
and inhalation injury are factors that may explain any differences between the 
groups rather than the presence or not of Acinetobacter. 
 
The details of the analysis are presented in Appendix III 
In summary the bootstrap confidence limits for the differences between the 
means indicate that the mean MOF score is higher for the MRA group (group 1) 
1.394 (CI 95%: 0.617, 2.155) than for the Drug Sensitive group (group 2). This 
is statistically significant. The mean MOF score is also higher for the MRA 
group than for the no infection group (group 3) 1.972 (CI 95%: 1.230, 2.640). 
Again this is statistically significant. The difference between the means for the 
group 2 and group 3 is not statistically significant 0.578 (CI: -0.195, 1.359). 
 
The covariate, which explains most variation in the MOF score, is the volume of 
blood transfused. In Appendix III section 3, blood volume transfused is used as a 
covariate to adjust the differences between the means of the total number of 
organ failures. The adjusted differences between the means are all smaller than 
the unadjusted differences shown in Appendix III, Section 2, and table 3. Despite 
this, the conclusions are the same. 
 
An analysis was then performed examining all the covariates (Appendix III, 
Section 4). The problem with this is that some of the covariates might not 
contribute to the model and would therefore increase the standard errors in the 
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model and would produce a more complex model. This now demonstrates that 
there was a statistical difference between all three groups. 
 
A final model was created looking at the covariates that produced the greatest 
variance in the results, the total volume transfused and the number of theatre 
visits (Appendix III, Section 5). This analysis confirms the initial findings of the 
differences between the groups as detailed in Appendix III tables 3 and 6. 
 
In summary the analysis of covariance provided estimated differences between 
the groups means adjusted for the covariates. However, the size of the 
differences is determined by which set of covariates is used. The best fit is 
provided using the covariates blood volume transfused, number of operating 
theatre visits, and the interaction between them. This accounts for 48.0% of the 
variance. When adding the factor for groups this goes up to 60.0%. The sizes of 
the differences between the means adjusted for the covariates, with their 
bootstrap multiplicity-corrected 95% confidence intervals (CI) are MRA – Drug-
Sensitive 1.001 (CI: 0.395, 1.588), MRA – No-infection 1.229 (CI: 0.615, 
1.811), and Drug-Sensitive – No-infection 0.228 (CI: – 0.351, 0.829). Thus the 
first two differences are statistically significant, but the third one is not. 
Therefore Multi-drug resistant Acinetobacter baumannii does cause multi-organ 
failure in the burn ICU population but Acinetobacter infection (drug sensitive) in 
itself does not. 
 
One of the interesting points that came out of the analysis was the influence of 
the total volume of blood transfused. Blood transfusions have previously been 
described as a risk factor for infections in burns patients (Graves et al., 1989). In 
a general ICU setting, multivariate analysis showed transfusion as an 
independent risk factor for infection, mortality, hospital and ICU length of stay. 
In addition A. baumannii accounted for a disproportionate share of infections 
among transfused patients (P < 0.001) (Rachoin et al., 2009). 
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5.4.3 Volumes of blood transfused and the relationship to multi-
organ failure 
Further analysis was performed to investigate the influence of blood transfusion 
before and after the inquisition of infection. The summary tables of the statistical 
data used to analyse blood volume and the relationship to Acinetobacter 
acquisition are in Appendix III section 6, tables 11-14. 
The recommended method for the comparison of groups in terms of a change 
from pre- to post-event is to regress the post-event values on the pre-event values 
(Dr Mike Parker, Anglia Ruskin University). This has been done for pre- and 
post-acquisition of infection in the graph below.  
 
 
Figure 5.5 Scatter plot showing the regression lines for blood volume 
transfused after acquisition of infection against blood volume transfused 
before acquisition of infection. The data shows the regression slope for Drug 
resistant Acinetobacter was -0.01; boot strap 95% CI (-0.285, 0.575) shown by 
the solid line. The drug sensitive Acinetobacter regression slope (dashed line) 
was 0.424; boot strap 95% CI (0.286, 0.729) Analyses have been performed 
using the computer program R (R development core team). Bootstrapping has 
been performed using functions one.boot and two.boot from R package 
simpleboot (Peng 2008). 
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Whilst figure 5.5 appears to show that the regression is statistically significant 
for the drug sensitive group the slope of this line is largely dependent in this data 
set on a single point and so the regression relationship is not very convincing. 
Therefore looking at the graph one must conclude that the blood volume 
transfused before and after the acquisition of infection is not related. 
A further way of looking at this is by looking at the difference between the 
means of the blood volumes pre-acquisition of Acinetobacter and the means of 
the blood volumes post acquisition of Acinetobacter, this is shown below in 
tables 5.7 and 5.8.  
Group difference Difference 
between  
means 
Standard 
error 
95% confidence limits 
Lower Upper 
Resistant – Sensitive 1745 1359 – 1196 4266 
 
Table 5.7 Difference between means of pre-acquisition blood volume with 
bootstrap standard error and 95% confidence limits. The means of blood 
volume transfused prior to Acinetobacter acquisition are compared between the 
drug resistant and drug sensitive groups. Bootstrapping shows the 95% 
confidence limits enclose zero, which confirms that the difference is not 
statistically significant (function boot.ci from R package boot (Canty and Ripley 
2011, Davidson and Hinckley 1997). 
  
Group difference Difference 
between  
means 
Standard 
error 
95% confidence limits 
Lower Upper 
Resistant – Sensitive 1577 1157 – 785 3750 
 
Table 5.8 Difference between means of post-acquisition blood volume with 
bootstrap standard error and 95% confidence limits. The means of blood 
volume transfused post Acinetobacter acquisition is compared between the drug 
resistant and drug sensitive groups. The bootstrapped 95% confidence limits 
enclose zero, which confirms that the difference is not statistically significant.  
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Tables 5.7 and 5.8 show that there is no statistical significance between the 
means of the blood volumes transfused prior to and post Acinetobacter 
acquisition. This confirms the earlier analysis shown in figure 5.5. 
Further analysis looking at the variance between the groups is given in appendix 
III, Section 7 and could be used for more detailed analysis (not performed). In 
addition post acquisition blood volumes and post- minus pre-acquisition blood 
volumes found no difference between the groups. Full analysis is detailed in 
Appendix III section 4. 
 
 
5.4.4. Organisms isolated concurrently with Acinetobacter 
baumannii 
A growing field of research is into competitive strategies between species of 
bacteria. It has revealed that there are diverse mechanisms by which bacterial 
species can coexist with, or dominate, other organisms competing for the same 
pool of resources. As well as engaging in intraspecies competition bacteria can 
also participate in cooperative behaviours (Hibbing et al., 2010). To see if there 
was any evidence that Acinetobacter may be involved in either cooperative or 
competitive behaviour with any other microorganisms we examined the 
organisms that were isolated at the same time as the Acinetobacter samples, 
figure 5.6. At a simple level it was thought that isolation of a particular organism 
at high frequency at the same time that Acinetobacter was isolated might suggest 
that they work in cooperation for example. It may be that any cooperative or 
competitive behaviour is different for drug sensitive and drug resistant 
Acinetobacter, 
 210 
 
Figure 5.6 Organisms isolated at the same time as Acinetobacter samples. 
The data shows the frequency and type of organisms isolated at the same time as 
positive Acinetobacter samples in the MRAB group (blue) and Drug sensitive 
group (purple). The data was obtained from the Acinetobacter baumannii 
database. 
 
To see if the presence of other organisms had any influence on Acinetobacter 
acquisition all bacteria isolated at the same time as Acinetobacter were recorded, 
figure 5.6. Of the 30 patients within group 1, seventeen had one or more 
organisms isolated at the same time. Within this group of 20 patients ten 
different organisms or species were identified. Within group 2, eighteen patients 
had one or more organisms isolated at the same time. The numbers are too small 
to draw any meaningful conclusions but there is no obvious pattern or difference 
between the two groups. A larger sample size is required to detect any potential 
links between Acinetobacter and other microorganisms. 
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5.4.5  Agency Nursing Staff as a contributing factor to MRA 
acquisition. 
 
From the start of what was considered the beginning of the Acinetobacter 
outbreak until the end of the main outbreak other factors were examined that may 
explain the persistence of Acinetobacter on the unit despite measures to prevent 
transmission and increased vigilance. 
In a one year period eighty four patients from the burns unit had a positive 
wound swab, sputum or blood culture for Acinetobacter baumannii and of these, 
19 were found to be multi-resistant (Table 5.9). 
 
 Percentage of Agency 
staff employed on the 
burns unit (%) 
No. of cases of Multi 
Resistant Acinetobacter 
Baumannii 
April-June 2004 42 4 
July-Sept 2004 43 5 
Oct-Dec 2004 27 3 
Jan-March 2005 64 7 
 
Table 5.9. MRA and agency staff. The data shows the number of MRAB cases 
during each quarter of the study period compared with the number of agency 
staff. 
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Figure 5.7. A scatter plot of the number of cases of Multi-resistant 
Acinetobacter Baumannii and percentage of agency staff. This graph looks at 
the number of cases of MRAB between April 2004 and March 2005 in each 
quarter of that year compared with the percentage of agency nursing staff used 
on the unit. The trendline shows the correlation coefficient r to be 0.95 (p<0.05). 
This is statistically significant. (Excel 2007) 
 
To see if there was any link between the MRA cases and use of agency staff the 
data from table 5.9 was plotted and the correlation coefficient plotted in figure 
5.7. Investigating staffing levels between April 2004 and Mar 2005 established a 
direct correlation between the number of agency staff employed and the rate of 
infection of patients with multi-resistant Acinetobacter baumannii. Data was 
analysed using Pearson Correlation Coefficient. Correlation is a technique for 
investigating the relationship between two quantitative, continuous variables, for 
example, age and blood pressure. Pearson's correlation coefficient (r) is a 
measure of the strength of the association between the two variables. Pearson's 
correlation coefficient (r) for continuous data ranges from -1 to +1. A value of 0 
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would indicate no correlation between the variables and 1 would indicate a 
perfect correlation between the variables. An r-value of 0.95 shows a strong 
correlation between the number of cases of MRA and the number of 
agency staff used. The square of the sample correlation coefficient, denoted r2 
is called the coefficient of determination and estimates the fraction of the 
variance in Y that is explained by X in a simple linear regression. The r2 for the 
above data is 0.89. This means we can say that 89% (0.952) of the variation in 
MRAB rates is explained by the percentage of agency staff. 
 
5.4.5 Bed Occupancy on Unit as a contributing factor to MRA 
acquisition. 
Another factor identified that may influence MRA acquisition was bed 
occupancy. Table 5.10 shows the quarterly data for bed occupancy and the 
number of cases of MRA during the study period. 
 
Study Period Percentage of Occupied 
Beds (%) 
No. Of Cases of multi-
resistant Acinetobacter 
April-June 2004 46 4 
July-Sept 2004 58 5 
Oct-Dec 2004 43 3 
Jan-March 2005 61 7 
 
Table 5.10. The number of cases of MRAB compared with the bed 
occupancy. The data shows the quarterly number of cases of MRAB and the 
percentage of occupied beds from April 2004 to March 2005. 
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Figure 5.8. A scatter plot of the number of cases of Multi-resistant 
Acinetobacter Baumannii against bed occupancy. This graph looks at the 
number of cases of MRAB between April 2004 and March 2005 in each quarter 
of that year compared with the occupancy of the unit (%). Data was analysed 
using Pearson Correlation The trend line shows the correlation coefficient r to be 
0.92, (p<0.05) which is statistically significant. (Excel 2007). 
 
The trendline in figure 5.8 shows the correlation coefficient r to be 0.92. This 
demonstrates there is a strong positive correlation between the number of cases 
of MRAB and the occupancy (p<0.05). As the occupancy increases the number 
of cases of MRAB also increase. The coefficient of determination (r2) is 0.86 and 
shows that 86% of the variance in the number of MRAB cases is explained by 
the occupancy of the unit. We can therefore saw that both the number of agency 
staff and how busy the unit is play a strong role influencing the rate of MRAB.   
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5.5 Discussion 
Burn wound infection and Acinetobacter baumannii.  
One of the main complications of burn wounds is infection. Sepsis and multi-
organ can potentially lead to death of the patient but more frequently results in 
prolonged hospital stays and possible poorer outcome in terms of function, 
psychological aspects and aesthetics. Despite advances in assessment, 
management, surgical treatment and vital antibiotic therapies over the last 40 
years infections and their sequelae are still a major contributor to the mortality 
figures for a burns unit. 
Without the patient developing sepsis, infections can still have a large impact on 
patient outcomes. Wound infections can increase the depth of superficial burns 
resulting in a greater likelihood of surgery or scarring. A wound bed that is 
infected and inadequately prepared will result in grafts not ‘taking’ and wound 
infections can destroy established grafted skin both of which result in longer in-
patient stays. 
Whilst improvements in burn care have been made, new hurdles have arisen that 
continually challenge the physician. Indiscriminate use of antibiotics both in 
hospitals and the community has resulted in a generation of organisms that are 
resistant to most mainstream antibiotics. The status of nosocomial infections has 
risen to national importance with frequent reports being in the media. The 
combination of these factors has resulted in major problems for both the 
hospitals and patients. 
Although methicillin resistant Staphylococcus aureus (MRSA) and Clostridium 
Difficile have received the majority of the press attention it is clear that a number 
of other organisms frequently acquired in the hospital setting are having a 
significant impact on patient care due to their bacterial resistance. 
One organism that is achieving a more prominent profile in hospitals and 
particularly burns units and ITUs is the gram-negative bacteria Acinetobacter 
baumannii. Its importance has only been realised relatively recently and few 
studies have actually assessed what impact it is having on patient morbidity and 
mortality in burn patients. 
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This study is therefore both topical and important as it sheds new light on the 
potential severity of a multi resistant Acinetobacter outbreak and demonstrates 
its association with multi-organ failure.  
5.5.1 Epidemiology 
Acinetobacter baumannii has been found on the burns unit for a number of years 
but the number of cases that were MRA numbered few and the majority were 
drug sensitive. Figure 5.1 shows that only 12 patients had Acinetobacter isolated 
in 2000 but that this had risen to 78 cases by 2001, 12 of which were MRAB. 
In figure 5.1 1 it can be seen that there is a significant drop in the number of 
cases of Acinetobacter. During 2001 there was a strain of multi-resistant 
Pseudomonas isolated from several patients on the burns unit. After investigation 
it was thought that staff hand hygiene was a major contributing factor to 
transmission of the organism. A strict hand washing policy was implemented and 
in time the Pseudomonas outbreak was stopped. A by-product of the strict hand-
washing regime was the reduction in the number of cases of Acinetobacter 
suggesting that the continued presence of Acinetobacter on the unit could be due 
to transmission by members of staff rather than multiple sporadic outbreaks. It 
can be seen that by 2003 there was an almost complete eradication of 
Acinetobacter from the unit, however without knowing the total number of 
patients admitted each year one cannot establish the true incidence per year. It is 
possible that there was a reduction in the number of patients admitted over this 
time period. A further outbreak of MRA occurred in 2004-2005, this will be 
discussed later. 
 
5.5.2 Seasonal Variation  
Throughout the study period (2000-2006) there was a marked seasonal variation 
with Acinetobacter being more frequent between October and March than the 
summer months (Figure 5.2). This is in contrast to previous studies. In the Spain, 
Pedraza et al., (1993) found no seasonal variation after a two and a half year 
study period; this picture was echoed in America by Seifert et al., (1995) who 
also found no seasonal variation. Elsewhere in America studies showed a greater 
number of cases in the summer months (Christie et al., 1995) and during July to 
October (McDonald et al., 1999).  
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It is unclear from our current data why this might be. Further analysis may show 
whether a particular strain of Acinetobacter is responsible or if there were any 
factors within the hospital that may have contributed i.e. changing in staffing 
patterns or characteristics of the patients admitted to the unit, for instance more 
patients from war zones at certain times of the year. 
 
5.5.3 MRA Incidence and Acquisition 
This study does not tell us where the strains originated. There are several 
potential agents. Firstly there may be a member of staff or a piece of equipment 
acting as a reservoir of infection. Secondly Acinetobacter may be introduced to 
the unit by a patient. Patients are not only admitted directly to the unit but are 
also transferred from other hospitals where surveillance of such organisms may 
not have been conducted. In addition patients are sometimes transferred from 
abroad and these patients tend to be from either war zones or as a result of 
industrial accidents (sometimes in remote areas), which increase the chance of 
acquisition of Acinetobacter as normal patterns of emergency care may not be 
instituted. Acinetobacter is the most common organism isolated from infected 
wounds in US army personnel in the most recent war in Iraq and with many 
isolates being multi-drug resistant (Petersen et al., 2007).     
The total incidence of MRA between April 2004 and June 2006 was 10.7%, 
which compares favourably with the rates found in other burn units or in the ITU 
setting, 11.5% (Sengupta et al., 2001), 13% (Simor et al., 2002) and 14% 
(Santucci 2003). In previous studies a range of factors have been linked to the 
acquisition of MRA including peripheral artery catheters, mechanical ventilation, 
or pulmonary artery catheters (Beck-Sague et al., 1990). Mortality due to 
Acinetobacter baumannii has been associated with recent surgery, urinary 
catheterization, nasogastric tubes and well as the factors listed above (Chen et al., 
2005) Whilst this study was not able to analyse all these factors that contribute to 
acquisition or mortality it looked at MRA and multi-organ failure. 
It has been shown that the mortality rate is increased in patients with MRA 
(Cisneros et al., 1996) with mortality being higher in those infected rather than 
colonized (Rodríguez-Baño et al., 2004). This study is the first to show an 
association between MRA and multi-organ failure. This is an important finding 
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because multi-organ failure is associated with a greater morbidity and mortality 
(Cumming et al., 2001). If the patient does not die, multi-organ failure means not 
only poorer outcomes for the patient (physically and psychologically) but has 
important financial implications in the short term for the hospital and in the long 
term for the patient and the community. Wilson et al., (2004) established that the 
mean hospital costs of patients that acquired MRAB was $98,575 higher than 
that of control patients who had identical burn severity of illness indices. 
The average mortality of patients with Acinetobacter was 18.86% (Group 1 
23.33%, Group 2 13.04%) which is lower than that reported in some other 
studies. Trottier et al., (2007) describe a 33% mortality rate in patients with 
Acinetobacter (a 30% rate is attributed to patients with active infection as one 
patient died of a gastrointestinal bleed). In other studies reported in burns units 
the mortality rates vary from 22% (Chen et al., 2005) to 4.42% (Sengupta 2001). 
It is impossible to compare these figures with the mortality rate in group 3 as this 
groups was matched as closely as possible to group 1 (in terms of age of patient 
and TBSA% sustained) and therefore may represent a skewed populations of 
those patients with no Acinetobacter infection.   
Data shown in figure 5.3 compares the mortality of the patients in the original 
ODIN study (Fagon et al., 1993) with the patients in all three groups of the 
current study. It can be seen that the mortality figures approximately follow that 
of the original study. It may be argued that a major burn wound is unique in its 
characteristic and thus a scoring system used for general medical problems is not 
appropriate. There are many different scoring systems used to assess multi-organ 
failure, injury or trauma or indeed combinations of these, at the time of the study 
the consensus paper by the American Burn Association (Greenhalgh et al., 2007) 
had not been published. Therefore commonly used systems were considered in 
consultation with both one of the lead anaesthetists of the burns ITU and the lead 
burns surgeon. These were generally thought to be firstly too complicated and 
that some of the data required would be too difficult to retrieve retrospectively 
from the patient records. 
In the end a balance was struck for a system that looked at all the major organ 
systems of the body and would allow collection of data that would be found in 
the records of all patients being admitted to the unit. The ODIN scoring system 
was therefore selected for this study. 
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5.5.4 Transmission of Acinetobacter - possible contributing 
factors 
In our unit, a previous outbreak of multiresistant Pseudomonas aeruginosa in 
2001 was thought, after extensive investigation, to be partly due to transmission 
via the hands of the staff. A strict hand washing policy was implemented using 
senior staff as opinion leaders (those who influence the behaviour of others) and 
as a result the unit had no further significant outbreak of multiresistant 
Pseudomonas for two years. This policy appears to have had the knock-on effect 
of reducing the rate of Acinetobacter baumannii infection over the subsequent 
two years. 
Unfortunately in April 2004 to March 2005 there were a number of cases of 
MRA in the unit despite the fact that the hand-washing regime implemented was 
still in place and the ‘culture’ of hand washing was firmly established. This study 
looked at other possible factors that might explain the increased number of cases 
of MRA over this period. Since nurses provide most of the care and 
manipulations to a patient on a burns unit, the level of care provided and 
adherence to protocol may be critical for the prevention of nosocomial 
infections. Previous reports have linked staffing grade and staffing levels with a 
greater number of infections and a higher mortality. We looked at the number of 
‘agency’ or ‘bank’ health care workers employed in comparison to the number of 
full time regular staff. In addition this study looked at how busy the unit was. 
This was judged by the occupancy of the unit, as it was thought that when the 
unit was very busy staff might be more prone to error or more likely to let 
standards slip. 
There are many factors that may be responsible nosocomial infections in the 
hospital setting. Our study suggests that in addition to the recognised factors 
associated with the spread of infection agency or bank nurses may be associated 
with a high rate of multiresistant Acinetobacter infections in a burns unit. 
Research on the relationship between staffing levels of nurses in hospitals and 
patients’ outcomes however, are conflicting. 
A number of studies have found that nurse staffing levels have a direct impact on 
a number of patient outcomes. Understaffing has been identified as a risk factor 
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for increased rates of healthcare associated infections (Arnow et al., 1982, 
Fridkin et al., 1996, Garfield et al., 2000). Conversely Mark et al., (2004) found 
increased nursing staff levels were associated with lower rates of urinary tract 
infections, decubitus ulcers, pneumonia and mortality. Other studies have also 
found the higher the ratio of registered nurses per bed is associated with lower 
mortality and failure to rescue (Silber et al., 2000) and that an inverse 
relationship between nurse staffing and mortality (Sasichay-Akkadechanunt et 
al., 2003) and failure to rescue exists (defined as the 30 day mortality in patients 
with complications plus deaths without a recorded complication) (Aitkin at al., 
2002). 
Further studies have established the importance of the experience level of the 
staff. McGillis et al., (2004) found that the lower the proportion of registered 
nurses on a unit and the less experienced the nurses, the higher the number of 
medication errors and wound infections. However a study by Jarman et al., 
(1999), like a number of other studies did not find a correlation between nursing 
numbers and any measure of mortality.  
This is the first time a correlation has been found between infection rates and the 
use of agency or ‘bank’ nurses in a burns unit. The only comparative study in the 
literature examined a surgical intensive care unit. Robert et al., (2000) found that 
increased use of ‘pooled nurses’ (the American equivalent of bank or agency 
nurses) may be an important risk factor for nosocomial blood stream infections 
in a surgical intensive care unit despite the nurse to patient ratio being not 
significantly different between case patients and controls.   
In our case there may be a number of reasons why agency staff may be 
associated with an increased risk of MRA acquisition. After a previous outbreak 
of MRA on the unit several years before a stringent policy of hand washing and 
hygiene was instituted. It may be that the increased MRA rate is due to the fact 
that agency staff may be less familiar and aware of departmental procedures that 
have maintained high standards. Even with limited training prior to working on 
the unit it is hard to seamlessly integrate into the ingrained ‘culture’ already 
prevalent on the unit. 
The use of agency staff most frequently occurs when the unit is busy. It is during 
these times of increased workload that all staff are put under increased pressure. 
Pittet et al., (1999) found a number of factors that altered compliance with hand 
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washing in a teaching hospital. They found that procedures that generated most 
opportunities for hand washing (after patient care, drug preparation, after 
intravenous care and during house keeping) and procedures associated with a 
high risk of transmission (before intravenous or respiratory care and care 
between clean and dirty body sites) were associated with low levels of hand 
washing compliance. In addition hand-washing compliance was lower when the 
activity level was high. It may be that during times when there are increased 
agency staff compared with regular staff the work load may increase for the 
regular staff thus mimicking the effect of understaffing despite the nurse to 
patient ratio being unchanged. 
  
This study also showed that there was an association between the occupancy of 
the unit and number of MRA cases. On some days the unit was running at 120% 
occupancy as patients were moved off the unit and new patients moved onto the 
unit.  
Some of the possible reasons for the number of MRA cases increasing with the 
occupancy have been covered already, hand washing compliance being lower 
when activity is high and use of agency staff. Other potential reasons may 
include inadequate washing of the rooms between patients or staff not changing 
clothing between seeing a patient on the unit and a subsequent emergency 
admission. 
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5.6 Conclusions 
Study limitations 
One of the limitations of this study into Acinetobacter baumannii is that it is only 
looking at one unit within the hospital. It would be useful to see if this picture is 
replicated throughout the whole hospital or similar units. Furthermore, to obtain 
a more accurate picture it may be useful to know the ratio of agency to regular 
staff that worked with the individuals that became infected to more closely 
identify any trend. Unfortunately this level of information was not available. 
Another factor that could have been looked at was the data regarding other 
healthcare staff such as doctors. Although the number of doctors working in the 
unit over the time period studied are relatively few there are still times when 
locum staff are used and may therefore suffer the same problems with 
unfamiliarity with the unit procedures and policies. So many factors affect the 
acquisition of nosocomial infections that we cannot exclude some as yet 
undiscovered confounding factor that may explain our results. 
Staff training is crucial to prevention of this problem to minimise the risk 
associated with increased use of agency staff. Burn Unit specific teaching for 
agency staff is essential. Other strategies to tackle this could involve targeting the 
patients at greatest risk of MRA and assigning the regular staff to these patients 
with agency staff being assigned to lower risk patients. 
In conclusion this study demonstrates an association between MRA and multi-
organ failure in a burns unit. In addition patients who acquired MRAB had more 
theatre visits, stayed longer in ITU and greater blood transfusion requirements. 
The consequences of MRAB acquisition and the development of MOF have 
serious implications for the unit in terms of workload and medical and nursing 
care but also financially for the hospital. 
Continued strategies to combat nosocomial infections are required and the 
identification of high-risk patients may be ways of tackling the growing problem 
of MRAB in the burns ITU. 
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Chapter 6 
Antimicrobial peptides and the role of the cathelicidin LL-37 
 
6.1 Introduction  
Mammals are constantly exposed to a variety of microorganisms and yet in 
healthy individuals rarely become infected because of the barrier function of the 
skin and epithelia. It is not only the physical barrier of skin prevents microbial 
entry, but also the presence of antimicrobial substances.  
Antimicrobial peptides (AMPs) make up one of the most ancient defence 
systems within the animal and plant kingdoms. It has been suggested that their 
widespread distribution and function have been fundamental in the evolution of 
complex multi-cellular organisms. Their ancient lineage and continued 
effectiveness may contradict the theory that bacteria, fungi and viruses 
eventually develop resistance to all substances (Zasloff 2002). 
In mammals, two forms of immunity have evolved. The first, the innate system is 
non-clonal and non-specific and the second is adaptive and antigen specific. 
Innate immunity is the first line of defence that is rapidly mobilized following 
the detection of microbial invasion. The effector branch of innate immunity 
consists of two major components: the recruitment and/or activation of 
leukocytes (e.g., phagocytic granulocytes, monocytes/macrophages, etc.) capable 
of combating the invading pathogens and the release and/or activation of a 
variety of extracellular humoral mediators (complement, cytokines and 
antimicrobial substances).  
Adaptive immunity is induced when lymphocytes are activated in response to 
antigen (Ag) presented by antigen-presenting cells (APCs). T cell antigen 
receptors recognize antigenic epitopes bound to the major histocompatibility 
complex (MHC) on the surface of APCs. CD8+ T cells, once activated 
differentiate into cytotoxic T cells that directly kill cells infected by intracellular 
pathogens. The complex of MHC class II and antigenic epitope triggers the 
activation of CD4+, generating T-helper cells that, by producing various 
cytokines, promote B cell activation and enhance the efficiency of phagocytes to 
eliminate pathogens (Yang et al., 2004). The combination of these two systems 
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working together and in parallel is an effective solution in eliminating microbial 
invaders. 
 
6.1.1 Antimicrobial peptides 
AMPs were initially discovered on the basis of their antibiotic activity but they 
have been found to have additional biological properties that assist in modulating 
the host immune system including amongst others, stimulation of chemotaxis, 
suppression of proinflammatory cytokine production, promotion of angiogenesis 
and wound healing (Schauber and Gallo 2008 B). Because of these other 
properties, these peptides are now sometimes referred to as host-defence peptides 
(HDPs). 
 
6.1.2 Antimicrobial peptide structure 
There are now more than 1000 recognised AMPs (Mangoni 2011) and the range 
of AMPs is so great that it has been difficult to categorize them except in general 
terms on the basis of their secondary structure and amino acid composition. 
AMPs are 8–50 amino acids long and there are three main AMP structural 
groups: a-helical peptides, b-sheet peptides and extended peptides as illustrated 
in Figure 6.1  
  
 225 
 
 
Figure 6.1. An overview of the major structural classes of antimicrobial 
peptides (AMPs). (a) a-Helical peptides, (b) b-sheet peptides and (c) extended 
peptides. Positively charged side chains are coloured in blue, negatively charged 
side chains in red and remaining side chains in grey (Nguyen et al., 2011). 
 
6.1.3 Antimicrobial peptide mechanism of action 
One of the reasons that AMPs are so effective is down to the physical 
characteristics of AMPs and the difference between the design of the membranes 
of microbes and multicellular animals.  
Bacterial membranes have a lot of lipids and anionic components in their cell 
wall (e.g., endotoxin or lipo- polysaccharide, LPS, in gram-negative bacteria, and 
lipoteichoic acid, LTA, in gram-positive bacteria) with negatively charged 
phospholipids in their membranes (Mangoni 2011).  
Lipids with no net charge, however, mainly populate the outer part of the 
membrane of plants and animals and most of the lipids with negatively charged 
headgroups are in the inner part of the bilayer (facing the cytoplasm) as shown in 
Figure 6.2. 
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Figure 6.2. The membrane target of antimicrobial peptides of multicellular 
organisms and the basis of specificity (Zasloff 2002). 
 
AMPs use this to their advantage. They possess firstly a cationic charge and 
secondly a significant proportion of hydrophobic residues. The positive cationic 
charge promotes selectivity for negatively charged microbial cytoplasmic 
membranes over zwitterionic mammalian membranes whereas the hydrophobic 
residues facilitate interactions with the fatty acyl chains (Nguyen et al., 2011). 
The majority of AMPs work by killing microbes by disrupting their membrane 
and causing irreversible damage although other mechanisms have now been 
characterized that target key cellular processes including DNA and protein 
synthesis, protein folding, enzymatic activity and cell wall synthesis (Nicolas 
2009). 
The classical description of the mechanism of action of membrane disruption is 
the Shai-Matsuzaki-Huang (SMH) model (Zasloff 2002). In this the outer part of 
the bilayer membrane becomes covered with the peptide. The peptide becomes 
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integrated into the membrane resulting in displacement of lipids. This results in 
the outer part of the bilayer increasing in size compared to the inner layer 
(curvature strain), which can allow an intracellular influx of AMPs in some cases 
or fragmentation and physical disruption of the membrane. (Zasloff 2002, 
Nicholas 2009). A variety of other models have been proposed (as illustrated in 
figure 6.3) and it may be that individual AMPs may utilize different methods.  
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Figure 6.3 Demonstrates the variety of models of membrane disruption that 
AMPs may use to fragment or physically disrupt the bilayer membrane. 
Events occurring at the bacterial cytoplasmic membrane following initial 
antimicrobial peptide (AMP) adsorption. These events are not necessarily 
exclusive of each other. In the classical models of membrane disruption, the 
peptides lying on the membrane reach a threshold concentration and insert 
themselves across the membrane to form either peptide-lined pores in the barrel-
stave model, solubilize the membrane into micellar structures in the carpet 
model, or form peptide-and-lipid- lined pores in the toroidal pore model. In the 
revised disordered toroidal pore model, pore formation is more stochastic and 
involves fewer peptides. The thickness of the bilayer can be affected by the 
presence of the peptides, or the membrane itself can be remodelled to form 
domains rich in anionic lipids surrounding the peptides. In more specific cases, 
non-bilayer intermediates in the membrane can be induced; peptide adsorption to 
the membrane can be enhanced by targeting them to oxidized phospholipids; a 
peptide may couple with small anions across the bilayer, resulting in their efflux; 
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the membrane potential can be dissipated without other noticeable damage; or 
conversely, in the molecular electroporation model, the accumulation of peptide 
on the outer leaflet increases the membrane potential above a threshold that 
renders the membrane transiently permeable to various molecules including the 
peptides themselves.(Nguyen et al., 2011) 
 
6.1.4 AMPs in humans 
AMPs are present at all human body sites normally exposed to microbes such as 
the skin and mucosal surfaces. Furthermore, some blood cell types including 
neutrophils, eosinophils and platelets contain large amounts of AMPs (Wiesner 
and Vilcinskas 2010). Production of AMPs may be constitutive, or frequently 
induced by inflammation or injury. AMPs are produced in varying amounts is 
different parts of the body as each tissue has its own profile of different AMPs 
that may vary significantly depending on physiological conditions. Certain 
AMPs predominate at specific body sites, but only a few of them are exclusively 
produced by a certain tissue or cell type. 
Whilst a number of endogenous AMPs that play an important role in the defense 
of the skin have now been discovered (Table 6.1) two particular classes of 
peptide have been the subjects of much research, defensins and cathelicidins. 
  
 230 
Peptide Cellular source Susceptible 
organisms 
Comments 
Dermcidin Eccrine sweat glands Broad-spectrum principal sweat 
antimicrobial peptide; 
-not inducible by 
injury or 
inflammation 
Psoriasin Keratinocytes, 
sebocytes 
Gram-negatives E. 
coli  
-most abundant 
antimicrobial peptide 
in healthy skin; -
induced by E. coli 
flagellin 
 
rNase 7 Keratinocytes Enterococcus faecium 
broad-spectrum 
-antimicrobial activity 
independent of rNase 
activity 
 
Cathelicidin (LL-37) Keratinocytes, 
sebocytes 
Gram-positives 
Gram-negatives 
-induced by injury or 
inflammation; -also 
plays a role in wound 
healing 
 
hBD-1  Keratinocytes, 
sebocytes  
Gram-negatives  -constitutively 
produced at low 
amounts 
 
hBD-2 Keratinocytes Gram-negatives -induced by injury or 
inflammation 
 
hBD-3 Keratinocytes Broad-spectrum -induced by injury or 
inflammation 
 
hBD-4 Keratinocytes Gram-positives 
Gram-negatives 
-inducible in primary 
keratinocytes in vitro 
SLPi Keratinocytes, hair 
follicles, eccrine and 
apocrine sweat 
glands, sebocytes 
Broad-spectrum -upregulated during 
inflammation; -also 
functions as an 
inhibitor of neutrophil 
elastase and cathepsin 
G; -plays a role in 
wound healing 
probably dependent 
on its antiprotease 
activity 
 
Adrenomedullin Keratinocytes, 
sebocytes, hair bulb 
cells 
Gram-positives 
Gram-negatives 
-pluripotent peptide 
also involved in 
wound healing and 
various other 
processes 
 
 
Table 6.1. Antimicrobial peptides of human skin (Wiesner and Vilcinskas 
2010). 
 
 
 231 
6.1.5 Defensins 
Defensins are a widely dispersed family of anti-microbial peptides (AMPs) that 
like cathelicidins are expressed by keratinocytes and mucosal epithelial cells 
(including those of gastrointestinal, genitourinary and pulmonary epithelia). 
They are cationic peptides containing 6-8 cysteine residues that form disulfide 
bridges (Milner and Ortega 1999) The alignment of the bridges determines the 
division of defensins into three subfamilies α-defensins, β-defensins (only 
present in humans) and θ-defensins. 
 
α-defensins 
α-defensins were first discovered in the granules of white cells. Human 
neutrophils express 4 distinct α-defensins (1-4) that are also known as human 
neutrophil peptides 1 to 4 (Liu at al., 1998). These peptides alter the host innate 
immune response to pathogens in addition to their anti-microbial properties.  
 
β-defensins 
Have 6 cysteine motifs connected by 3 disulfide bridges. The difference in 
spacing of these disulfide bridges determines the classes of defensins. The 
disulfide bonds of β-defensins are C1-C5, C2-C4 and C3-C6 (Izadpanah and 
Gallo 2003).  
β-defensins have been identified in many cell types, including epithelial cells and 
neutrophils. Four types have been identified in humans HBD-1 to -4. HBD-1 
expression appears predominately constitutive; HBD-2 expression is increased 
with inflammatory insults (Liu A et al., 2002). 
β-defensins have multiple other functions in addition to their anti-microbial 
properties. HBD-1 and 4 promote histamine release and prostaglandin D2 
production in mast cells (Befus et al., 1999) and like LL-37 chemoattract 
monocytes and T-cells (Chertov et al., 1996). Niyonsaba et al., (2007) have 
shown a key role human beta defensins play stimulating epidermal keratinocyte 
migration, proliferation and production of pro-inflammatory cytokines and 
chemokines. Defensins -2, -3 and -4 increased the protein production of IL-6 and 
IL-10. 
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The normal levels of β-defensins are minimal but they increase in skin affected 
by inflammatory diseases. 
 
6.1.6 Cathelicidins 
Similar to defensins, cathelicidins act as pre-cursor molecules that can release an 
antimicrobial peptide after proteolytic cleavage. A key characteristic of the 
cathelicidin family of proteins is the presence of a highly conserved cathelin 
domain (Zanetti 2004). The cathelicidin proteins are characterized by a highly 
conserved N-terminal domain of about 100 amino acid residues. This 14 kDa 
cathelin-like domain is flanked by a signal peptide domain (approximately 30 
residues long) on its N-terminus, and by an antimicrobial peptide region on its C-
terminus (see figure 6.4). The single 16 kDa human cathelicidin is denoted as 
hCAP18. 
 The primary translation product is called the ‘preprotein’, since it contains a 
signal sequence as a prelude to the cathelicidin holo-protein. This signal peptide 
is cleaved off once it has fulfilled its purpose of targeting the cathelicidin to 
storage granules or to the exterior of the cell. The formation of two disulfide-
bridges finalizes post-transcriptional processing. The cathelicidin holo-protein is 
then referred to as the ‘pro- protein’, since it does not represent the active form, 
but a storage form instead. Only after cleavage of the proprotein into the cathelin 
domain and the cathelicidin-derived AMP, does it unfold its host of activities 
(Durr et al., 2006). 
 
Figure 6.4. A simplified representation of the only human cathelicidin 
hCAP18 (Durr et al., 2006). 
LL-37 is the only human cathelicidin-derived AMP, it belongs to the class of α-
helical AMPs. LL-37 owes its name to its 37 amino acid overall length with the 
two leading residues being leucines.  
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6.1.7 Presence of LL-37 in the human body 
LL-37 and its precursor, hCAP18, are found at different concentrations in very 
different cell and tissue types and body fluids, this probably reflects the fact that 
it acts not only as a peptide antibiotic but also as a signaling molecule. 
LL-37 was first described in 1995 by two separate teams, in the testis by 
Agerberth et al., (1995) and in leukocytes by Cowland et al., (1995). 
Subsequently LL-37 has been found to be constitutively expressed in many 
different tissues, cells and fluids in the human body. In general these seem to be 
epithelial lined areas that will have close contact with the environment such as 
the skin (Marchini et al., 2002), lung epithelia, (Bals et al., 1998), salivary glands 
(Woo et al., 2003) and colonic mucosa (Tollin et al., 2003) for example. Of 
particular interest to this study is the presence of LL-37 in wound and blister 
fluid (Frohm et al., 1996).  
LL-37 is up regulated in some disease states and down regulated in others. In a 
number of skin disorders such as psoriasis LL-37 is up regulated, but down 
regulated in both acute and chronic atopic dermatitis and there is an inverse 
correlation between severity of the disease and the level of AMP production 
(Ong et al., 2002). It has been postulated by Ong et al., (2002) that a deficiency 
in the expression of antimicrobial peptides may account for the susceptibility of 
patients with atopic dermatitis to skin infection with S. aureus. 
 
6.1.8 LL-37 expression 
At the cellular level, cathelicidins are most abundant in granules of neutrophils of 
(Turner et al., 1998); however, other cell types also express them, either 
constitutively or in an inducible manner. LL-37/hCAP18 is expressed by various 
epithelial cells and keratinocytes, (Dorschner et al., 2001, Frohm et al., 1999, 
Sorensen et al., 2003) as well as in monocytes, NK cells, B cells, and γδT cells 
(Agerberth et al., 2000), mast cells (Di Nardo et al., 2003), and eccrine glands 
(Murakami et al., 2002). Furthermore, LL-37 is induced in keratinocytes in 
response to inflammatory stimuli (Bals et al., 1998 and Frohm et al., 1997) or 
injury (Dorschner et al., 2001). Di Nardo’s work (2003) found not only the 
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presence of cathelicidins in human mast cells, but the expression could also be 
up regulated by bacterial components such as LPS or lipoteichoic acid.  
 
6.1.9 Cathelicidins and direct microbial activity. 
Ll-37 was initially recognised for its antimicrobial properties. It exhibits a broad 
spectrum of antimicrobial activity against bacteria, fungi, and viral pathogens, 
with microbicidal activity varying against different species and strains. It activity 
against Streptococcus, Staphylococcus aureus and Escherichia coli has been 
demonstrated by Dorschner el al., (2001). Bals et al., 1998 has shown its activity 
against Pseudomonas aeruginosa. In addition it is effective against Spirochaetes  
(Sambri et al., 2002) and Candida albicans (Larrick et al., 1995) as well as 
many other organisms. 
 
Nizet et al., (2001) provided some of the evidence for the antimicrobial 
properties of cathelicidin by creating knockout mice in which the gene coding for 
CRAMP, the mouse analogue of LL-37 was disrupted. These animals 
demonstrated diminished resistance to skin infections caused by Group A 
Streptococcus. With the finding of Ong et al., (2002) that in atopic dermatitis 
there is an inverse correlation between severity of the disease and the level of 
AMP production LL-37 seems to play an important defensive role in the skin due 
to its antimicrobial properties.  
LL-37 shows a strong binding affinity for lipopolysaccharides (LPS) (Turner et 
al., 1998). LPS form the outermost membrane leaflet of Gram-negative bacteria. 
Released from those bacteria in sepsis, LPS is called ‘endotoxin’ and causes 
adverse effects like septic shock by inducing the production of higher 
concentration of systemic pro-inflammatory cytokines. There is evidence that 
LL-37 can neutralize the biological activity of LPS by binding with it and may 
therefore have a protective role against gram-negative sepsis. 
Cirioni et al., (2006) used an animal model of gram-negative sepsis in which rats 
were given an intraperitoneal injection of Escherichia coli. The animals then 
received either LL-37 or antibiotics. Endotoxin and TNF-alpha plasma levels 
were significantly higher in conventional antibiotic-treated rats than in LL-37- 
and polymyxin B-treated animals.  
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6.1.10 Immunomodulatory functions of LL-37 
In addition to its antimicrobial activity LL-37 has also been found to be involved 
in the modulation of the inflammatory response. LL-37 can exert both pro- and 
anti-inflammatory effects and can mediate these effects either directly by 
stimulating cells or indirectly by modulating the cellular response to a particular 
cytokine or signal.  Alalwani et al., (2010) exposed human neutrophils were to 
LPS, Staphylococcus aureus and Pseudomonas aeruginosa subsequent to 
incubation with LL-37. The incubation with LL-37 significantly decreased the 
release of proinflammatory cytokines from stimulated human neutrophils as well 
as increasing the neutrophil generation of reactive oxygen species (ROS) and 
phagocytosis. 
LL-37 can promote the recruitment of inflammatory cells directly by stimulating 
leukocyte chemotaxis (Yang et al., 2001) or indirectly by inducing IL-8 release 
by bronchial epithelial cells and airway smooth muscle cells (Filewod et al., 
2009). LL-37 also induces IL-8, IL-18 and IL-20 production by human 
keratinocytes through MAP kinase pathway (Niyonsaba et al., 2005). 
Scott et al., (2002) used gene expression profiling to identify macrophage 
functions that might be modulated by LL-37. Their studies revealed that LL-37 
directly up-regulates 29 genes and down-regulated another 20 genes. Among the 
genes predicted to be up-regulated by LL-37 were those encoding chemokines 
and chemokine receptors. Consistent with this, LL-37 up-regulated the 
expression of chemokines in macrophages and whole human blood (monocyte 
chemoattractant protein 1 and IL-8), without stimulating the proinflammatory 
cytokine, TNFalpha. LL-37 also up-regulated the chemokine receptors CXCR-4, 
CCR2, and IL-8RB.  
Brown et al., (2011) suggested that the effect of LL- 37 could differ with the type 
of tissue macrophage examined. They found the potent inhibitory effect of LL-37 
was restricted to specific functions of classically activated (LPS or LPS/IFN-g) 
macrophages, (mainly TNF-a and NO production), but did not affect the ability 
of M1-BMDM (Bone marrow derived macrophages) to phagocytose and kill 
bacteria or the ability of M2-BMDM to phagocytose apoptotic neutrophils, 
events that are essential for wound healing and inflammatory resolution. 
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LL-37 has been found to have many other immunomodulatory effects and all 
these findings tend to indicate that LL-37 may contribute to the immune response 
by limiting the damage caused by bacterial products and by recruiting immune 
cells to the site of infection so that they can clear the infection. 
 
6.1.11 LL-37 and wound healing. 
LL-37 may also have a key role in wound healing. Koczulla et al., (2003) 
showed LL-37 induced angiogenesis, mediated by formyl peptide receptor–like 1 
expressed on endothelial cells, and in a rabbit model of hind-limb ischemia 
application of LL-37 resulted in neovascularization. Furthermore using mice 
deficient for CRAMP, the murine homologue of LL-37/hCAP-18, decreased 
vascularization during wound repair was shown. In the same year Heilborn et al., 
(2003) found that high levels of hCAP18 are produced in skin in vivo upon 
wounding. The highest hCAP18 levels are attained at 48 h post-injury, declining 
to pre-injury levels upon wound closure. hCAP18 was detected in the 
inflammatory infiltrate and in the epithelium migrating over the wound bed. In 
chronic ulcers, however, hCAP18 levels are low and immunoreactivity for 
hCAP18/LL-37 is absent in ulcer edge epithelium, which may be one of the 
factors responsible for their slow healing. 
 
6.1.12 Control of LL-37 expression in the skin 
Since it has been found that LL-37 is up regulated in response to bacterial skin 
infections and cutaneous mechanical disruption the mechanism that controls this 
has been sought. 
A number of studies have found that cathelicidin is a direct target of vitamin D3 
in keratinocytes (Wang et al., 2004 and Weber et al., 2005). On skin injury or 
bacterial infection, there is a local increase in expression of 1a-hydroxylase 
(CYP27B1), and as a direct consequence, more vitamin D3 is activated to induce 
cathelicidin expression and function (Schauber and Gallo 2008 A, Schauber and 
Gallo 2008 B). This may lead to therapies that can target the vitamin D3 pathway 
and thereby alter the response of LL-37 to infectious and inflammatory skin 
diseases. 
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6.2 AMPs in burn wounds 
6.2.1 Defensins in burns 
Studies of both the defensins and LL-37 have been limited in burn wounds. The 
first study looking at B defensins showed reduced anti-microbial peptide 
expression in human burn wounds. Milner and Ortega (1999) took samples of 
normal and burned skin from four patients with full thickness burns at time of 
wound excision and skin grafting. Total RNA was isolated and purified from the 
samples and then mRNA was subjected to reverse transcriptase polymerase chain 
reactions (RT-PCR) for hBD-1, hBD-2 and 2 control genes (ϒ-actin and 
cyclophilin) using specific primers. 
Their results showed that hBD-2 was present in normal skin but profoundly 
reduced in burnt tissues (1 patient had low hBD-1 in burnt and normal skin). 
HBD-1 expression was preserved in all the burn wounds and was identified in all 
normal skin samples (Milner and Ortega 1999). 
 
Using a different technique Milner identified hBD-2 protein in skin samples of 
partial and full thickness burns (6 patients) and normal skin using fluorescence 
deconvolution microscopy. 
Their study showed decreased hBD-1 staining in partial thickness burns 
compared to normal skin, but no hBD-2 staining in full thickness burns although 
there was some staining in a number of subcutaneous structures and reticular 
dermis, most notably in eccrine and apocrine gland acini (Milner et al., 2004). In 
a further study the same group looked at blister fluid from partial thickness 
burns. No hBD-2 was found in the burn blister fluids of the 5 patients’ analysed 
(Ortega et al., 2000) 
Bick et al., (2004) examined the effects of pro-inflammatory cytokines, 
interleukin-1 β(IL-1β), gamma interferon (IFNϒ) and tumour necrosis factor 
α(TNFα) on human β-defensin 2 levels in cultured keratinocytes as well as the 
effect of heat shock (at 42 c). Their results showed only TNFα showed 
significant induction of hBD-2 but that this was not sustained in the long-term. 
The endogenous levels of hBD-2 were significantly reduced by exposure to heat 
shock (Bick et al., 2004) 
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A further study looked at hBD-1, hBD-2 and hBD-3 in cultured keratinocytes 
and CSS (cultured skin substitutes) in uninjured donors and burn patients. They 
found that hBD-1 was expressed in all keratinocyte stains analysed. HBD-2 
expression in keratinocyte monocyte layers was highly variable but did not 
correlate with burn injury. HBD-3 was expressed at variable levels in all but one 
keratinocyte strain (Supp et al., 2004). Poindexter et al., (2006) found that after 
burns (of a depth that disrupted or destroyed most of the epidermis) HBD-1 was 
localized to dermal glandular structures and hair shafts but HBD-2 and HBD-3 
was found in the upper portions of the remaining keratin layers. They concluded 
that although the upper layers of skin are destroyed and disrupted by burn, cells 
in the lower portions of the skin could demonstrate an ability to synthesize most 
of the AMPs, and thereby maintain some barrier against infection.  
 
6.2.2 LL-37 in burns and trauma 
Kaus et al., (2007) examined LL-37 in addition to defensins in burn wounds. 
They found no differences in hCAP-18/LL-37 expression levels when comparing 
burned skin with healthy controls. Unburned sections of the wound edge 
however, showed a 10-fold decrease of mRNA levels of hCAP-18/LL-37 (p < 
0.05) compared with healthy and burned skin. The unburned skin was skin taken 
from adjacent to the burned skin and not from other parts of the body. 
Most of the analysed host defence peptides and proteins showed higher mRNA 
levels in partial-thickness burns than in unburned tissue. In situ hybridisation 
revealed expression of hCAP-18/LL-37, hBD2 and hBD3 at the surface of burns 
was independent of burn depth. They found however that higher host defence 
peptide gene expression rates did not correlate with the incidence of wound 
infection in burns.  
Lippross et al., (2011) examined the serum profiles of defensins, cathelicidins 
and pro-inflammatory cytokines post trauma and found that hBD-2, hBD-3 and 
LL-37 concentrations were significantly elevated after trauma and followed 
different characteristic concentration curves. In addition, similar patterns of 
concentration profiles were recorded for hBD-2/IL-6 and hBD-3/IFN-gamma.  
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6. 3 Aim 
To determine the presence of LL-37 in skin after a burn injury and subsequently 
in the healing phase, these samples will be compared with compared with 
normal, healthy controls firstly by immunohistochemistry and then rt PCR.  
LL-37 has been found in the serum of patients who have sustained trauma and 
developed sepsis. Concurrently with the skin samples blood samples will also be 
taken to determine the presence of serum levels of LL-37 by ELISA to see if 
there is any relationship with the size of the burn injury. Significant pro-
inflammatory cytokines will be also be measured at the same time as LL-37 to 
determine if there is any correlation between the molecules. 
LL-37 is known to have antimicrobial activity against many organisms. With 
growing antibiotic drug resistance LL-37 may have role to play as an alternative 
to treatment when conventional antibiotics do not work. The activity of LL-37 
against multi drug resistant strains of Acinetobacter baumannii that have been 
isolated from the burn ICU will be tested to determine if it may have useful 
clinical application. 
 
6.4 Methods 
6.4.1 Collection and preparation of clinical samples 
The Burns Service compromises twenty beds including four intensive care and 
four high dependency beds. There are twelve low dependency / rehabilitation 
beds. The unit is a tertiary referral centre and accepts patients from a population 
of over 6 million people. Patients are also taken from out of traditional catchment 
areas and occasionally internationally. 
A multidisciplinary team including microbiologists, pharmacists, anaesthetists 
and burn surgeons review all major burns daily. The Parkland formula is used in 
the initial resuscitation to maintain a urine output of 0.5 ml/kg/h in adults and 1 
ml/kg/h in children. Nutritional supplementation is via nasoduodenal enteral 
nutrition with high calorie, low fat formulas. As part of the burn treatment 
protocol, gastric ulcer prophylaxis is performed with H2 antagonists. Low 
molecular weight heparin (40mgs/day) is prescribed daily. Early excision and 
grafting is routinely performed for deep burns that would take more than two 
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weeks to heal without surgical intervention using allografting, auto-grafting or 
dermal substitutes depending on the individual characteristics of burn injuries.  
 
All research was carried out under Local Research Ethical Committee approval 
(North and Mid Essex Local Research Ethical Committee-Ref 04/Q0303/9) with 
approval from the local Research and Development Departments. All procedures 
were performed under written informed consent from the patients if the patients 
were conscious or from their parents when the patient was under the age of 
consent. If the patient was unconscious and unable to consent, ethical approval 
was granted to collect samples and gain consent when the patient was conscious. 
In the event of the patients death before gaining consent all samples for that 
patient were to be destroyed.  
Patients included in the study were those sustaining deep dermal or full thickness 
burns that required hospital treatment and admission.  
Exclusions were those patients with non-thermal processes including 
desquamating skin disorders, meningococcal septicaemia, necrotising fasciitis 
and purpura fulminans; patients who stayed in the ITU for less than 24 hours 
were excluded; patients who were transferred from other hospitals where 
treatment other than resuscitation had been commenced. Healthy controls were 
patients undergoing plastic surgery procedures such as abdominoplasty and 
breast reduction or procedures where a full thickness portion of skin would 
otherwise be discarded. 
Both sets of patients attended St Andrew’s Hospital for Burns and Plastic 
Surgery in Chelmsford, Essex. 
Skin samples 
Punch biopsies of 3 or 4mm diameter were taken from areas of deep dermal or 
full thickness burn at the time of operation. The burn was assessed clinically by 
appearance, its response to pressure and degree of sensation prior to the 
operation in those patients who were conscious before the operation. 
In patients who were unconscious prior to admission the burn was assessed by 
appearance and response to pressure.  
The first sample was taken on the day of the first operation; this (unless stated 
otherwise) was the day after admission in keeping with the unit policy of early 
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excision and treatment of deep dermal and full thickness burns. The samples 
were taken prior to any wound débridement or surgery or other wound 
manipulations bar removal of dressings. Subsequent punch biopsies were taken 
in the first week (typically days 3-6), the second week and the last sample at 21 
days or greater (or as close to these dates as possible). Once again these samples 
were taken prior to any wound manipulation. 
All punch biopsies were taken under sterile conditions and were sutured closed 
afterwards. The samples were placed in formaldehyde and processed into 
paraffin wax blocks for immunohistochemistry or frozen in liquid nitrogen until 
need for PCR work. 
Table 6.2 shows the details of the patients recruited to the study thus far. 
There were 21 patients in the burn arm of the study three of whom died whilst 
inpatients of the burns unit and before regaining consciousness. This means that 
although samples were gathered it was impossible to consent the patients. In 
accordance with Ethic Committee requirements these samples have been 
disposed of according to hospital policy and these patients are no longer in the 
study.  
Of the remaining 18 patients the male to female ratio is 13:5. The age range is 2-
77 with a mean of 27.3. The range percentage of burn (of total body surface area) 
was 1-46% with a mean of 20.38. 
The majority of the burns were caused by contact with flames (n=12) with 2 
scalds caused by hot water, 2 scalds caused by food (normally a combination of 
hot water and oil), one electrical flash burn and one caused by prolonged contact 
with hot metal (a cooker).  
There were 10 patients in the control arm of the study. The male to female ratio 
was 1:1. The age range was 37-86 with a mean of 58.1 years. 
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Burn 
patients 
Age in 
years 
Sex TBSA% 
Burn 
Mode of Injury Other 
B001 17 ♂ 4 Flame  
B002 77 ♂ 15 Flame  
B003     Died 
B004 2 ♀ 30 Scald  
B005 17 ♂ 3 Flame-petrol  
B006 3 ♂ 15 Hot fat  
B007     Died 
B008 32 ♂ 19 Flash –electrical 
burn 
 
B009 26 ♀ 40 Flame  
B010 3 ♂ 8 Scald  
B011 27 ♂ 46 Flame  
B012 33 ♂ 7 Hot oil/flame  
B013 60 ♀ 17 Flame  
B014 23 ♂ 18 Gas explosion  
B015     Died 
B016 42/12 
months 
♀ 22 Scald-oil  
B017 37 ♂ 44 Flame  
B018 18 ♂ 1% FT 
11% PT 
Flame-petrol  
B019 32/12 
months 
♂ 40 Scald-food/oil  
B020 53 ♀ 35 Flame  
B021 59 ♂ 3 Contact burn Hot metal, 
5 mins 
      
Non-burn 
control 
patients 
   Site of skin 
sample 
 
FT01 50 ♀  DIEP  
FT02 48 ♀  DIEP  
FT03 37 ♀  DIEP  
FT04 49 ♀  DIEP  
FT05 47 ♂  Arm  
FT06 70 ♂  Post auricular  
FT07 81 ♀  Pre auricular  
FT08 63 ♂  Pre auricular  
FT09 86 ♂  Supra clavicular  
FT10 50 ♂  Arm  
Table 6.2. Patients recruited to study LL-37 in human skin. The table shows 
the number of patients in both the investigation and control group who provided 
skin samples. For the patients in the burn group the TBSA% and mode of injury 
is also shown.  
 
 243 
6.4.2 Immunohistochemistry 
LL-37 
The paraffin sections were firstly deparaffinised and hydrated this was done by 
sequentially dipping the slides in the following solutions 
Xylene    2 x 5 minutes 
100% ethanol   2 x 3 minutes 
95% ethanol   1 x 3 minutes 
70% ethanol   1 x 3 minutes 
Excess endogenous peroxidases were destroyed by 15 minutes in 1:100 
Peroxide: Methanol bath followed by 
H20 (running tap)  1 x 15 minutes  
 
The slides were then microwaved at a high setting in citrate buffer (1L x 10 
3.78g Citric acid (monohydrate), 23.78g Tri-sodium citrate, 3.7g  EDTA di-
sodium salt pH to 6.0) for 5 minutes, the buffer solution was changed to fresh 
citrate buffer and the slides were micro waved for a further 5 minutes and 
allowed to cool for 20 minutes prior to a wash in H20 (running tap) for 5 minutes 
and then a TBS water bath for 10 minutes. (Tris Buffered Saline TBS (1 litre) 
80g NaCl, 2g KCl, 30g TRIS pH to 7.4 to make 1L x10) 
The slides were removed and the sample encircled with a PAP pen. 
Blocking solution was added to the samples and the slides before incubating the 
slides in the humidity chamber for 20 minutes. Blocking solution 10mls TBS, 
10µL 10% BSA (A8806, Sigma-Aldrich, Gillingham, Dorset, UK), 150µl goat 
serum (S-1000 Vector Laboratories, Peterborough, UK), 50µl human serum 
(from patient samples). The blocking solution was then removed and the sections 
were incubated with a rabbit anti-LL-37 polyclonal antibody (LL-37 PA-LL37-
100, Innovogen, Sweden) diluted 1:100 at room temperature for 1 hour. 
The slides were washed in TBS for 3 x 5 minutes and the secondary antibody 
applied (10mls TBS, 150µl goat serum, 50µl biotinylated anti rabbit serum). 
The slides were incubated at room temperature for 45 minutes. The slides were 
then washed in TBS for 15 minutes before application of the ‘ABC’ complex 
(Vectastain Elite Kit PK-6100, Vector Laboratories, Peterborough, UK). The 
slides then underwent a further 15-minute wash in TBS before application of 
DAB solution for 2 minutes and then another wash in TBS and H20 for 4 minutes 
each. The slides were counterstained with Mayer’s Haemalum (Mayer’s 
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Haemalum 350604 T, VWR, Belgium) before dehydration in the reverse process 
to that outlined at the beginning of the procedure. 
Once the slides were removed from the xylene they had a few drops of DPX 
applied to the tissue and a cover slip mounted. 
Controls included the substitution of primary or secondary antibody with TBS. 
The positive control Erythropoetin receptor, EPOR was processed using the same 
protocol. The EPOR has been used as a positive control in previous experiments 
and was kindly donated by Dr Alan Cruchley (Centre for Clinical and Diagnostic 
Oral Sciences). 
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6.4.3 Data analysis of LL-37 immunohistochemistry 
The staining data were analysed by visual assessment and quantitated by image 
analysis. Two observers visually assessed each slide, independently, and those 
showing positive staining were graded on a three-point equally weighted scale 
(+, ++ or +++) for staining in the basal layer and the suprabasal layers. A 
cumulative staining quotient (CSQ) was then calculated for LL-37, in normal and 
burn samples: 
Cumulative staining quotient (CSQ)= Number of (+) in all samples/Number of 
samples x 100 
Slides were photographed with a NanoZoomer 2.0-RS slide scanner (Hamamatsu 
Photonics, Hertfordshire, UK) and the images assembled using ADOBE 
PHOTOSHOP CS4 (Adobe Systems Inc., San Jose, CA, USA). 
For quantification of staining showing a different pattern in normal and burn 
samples, pixel analysis was performed on the digital images, using the technique 
described by Lalli et al., (2008) which is a modification of the approach 
described by (Elie et al., 2003). Photographs were taken at 100x magnification 
with identical optical and digital zoom camera settings. In PHOTOSHOP, the 
epithelium was carefully selected from the tissue section using the Lasso tool and 
the total pixel count in the selected area recorded from the Histogram palette 
(Fig. 6.5). A new image was created by cutting and pasting the selected 
epithelium and from this the basal and suprabasal compartments carefully 
delineated by the Lasso tool to give the pixel count for each segment of the 
epithelium. To separate brown DAB staining from the blue haematoxylin 
counterstain, a colour range selection was performed using the same sampled 
colour with RGB values of 193, 157 and 137, respectively, as confirmed in the 
Colour palette of the software. The RGB values were determined by the staining 
colour produced in the positive control. The range of colours selected was set to 
100 on the Fuzziness slider, which selects other parts of the image by the degree 
their colour is related to the sample colour. To confirm that all DAB-stained 
sections of the image were selected, these pixels were cut from the image to 
leave just the counterstained areas. Any DAB-stained areas remaining when the 
selected pixels were removed, for example, with very dark brown staining, were 
manually selected and employed for the evaluation using the Plus Eyedropper 
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tool of the software. The DAB pixel count in the basal and the suprabasal 
compartments of the epithelium was recorded and calculated as a percentage of 
the total basal or suprabasal pixel count (that will include DAB and 
haematoxylin).  
 
 
 
Figure 6.5. Quantitative analysis of 3,3’-diaminobenzidine (DAB)-
immunostained and haematoxylin-counterstained tissue images. (a) Original 
images imported into ADOBE PHOTOSHOP CS2 v9.0.2 (Adobe Systems Inc.), 
(b) with epithelium delineated and (c) DAB staining specifically selected or (d) 
haematoxylin counterstain selected by adjustment of ‘colour selection’ 
properties. (e) The pixel count of the selected area is given in the Histogram 
palette. (Lalli et al., 2008) 
 
6.4.4 Collection of Blood samples  
Blood samples were collected from arterial lines in burns patients in the intensive 
care unit or prior to any subsequent surgical procedure in theatre. Whilst on the 
wards or in the follow-up clinic venous blood was collected from the patients. 
The first sample was taken on the day of the first operation; this (unless stated 
otherwise) was the day after admission in keeping with the unit policy of early 
excision and treatment of deep dermal and full thickness burns. The samples 
were taken prior to any wound débridement or surgery or other wound 
manipulations bar removal of dressings. Subsequent blood samples were taken in 
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the first week (typically days 3-6), the second week and the last sample at 21 
days or greater (or as close to these dates as possible). Once again these samples 
were taken prior to any wound manipulation. All the blood samples were taken at 
the same time as the skin samples. 
For the healthy controls venous or arterial blood was collected whilst the patients 
were under a general anaesthetic undergoing their in-patient treatment. This was 
taken prior to any procedure starting.   
 
6.4.5 Isolation of plasma 
Blood samples were collected in Vacutainer blood bottles (Becton Dickinson, 
Oxford, UK), containing EDTA (Ethylenediaminetetraacetic acid). The blood 
was returned to the laboratory and spun down at 1000 rpm for 15 minutes as per 
the instructions from the ELISA kits (R&D Systems, Abingdon, UK and HyCult 
biotechnology, The Netherlands). The plasma (top layer) was removed and 
stored at -20o C prior to experimental use. 
 
6.4.6 Elisa Protocol for LL-37  
Elisa Protocol Assay procedure (HyCult biotechnology Human Elisa LL-37 
Kit HK 321) 
All reagents were brought to room temperature (20 - 25°C) before use. 
100µL of the sample or the standard (in duplicate) was added to each well. The 
plasma samples were diluted 20 times with wash/dilution buffer as per the 
protocol instructions. The plate was then covered and incubated for one hour at 
room temperature. The aspiration/wash was repeated four times with 200µL of 
wash/dilution buffer to each well. 100µL of diluted tracer was added to each 
well. The plate was then covered and incubated for one hour at room 
temperature. The washing procedure was repeated and 100µL of diluted 
streptavadin-peroxidase conjugate was added to each well. The plate was then 
covered and incubated for one hour at room temperature. The washing procedure 
was repeated and 100µL of TMB substrate solution was added to each well. The 
plate was then covered and incubated for thirty minutes at room temperature 
avoiding exposure to strong light. The reaction was stopped by adding 100µL of 
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stop solution to each well. The plate was read in a spectrophotometer with the 
absorbance measured at 450nm. All samples were tested in triplicate. 
 
6.4.7 Elisa Protocol IL-6, IL-8 and IFN-ϒ   
Commercial kits available from R&D Systems (Abingdon, UK) were used to 
measure IL-6 (DY-206), IL-8 (DY-208) and IFN-ϒ (DY-285) following the 
manufacturers protocol. However detailed below is a brief description of the 
method used.  The standard curves for the ELISA plates are shown in Appendix 
IV, section 2. 
 
Plate preparation 
The capture antibody was diluted to the working concentration∗ in PBS and 
100µmL were added per well to a 96-well microplate. The plate was sealed at 
incubated overnight at room temperature. In the morning each plate was 
aspirated and washed a total of three times with 400µL of wash buffer (Wash 
buffer 0.05% Tween 20 in PBS). 
Plates were then blocked by adding 300µL of reagent diluent to each well and 
incubating at room temperature for a minimum of an hour. (Reagent diluent 
0.05% tween with PBS) The aspiration/wash as before was repeated three times. 
 
Assay procedure 
100µL of the sample or standard** in reagent diluent was then added to each 
well. The plate was then covered and incubated for two hours at room 
temperature. The aspiration/wash was repeated as before. 
After the final wash 100µL of the detection antibody$ (diluted in reagent diluent) 
was added to each well. The plate was then covered and incubated for two hours 
at room temperature. The aspiration/wash was repeated as before. 
After the final wash 100µL of the working dilution of Streptavidin –HRP was 
added to each well. The plate was cover and placed out of direct sunlight for 20 
minutes. The aspiration/wash was repeated as before. 
After the last wash 100µL of substrate solution was added to each well.  The 
plate was cover and placed out of direct sunlight for 20 minutes. 
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Finally 50µL of stop solution was added to each well. The plate was tapped 
gently to ensure through mixing of the stop solution. 
The optical density was then determined using a microplate reader at 450 nm. 
Wavelength correction was available which meant readings taken at 570nm were 
subtracted from those taken at 450nm to correct for optical imperfections in the 
plate. All samples were tested in triplicate. The standard curves for each ELISA 
plate are found in Appendix IV. 
 
∗ Capture antibody 
IFN-ϒ 720µg/mL of mouse anti-human IFN-ϒ reconstituted with 1.0 mL of PBS. 
Diluted to a working concentration of 4.0µg/mL in PBS. 
IL-6 360µg/mL of mouse anti-human IL-6 reconstituted with 1.0 mL of PBS. 
Diluted to a working concentration of 2.0µg/mL in PBS. 
IL-8 720µg/mL of mouse anti-human IL-8 reconstituted with 1.0 mL of PBS. 
Diluted to a working concentration of 4.0µg/mL in PBS 
 
** Standard 
IFN-ϒ 30ng/mL of recombinant human IFN-ϒ when reconstituted with 0.5 mL 
of distilled water. A seven point standard curve using 2-fold serial dilutions in 
reagent diluent was performed. High standard 1000pg/mL. 
IL-6 70ng/mL of recombinant human IL-6 when reconstituted with 0.5 mL of 
distilled water. A seven point standard curve using 2-fold serial dilutions in 
reagent diluent was performed. High standard 600pg/mL. 
IL-8 100ng/mL of recombinant human IL-8 when reconstituted with 0.5 mL of 
distilled water. A seven point standard curve using 2-fold serial dilutions in 
reagent diluent was performed. High standard 2000pg/mL. 
 
$ Detection antibody 
IFN-ϒ 18µg/mL of goat anti-human IFN-ϒ reconstituted with 1.0 mL of Reagent 
Diluent. Diluted to a working concentration of 100 ng/mL in reagent diluent. 
IL-6 36µg/mL of goat anti-human IL-6 reconstituted with 1.0 mL of Reagent 
Diluent. Diluted to a working concentration of 200µg/mL in Reagent Diluent. 
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IL-8 3.6 mg/mL of biotinylated goat anti-human IL-8 when reconstituted with 
1.0 mL of Reagent Diluent. Dilute to a working concentration of 20 ng/mL in 
Reagent Diluent. 
 
 
6.4.8 PCR 
Extraction of RNA 
Homogenization 
The skin samples were homogenized with UltraspecTM (Biotecx, Houston, 
USA) RNA reagent (2ml per 0.1g of tissue).  
 
RNA Extraction 
The skin samples were homogenized by grinding them in a pestle and mortar in 
liquid nitrogen.  Once homogenised, 0.2 ml of chloroform was added (per 1 ml 
of UltraspecTM RNA), the samples covered, vortexed for 15 seconds and placed 
on ice at 4' C for 10 minutes. The homogenate was then centrifuged at 12,000 g 
(4 C) for 10 minutes (Beckman J2 centrifuge, GMI, USA). 
 
RNA Precipitation 
The aqueous phase was transferred to a new eppendorf and an equal volume of 
isopropanol was added the samples were then stored for 10 minutes at 4' C. The 
samples were centrifuged as before and the supernatant removed. 
 
RNA Wash 
The RNA pellet was washed twice with cold 75% ethanol (1 ml of 75% ethanol/l 
ml of reagent used) vortexed briefly and was subsequently centrifuged as before. 
At the end of procedure, the pellet was aired dried on ice for 30-60 minutes. The 
pellet was dissolved in 25ul of DEPC treated water. To ensure the RNA 
dissolved it was heated for 10-15 minutes at 55-60 C.  
 
TURBO DNase Digestion 
To clear any DNA contamination from RNA samples prior to RT-PCR the 
process outlined below was used as even a few copies of DNA can lead to false 
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positive outcomes by PCR. This process was performed using reagents supplied 
in the Turbo DNase kit produced by Ambion (Applied Biosystems, Carlsbad, 
California, Cat # AM1907). 
 
After defrosting the buffer, the mastermix was prepared combining DNase 
reaction components as shown below in table 6.3: (Buffer, DNase enzyme, 
RNase Out (optional) and/or H20). It was briefly mixed by vortex and the RNA 
sample added. 
 
Treatment 
Components 
X 1 reaction 
(µl) 
10X TURBO Buffer 5.00 
H20 8.00 
TURBO Dnase*  
( 2U /10ug RNA) 
 
1.00 
RNA (gDNA) 
sample 
36.00 
Total Rxn Vol 50.00 
*1 µl DNase (2U) removes maximum 2 µg genomic DNA in 50 µl rxn 
 
Table 6.3. Example calculation for 1 sample treated with the Turbo DNase 
mastermix. 
 
The resulting mastermix was placed on PCR heat block: 37oC, 30 min. When 
complete, the samples were taken off the heat block and 5µl of DNase 
Inactivation Reagent added (for a 50µl volume reaction). This was incubated for 
5 min at room temperature and then centrifuged at 10,000g for 1.5 min. The 
purified RNA, a clear fluid was removed taking care not to disturb the pelleted 
material. The RNA yield (ng/µl) was measured by absorbance at 260nm using 
NanoDrop® spectrophotometer (Thermo Fisher Scientific, Wilmington USA). 
The samples were stored at -70 C until required.   
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Reverse transcription protocol 
Reverse Transcription Reaction (First-Strand cDNA Synthesis) 
cDNA was obtained by reverse transcription using reagents supplied in the 
Promega reverse transcription system (Promega, Southampton, UK) shown in 
table 6.3. 
1µg (2µl) of total RNA was in a microcentrifuge tube, and incubated at 70°C for 
10 minutes, centrifuged briefly in a microcentrifuge, then place on ice. 
A 20µl volume of the following reaction was created by adding the following 
reagents in the order listed in table 6.4. The resulting solution was incubated at 
42°C for 15 minutes.  
The sample was heated at 95°C for 5 minutes, then incubated at 0–5°C for 5 
minutes then stored at -20oC until required. 
 
Component  Amount 
MgCl2, 25mM 4µl 
Reverse Transcription 10X Buffer  2µl 
dNTP Mixture, 10mM 2µl 
Recombinant RNasin® Ribonuclease 
Inhibitor 
0.5µl 
AMV Reverse Transcriptase (High 
Conc.) 
15u 
Oligo(dT)15 Primer 0.5µg 
Total RNA  1µg 
Nuclease-Free Water to a final volume 
of 
20µl 
 
Table 6.4. Master mix for one reverse transcription reaction. The above 
components were used to make the mastermix for one reverse transcription 
reaction. 
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Testing qPCR primer design and specificity 
Before qPCR analysis of LL-37 gene expression in skin samples it was necessary 
to confirm primer specificity. The forward (Fw) and reverse (Rw) primers for 
qPCR for L-37 were designed online to produce an amplification product 
<150bp in the primer design tool of the Roche Applied Science website  
(https://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp?id=UP030000).  
Primers were supplied by Sigma-Aldrich (Dorset, UK), see table 6.5 for 
sequences. 
http://www.sigmaaldrich.com/configurator/servlet/DesignCenter 
 
Primer name Primer sequence Primer Tm Product size 
LL-37_F TCGGATGCTAACCTCTACCG 60 oC  
LL-37_R GTCTGGGTCCCCATCCAT 60 oC 
PPIA_F TCATCTGCACTGCCAAGACTG 
 
66.6 oC  
71 bp 
PPIA_R CATGCCTTCTTTCACTTTGCC 65.7 oC 
 
Table 6.5 Primer sequences for LL-37 and the reference gene PPIA. 
 
Primers were tested for gene specificity by production of a single PCR product 
from RNA from hTERT cells supplied by Dr Eleni Pantazi (CDOS, QMUL). 
PCR was carried out using SYBR Green I Master Mix (5ml; LightCycler® 480 
SYBR Green I Master, Roche Applied Biosciences, Burgess Hill, UK) 
containing 30µl of 0.001% bromophenol blue (BPB; Table 6.6) in a 
LightCycler® 480 multi-well plate 96 (Roche Applied Biosciences). The plate 
was sealed with sealing foil and centrifuged for 10 seconds to allow through 
mixing at the bottom of the well. The plate was transferred to the LightCycler® 
LC480 and amplification carried out using the following protocol: 
1) Initial denaturation step to activate the Taq polymerase enzyme for 5 minutes 
at 95oC. 
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2) 40-45 amplification cycles consisting of a) double strand melting for 
10seconds at 95oC, b) annealing for 10 seconds at 60 oC and c) extension at 72 oC 
for 10 seconds with acquisition of the fluorescence signal. 
Reagent Volume per reaction well 
2X SYBR Green I Master Mix 20µl 
dH2O 20µl 
Template cDNA 5µl 
5 mM Fw/Rw Primer 7µl 
Total volume/well 50µl (+/-2µl) 
 
Table 6.6. PCR mixture using LC480 Sybr Green I. The above mixture of 
components was used to assess the specificity of primer pairs resulting in a single 
peak (i.e. a single PCR product). The Fw (forward) and Rw (reverse) pair (25µl 
each) of primers were from a 100µM stock solution dissolved in 450µl dH2O to 
give 5µM working strength (final concentration of primers in the 50µl mix was 
0.7µM). 
 
Following amplification, the number of PCR products in each well was 
determined by initial melting for at 95oC for 10 seconds, followed by x45 cycles 
of an annealing phase at 67 oC for 12 seconds and extention phase of 72 oC for 10 
seconds. The melting curve analysis should show a single narrow peak, 
indicating a single PCR product and therefore primer specificity. 
In order to determine DNA copy number of the purified amplicon (for creating a 
standard curve), the formula was completed which takes into account the length 
in base pairs (bp) and quantity of the DNA. First, the molecular weight (MW) 
was determined by multiplying the number of bp in the amplicon by 665 (which 
is the assumed average weight of a bair pair). The quantity of DNA (ng) was 
measured by Nanodrop® (260nm, Thermo Fisher Scientific, Wilmington USA) 
on 1 µl of sample and was incorporated into the formula below in order to 
determine DNA copy number. 
Formula:  [(ng/MW)/1x10^9] x 6.02x1023 molecules/mole = number of copies 
(per µl). 
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Determining the reference gene PPIA 
The housekeeping (reference gene) was determined using the Real Time ready 
Human Reference Gene Panel kit (Cat No. 05467675001 Roche, Burgess Hill, 
UK). The reference gene is used to normalize for possible variations in the 
amount and quality of RNA between different samples. The Real Time ready 
Human Reference Gene Panel allows quantification of the expression levels of 
19 human genes that can be used as reference genes. This panel can be assayed 
directly on a LightCycler® 480 Instrument. A reference gene is used to 
determine expression levels of other genes by relative quantification.  If one of 
the reference genes in the panel is expressed at a level similar to the gene being 
studied, it can be used for relative quantification of the gene. 
 
Three samples were used in the Reference gene panel kit an early burn, a healing 
burn and a control patient (unburnt skin). 
To perform the analysis the stock solutions from the kit were thawed, mixed 
carefully and stored on ice. The PCR mix for 96 reactions is detailed below, table 
6.7. 
Component Volume Final Conc. 
Water (PCR grade) 480 µl  
LightCycler 480 probes 
Master, 2x conc 
960 µl X1 
Total volume 1440 µl  
Table 6.7 PCR mix for 96 reactions in the Real Time ready Human 
Reference Gene Panel 
The solution was mixed carefully by pipetting only. 15µl was placed into each 
well of the LightCycler 480 Multiwell Plate. 5µl of the cDNA template was 
placed into each well (except well H12 which contained the negative control, 5 
µl of the untranscribed RNA was placed in well H12). The plate was sealed and 
with sealing foil and centrifuged for 2 minutes at 1500 x g. The plate was 
transferred to the LightCycler 480 and the programme started. The run protocol 
was imported directly into the LightCycler 480 software via the Roche website 
http://www.roche-applied-science.com. 
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geNorm analysis was performed on the results. geNorm is an algorithm to 
determine the most stable reference (housekeeping) genes from a set of tested 
candidate reference genes in a given sample panel. From this, a gene expression 
normalization factor can be calculated for each sample based on the geometric 
mean of a user-defined number of reference genes. This data was analysed using 
Biogazelle qbasePlus, which incorporates the geNorm program (Biogazelle, 
Zwijnaarde, Belgium). The geNorm software ranks the reference (house-
keeping) genes in order of stability of expression (see appendix IV section 3 for 
results). Melting peak and standard curves for genes analysed Appendic IV, 
figure 4and figure 5. 
Reference gene work was performed by Tanya Novak. 
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6.4.9 The activity of LL-37 against Acinetobacter baumannii-
determining the MIC and LD 50. 
 
Minimum inhibitory concentrations (MICs) are considered the `gold standard’’ 
for determining the susceptibility of organisms to antimicrobials and are 
therefore used to judge the performance of all other methods of susceptibility 
testing (Andrews 2001). Minimum inhibitory concentrations (MICs) are defined 
as the lowest concentration of antimicrobial that will inhibit the visible growth of 
a microorganism after overnight incubation. The minimum bactericidal 
concentration (MBC) is the lowest concentration that kills 99.9% of the 
population (Collins et al., 2004). The term half maximal effective concentration 
(EC50) refers to the concentration of a drug or antibody, which induces a 
response halfway between the baseline and maximum after some specified 
exposure time. It is commonly used as a measure of drug's potency. 
The range of antibiotic concentrations used for determining MICs is normally 
performed in doubling dilution steps, up and down from 1 mg/L as required. 
Although the MIC is defined as the lowest concentration of a drug that will 
inhibit the visible growth of an organism after overnight incubation, this period 
is extended for organisms such as anaerobes, which require prolonged incubation 
for growth (Andrews 2001). The protocol used followed the method of Chromek 
et al., (2006) using a microtiter plate method (modified according to The 
Swedish Reference Group for Antibiotics- subcommittee on methodology, 
www.srga.org). 
 
Preparation of antibiotic dilution range and MIC broth 
LL-37 peptide (SP-LL37-1 Innovogen, Sweden) was diluted in 0.1% 
trifluoroacetic acid and a peptide range of concentrations was produced from 
2µM to 32µM. 
The organism suspension was prepared by growing the bacteria on ISO-Sensitest 
Agar (CM0471, Oxoid Basingstoke, UK). Four or five colonies of pure culture 
(to avoid selecting an atypical variant) were then suspended in 10 ml of Mueller 
Hinton broth (CM0405 Oxoid Basingstoke, UK). This was grown overnight and 
the resulting solution was diluted to produce an inoculum of 105 cfu/ml. Using a 
96 well plate the bacterial suspension (90µl) was grown in the presence of 
 258 
different concentrations of the peptides diluted in 0.1% trifluoroacetic acid 
(10µl). As a control both inoculated and uninoculated wells of antibiotic-free 
broth were included on the plate (the first controls the adequacy of the broth to 
support the growth of the organism, the second is a check of sterility). Each 
inoculum was in duplicate and the experiment repeated three times. The plates 
were covered with sealing tape and incubate at 35-370C for 18-20 h in air.  The 
MIC endpoint was the lowest concentration of antibiotic at which there is no 
visible growth. The control strain of bacteria used was Pseudomonas aeruginosa 
(supplied by Dr R Wade). This was chosen because the MIC for the control 
strain should be within one two-fold dilution of the expected MIC for the 
bacteria being tested. All of the Acinetobacter baumannii samples were supplied 
by Dr Jane Turton, (Laboratory of HealthCare Associated Infection, Centre for 
Infections, Health Protection Agency, Colindale, UK). They are all multi 
resistant strains isolated from the unit and at the time of the study prevalent in a 
number of hospitals and critical care units in the south east of England. The 
strains used were Southeast Clone AB 11, Southeast Clone AB 12 and Oxa 23 
Clone 2. (See Appendix IV, section 1 for the dendrograms). 
EC50 was determined by analyzing plated serial dilutions of the bacteria-peptide 
Acinetobacter baumannii solutions (in Mueller Hinton broth) on ISO agar plates 
after 60 minutes of growth. 
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6.5 Results 
 
6.5.1 Immunohistochemistry 
 
The presence of LL-37 was determined in skin samples of patients on the first 
day after admission to a burn ICU. 
 
The positive control tissue was salivary gland tissue where it has been shown that 
LL-37 can be demonstrated in the ducts (Woo et al., 2003). 
 
A.      B.  
 
 
C.      D. 
 
 
 
Figure 6.6. LL-37 in salivary gland tissue. Panel A demonstrates the presence 
of LL-37 (1:100) in the ductal tissue. Panel B is the negative control with no 
primary antibody. Panel C shows EPOR staining of the ductal tissue (1:500). 
Panel D is a skin sample with no primary antibody (all pictures magnification 
x200). 
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To ensure the protocol for immunohistochemistry worked, salivary tissue was 
tested with an antibody known to be present in salivary glands, EPOR (supplied 
by Dr Alan Cruchley, CDOS) shown in Figure 6.6, Panel C. The LL-37 antibody 
has also been found in the salivary glands and these tissue samples were used as 
a positive control when all of the skin samples were analysed. Panel D 
demonstrates that there was no staining present when the primary antibody was 
not used in both salivary tissue and skin.  
 
 
A.     B.  
 
C.     D.  
 
       
Figure 6.7 The presence of LL-37 in skin samples. Panel A LL-37 in normal 
unburnt skin. Panel B shows LL-37 in a burnt skin sample taken on day 1 after 
admission to the burn ICU. Panel C shows a tissue sample taken a few days after 
surgery where the burnt skin has been tangentially excised and a split thickness 
skin graft has been placed. Panel D demonstrates the positive staining seen in a 
healing grafted area 46 days after the initial injury (magnification x 200). 
 
In figure 6.7 panel A shows there is staining through out the epidermis but the 
greatest concentration is in the more superficial layers. Panel B demonstrates the 
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destruction of the epidermis with an ill-defined layer above the dermis with loss 
of the normal architecture of the epidermis. There is scattered staining 
throughout his layer. Panel C shows recently grafted tissue. The epidermis is 
only a few cells in height and yet the upper layers show some marked positive 
staining. Finally panel D is a healed grafted area with a thick epidermis, possibly 
showing some hyperproliferation. The staining is more like the control samples 
with less basal staining and increased staining more superficially.  
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A.      B.  
 
 
Figure 6.8 The presence of LL-37 in the dermal adnexal structures. Panel A, 
A hair follicle in transection. Panel B Sebaceous gland (magnification x200). 
Figure 6.8 shows positive staining in deeper dermal structures. 
 
The burnt skin samples of day one invariably had the majority of the epidermis 
destroyed with variable amounts of the dermis. In general there was minimal 
positive staining due to LL-37 in the epidermal remnants but it was often found 
that there was some positive staining on the surface of the resultant wound. This 
echoes the findings of Kaus et al., (2008) who through detection of hCAP-
18/LL-37 mRNA by In situ hybridisation determined that the LL-37 was 
localised to the wound surface in burns. The areas of LL-37 they detected were 
located in the cytoplasm of the remaining intact cells, whereas the majority of the 
surrounding cells were disrupted. 
 
In the healthy controls, LL-37 was observed throughout the epidermal layer from 
the stratum basale, throughout the stratum spinosum and corneal layers. This 
contrary to many other studies that have found little or no LL-37 in the skin of 
the normal, healthy, controls (Frohm et al., 1997).  
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Figure 6.9. Correlation between visual assessment grading and image 
analysis. Healthy controls labeled 1-10 and burn samples coded for individual 
patients on the day 1. The blue line represents image analysis and shows the 
number of positively stained pixels (as seen on the left sided y-axis). The red line 
represents visual assessment as determined by CSQ (as seen on the right sided y-
axis). There is close correlation between visual assessment grading and image 
analysis of 3,3’-diaminobenzidine immunostaining for LL-37 in the samples of 
burnt skin and control healthy patients on day one (r=0.69). 
 
In an attempt to quantify the amount of staining present the CSQ (Cumulative 
Staining Quotient) was utilized as described by Lalli et al., (2008). 
Quantification in this manner permitted use of the Mann–Whitney U-test to 
determine statistically significant differences in the DAB staining between 
normal and diseased samples. The validity of the pixel analysis was confirmed 
by correlation coefficient r = 0.69 (P < 0.005; Figure 6.9) with our visual 
assessment grading, even with all non-stained remnants of the epithelium 
disregarded. Figure 6.9 is used to give as a visual aid to demonstrate the close 
correlation between the visual assessment grading and the image analysis. The 
same graph as used by Lalli et al., (2008) has the data points connected to make 
this visual aid clearer as in reality the data points are not connected. This graph 
was chosen over a histogram because it makes the correlation clearer. Because of 
0
10
20
30
40
50
60
70
80
90
b0
02
/0
1
b0
05
/0
1
b0
08
/0
1
b1
0/
01
b1
2/
01
b1
4/
01
b1
7/
01
b1
9/
01 1 3 5 7 9
Patient
P
o
s
ti
v
e
ly
 s
ta
in
e
d
 p
ix
e
ls
 (
%
)
0
0.5
1
1.5
2
2.5
3
3.5
C
S
Q Pixels %
 CSQ
 264 
the difference in units between the image analysis and visual grading scale it is 
not so easy to appreciate the correlation when looking at a histogram. 
 
 
Figure 6.10. Percentage of positively stained pixels in the skin samples. This 
graph demonstrates the percentage of positively stained pixels in the skin 
samples in both the basal and suprabasal layers of the epidermis over time 
compared with the control group.  
 
It must be noted when examining the data in figure 6.10 that for the day one burn 
sample the epidermis has been variably destroyed and it is difficult to 
differentiate the layers of the epidermis. The surface staining therefore reflects 
the amount of staining above the dermis. This staining may represent LL-37 that 
has been released from the cells due to the thermal damage (as found by Kaus et 
al., 2008) or non-specific staining of denatured proteins. In addition at day three 
the skin graft does not have a clearly defined basal layer so the deepest layer of 
skin graft was considered the basal layer. 
The LL-37 staining in the samples of the burn patients taken in the subsequent 
time periods showed a mixed pattern of distribution but consistently had reduced 
LL-37 in both the basal and supra basal areas compared with the control patients 
(see figure 6.10). As time progressed there was a gradual increase in the amount 
of LL-37 staining (both basal and supra basal) although it never reached the 
amounts seen in the healthy controls.  
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6.5.2 qPCR 
The reference gene PPIA (peptidylprolyl isomerase A) was present in all the 
samples. The raw data is show in Appendix IV, section 4 with the melt point, 
amplification and standard curve graphs for both PPIA and LL-37.  
 
Figure 6.11. The number of patients with LL-37 detected in the skin sample 
by rtPCR. The data shows the number of patients with LL-37 detected in their 
sample on each day of analysis. In total there were 42 burn patient samples and 
six control patient samples for the LL-37 analysis. For day 1 there were 17 
samples, for day 3 there were 11 samples, for week two 9 samples, for over week 
two 5 samples and six control samples. 
 
LL-37 was detected in only twenty of the 48 patient skin samples analysed. 
Figure 6.11 suggests that LL-37 expression was more frequent in the earlier 
stages i.e. day 1 the acute burn, and in the immediate post-admission period. 
There appears to be a trend showing expression decreasing during the healing 
time towards levels seen in the control patients. An Anova analysis of the data 
shows there is no statistical difference in the patient samples, p=0.054. This 
result may not be accurate however. Firstly the total population size is small and 
sample size within each group is small. Drawing any firm conclusions from the 
statistical analysis is likely to be flawed. However looking at the raw data may 
allow some basic ideas about the results. Looking at the raw data (Appendix 4) 
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shows that only two of the patients showed a significant amount of LL-37 (one a 
burn patient on day three after the burn and one in a patient over three weeks 
after the burn injury). 15 patients had only one positive result out of the samples 
run in triplicate. Two patients had two positive results out of the three samples. 
Only one patient had three positive results.  
 
In these 18 patients there are weak reactions that may indicate minimal amounts 
of nucleic acid. In a real time PCR assay a positive reaction is detected by 
accumulation of a fluorescent signal. The cycle threshold (Ct) or crossing point 
(Cp) is defined as the number of cycles required to reach a defined fluorescence 
intensity or for the fluorescent signal to cross the threshold (i.e. exceeds 
background level). Ct levels are inversely proportional to the amount of target 
nucleic acid in the sample (i.e. the lower the Ct level the greater the amount of 
target nucleic acid in the sample). Normally Cts < 29 are strong positive 
reactions indicative of abundant target nucleic acid in the sample. Cts of 30-37 
are positive reactions indicative of moderate amounts of target nucleic acid but 
Cts of 38-40 are weak reactions indicating minimal amounts of target nucleic 
acid, which could represent an infection state or environmental contamination. 
The Cts for the two samples with large amounts of nucleic acid were between 
21-24 whilst for the remaining 18 patients not only in the majority of these cases 
did only one sample out of the three test positive but with Cts between 38-40 it is 
possible that these results are due to contamination.  
 
 
  
 267 
6.5.3 Serum levels of LL-37 and proinflammatory cytokines 
 
 
 
Figure 6.12 Box plot graph of serum levels of LL-37. The data show the serum 
levels of LL-37 at varying time periods compared with the control group. The 
length of the box covers the interquartile range, the lower edge of the box being 
the lower quartile, and the upper edge of the box being the upper quartile. The 
line across the box is at the median. The whiskers extending beyond the box go 
to the extremes of the data. There is no difference between the LL-37 levels in 
the serum on day 1 compared with the controls (p=0.18), Mann U Whitney. 
 
It can be seen in figure 6.12 that the serum LL-37 levels are very low with a wide 
range in values in the samples taken on day 1 of admission to the unit. It can be 
seen that during the period of study from acute injury throughout the healing 
period that the LL-37 levels are depressed compared with the control subjects. 
Specifically there is no significant difference between the control group and the 
admission values (p-0.18, Mann U Whitney). Analysis of all the groups show 
there is no statistical difference between any of the groups (p=0.054 Anova). 
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Figure 6.13 Box plot graph of serum levels of IL-8. The data show the serum 
levels of IL-8 at varying time periods compared with the control group. The 
length of the box covers the interquartile range, the lower edge of the box being 
the lower quartile, and the upper edge of the box being the upper quartile. The 
line across the box is at the median. The whiskers extending beyond the box go 
to the extremes of the data. There is no difference between the IL-8 levels in the 
serum on day 1 compared with the controls (p=0.16), Mann U Whitney. 
 
Each group in figure 6.13 shows a wide range in the values which given the 
small sample size means any interpretation of the results should be done with 
caution. Statistically there is no difference between any of the groups (p=0.096 
Anova), however the broad trend of IL-8 levels in the serum post injury seem to 
be slightly elevated levels in the acute stage after injury and then a rise in levels 
over the next two weeks. There is a gradual return towards normal levels (control 
group) as time passes. There is no difference between the serum IL-8 values on 
day 1 and the control group (p=0.16), Mann U Whitney. 
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Figure 6.14 Box plot graph of serum levels of IL-6. The data show the serum 
levels of IL-6 at varying time periods compared with the control group. The 
length of the box covers the interquartile range, the lower edge of the box being 
the lower quartile, and the upper edge of the box being the upper quartile. The 
line across the box is at the median. The whiskers extending beyond the box go 
to the extremes of the data. There is no statistical difference between the groups 
(p=0.31 Anova). 
 
Figure 6.14 shows that IL-6 serum levels are slightly elevated in the first two 
weeks after a burn injury but fairly rapidly return towards normal levels by week 
three. There is no difference however, between the IL-6 levels in the serum on 
day 1 compared with the controls (p=0.0537), Mann U Whitney.  The wide range 
of results that are seen in the first two weeks are due to a small number of 
patients having very high values and suggests that these patients may have 
another inflammatory process, such as sepsis going on. Further more there is no 
statistical difference between any of the groups (p=0.31 Anova). 
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Figure 6.15 Box plot graph of serum levels of IFN-gamma at selected time 
periods post injury. The data show the serum levels of IFN-gamma at varying 
time periods compared with the control group. The length of the box covers the 
interquartile range, the lower edge of the box being the lower quartile, and the 
upper edge of the box being the upper quartile. The line across the box is at the 
median. The whiskers extending beyond the box go to the extremes of the data. 
There is no difference between the IFN-gamma levels in the serum on day 1 
compared with the controls (p=0.0582), Mann U Whitney. 
 
Again, with the box plot graphs the small sample group must be borne in mind 
when trying to infer from the results but figure 6.15 shows a broad trend of IFN-
gamma being suppressed in the acute stage and gradually returning towards 
normal levels as time passes despite this there is no difference between the 
groups compared with the control group (p=0.17 Anova). 
 
The relationship of LL-37 and proinflammatory cytokines to TBSA% burn  
As LL-37 has been found to be elevated after multiple trauma (Lippross et al., 
2011) LL-37 and the proinflammatory cytokines were examined to see if there 
was any relationship with the magnitude of injury (defined by TBSA % burn). 
There is no relationship between the TBSA % and the serum levels of IL-6 and 
IFN-gamma and that there may be a weak association between TBSA % and IL-
8 levels in this sample group (Results in Appendix IV, section 6 tables 6 A-D). 
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The relationship between serum levels of LL-37 and cytokines with age  
 
As age can have an influence on the inflammatory response (Nomellini et al., 
2009) the serum levels of LL-37 IFNγ and the proinflammatory cytokines IL-6 
and IL-8 were examined to see if a relationship existed that might have 
influenced our results.  
No relationship was found between age and serum levels of any of the molecules 
examined (Results in Appendix IV, section 5 tables 5 A-D).     
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6.5.4 Minimum inhibitory concentrations of LL-37  
To determine whether LL-37 might have an effect on drug resistant 
Acinetobacter baumannii the minimum inhibitory concentrations were examined 
after an overnight growth of the organisms. Three strains of Acinetobacter were 
investigated, Southeast Clone AB 11, Southeast Clone AB 12 and Oxa 23 Clone 
2. All three strains had been isolated in the unit and a number of other ICUs in 
the south east of England. They were all multi-drug resistant and were perceived 
to be difficult to eradicate (Personal correspondence, Dr L Teare, Broomfield 
Hospital, Essex and Dr J Turton, Health Protection Agency, Colindale, UK). The 
control had no LL-37.   
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A. 
 
B. 
 
Figure 6.16.  Minimum inhibitory concentrations for Acinetobacter 
Baumannii Southeast Clones AB11 and AB 12. 
A. Southeast clone AB11, B. Southeast Clone AB 12.  
 
Figure 6.16 shows that the MIC was 8µM (which corresponds to 36 g/ml LL-37) 
for both Southeast clones, AB 11 and AB 12. The time overnight culture was for 
a total of 16 hours. It can be seen that for both samples a concentration of 4µM 
appeared to inhibit bacterial growth but not ultimately stop it.  
0
0.2
0.4
0.6
0.8
1
1.2
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49
Time (in hours)
O
p
ti
ca
l 
d
e
n
si
ty LL-37 32uM
LL-37 16uM
LL-37 8uM
LL-37 4uM
LL-37 2uM
Control
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49
TIme (in hours)
O
p
ti
ca
l 
d
e
n
si
ty LL-37 32uM
LL-37 16uM
LL-37 8uM
LL-37 4uM
LL-37 2uM
Control
 274 
 
 
A. 
 
B.  
Figure 6.17.  Minimum inhibitory concentrations for Acinetobacter 
Baumannii (Oxa 23 Clone 2) and Pseudomonas Aeruginosa.  
 
Figure 6.17 shows that the MIC was 8µM for Oxa 23 Clone 2 and 16µM for 
Pseudomonas Aeruginosa. Again it can be seen that for the Acinetobacter 
species a concentration of 4µM appeared to inhibit bacterial growth although in 
this case growth was minimal and only at the end of the study period and could 
represent a contaminant as well as inhibited Acinetobacter growth. 
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6.5.5 Determining the EC50 for LL-37 against Acinetobacter 
Baumannii 
A way of giving some idea of the potency is to test the EC50. This refers to the 
concentration that induces a response halfway between the baseline and 
maximum after some specified exposure time.  
EC50 was determined by analyzing plated serial dilutions of the bacteria-peptide 
Acinetobacter baumannii solutions on ISO agar plates after 60 minutes of 
growth. The numbers of colony forming units were counted after incubation. 
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C. 
 
  
Figure 6.18 EC50 for the three strains of drug resistant Acinetobacter 
baumannii with EC 50 shown on graph. The data shows the EC50 for the three 
strains of Acinetobacter baumannii. Graph A. demonstrates Southeast Clone AB 
11, with an EC50 <6µM, graph B shows Southeast Clone AB 12 (EC50 6µM) and 
graph C. Oxa 23 Clone 2 (EC50 4µM).  
 
It can be seen in figure 6.18 that after 60 minutes of incubation of the bacteria-
peptide solution a concentration of 6µM was sufficient to reduce the number of 
colony forming units by half. LL-37 is more effective against Acinetobacter than 
Pseudomonas as the EC50 for Pseudomonas was 10µM (results not shown) 
under the same conditions in our study. 
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6.6 Discussion 
In mammals, two forms of immunity have evolved. The first, the innate system is 
non-clonal and non-specific and the second is adaptive and antigen specific. 
Antimicrobial peptides (AMPs) are part of the innate system and make up one of 
the most ancient defence systems within the animal and plant kingdoms. 
A growing number of AMPs have been found to play a role in the defence of the 
human skin. LL-37 is the only human cathelicidin-derived AMP; it belongs to 
the class of α-helical AMPs.  
First found in the testis (Agerberth et al., 1995) and in leukocytes by Cowland et 
al., (1995), it has subsequently been found to be constitutively expressed in many 
different tissues, cells and fluids in the human body. In general these seem to be 
epithelial lined areas that will have close contact with the environment. 
As well as having direct antimicrobial properties, LL-37 also displays a range of 
immunomodulatory functions as well as being involved in neovascularization 
and epithelial wound healing. 
Its role in the defence of skin is particularly important, as in conditions where 
LL-37 has been down regulated (acute and chronic dermatitis) there is an inverse 
correlation between severity of the disease and the level of AMP production 
(Ong et al., 2002). 
In burn patients not only has the protective mechanical barrier been disrupted but 
the immunomodulatory response has also been modulated making the patients 
susceptible to infection. The role of LL-37 in burn patients is not clear and the 
studies limited. 
 
By immunohistochemistry this study has shown that LL-37 is present in the 
acute and healing burn wound. Like Kaus et al., (2008) LL-37 was shown at the 
surface of burned tissue (Panal 6.7, Picture B). In their study this was 
independent of burn depth. Our sample size was too small to draw any clear 
statistical conclusions but it was noted that if the whole of the epidermis was 
destroyed there was minimal LL-37 at the surface but even a small layer of 
epidermal remnants seemed to be associated with more LL-37 at the surface. 
This may be because the integrity of the cell wall has been disrupted by the 
thermal injury thereby allowing release of LL-37 to the wound surface. Few 
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studies have been conducted into other skin AMPs and it would be interesting to 
compare LL-37 with other defense peptides found in the skin. 
Unlike other studies (Frohm et al., 1997) we found significant LL-37 in the 
healthy control patients. The reasons for this are unclear but could be due to the 
way in which the samples were collected. The speed in which LL-37 may be 
released is unknown and it could be that in the process of taking a punch biopsy 
and processing the sample some signaling and transcriptional factors may have 
been induced. As a result an increase in LL-37 levels may be seen. This would be 
true for both the control patients and the burn patients. Because the samples had 
to be transported from Chelmsford to London it may have allowed more time for 
signaling and transcriptional factors have been induced compared with other 
studies which may have been able to process their samples quicker. 
Furthermore our data may not reflect the true level of LL-37 in ‘‘quiescent’’ 
normal skin. Unique phenotypes and variable responses to environmental stimuli 
mean that differential gene expression exists between individuals. This may 
manifest as different levels of LL-37 under the same conditions. For instance 
different patients may show a different response (i.e. release of LL-37) to the 
same stimuli (such as a punch biopsy) under the same conditions (an operating 
theatre). Such a small sample size is prone to pick up errors due to normal 
variation in normal skin, which may lead to false positive or false negative 
conclusions about affected tissue samples. Steps to reduce the variability include 
faster and more consistent processing or larger sample sizes to average out the 
results. A way to examine differential gene expression between individuals 
would be to take two samples from each patient, one of burned skin and a tissue 
sample of unaffected skin (a control sample). This may help elicit some of the 
variability between individuals however as Kaus et al., (2008) demonstrated, LL-
37 levels were increased in non burnt tissue adjacent to the burn wound. Control 
samples would have to be taken from areas distant to any injury, which would 
involve scarring in a previously uninjured area (which may not be popular with 
patients). 
To try and quantify the amount of staining seen, both the CSQ and total pixel 
count was used (as described by Lalli et al., 2008). Both visual assessment and 
pixel count showed good correlation with each other (correlation coefficient r = 
0.69, P < 0.005; Figure 6.9). Figure 6.10 shows how the pixel count of positive 
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staining stained varied over time and showed that the LL-37 in the skin samples 
was initially low and gradually increased through the healing period. It is unclear 
how long it would take for levels to return to normal values.  
From this result one might postulate that systemic LL-37 levels may also be 
depleted. 
Serum samples of LL-37 also appear to be reduced in the acute phase and 
healing period (figure 6.12). The trend appears to suggest that LL-37 increases as 
time goes on towards that of the control patients; however statistically there is no 
difference between the expression on day 1 and the control patients. Whist this 
may be a true finding with a small sample size firm conclusions cannot be made 
about the results.   
In addition, like the work of Poindexter (2005) we found LL-37 tended to be 
found in the upper epidermal layers, especially the stratum corneum. Figure 6.10 
shows most of the staining is suprabasal (clearly so in the control patients). In the 
early healing phases when skin has been grafted there is not a well-defined basal 
layer until later when the skin graft cells start proliferating and differentiating. 
Therefore the suprabasal layer staining that is seen may just reflect the transfer of 
the LL-37 in the skin graft rather than a change in the levels due to the injury. 
One way of determining this may be to try and define keratinocyte expression 
throughout the healing period to match keratinocyte activity to LL-37 levels. 
 
As figure 6.8 shows LL-37 was also found in adnexal structures such as hair 
follicles and sweat glands. This confirms the work of Poindexter (2005) who has 
shown that other AMPs were present in dermal structures such as human beta 
defensin-1 in hair shafts; human beta defensin-2 and human beta defensin-3 in 
the glands of the lower dermis and LL-37 was evident in very high 
concentrations in the epithelium of sweat ducts. 
The rt PCR showed significant results in only two of the samples (one a burn 
patient on day three after the burn and one in a patient over three weeks after the 
burn injury).  
In another 18 patients there are weak reactions that may indicate minimal 
amounts of nucleic acid. Normally Cts < 29 are strong positive reactions 
indicative of abundant target nucleic acid in the sample. Cts of 30-37 are positive 
reactions indicative of moderate amounts of target nucleic acid but Cts of 38-40 
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are weak reactions indicating minimal amounts of target nucleic acid, which 
could represent an infection state or environmental contamination. As in the 
majority of these cases only one sample out of the three tested was positive it is 
possible that this is due to contamination. 
There are a number of reasons for the PCR results. Firstly the processing of the 
samples may have influenced the results. When looking at the results in more 
detail it was clear that the two samples with a highest yield of nucleic acid were 
those that had the best yield of RNA (ng/µl) determined by measuring the 
absorbance at 260nm using NanoDrop® spectrophotometer. Most of the 
remaining samples had 260/280 ratios < 1.6, as determined by NanoDrop® 
spectrophotometer. This can be an indication of incomplete extraction or 
inefficient isolation. No yield or a small yield may be expected in the acute burn 
samples where the tissue and protein destruction is so great that all genomic 
material is destroyed but the poor yields in the healing wounds and control 
samples suggest that the processing could be a contributing factor. One part of 
the process where this is possible is the homogenization of the samples. Skin has 
evolved to withstand substantial shearing forces and as such trying to grind a full 
thickness sample may result in incomplete sample disruption (Berglund et al., 
2006). The difficulty in disrupting the sample sufficiently also increases the risk 
that the sample will thaw. A study by Ambion (Tech notes 9.3) has shown that 
samples that are allowed to thaw result in more RNA degradation. Slow 
processing may allow endogenous RNases released internally resulting in RNA 
degradation.  Another potential influence is the timing of the sample acquisition. 
Due to logistical reasons there was sometimes a delay in freezing the samples of 
over an hour. A study by Cole et al., (2001A) demonstrated how important 
timing of sample collection is to the final result. They collected samples of 
normal and injured skin from healthy patients undergoing surgery. Specimens 
were obtained at 30 minutes and 1 hour after the initial injury. RNA was 
extracted; reverse transcribed into cDNA and hybridized onto high-density 
cDNA microarray membranes of 4,000 genes. At 30 minutes, injury resulted in a 
consistent increase (> 2 standard deviations) in gene expression in 3% of genes. 
These genes were primarily involved in transcription and signaling. None of the 
4,000 genes were decreased (< 2 standard deviations) at 30 minutes. At 1 hour 
however only 46 out of the 4,000 genes were increased in expression (1.15%) but 
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264 out of 4,000 (6.6%) genes were decreased greater than 2 fold. This is 
important as the delay in freezing the skin samples could result in reduced LL-37 
expression. Furthermore Cole et al., (2001A) were only able to extract useable 
RNA in 56% of their samples (defined as A 260/280 ratios > 1.8). Using this 
criteria only one specimen in the skin samples was adequate quality for analysis. 
Even with rapid sample excision and freezing in liquid nitrogen there may be 
some problems as some signaling and transcriptional factors may be have been 
induced already and as noted before for the immunohistochemistry the data even 
for the control samples may not reflect the true level of gene expression of 
‘‘quiescent’’ normal skin (Cole et al., 2001B). The speed with which cells on the 
sample border may respond to the excisional injury and influence AMP 
expression is unknown. This creates a difficult challenge: to accurately obtain a 
genomic expression profile for normal human skin under ideal quiescent 
conditions let alone acutely injured skin. Also in the majority of cases the 
patients were under general anesthesia, the potential variable of general 
anesthesia on baseline levels of gene expression is also unknown.  
 
As well as its antimicrobial properties the immunomodulatory properties of LL-
37 may mean it has a role in sepsis or the immune response seen after a burn. In 
a rat model of intra-abdominal sepsis, LL-37 therapy improved outcome and in 
combination with hyperthermic preconditioning the survival rate after sepsis was 
increased and the proinflammatory cytokine response was downgraded. A study 
of 31 sepsis patients in a general intensive care unit found that whilst some 
alpha-defensins and other AMPs were increased in these patients LL-37 was not 
(Berkestedt et al., 2010). Another study looking at LL-37 levels in the critically 
ill found that the mean plasma LL-37 levels were significantly lower in critically 
ill subjects compared to healthy controls (Jeng et al., 2009). In contrast Lippross 
et al., (2011) examined the serum profiles of defensins, cathelicidins and pro-
inflammatory cytokines post trauma and found that hBD-2, hBD-3 and LL-37 
concentrations were significantly elevated after trauma and followed different 
characteristic concentration curves. In addition, similar patterns of concentration 
profiles were recorded for hBD-2/IL-6 and hBD-3/IFN-gamma.  
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Burn patients not only frequently suffer concurrent trauma as well as the burn 
injury but also frequently develop complications such as infections or sepsis. The 
role of LL-37 in burns patients may therefore be complex.   
As can be seen from figure 6.12, in our study, serum LL-37 levels were reduced 
in the acute and healing phase compared with the healthy controls. Initially low, 
the serum LL-37 dropped even more over the first few weeks before rising 
slightly again. 
The hypermetabolic response after a major burn begins on the fifth day post 
injury and continues up to 24 months post burn. The increased metabolic 
requirements cause tissue catabolism, leading to nitrogen loss and a potentially 
lethal depletion of essential protein stores. The energy requirements are met by 
the mobilization of proteins and amino acids. As a consequence, the structure 
and function of essential organs, such as the heart, the liver, skeletal muscle, the 
skin, the immune system and cellular membrane transport functions, are 
compromised (Jeschke et al., 2007). It may be that the reduced LL-37 levels are a 
direct consequence of this catabolic state and therefore could potentially stay 
depleted for many months. 
This is an important finding as reduced levels of LL-37 are associated with 
severity of diseases such as in atopic dermatitis. Therefore in the burn patients 
this may manifest as poor wound healing or may predispose to increase levels of 
sepsis and potentially increased morbidity.  
Like Jeschke et al, (2007) we found that both IL-6 and IL-8 were increased after 
the burn injury (figures 6.13 and 6.14) but unlike their study we found there was 
no link to the burn size. In concordance with their results, IFNγ although affected 
by the burn was not affected by the burn size. There was no statistical difference 
between the pro-inflammatory cytokine levels on day 1 and the controls. 
The relationship between AMPs and cytokines is complex. In the study by 
Lippross et al., (2011) IL-6 showed a similar concentration profile to hBD-2 in 
the trauma patients. LL-37 has been shown to induce the production of a number 
of cytokines (IL-8, IL-18 and IL-20) through the MAP kinase pathway 
(Niyonsaba et al., 2005) and in psoriasis patients’ LL-37 levels have been 
correlated with interferon (IFN)-γ and IL-10 levels (Kanda et al., 2010). 
Although the possibility of LL-37 influencing IL-8 or (IFN)-γ in burns patients 
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exists the sample size was too small and the variability in the results too great to 
see if any such relationships is present.  
 
The role of LL-37 as immune response modulator is complex and it may be that 
its antimicrobial abilities may be more useful in the immediate clinical setting. 
The rapid emergence of bacterial strains with growing resistance to 
conventionally used antibiotics mean alternative solutions to treating infection 
should be sought.  
The antimicrobial activity of LL-37 has been shown against a variety of 
organisms, but no studies have been conducted to determine its direct action on 
Acinetobacter baumannii. After obtaining clinical isolates of three multi drug 
resistant strains that were prevalent in the area the MIC of LL-37 against the 
strains was determined.  
For all three strains the MIC was 8µM (Figures 6.16 and 6.17) showing it to be 
slightly more effective than against Pseudomonas aeruginosa. The peptide 
concentration killing 50% of the bacteria, EC50 was around 6µM. The study by 
Chromek et al., (2006) when investigating the role of cathelicidin in protecting 
the urinary tract against invasive bacterial infection found similar levels of 
activity against E.coli.  
The levels of LL-37 found in these studies are low and reduced by the burn 
injury therefore to be of clinical use levels would have to be increased. There are 
several factors that have to be considered however. 
To be of clinical use, any increase in LL-37 must reach a concentration that is 
sufficient not only to effectively kill bacteria but also then maintain that effective 
killing concentration for a time period needed to keep the bacteria from re-
growing.  
Whilst the MIC is the concentration that will kill the microbe in vitro, the MBC 
(minimum bacteriological concentration) is the concentration that will effectively 
kill the microbe in vivo. If an antimicrobial agent produces its activity in a 
concentration-dependent manner, it must reach the effective MBC in order to kill 
the microbe by producing a peak concentration that is generally about 8–10 times 
the MIC.  
If an antimicrobial agent produces its activity in a concentration-independent or 
time-dependent manner, it must maintain a concentration at least 1–2 times the 
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MIC for the entire period between dosing intervals in order to kill the microbe 
and prevent its re-growth (Herndon 2007). These factors determine in which way 
LL-37 may be utilized.  
Some efforts have been made in testing various ways of delivering or increasing 
LL-37. Bals et al., (1999) used a murine model of infection and sepsis and 
demonstrated that systemic gene transfer resulted in high concentrations of the 
mature peptide in the serum, and this over expression of LL-37/hCAP-18 
improved the survival of mice after injection of LPS or E.Coli.  
Transient cutaneous adenoviral transfection with hCAP-18/LL-37 into infected 
burn wounds (in rats) was shown to be more effective than using a synthetic LL-
37 in bacterial inhibition in a study by Jacobsen et al., (2005). 
Other methods to use LL-37 would be to determine if there are there drugs or 
chemicals that could target specific cell types to induce increased synthesis of 
defensins and LL-37 in the remaining skin elements following burn injury.  
Alternatively when cells are cultured for CEA (cultured epithelial autograft) the 
defensins or LL-37 could be combined with keratinocytes other cell types to 
provide a form of topical application in which AMPs can be delivered to the 
wound bed.   
 
The role of AMPs in burns is complex and needs further investigation but in an 
era of growing bacterial drug resistance offers an exciting alternative strategy to 
improve care and combat the constant threat of wound infection and sepsis. 
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7.0 Conclusions 
Since humans have suffered thermal injuries the battle has always been to keep 
the wound clean and prevent infection, the consequence of uncontrolled infection 
may be sepsis, multi-organ failure and death. 
The treatment of sepsis and multi-organ failure is facilitated by the early 
detection of those patients that may suffer from these conditions so treatment can 
be initiated as soon as possible and the right patients targeted effectively.  
What is required is a relatively cheap easily performed test that would identify 
those patients that will develop sepsis and multi-organ failure.  
 
We identified the urinary ACR as a possible candidate for this role. Severe burn 
causes a systemic inflammatory response, endothelial dysfunction and a 
microvascular leak of fluid and protein into the interstitium. Almost 40 years ago 
Parving et al (1974) showed that there was a correlation between 
microalbuminuria and the increased rate of transcapillary escape of radiolabelled 
albumin in hypertensive and diabetic patients. A link between increased systemic 
vascular permeability to albumin and microalbuminuria was therefore made. 
In the intervening years microalbuminuria has been used as a surrogate marker 
for systemic endothelial dysfunction and a predictor of outcome in a variety of 
surgical and intensive care settings (Vlachou et al 2006).  
There have been limited studies looking at ACR in the burn ICU setting. The 
three most relevant studies (Yew and Pal 2006, Vlachou et al., 2006 and Vlachou 
et al., 2008) look at specific populations in this setting.  
This study demonstrates firstly the prevalence of microalbuminuria in a general 
burn ICU population (including all types of thermal injuries, sizes and age 
ranges) for the first time with 45.5% having an elevated ACR (>2.3 mg mmol-1) 
on admission to the unit. It was found the peak ACR is related to the length of 
stay of the patients who survive, (which suggesting it may have some predictive 
value in patient outcome as those with longer in-patient stays tend to have a more 
complicated stay and recovery). The peak ACR has little clinical benefit, as one 
cannot predict when the peak may be. Therefore, the admission ACR and ACR 
after resuscitation (at 48 hours) was examined. No relationship was found 
between the TBSA% length of stay and either of these time periods.  
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In addition no link was found between the log admission ACR and the TBSA% 
sustained. This is in contradiction to the work of Vlachou et al., (2006). This 
showed a positive correlation between urinary ACR and TBSA at 3 and 7 hours 
post injury and with the percentage of full thickness burn between 3 and 7 hours. 
Vlachou’s later work (2008) showed per-operative ACR was associated with % 
TBSA excised. One reason for this may be in the recording of the surface area 
burned. Only recording the TBSA % and not consistently differentiating the 
amount of full thickness burn as opposed to more superficial burns makes the 
results difficult to interpret. As noted before a 10% full thickness burn may be a 
more significant injury or cause a greater inflammatory response than a 20% 
partial thickness burn. Secondly the timing of the samples is important. In 
Vlachou’ s study (2006) all patients that presented to the unit 6 hours after the 
injury were excluded. It is likely these results offer a more accurate idea of 
whether ACR on admission and TBSA% are related. Due to the geographical 
position of the unit in our study and nature of the referrals many patients’ 
samples were not collected until after 6 hours.   
The ACR at admission did predict outcome (death) with a sensitivity and 
specificity comparable to some other studies that have examined ACR in the 
critical care setting (although not burns) at a low level of ACR, 3.78 mg mmol-1. 
This predicts outcome at a far lower level than previously described by Yew and 
Pal (2006) who had determined that a mean ACR of 20 mg mmol-1 was 
associated with poorer outcomes. Despite this, the sensitivity and specificity are 
not high enough to use it as a clinical tool in our ICU. It may be that its 
diagnostic accuracy could be improved by using it in conjunction with another 
marker of inflammatory response (such as C-reactive protein or procalcitonin). 
Because ACR was related to the length of stay (in survivors) the relationship 
between ACR and both sepsis and multi-organ failure (complications that may 
increase length of stay) was examined. Whilst on the ICU may patients suffer 
from one or both of these conditions and the concurrent inflammatory response 
may be reflected in the degree of endothelial dysfunction.   
Our analysis demonstrated that there is a clear relationship between the 
admission ACR and the development of sepsis (figure 3.4 and 3.5). Again 
however the sensitivity and specificity make its utility poor in the clinical 
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scenario. More important factors for developing sepsis were the TBSA% and the 
presence of an inhalation injury. 
This study showed that the ACR value was directly related to the multi-organ 
failure score which we analysed further to see if ACR could be used to 
differentiate patient outcomes in those patients suffering from multi-organ 
failure. From our study although there was a clear relationship between ACR and 
MOF it does not offer clear a clinical utility at the moment to identify those 
patients that may suffer from multi-organ failure. It may be that burn injuries are 
too complex and there are too many confounding factors in multi-organ failure 
for ACR to be able to distinguish those patients who will achieve higher MOF 
scores. An interesting result that appeared to come of the analysis was a 
correlation between MOF score and ACR value from 20 days before which 
suggest that the relationship may be far more complex than suspected from the 
results in both this and previous studies of ACR. It is unclear why there may be a 
correlation between MOF score and ACR from a number of weeks before. It may 
be related to the pattern of “two cascades of organ failure” described by Yew and 
Pal (2006) who noted deaths in the first week post injury result from failure of 
reversal of the burn shock and then a second group of patients dying several 
weeks after the burn injury typically from an infectious process usually 
associated with pneumonia. In the initial injury the same process that causes 
endothelial dysfunction (and therefore an ACR rise) also affects the immune 
system with the result that the body is immunosuppressed. By the third week 
post injury with adequate support most patients are able to mount an effective 
immune response. It may be that the ACR picks up on those patients that are not 
so able to mount an immune response. This becomes more obvious at around the 
20-day post injury stage with the result that these patients suffer from more 
complications and organ failure.  
It must be noted however, that this apparent link could be spurious. The number 
of patients this data is based on gets smaller and smaller as generally the number 
of patients remaining on the unit for a long period reduces. It could therefore be 
an artefact arising from the few patients that have both high MOF scores and 
high ACR (perhaps for unrelated reasons) and remain in the unit. 
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In conclusion, although ACR may have a role in demonstrating outcome and the 
development of sepsis and multiorgan failure, currently in burns care it appears 
to be limited. It may be that because of the systemic impact that burns injuries 
are more complex than may other medical illnesses and looking at ACR in 
isolation is inadequate to reflect the inflammatory changes going on. Perhaps 
sampling ACR in combination with another marker of inflammation such as 
CRP or procalcitonin would provide more accurate results. 
 
Despite all the technical advances in burn care in the last 50 years one of the 
reasons that sepsis and multi-organ failure are the most frequently reported 
causes of death in the burns units throughout Europe (Brusselaers et al 2010) and 
the US is the rise of multi drug resistant organisms. A striking example of this is 
in a study of five-thousand two-hundred-sixty paediatric patients over a twenty 
tears period in Galveston, Texas. The leading causes of death over 20 years were 
sepsis (47%). From 1989 to 1999, sepsis accounted for 35% of deaths but 
increased to 54% from 1999 to 2009, with a significant increase in the proportion 
due to antibiotic resistant organisms (William et al., 2009). 
One of the multi-drug resistant bacteria that have caused problems in the UK is 
Acinetobacter baumannii (MRAB), illustrated by the rise in cases resistant to 
carbapenem in one unit increasing from 0% to 55% between 1998 and 2006. 
This overall increase coincides with the emergence of the MRAB-C OXA-23 
clone-1 as the most prevalent strain in London and South East England 
(Wareham et al., 2008). 
Anecdotally it was felt (by the surgical and anaesthetic consultants running the 
unit) that those patients with the multi-drug resistant strain of Acinetobacter 
baumannii tended to have a greater morbidity than those with drug sensitive 
Acinetobacter or no infection, this was not based on any data however.  
We therefore investigated this by examining acquisition of MRAB and drug 
sensitive Acinetobacter and the development of multi-organ failure during an 
outbreak of Acinetobacter in the ICU. MRAB was shown to be related to the 
acquisition of Acinetobacter baumannii and in table 5.6 it can be seen the impact 
this had. The patients in this group not only had more visits to theatre, but also 
spent longer on the unit. It is difficult to determine whether MRAB was the cause 
of the MOF or a consequence of it, but the regression analysis and use of 
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matched groups (who had drug sensitive Acinetobacter baumannii and no 
Acinetobacter infection) shows that the group with MRAB had a higher rate of 
multi-organ failure despite the other parameters remaining similar between the 
groups. We therefore concluded that MRAB was responsible for the multiorgan 
failure.  
This study is the first to show an association between MRA and multi-organ 
failure. This is an important finding because multi-organ failure is associated 
with a greater morbidity and mortality (Cumming et al 2001). If the patient does 
not die, multi-organ failure means not only poorer outcomes for the patient 
(physically and psychologically) but has important financial implications in the 
short term for the hospital and in the long term for the patient and the 
community. Wilson et al (2004) established that the mean hospital costs of 
patients that acquired MRAB was $98,575 higher than that of control patients 
who had identical burn severity of illness indices. 
The isolation of multi resistant Acinetobacter should result in an aggressive 
policy of management to identify the source, educate the staff and ensure good 
hand hygiene to avoid transmission to other patients and potentially life 
threatening problems and a large extra cost. 
Even with all these measures in place the main problem is the emergence of 
multi resistance to conventional antibiotic treatment. New therapies are required 
that can help the fight against these organisms. One such group of molecules 
with this potential are the AMPs, part of the innate immune system that are 
increasingly found to play an important role in the defence of the body. Studies 
have shown not only direct antimicrobial properties but also indirect 
antimicrobial ability through their modulation of the immune response by 
interaction with a number of cytokines and cells. The presence of the main 
AMPs in skin, both defensins and cathelicidin has been established in burns.  
Our study demonstrated how the LL-37 is reduced in the acute burn and for some 
time afterwards in the healing wound although statistical significance was not 
achieved in the analysis of serum levels of LL-37 and LL-37 levels in the skin 
through rtPCR analysis. Unlike Frohm et al., 1997 we found significant LL-37 in 
the healthy control patients in the immunohistochemical analysis. The reasons 
for this are unclear but could be due to the way in which the samples were 
collected. The speed in which LL-37 may be released is unknown and it could be 
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that in the process of taking a punch biopsy and processing the sample some 
signaling and transcriptional factors may have been induced. The time taken for 
the samples to be transported to London for analysis may have allowed for this 
process to occur whereas in other studies the samples are processed immediately 
perhaps before these processes occur. 
Another factor to consider is that unique phenotypes and variable responses to 
environmental stimuli may mean that differential gene expression exists between 
individuals. This may manifest as patients having different levels of LL-37 under 
the same conditions. The number of samples in this study may be too small to 
determine abnormal LL-37 expression especially if there is a very variable 
expression in the standard population.  
In general the immunohistochemistry results showed that LL-37 was reduced in 
the post injury period but began to return towards normal as healing commenced. 
To try and quantify the amount of staining seen, both the CSQ and total pixel 
count was used (as described by Lalli et al., 2008). Both visual assessment and 
pixel count showed good correlation with each other (correlation coefficient r = 
0.69, P < 0.005; Figure 6.9). Figure 6.10 shows how the pixel count of positive 
staining stained varied over time and showed that the LL-37 in the skin samples 
was initially low and gradually increased through the healing period (towards 
values seen in the control patients). It is unclear how long it would take for levels 
to return to normal values or indeed if LL-37 returns to normal in the injured 
areas of skin. 
The rtPCR showed significant results in only two of the samples (one a burn 
patient on day three after the burn and one in a patient over three weeks after the 
burn injury). In another 18 patients there are weak reactions that may indicate 
minimal amounts of nucleic acid. Again these results maybe a result of the 
processing. It was clear that the two samples with a highest yield of nucleic acid 
were those that had the best yield of RNA (ng/µl) determined using the 
spectrophotometer. This can be an indication of incomplete extraction or 
inefficient isolation. Studies by Cole et al., (2001A) found useable RNA in only 
56% of their samples (a useable sample was defined as having a 260/280 ratio> 
1.8). Using these criteria only one of the burn or control samples was suitable for 
analysis. As noted above even with rapid sampling, some signaling and 
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transcriptional factors may be have been induced already by the process required 
to take the sample.  
With results such as these it is difficult to draw clear conclusions regarding the 
significance of the presence of LL-37 in burns without further studies but 
irrespective of this LL-37 may yet have a role in the treatment of burns by 
modulation of the immune system or by its direct antimicrobial action. With the 
rapid emergence of bacterial strains with growing resistance to conventionally 
used antibiotics it is imperative that alternative solutions to treating infection 
should be sought.  
Whilst the antimicrobial activity of LL-37 has been shown against a variety of 
organisms, no studies have been conducted to determine its direct action on 
Acinetobacter baumannii. The last part of this study demonstrated LL-37 had 
bactericidal activity against Acinetobacter baumannii and therefore has potential 
to be used in a clinical setting such as the burn ICU.  Three strains of drug 
resistant Acinetobacter baumannii that are prevalent in hospitals in the southeast 
of England were studied and LL-37 had similar MIC and EC50 values for all 
three strains. 
This is important because studies both in the laboratory and in the clinic confirm 
that emergence of resistance against antimicrobial peptides is less probable than 
observed for conventional antibiotics (Zasloff 2002). This has provided the 
impetus to develop antimicrobial peptides, both natural and laboratory 
conceived, into therapeutically useful agents. These are several ways in which 
LL-37 and other antimicrobial peptides may have a therapeutic role: (1) as single 
anti-infective agents, (2) in combination with conventional antibiotics or 
antivirals to promote any additive or synergistic effects, (3) as 
immunostimulatory agents that enhance natural innate immunity, and (4) as 
endotoxin-neutralizing agents to prevent the potentially fatal complications 
associated with bacterial virulence factors that cause septic shock (Gordon et al., 
2005). 
Studies have so far been limited in the burns world. Bals et al., (1999) tried to 
increase LL-37 availability in a murine model by systemic gene transfer. Over 
expression of LL-37/hCAP-18 improved the survival of mice after injection of 
LPS or E.Coli. Jacobsen et al., (2005) found that transient cutaneous adenoviral 
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transfection of hCAP-18/LL-37 in infected burn wounds (using a rat model) was 
more effective than using synthetic LL-37. 
There are a number of difficulties in developing antimicrobial peptides as anti- 
infective drugs, which include systemic and local toxicity, costs of synthesis and 
economic viability in production, natural resistance and confounding biological 
functions of LL-37. The potential advantages of broad-spectrum activity, 
potentially low levels of induced resistance and concomitant broad anti-
inflammatory properties remain an attractive proposition.  
So whilst AMPs will not be the magic bullet to solve all issues associated with 
increasing antimicrobial resistance and overwhelming immune response in sepsis 
they have the potential to be significant reinforcements to the currently available 
therapeutic options. 
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8.0 Future work 
 
ACR 
The study into ACR was broad based and inclusive. It may be that there has been 
a loss of discriminatory power by such an approach and that by focusing on a 
more selective patient group may clarify the role of ACR. The patient cohort is 
therefore currently being analyzed further with all patient co-morbidities 
included (i.e. diabetes, high blood pressure and other illnesses that may influence 
ACR). A separate analysis of children with regards to sepsis and MOF is also 
being undertaken. The work by Vlachou et al., (2006 and 2008) showed a 
correlation between ACR and TBSA%, which was not seen in this study. One 
possible reason is their more accurate measurement of the surface area involved 
in the burn as they measured the percentage of full thickness burn (%FTB) as 
well as TBSA%. Further studies will include the % FTB as well as the TBSA % 
to clarify the relationship between ACR and burn size. In addition Vlachou’s 
studies also highlighted the importance of the timing of the urine analysis. Future 
studies need to ensure there is a consistent approach and like Vlachou ensure all 
specimens are taken within six hours of injury. One way in which this maybe 
achieved is by requesting all referring hospitals take a urine sample at the time of 
the first assessment and send it to the burn unit for analysis.  
There is yet no investigation to determine if the urine samples can deteriorate if 
left for a number of hours so a small pilot would have to be performed to see if 
the urine samples give consistent ACR results overtime. This could be achieved 
by testing the same urine sample of 20 different patients on an hourly basis to see 
if the ACR varies.  
An intriguing part of the analysis of ACR was the correlation of the MOF score 
with the ACR from 20 days before at this stage it is unclear if this is of 
significance. Further analysis is required of those patients staying for long 
periods (greater than 30 days). As the number of patients staying for long periods 
is small this may be best achieved by collaboration with one or more other large 
burn units.  
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Acinetobacter baumannii 
One of the most intriguing results of the Acinetobacter baumannii study was the 
correlation between MRAB transmission and the number of agency staff on the 
unit i.e. it acted as a flag for potential underlying problems.  
If transmission of Acinetobacter baumannii is increased because of staff being 
unsure of unit protocols or through inadequate training then other mistakes may 
also being made for the same reasons. It is therefore planned to see 
retrospectively if there is any link to overall patient outcomes (assessed by 
patient death or increased length of stay) during these periods. 
As the number of cases of Acinetobacter baumannii varies seasonally and is not 
a problem in many other critical care units it would be useful to know if there are 
any other infective organisms that can be used as such a flag instead of 
Acinetobacter baumannii. This would allow the results to be extrapolated to 
other units or allow other units to look at their staffing levels and the 
consequences for patient care.  
 
LL-37  
Whilst the LL-37 immunohistochemistry results fit in with current understanding 
of AMPs in thermal injury the rt PCR does not endorse this work. It may be a 
fault of the processing of the samples but needs confirmation by repeating the 
analysis with refinement of the technique. This can firstly be approached by 
speeding up the process of sample collection with quicker freezing of the 
samples in liquid nitrogen. The grinding down of the skin samples in a pestle and 
mortar is also a potential source of RNA degradation due to thawing and 
endogenous RNAse release. An alternative technique as described by Berglund 
et al., 2007 will be tried to provide improved RNA yield and also provide protein 
for more in depth analysis.  
Unique phenotypes and variable responses to environmental stimuli means that 
differential gene expression exists between individuals. As the control patients 
showed greater staining of LL-37 compared to other studies it is clear there may 
be greater variability in the normal uninjured population than has previously 
been understood. To examine this further we will examine whether there is any 
variation in LL-37 expression with age and racial background and whether there 
is any variation in LL-37 skin in different areas of the body. In addition samples 
 295 
of unburnt skin would be collected at the same time as the burnt samples from 
areas distant from the wound site (pending ethical approval) to see the patients 
normal baseline level to get a comparative idea of how much a burn injury 
affects the skin locally.  
 
The immunohistochemistry results showed that the LL-37 was initially reduced 
and then returned towards normal levels. In future work it is hoped to follow the 
patients for a longer time to see if the LL-37 does return back to normal or if the 
levels in the damaged or grafted skin are always suppressed. 
A further question that became apparent is that when taking samples from the 
healing wounds that had been grafted it was impossible to tell if the LL-37 that 
was stained was due to LL-37 being transferred with the skin graft or because of 
local factors increasing expression in the healing wound. To examine this a 
sample of the donor skin should be analysed to see how much LL-37 is 
transferred and if there is any relationship with the depth of the skin graft taken.  
 
Although the levels of pro-inflammatory cytokines studied showed no significant 
findings they do echo the results of larger studies and the results probably reflect 
the small sample size. The finding of Lippross et al., 2011 that LL-37 was 
significantly elevated after trauma and that hBD levels were related to IL-6 
levels show that the relationship between AMPs and cytokines may be complex. 
The collection of serum samples will be continued with the targeting of those 
patients who develop sepsis.  
The work of Vlachou et al., (2006 and 2008) demonstrated how sensitive ACR 
was to wound manipulation. Papini et al., (1997) also showed that cleaning or 
debriding a wound altered serum IL-6 levels. It is feasible that LL-37 could be 
equally sensitive to wound manipulation. It is therefore planned to see how 
serum LL-37 levels are influenced by these factors by taking serial samples 
before, during and after a range of procedures and interventions including, 
changing a dressing, cleaning a wound, surgical débridement of a wound and a 
non wound related intervention such as changing an intravenous line.  
LL-37 has been used to treat sepsis in the animal model, raising the possibility 
that it or an analogue could be used in some form in humans. Before this, a 
clearer understanding of LL-37 is needed and I hope my work contributes to this. 
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Appendix I 
Chapter 2 details the role of ACR in the burns ICU and these results relate to the 
study of both adults and children. 
Section 1  
 
 Mean Standard 
deviation 
Percentiles 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Peak ACR 17.7 33.3 0.5 2.6 6.3 16.6 231.0 
Table 1. Summary statistics of peak ACR (see p92) 
 
 Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Admission 
ACR 0.599 0.931 0.020 0.130 0.310 0.690 8.800 301 
Table 2. Summary statistics of length of stay per percent TBSA by ACR at 
admission (see p97) 
  
 297 
Section 2 
 
 
Figure 1. The scatterplot matrix above shows all the variables plotted against 
each other in both directions (y vs. x and x vs. y), and also the histograms of the 
individual variables. There are no clear relationships. Table created by Dr Mike 
Parker, Anglia Ruskin University. 
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Section 3. Multiple regression models (see p89) Performed by Dr Mike Parker, 
Anglia Ruskin University. 
Model response variable. 
Log_ACR   Log ACR at admission 
 
Potential model predictor variables 
1. Age Age at admission in years 
2. TBSA_pct Percentage of total body surface area burned 
3. Sex 
4. Inhalation A categorical variable (Yes, No) 
5. Mechanism3 A categorical variable (Flame, Scald, Other) 
 
Model goodness of fit summary statistics 
The tables below list the following statistics for each model. 
1. p  The number of parameters fitted. The more parameters fitted the 
more complex the model is, and is therefore more likely not to be 
generalisable to other groups of patients.  
2. AdiR2  In modelling using ordinary multiple regression with a continuous 
response models the adjusted R-square indicates the proportion of 
the variance explained by the model. 
3. AIC  Akaike Information Criterion. This penalises models for every 
additional parameter that they estimate. Lower values are sought. 
4. PRESS Prediction error sum of squares. Smaller values are sought. 
5. CVE Cross-validation estimate of the Mean Square Prediction Error 
(MSPE) and is an unbiased estimate of the residual variance. 
 
Over fitting 
Models can be found that will fit all the observations in a data set perfectly, but 
this model will be of no value for a different data set. The more complicated a 
model is the more likely it is that it will apply only to the current data set and be 
poor at prediction for other data sets.  
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Models with all possible combinations of predictors 
The tables below should be treated with some caution. If any one of the models 
were to be examined in detail it might be found to be unsuitable because of large 
standard errors. The search for multiple regression models involves 301 cases. 
Table 3 Single-predictor models (5 possible models) 
Model Predictors p AdjR2% AIC PRESS CVE 
1.1 Age 1 2.1 885 332 1.1 
1.2 Mechanism3 2 2.0 886 332 1.1 
1.3 TBSA_pct 1 0.4 890 338 1.1 
1.4 Inhalation 1 -0.2 892 339 1.1 
1.5 Sex 1 -0.3 892 339 1.1 
 
The table above shows that the fit of the models is very poor. 
 
Table 4 Two-predictor models (10 possible models) 
Model Predictors p AdjR2 AIC PRESS CVE 
2.1 Mechanism3+Age 3 5.3 876 322 1.1 
2.2 TBSA_pct+Mechanism3 3 2.7 885 332 1.1 
2.3 TBSA_pct+Age 2 2.4 884 333 1.1 
2.4 Mechanism3+Inhalation 3 2.3 886 333 1.1 
2.5 Age+Inhalation 2 1.8 886 334 1.1 
2.6 Sex+Age 2 1.7 887 334 1.1 
2.7 Mechanism3+Sex 3 1.7 888 334 1.1 
2.8 TBSA_pct+Sex 2 0.1 892 340 1.1 
2.9 TBSA_pct+Inhalation 2 0.1 892 340 1.1 
2.10 Sex+Inhalation 2 -0.5 894 341 1.1 
 
The two-predictor models still show a very poor fit. 
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Table 5 Two-predictor models with interaction (20 possible models) 
Mode
l Predictors p 
AdjR
2 AIC PRESS 
CV
E 
2.1i Mechanism3+Age+Mechanism3:Age 5 6.2 875.6 324.5 1.1 
2.2i Mechanism3+Age 3 5.3 876.4 322.4 1.1 
2.3i 
TBSA_pct+Mechanism3+TBSA_pct:
Mechanism3 5 5.3 878.4 324.3 1.1 
2.4i TBSA_pct+Age 2 2.4 884.4 332.7 1.1 
2.5i TBSA_pct+Mechanism3 3 2.7 884.5 331.9 1.1 
2.6i 
Mechanism3+Inhalation+Mechanism
3:Inhalation 5 3.2 885.1 Inf Inf 
2.7i Mechanism3+Inhalation 3 2.3 885.9 332.7 1.1 
2.8i Age+Inhalation+Age:Inhalation 3 2.2 886.2 334.9 1.1 
2.9i TBSA_pct+Age+TBSA_pct:Age 3 2.1 886.3 336.3 1.1 
2.10i Age+Inhalation 2 1.8 886.4 334.1 1.1 
 
The models with interaction still have not improved the goodness of fit to useful 
levels. Further analysis (not shown) reveals that the best three-predictor models 
only explain 6.1% of the variance, and the best three-predictor model with 
interactions only explains 11.2% of the variance. It is clear that the predictors 
considered here are not useful in a model of log ACR. 
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Appendix II 
 
Chapter 3 details the investigation into whether ACR has a predictive role 
in identifying sepsis in burn patients admitted to the ICU. Statistical analysis 
performed by Dr Mike Parker, Anglia Ruskin University. 
 
Section 1 
 
Condition Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
No sepsis 0.983 0.911 -0.174 0.372 0.693 1.322 4.316 125 
Sepsis 1.281 1.248 -0.528 0.320 0.978 1.722 5.260 88 
Overall 1.107 1.071 -0.528 0.329 0.846 1.502 5.260 213 
Table 1. Log ACR at admission by condition (see p139) 
 
 
Condition Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 
25% Median 
50% 
75% Largest 
100% 
No sepsis 42.4 20.2 16 24 39 55 95 136 
Sepsis 45.0 16.8 16 33 44 57 85 103 
Overall 43.5 18.8 16 28 42 56 95 239 
 
Table 2 Summary of statistics used comparing age at admission by condition 
(see p142) 
The difference between the means for the two groups is 2.6 with 95% confidence 
limits 43.5 (41.12, 45.88). 
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Appendix III 
Chapter 5 examines the role of Acinetobacter on burn ICU outcomes and 
the relationship to multi-organ failure. Statistical analysis performed by Dr 
Mike Parker, Anglia Ruskin University. 
Section 1 
Infection group Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Drug resistant 3.13 1.14 1 2 3 4 5 30 
Drug sensitive 1.74 1.54 0 0 2 3 5 23 
No infection 1.16 0.86 0 1 1 2 3 31 
Overall 2.02 1.45 0 1 2 3 5 84 
 
Table 1: Total number of organ failures by infection group (see p 197) 
 
 
Section 2  
Analysis of variance of the total number of organ failures 
In this section the group mean total number of organ failures are compared 
without any attempt to allow for any imbalance of the groups (see p205).  
 
Source of 
variation 
Degrees of 
freedom 
Sum of 
squares 
Mean 
Square 
Variance 
ratio 
Permutation 
test P-value 
Group 2 61.857 30.929 22.35 < 0.00001 
Residual 81 112.095 1.384   
Total 83 173.952    
 
Table 2: Analysis of variance summary table of organ failures 
 
 
The residual variance is 1.384 and its bootstrap 95% confidence limits are 
(1.093, 1.895). 
The residual standard deviation is 1.176 and its bootstrap 95% confidence limits 
are (1.045, 1.376). 
The model underlying the analysis of variance involving just the Groups factor 
has an adjusted R-square times 100 of 34.0%. This is the percentage variance 
accounted for by the model.  
The usual F test invokes Normal distribution theory, but permutation tests do not. 
An exact permutation test finds all possible permutations of the data to find the 
probability of the observed result or any result more extreme. This is not 
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practical for any but very small samples, so the approach used is to generate a 
large number of random permutations. This has been done here and the P-value 
obtained is presented in Table 2. The conclusion is the same for the Normal 
theory P-value and the permutation test P-value. 
 
Normal distribution theory is usually invoked to calculate confidence limits. The 
required assumptions can be avoided using bootstrap analyses. This involves 
taking repeated random samples of the data and performing calculations of the 
resulting distribution of the estimate of interest. In the bootstrap analyses here 
9999 samples have been selected. The confidence limits below have been 
adjusted using the Dunn-Sidak adjustment for multiplicity so that a nominal 95% 
confidence level has become a 98.3% confidence level. 
 
Group difference Difference 
between  
means 
Standard 
error 
98.3% confidence 
limits 
Lower Upper 
Resistant – Sensitive 1.394 0.320 0.617 2.155 
Resistant – No 
infection 
1.972 0.296 1.230 2.640 
Sensitive – No 
infection 
0.578 0.319 – 0.195 1.359 
 
Table 3: Differences between the means of organ failures with bootstrap 
standard errors and 98.3% confidence limits 
 
The bootstrap confidence limits for the differences between the means indicate 
that the mean number of total organ failures is higher for the Resistant group 
than for the Sensitive group. The mean number of total organ failures is also 
higher for the Resistant group than for the No-infection group. The difference 
between the means for the Sensitive and No-infection groups is not statistically 
significant. 
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Section 3 Statistical analysis performed by Dr Mike Parker, Anglia Ruskin 
University. 
Analysis of variance of the total number of organ failures with covariates 
In this section an attempt is made to adjust for imbalance between the groups by 
adjusting the differences between the means using covariates (see p205). 
Blood volume transfused as a single covariate 
The potential covariate which, on its own, explains most variation in the total 
number of organ failures is the volume of blood transfused. In this section this 
variable is used as a covariate to adjust the differences between the means of the 
total number of organ failures. 
 
 
Figure 1. A scatter plot of total organ failure against total blood volume 
transfused with scatter plot regression lines fitted separately to groups.  
MRAB solid line, Drug sensitive dashed, no Acinetobacter infection, dotted. 
MRAB regression slope (and bootstrap 95% CI) 5.911e-05 (8.04e-06, 
0.00011163). Drug sensitive regression slope .0001699 (0.00011589, 
0.0002425). No Acinetobacter group regression slope 5.247e-05 (1.561e-05, 
9.491e-05)  
The graph above suggests that the regression line for the drug sensitive patients 
differs from the regression lines for the other two groups. However, there is a 
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great deal of scatter and it might be that parallel lines provide an adequate 
description of the data. 
 
 
Source of 
variation 
Degrees of 
freedom 
Sum of 
squares 
Mean 
Square 
Variance 
ratio 
Permutation 
test P-value 
Group 2 61.857    
Blood vol 1 27.821    
Slopes 2 9.546 4.773 4.98 0.005 
Residual 78 74.728 0.958   
Total 83 173.952    
 
Table 4: Analysis of variance summary table for testing parallelism 
 
The adjusted R-square or percentage variance accounted for by the model with 
separate regression lines is 54.3%. For the model with parallel regression lines it 
is 49.7%. Although there is some evidence of a lack of parallelism the 
simplification in the analysis achieved by using the model with parallel 
regression lines makes this model much more useful and is the one generally 
adopted except in cases where there is a marked reduction in the goodness of fit 
of the model with parallel regression lines. 
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Figure 2 Scatterplot with parallel lines for groups. The adjusted differences 
between the means of the total numbers of organ failures are the vertical 
distances between the parallel regression lines. The analysis of variance for 
testing these adjusted differences is as follows. 
Source of 
variation 
Degrees of 
freedom 
Sum of 
squares 
Mean 
Square 
Variance 
ratio 
Permutation 
test P-value 
Group 2 38.325 19.177 18.20 < 0.00001 
Blood vol 1 51.325 51.325 48.72 < 0.00001 
Residual 80 84.274 1.053   
Total 83 173.952    
 
Table 5: Analysis of variance summary table for adjusted means 
The residual variance is 1.053 and its bootstrap 95% confidence limits are 
(0.847, 1.441). 
The residual standard deviation is 1.026 and its bootstrap 95% confidence limits 
are (0.920, 1.200). 
The very small P-value indicates that there are statistically significant differences 
amongst the group means. The confidence limits below have been adjusted using 
the Dunn-Sidak adjustment for multiplicity so that a nominal 95% confidence 
level has become a 98.3% confidence level. 
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Group difference Difference 
between  
means 
Standard 
error 
98.3% confidence 
limits 
Lower Upper 
Resistant – Sensitive 1.120 0.284 0.428 1.792 
Resistant – No 
infection 
1.614 0.266 0.959 2.238 
Sensitive – No 
infection 
0.495 0.277 - 0.177 1.160 
 
Table 6: Differences between the means of organ failures, adjusted for blood 
volume transfused, with bootstrap standard errors and 98.3% confidence 
limits 
 
The adjusted differences between the means are all smaller than the unadjusted 
differences shown in Section 1, Table 3. However, the conclusions are the same. 
The bootstrap confidence limits for the adjusted differences between the means 
indicate that the mean number of total organ failures is higher for the resistant 
group than for the sensitive group. The mean number of total organ failures is 
also higher for the resistant group than for the No-infection group. The difference 
between the adjusted means for the sensitive and No-infection groups is not 
statistically significant. 
 
Section 4 
Adjustment using all available covariates (see p 208) 
All of the six available covariates are used in this section in an attempt to adjust 
the differences between the group means using all the available information. This 
might not be a sensible approach as some of the covariates might not contribute 
the model and would therefore unnecessarily increase the standard errors in the 
model and its complexity. There also no attempt being made here to include 
interactions between the covariates which could also be important. 
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Source of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Mean 
Square 
Variance 
ratio 
Permutation 
test P-value 
Group 2 40.271 20.135 21.55 < 0.00001 
Sex 1 0.978 0.978 1.05 0.421 
Age 1 10.552 10.552 11.30 0.001 
TBSA 1 24.891 24.891 26.64 < 0.00001 
Theatre 
vsts 
1 9.994 9.994 10.70 0.003 
Blood vol 1 16.050 16.050 17.18 0.00006 
Inhalation 1 1.151 1.151 1.23 0.433 
Residual 75 70.066 0.934   
Total 83 173.952    
 
Table 7: Analysis of variance summary table for adjusted means using all 
covariates 
 
The residual variance is 0.934 and its bootstrap 95% confidence limits are 
(0.788, 1.490). 
The residual standard deviation is 0.967 and its bootstrap 95% confidence limits 
are (0.888, 1.221). 
 
The model with just the six covariates accounts for 31.6% of the variance. When 
the Groups factor is added the model accounts for 55.4% of the variance. The 
confidence limits below have been adjusted using the Dunn-Sidak adjustment for 
multiplicity so that a nominal 95% confidence level has become a 98.3% 
confidence level. 
 
Group difference Difference 
between  
means 
Standard 
error 
98.3% confidence 
limits 
Lower Upper 
Resistant – Sensitive 0.948 0.270 0.311 1.591 
Resistant – No 
infection 
1.713 0.248 1.107 2.295 
Sensitive – No 
infection 
0.765 0.265 0.136 1.394 
Table 8: Differences between the means of organ failures, adjusted for six 
covariates, with bootstrap standard errors and 98.3% confidence limits 
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When compared with the unadjusted differences shown in Table 3, the results in 
Table 8 show that the adjusted differences between the means are smaller when 
the resistant group is involved but the adjusted difference between the sensitive 
and No-infection group is larger. All the differences are now statistically 
significant. 
 
Section 5 
Adjustment using blood volume transfused and number of theatre visits (see 
p206) 
The model involving just covariates which accounts for the largest percentage of 
variance has the blood volume transfused, the number of visits to the operating 
theatre, and their interaction. 
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Drug sensitive
No acinetobacter infection
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Source of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Mean 
Square 
Variance 
ratio 
Permutation 
test P-value 
Group 2 21.322 10.661 12.72 < 0.00001 
Blood vol 1 17.476 17.476 20.85 < 0.00001 
Theatre 
vsts 
1 33.866 33.866 40.41 < 0.00001 
Interaction 1 35.942 35.942 42.89 0.00001 
Residual 78 65.346 0.838   
Total 83 173.952    
 
Table 9: Analysis of variance summary table for adjusted means 
 
The residual variance is 0.837 and its bootstrap 95% confidence limits are 
(0.683, 1.232). 
The residual standard deviation is 0.915 and its bootstrap 95% confidence limits 
are (0.827, 1.110). 
 
The model with just the covariates accounts for 48.3% of the variance. When the 
Groups factor is added the model accounts for 60.0% of the variance. The 
confidence limits below have been adjusted using the Dunn-Sidak adjustment for 
multiplicity so that a nominal 95% confidence level has become a 98.3% 
confidence level. 
 
Group difference Difference 
between  
means 
Standard 
error 
98.3% confidence 
limits 
Lower Upper 
Resistant – Sensitive 1.001 0.250 0.395 1.588 
Resistant – No 
infection 
1.229 0.249 0.615 1.811 
Sensitive – No 
infection 
0.228 0.249 – 0.351 0.829 
 
Table 10: Differences between the means of organ failures, adjusted for 
covariates, with bootstrap standard errors and 98.3% confidence limits 
 
When compared with the unadjusted differences shown in Table 3, the results in 
Table 10 show that the adjusted differences between the means are always 
smaller than the unadjusted differences. The bootstrap confidence limits for the 
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differences between the means in Table 10 indicate the same conclusions as in 
Table 3 and Table 6. The mean number of total organ failures is higher for the 
resistant group than for the sensitive group. The mean number of total organ 
failures is also higher for the resistant group than for the No-infection group. The 
difference between the means for the sensitive and No-infection groups is not 
statistically significant. 
 
Section 6 (see p207) 
 
Infection 
group 
Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Drug resistant 4000 5486 0 1249 2227 4289 28222 30 
Drug sensitive 2255 4391 0 0 775 2775 20402 23 
Overall 3243 5070 0 458 2026 3894 28222 53 
 
Table 11 Summary table of blood volume by infection group pre-acquisition 
of Acinetobacter 
 
Infection group Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Drug resistant 3906 5038 0 970 2433 4479 26135 30 
Drug sensitive 2329 2975 0 0 931 3172 10359 23 
Overall 3221 4304 0 450 2061 4045 26135 53 
 
Table 12 Summary table of blood volume by infection group pre-acquisition 
of Acinetobacter 
 
Infection 
group 
Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Drug resistant -94.3 7846 -24177 
-
2093 -234 3524 23939 30 
Drug sensitive 73.8 3434 -11937 -517 0 1547 5467 23 
Overall -21.4 6271 -24177 
-
1245 0 1691 23939 53 
 
Table 13 Post- minus Pre-acquisition blood volume by infection group 
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Infection 
group 
Mean Standard 
deviation 
Percentiles Number 
of 
values 
Smallest 
0% 25% 
Median 
50% 75% 
Largest 
100% 
Drug resistant 7897 7249 993 4205 5981 8636 33971 30 
Drug sensitive 4639 6656 0 388 3230 4769 28867 23 
No infection 3652 6875 0 0 928 4200 32365 31 
Overall 5438 7123 0 725 4078 6546 33971 84 
Table 14 Total blood volume by infection group 
Tables 11-14 summarise the results used in the statistical analysis. 
 
Section 7 (see p 209) 
Pre-acquisition blood volumes 
The comparison of the pre-acquisition blood volumes for the two infection 
groups is presented as an analysis of variance (ANOVA), which is equivalent to 
a two-sample t-test. A permutation test has been used to avoid the assumption of 
Normally distributed data. 
Source of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Mean 
square 
F ratio Permutation 
test 
probability 
Group 1 39648705 39648705 1.56 0.24 
Residual 51 1296892785 25429270   
Total 52 1336541490    
 
Table 15 Analysis of variance summary table for pre-acquisition blood 
volume. The residual variance is 25429270 and its bootstrap 95% confidence 
limits are (8737554, 68753541). The residual standard deviation is 5043 and its 
bootstrap 95% confidence limits are (2925, 8284). 
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Post-acquisition blood volumes 
 
Source of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Mean 
square 
F ratio Permutation 
test 
probability 
Group 1 32377595 32377595 1.77 0.20 
Residual 51 930898210 18252906   
Total 52 963275805    
Table 16 Analysis of variance summary table for post-acquisition blood 
volume. The residual variance is 18252906 and its bootstrap 95% confidence 
limits are (7546503, 64348638). 
The residual standard deviation is 4272 and its bootstrap 95% confidence limits 
are (2746, 7935). 
 
A claim for a difference between the group means is not supported by this 
statistical analysis. 
 
Post- minus pre-acquisition blood volumes 
Table 17 Analysis of variance summary table for post- minus pre-
acquisition blood volume 
Source of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Mean 
square 
F ratio Permutation 
test 
probability 
Group 1 367952 367952 0.01 0.93 
Residual 51 2044871037 40095511   
Total 52 2045238988    
The residual variance is 40095511 and its bootstrap 95% confidence limits are 
(18945199, 91465295). 
The residual standard deviation is 6332 and its bootstrap 95% confidence limits 
are (4351, 9558). 
A claim for a difference between the group means is not supported by this 
statistical analysis. 
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Table 18 Difference between means of post- minus pre-acquisition blood 
volume with bootstrap standard error and 95% confidence limits 
Group difference Difference 
between  
means 
Standard 
error 
95% confidence limits 
Lower Upper 
Resistant – Sensitive – 168 1711 – 3439 3370 
 
The 95% confidence limits enclose zero which confirms that the difference is not 
statistically significant. 
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Appendix IV 
 
 
 
Figure 1. Dendrograms for Acinetobacter baumannii isolates 
Supplied by Dr Jane Turton, (Laboratory of HealthCare Associated Infection, 
Centre for Infections, Health Protection Agency, Colindale, UK). The strains 
used were Southeast Clone AB 11, Southeast Clone AB 12 and Oxa 23 Clone 2. 
See p 258 
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Section 2 (see p248) 
 
A.      B. 
 
 
 
 
C.               D.  
 
 
 
Figure 2. Standard curves for ELISA plates A. LL-37, B. IL-8, C. Il-6 and 
D. IFN-gamma 
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Human reference gene panel for three samples, healing burn , early burn and no burn (Control sample) 
Section 3 (see p 256) 
 318 
 
The average expression stability of the reference genes. It can be seen that PPIA is the most stable for the three samples tested.
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Section 4. Figure 3 A. Raw data for PPIA reference gene for analysis of LL-
37 (see p 265) 
 
Pos$ Name$ Cp$
Concentra
tion$
A4$ ft006$ 24.34$ 5.53E+06$
A5$ ft006$ 23.8$ 6.93E+06$
A6$ ft006$ 24.11$ 6.08E+06$
A7$ ft009$ 31.2$ 3.09E+05$
A8$ ft009$ 30.96$ 3.43E+05$
A9$ ft009$ 31.14$ 3.17E+05$
A10$ b20/03$ 24.02$ 6.33E+06$
A11$ b20/03$ 23.9$ 6.65E+06$
A12$ b20/03$ 23.73$ 7.14E+06$
B4$ ft004$ 32.45$ 1.83E+05$
B5$ ft004$ 32.01$ 2.20E+05$
B6$ ft004$ 32.66$ 1.68E+05$
B7$ b13/05$ 22.21$ 1.35E+07$
B8$ b13/05$ 22.23$ 1.34E+07$
B9$ b13/05$ 22.33$ 1.29E+07$
B10$ b14/02$ 21.03$ 2.22E+07$
B11$ b14/02$ 21.26$ 2.02E+07$
B12$ b14/02$ 21.02$ 2.22E+07$
C4$ b009/03$ 22.08$ 1.43E+07$
C5$ b009/03$ 22.34$ 1.28E+07$
C6$ b009/03$ 22.18$ 1.37E+07$
C7$ ft002$ 29.8$ 5.56E+05$
C8$ ft002$ 30.26$ 4.60E+05$
C9$ ft002$ 30.01$ 5.09E+05$
C10$ b19/01$ 23.74$ 7.12E+06$
C11$ b19/01$ 24.35$ 5.49E+06$
C12$ b19/01$ 24.09$ 6.14E+06$
D4$ b006/05$ 22.56$ 1.17E+07$
D5$ b006/05$ 22.75$ 1.08E+07$
D6$ b006/05$ 22.55$ 1.17E+07$
D7$ b14/03$ 22.72$ 1.09E+07$
D8$ b14/03$ 22.6$ 1.15E+07$
D9$ b14/03$ 22.47$ 1.21E+07$
D10$ b006/01$ 33.45$ 1.20E+05$
D11$ b006/01$ 32.81$ 1.58E+05$
D12$ b006/01$ 33.28$ 1.29E+05$
E4$ Water$ $$ $
E5$ b20/02$ 23.11$ 9.26E+06$
E6$ b20/02$ 22.99$ 9.72E+06$
E7$ b20/02$ 23.05$ 9.50E+06$
E8$ Water$$ $$ $
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E9$ b18/01$ 21.95$ 1.50E+07$
E10$ b18/01$ 22.01$ 1.47E+07$
E11$ b18/01$ 21.95$ 1.51E+07$
E12$ Water$$ $$ $
F4$ b13/04$ 22.78$ 1.06E+07$
F5$ b13/04$ 23.05$ 9.52E+06$
F6$ b13/04$ $$ $
F7$ b005/01$ 23.66$ 7.35E+06$
F8$ b005/01$ 32.82$ 1.57E+05$
F9$ b005/01$ $$ $
F10$ ft010$ 23.88$ 6.71E+06$
F11$ ft010$ 23.81$ 6.89E+06$
F12$ ft010$ 24.01$ 6.35E+06$
G4$ b004/01$ 35.31$ 5.39E+04$
G5$ b004/01$ 35$ 6.27E+04$
G6$ b004/01$ 36.6$ 1.35E+04$
G7$ b002/01$ 27.56$ 1.43E+06$
G8$ b002/01$ 27.31$ 1.59E+06$
G9$ b002/01$ 27.23$ 1.64E+06$
G10$ b001/03$ 31.09$ 3.24E+05$
G11$ b001/03$ 31.07$ 3.27E+05$
G12$ b001/03$ 31.13$ 3.19E+05$
H4$ b006/03$ 23.56$ 7.66E+06$
H5$ b006/03$ 23.9$ 6.64E+06$
H6$ b006/03$ 23.7$ 7.24E+06$
H7$ b002/05$ 26.87$ 1.91E+06$
H8$ b002/05$ 26.64$ 2.10E+06$
H9$ b002/05$ 26.63$ 2.11E+06$
H10$ b14/01$ 22.9$ 1.01E+07$
H11$ b14/01$ 22.83$ 1.04E+07$
H12$ b14/01$ 22.71$ 1.10E+07$
 
 
Figure 3. B. Raw data for PCR analysis of LL-37  
$$
CDNA%
Sample%1%
in3%
dilution%
and%
NegC% %% %%
Pos$ Name$ Cp$ Concentration$
A4$ b19/01$ $$ $$
A5$ b19/01$ $$ $$
A6$ b19/01$ $$ $$
A7$ ft009$ $$ $$
A8$ ft009$ $$ $$
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A9$ ft009$ $$ $$
A10$ ft004$ $$ $$
A11$ ft004$ $$ $$
A12$ ft004$ $$ $$
B4$ ft006$ $$ $$
B5$ ft006$ $$ $$
B6$ ft006$ $$ $$
B7$ b002/05$ $$ $$
B8$ b002/05$ $$ $$
B9$ b002/05$ $$ $$
B10$ b001/03$ $$ $$
B11$ b001/03$ 39.23$ 8.82EG50$
B12$ b001/03$ $$ $$
C4$ b18/01$ $$ $$
C5$ b18/01$ $$ $$
C6$ b18/01$ $$ $$
C7$ b006/01$ $$ $$
C8$ b006/01$ $$ $$
C9$ b006/01$ $$ $$
C10$ b20/02$ $$ $$
C11$ b20/02$ $$ $$
C12$ b20/02$ $$ $$
D4$ ft002$ $$ $$
D5$ ft002$ 40$ 4.85EG57$
D6$ ft002$ $$ $$
D7$ b14/01$ $$ $$
D8$ b14/01$ $$ $$
D9$ b14/01$ 40$ 4.85EG57$
D10$ b13/04$ $$ $$
D11$ b13/04$ 40$ 4.85EG57$
D12$ b13/04$ 40$ 4.85EG57$
E4$ Water$ $$ $$
E5$ ft010$ $$ $$
E6$ ft010$ $$ $$
E7$ ft010$ $$ $$
E8$ Water$ $$ $$
E9$ b14/02$ $$ $$
E10$ b14/02$ 40$ 4.85EG57$
E11$ b14/02$ $$ $$
E12$ Water$ $$ $$
F4$ b002/01$ $$ $$
F5$ b002/01$ $$ $$
F6$ b002/01$ $$ $$
F7$ b13/05$ $$ $$
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F8$ b13/05$ $$ $$
F9$ b13/05$ 40$ 4.85EG57$
F10$ b006/03$ $$ $$
F11$ b006/03$ $$ $$
F12$ b006/03$ 40$ 4.85EG57$
G4$ b005/01$ 40$ 4.85EG57$
G5$ b005/01$ $$ $$
G6$ b005/01$ $$ $$
G7$ b004/01$ $$ $$
G8$ b004/01$ $$ $$
G9$ b004/01$ $$ $$
G10$ b009/03$ $$ $$
G11$ b009/03$ $$ $$
G12$ b009/03$ 40$ 4.85EG57$
H4$ b14/03$ $$ $$
H5$ b14/03$ $$ $$
H6$ b14/03$ $$ $$
H7$ b20/03$ $$ $$
H8$ b20/03$ $$ $$
H9$ b20/03$ $$ $$
H10$ b006/05$ 40$ 4.85EG57$
H11$ b006/05$ $$ $$
H12$ b006/05$ $$ $$
Pos$ Name$ Cp$ Concentration$
A4$ b16/01$ $$ $$
A5$ b16/01$ $$ $$
A6$ b16/01$ $$ $$
A7$ b001/02$ 40$ 6.81EG110$
A8$ b001/02$ $$ $$
A9$ b001/02$ 40$ 6.81EG110$
A10$ b12/02$ $$ $$
A11$ b12/02$ $$ $$
A12$ b12/02$ $$ $$
B4$ ft003$ $$ $$
B5$ ft003$ $$ $$
B6$ ft003$ $$ $$
B7$ b12/02$ $$ $$
B8$ b12/02$ 40$ 6.81EG110$
B9$ b12/02$ $$ $$
B10$ b20/04$ $$ $$
B11$ b20/04$ 22.52$ 1.40E+05$
B12$ b20/04$ 24.38$ 4.51E+04$
C4$ b002/04$ $$ $$
C5$ b002/04$ $$ $$
C6$ b002/04$ $$ $$
 323 
C7$ b006/02$ $$ $$
C8$ b006/02$ $$ $$
C9$ b006/02$ $$ $$
C10$ b13/01$ $$ $$
C11$ b13/01$ $$ $$
C12$ b13/01$ $$ $$
D4$ b11/01$ $$ $$
D5$ b11/01$ 40$ 6.81EG110$
D6$ b11/01$ $$ $$
D7$ b17/02$ 23.47$ 7.84E+04$
D8$ b17/02$ 40$ 6.81EG110$
D9$ b17/02$ 21.24$ 3.04E+05$
D10$ b001/01$ $$ $$
D11$ b001/01$ $$ $$
D12$ b001/01$ $$ $$
E4$ b002/03$ $$ $$
E5$ b002/03$ $$ $$
E6$ b002/03$ $$ $$
E7$ ft008$ $$ $$
E8$ ft008$ 40$ 6.81EG110$
E9$ ft008$ $$ $$
E10$ b17/01$ 40$ 6.81EG110$
E11$ b17/01$ 40$ 6.81EG110$
E12$ b17/01$ 40$ 6.81EG110$
F4$ b20/01$ $$ $$
F5$ b20/01$ $$ $$
F6$ b20/01$ $$ $$
F7$ b11/02$ $$ $$
F8$ b11/02$ $$ $$
F9$ b11/02$ $$ $$
F10$ b21/01$ $$ $$
F11$ b21/01$ 40$ 6.81EG110$
F12$ b21/01$ $$ $$
G4$ ft007$ $$ $$
G5$ ft007$ $$ $$
G6$ ft007$ $$ $$
G7$ b002/02$ $$ $$
G8$ b002/02$ 40$ 6.81EG110$
G9$ b002/02$ $$ $$
G10$ b13/02$ $$ $$
G11$ b13/02$ $$ $$
G12$ b13/02$ $$ $$
H4$ b008/01$ $$ $$
H5$ b008/01$ $$ $$
H6$ b008/01$ $$ $$
H7$ ft001$ $$ $$
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H8$ ft001$ $$ $$
H9$ ft001$ $$ $$
H10$ b009/01$ 40$ 6.81EG110$
H11$ b009/01$ $$ $$
H12$ b009/01$ $$ $$
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Melting peak and standard curve for genes analysed using PCR 
 
PPIA 
 
 
  
Error .00876 
Efficiency 1.924 
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LL-37  
 
 
 
 
 
 
 
 
 
Figure 5. Melting peak and standard curve for genes analysed using PCR 
 
LL-37 
Error 0.0134 
Efficiency 1.839 
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Section 5 (see p271) 
Figure 5. Serum levels of LL-37 and proinflammatory cytokines related to 
age of patient. There is no relationship between age and any of the molecules 
studied. 
 
 
 
 
Figure 5.A. The relationship between serum LL-37 and age. (R2=0.02) 
 
 
 
 
Figure 5.B. The relationship between serum IL-8 and age. (R2=0.03) 
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Figure 5.C. The relationship between serum IL-6 and age. (R2=0.08) 
 
 
Figure 5.D. The relationship between serum LL-37 and age. (R2=0.009) 
 
 
 
 
 
0
100
200
300
400
500
600
700
0 10 20 30 40 50 60 70 80 90
Age of patient
S
e
ru
m
 I
L
-6
 p
g
/
m
l
0
5
10
15
20
25
30
35
0 10 20 30 40 50 60 70 80 90
Age of patients (in years)
S
e
ru
m
 I
F
N
-g
a
m
m
a
 p
g
/
m
l
 328 
Section 6 (see p 270) 
 
Figure 6.A. The relationship between serum LL-37 and TBSA%. (R2=0) 
 
Figure 6.A shows that there was no relationship between the size of the injury 
sustained (as determined by TBSA %) and serum LL-37. 
 
 
Figure 6.B. The relationship between serum IL-8 and TBSA%. (R2=0.34) 
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Figure 6.C. The relationship between serum IL-6 and TBSA%. (R2=0.01) 
 
 
 
 
 
 
Figure 6.D. The relationship between serum IFN-gamma and TBSA%. 
(R2=0.18) 
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